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ABSTRACT 
Protein Purification and eDNA Cloning of suGFl, 
a Sea Urchin Nuclear DNA-Binding Factor 
The upstream regulatory regions of numerous genes contain contiguous deoxyguanosine residues 
(G·C-rich sequences) which have been implicated in the regulation of gene expression, since they 
may involve alterations in their DNA structure, the binding of G-string factors and in some cases even 
the displacement of a nucleosome positioned over this area. A poly( dG).poly( de)-binding protein 
(suGF1) has previously been identified and purified on a small scale from embryonic nuclear extracts 
of the sea urchin Parechinus angulosus (1, 2). suGF1 binds in vitro to the H1-H4 intergenic region of 
the early histone gene battery, and the recognition site contains 11 contiguous Gs which are 
incorporated into a positioned nucleosome core in vitro. suGFI may be a member of a family of G-
string factors which could be involved in the developmental regulation of unrelated genes in various 
orgamsms. 
Prior to the commencement of this project no protein or DNA sequence information was available on 
the protein. The main objective of this thesis was to obtain the eDNA and the primary amino acid 
sequence for suGFI. Using this information, additional aims were to determine the developmental 
distribution of the protein and obtain insight into the molecular basis of the regulatory function of 
suGF 1 by analysis of the primary protein structure and expression of the eDNA. 
A large scale purification system was established to purify suGF1, essentially using affinity 
purification. The purification procedure involved isolating nuclei from 14 hour sea urchin embryos 
and extracting their nuclear proteins. These were fractionated by a combination of a phosphocellulose 
ion exchange step and poly(dG).poly(dC) affinity chromatography, and finally SDS-PAGE. In total, 
the purification yielded about 600 ng of suGFl protein. The 57 kDa protein (about 300 ng) was 
excised from a Coomassie stained gel and treated by enzymatic cleavage to generate peptides, three 
of which were identified by mass spectral analysis. 
v 
The protein isolation and eDNA cloning strategies were developed concurrently. Since the protein 
sequence was only available towards the end of the project, extensive work was performed to obtain 
the eDNA prior to the identification of the protein sequence. 
The suitability of suGFl as a candidate for the DNA-ligand screening approach was established by 
characterising its DNA-binding specificity and affinity. A sea urchin recombinant DNA library 
constructed in lambda ZAP was expressed in bacteria and protein replica filters were screened with 
radiolabeiled recognition site DNA containing multiple copies of the binding site. Several putative 
eDNA clones which recognise the DNA-binding site sequence-specificaiiy were detected after two 
rounds of screening. These clones were further characterised by DNA sequencing and database 
comparisons. Some of the clones have reading frames which do not correspond to any previously 
identified proteins in the database. However, despite extensive attempts to express these putative 
positive clones in various expression systems, including bacterial systems, eukaryotic COS ceiis and 
in vitro expression with rabbit reticulocyte lysate, no protein expression was obtained to enable 
further characterisation of the clones, which were subsequently shown to be false positives. 
During the course of the project, and prior to obtaining the amino acid sequence for suGFl, another 
G·C-binding factor, SpGCFl, was isolated from the sea urchin Strongylocentrotus purpuratus (3). 
Since the DNA-binding characteristics of SpGCFl were very similar to suGFl, we predicted that they 
may be homologous proteins. Degenerate PCR primers were designed to the eDNA sequence of 
SpGCFl to obtain a partial DNA sequence of a homologous protein in P.angulosus using genomic 
DNA as template. The 2.1 kb fuiilength P.angulosus eDNA homologue to SpGCFl was obtained by 
5' and 3' RACE performed on eDNA prepared from total RNA isolated from P.angulosus embryos. 
Finaily, the mass spectral analysis of native suGF1 confirmed that the isolated eDNA codes for 
suGF1 protein isolated from P.angulosus embryos, and that suGF1 and SpGCF1 are indeed 
orthologues. 
Analysis of the primary structure of suGF1 shows that the fuiilength protein has a precise molecular 
weight of 57.2 kDa, whereas SpGCFl has a predicted molecular weight of 54.6 kDa. The difference 
in molecular weights of the two proteins is mostly accounted for by the 27 amino acids difference in 
their primary structure. Overaii the proteins are 94 % similar on the amino acid level, and the highest 
degree of conservation is retained within the respective putative DNA-binding domains. There is no 
overaii homology to any other proteins reported in the databases. The homology on the eDNA level is 
84 % similar over a region of 1989 nucleotides, which includes the entire coding region of 513 amino 
acids as we II as some 5' and 3' untranslated sequence. The sequences of the two cDNAs are most 
VI 
diverse in the untranslated regions. The 5' untranslated sequence of suGFl does not contain any 
characteristic consensus initiation signals, however at least two in frame stop codons precede the first 
methionine in the predicted open reading frame. The 3' untranslated region is very short and has no 
distinguishing features. 
suGFl consists of several characteristic domains. The putative DNA-binding domain is situated 
centrally in the protein and is strongly basic. It is closely associated with potential heptad repeats of 
hydrophobic residues, which are also found in other regions of the protein. These repeats are 
commonly associated with the leucine zipper class of DNA-binding proteins, as well as proteins 
which adopt "coiled-coil" structures. The N-terminus of the protein is characterised by nine tandem 
copies of a pentapeptide repeat (N/SVSMP), which is unique to suGF1 and SpGCF1 and to which no 
function can be assigned yet. Another characteristic of the N-terminus is its high proline content, 
which is associated with the activation domains of various other transcription factors. A third 
prominent feature of the N-terminus is the presence of multiple methionine residues, which may act 
as alternative initiation codons during translation. This is a common feature of genes which have 
TAT A-less promoters, and therefore lack strong initiation consensus sequences. 
The expression of suGF1 from the isolated eDNA using rabbit reticulocyte lysate was shown by SDS-
p AGE to contain several translated products of approximately 57 kDa, 53 kDa, 49 kDa, 42 kDa and 
39 kDa. The multiple protein products are present in a ratio of about 4 : 3 : 1 : 2 : 2, and are consistent 
with multiple translation start sites within the eDNA. Gel shift retardation assays of the in vitro 
translated full length eDNA showed the same characteristic protein doublet obtained with native 
purified protein and nuclear extracts, and was also consistent with multiple protein products being 
formed from several start sites within the eDNA. Gel shifts of the expressed suGF1 proteins from 
truncated cDNAs showed that the DNA binding domain is contained in the region of nt 760 - 1662, 
and that the ability of suGF1 to recognise its cognate DNA-binding site does not require 
homodimerisation. RT-PCR showed that the mRNA transcript for suGF1 is present in eggs, 4 to 45 
hour embryos, as well as adult testes and muscle tissue, however it is absent in ovaries. 
vii 
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Investigations regarding the fundamental processes of development have been approached by the analysis 
of gene control mechanisms, showing that the differential control of gene transcription depends on a 
complex array of interactions within the cis-regulatory regions of the genes. These elements are 
recognised and bound by sequence-specific DNA-binding proteins, which are of central importance to 
transcriptional regulation and the deciphering of structural and regulatory information encoded in 
genomes (4, 5, 6). Transcription factors initiate and control procedures such as transcription, replication 
and site-specific recombination of DNA. The control functions are executed by the occupancy of target 
sites, the interaction of transcription factors with one another and the basal transcription apparatus (7). 
They determine the activity and specificity of enzymatic assemblies on DNA, by either activating or, in 
some cases, repressing the initiation of the general transcription apparatus (8). These DNA-binding 
proteins differ in their DNA-sequence specificities and in the way they themselves are regulated (9). For 
instance, some transcription factors are activated in response to physiological stimulation (eg hormones), 
whilst others are restricted to particular cell types or are expressed at certain stages of development only 
(1 0). Different combinations of these sequence-specific factors at specific target sites function to achieve 
highly complex and unique patterns of gene expression. 
1.1 Gene Regulation Via Transcription Factors Binding to G·C-Rich DNA 
DNA sequences containing characteristic homo(pur).(pyr) stretches, for instance G·C-rich regions found 
upstream of several unrelated eukaryotic genes, have been implicated in gene regulation (11, 12). Several 
investigations have reported that G-binding factors (found in a variety of tissues and organisms) are able 
to associate with these sequences (1, 3, 12, 13, 14, 15, 16). The relation amongst G-binding proteins, their 
· biological significance with respect to gene regulation and the similarities amongst their DNA 
recognition sites need to be established via structural and functional investigations. It has been proposed 
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that G·C-rich DNA sequences, and homo(pur).(pyr) stretches in general, may either function to stabilise 
or hinder factor binding, and they could therefore act as conformational switches which are modulated by 
DNA-binding factors (11, 12, 17, 18). G·C-rich sequences are able to form unusual DNA structures (such 
as triple helices) in vitro. In general homo(pur).(pyr) regions are associated with the formation of unusual 
DNA structures in vitro, depending on the length of the homopurine stretch, the chemical environment 
and the degree of superhelical stress (19, 20). Another characteristic of these sequences is that they are 
often nuclease sensitive in vivo, a feature which is closely associated with promoter and enhancer 
functions, as a result of altered chromatin structure in the vicinity of actively transcribed genes (21 ). 
These hypersensitive domains are thought to result from the disruption or displacement of nucleosomes 
by transcription factors which bind sequence-specifically (22). 
The molecular mechanisms whereby the transcriptional machinery can gain access to DNA is central to 
gene regulation. The DNA of genes is wrapped around histone proteins to form nucleosomes and the 
chromatin fibre. Chromatin structure is dynamic and can be altered during regulatory events (23), as 
elucidated by the inhibitory effects of higher order chromatin structures on transcription, whilst nuclease 
hypersensitive promoter regions (depleted of nucleosomes) are associated with transcriptional activity 
(24). This is exemplified by numerous systems, such as the yeast PH05 gene promoter (25) and the 13-
globin genes (26). Recruitment of the transcriptional machinery may directly result in nucleosome 
remodelling (8). However there is also evidence that numerous genes code for proteins which are 
required for regulation and normal transcription by functioning as activators or repressors. Some of these 
factors can interact directly with nucleosomes to stabilise or destabilise them, thereby effecting their 
function of repression or activation (27). Examples of candidate complexes which appear to mediate 
factor loading on the DNA template include the SWI/SNF genes from Saccharomyces cerevisiae (28, 29) 
and Drosophila melanogaster nucleosome remodelling factor (NURF). 
Multiple transcription factors bring regulatory information to the gene and execute their respective 
biochemical control functions by binding to DNA target sites, ancillary proteins and to the basal 
transcription apparatus (30). The regulation of gene expression is executed via distinct cis-regulatory 
regions (containing several transcription factor target binding sites) which have a modular organisation 
(31 ). Individual modules (each with a specific and individual function) interact with each other, as well as 
the basal promoter, in a variety of combinations to determine diverse spatial, temporal and quantitative 
patterns of gene expression (5). Adaptor proteins or direct interactions of transcription factors may 
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mediate the intercommunication of distant regulatory elements (sometimes separated by several hundred 
base pairs) by causing the intervening DNA to form loops. Direct evidence for DNA looping was first 
obtained by electron microscopy in a bacterial system (32), and since then several observations have 
confirmed these findings. DNA bending is another method which facilitates the communication between 
distant regulatory elements situated at distant sites which can be correlated with stimulation of promoter 
activity (33) and transcriptional initiation (34). 
1.2 Examples of G·C-Rich Promoter Sequences 
G·C-rich sequences have been identified in the regulatory domains of many different genes, in particular 
several housekeeping genes appear to have homo(pur).(pyr) stretches which are Sl nuclease sensitive and 
which are able to bind factors. Commonly, genes which possess multiple G·C-boxes in their 5' flanking 
regions may have multiple transcription initiation sites and lack a TAT A-box (35). 
The c-myc promoter, whose transcriptional activity correlates with a change in chromatin conformation 
(36) and is DNase I hypersensitive during transcription (37), has G·C-rich elements associated with 
promoter activity. These elements are bound by several zinc finger proteins (such as Spl and Zif87) and, 
together with their cognate proteins, function to regulate c-myc expression (38, 39). The type I collagen 
genes are coordinately regulated, and they, too, have been associated with a change in chromatin structure 
during transcriptional activity (40). The promoters of these genes are highly conserved amongst 
mammals ( 41 ), and it has been reported that G·C-rich elements may play an important role in enhancing 
the activities of the mouse, rat and human collagen gene proximal promoters (42, 43, 44). These binding 
sites are targeted by different classes of DNA-binding proteins, some of which are likely to be ubiquitous 
or cell specific transcription factors. Two G-binding factors (IF-1 (see section 1.3) and C-Krox (45)) have 
been identified as binding to the collagen promoter. The ornithine decarboxylase gene (whose activity 
regulates polyamine biosynthesis) is also highly conserved amongst human, rat and mouse (46). It 
contains G·C-rich sequences in the region -345 to -93, which is critical to the gene's expression. This 
region contains five Sp 1 sites, and binds multiple nuclear proteins whose cooperative interactions may 
regulate expression. For instance Sp3 is able to inhibit Sp1-mediated trans-activation of the ·ornithine 
decarboxylase gene (47), and it is thought that the ratio of the two proteins in the cell is critical in the 
regulation of expression. The gastrin EGF response element (gERE) is a G·C-rich element with the target 
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site 5 '-GGGGCGGGGTGGGGGG-3 '. Sp 1 is one of several factors which binds to this region, and it is 
thought to function in the developing and neoplastic stomach ( 48). Further, the human multidrug 
resistance (MDRl) promoter has two G·C-rich boxes in the 5'flanking region (-110 to -103 and -61 to-
43), which both modulate promoter activity but have functionally distinct roles. The -110 G·C-box 
functions as a transcriptional "repressor" binding site, whereas the -50 G·C-box activates the basal 
promoter activity via the binding of Spl (49). Other examples of genes which have G·C-rich elements in 
their promoters include the luteinising hormone receptor (50), and the collagen II gene (51). This 
promoter interacts with various nuclear proteins and contains regulatory elements which include two 
G·C-boxes required for enhancer mediated transcription. A protein-mediated loop structure between the 
promoter and enhancer is implicated in the regulation of transcription of the gene. 
The globin genes (especially the 13-globin genes), have served as one of many model systems used to 
study developmental gene regulation (26). The mammalian and chick globin gene families form clusters 
of a- and 13-like genes on two distinct chromosomal loci. Their sequential expression at distinct stages of 
development is exclusive to erythroid cells. The strict expression pattern is controlled mainly at the 
transcriptional level (26), although there is a complex regulatory interplay between far upstream regions, 
promoters, 3' flanking regions, as well as regulatory regions within the genes themselves, which may be 
mediated by transcription factors (52). 
High level expression is probably controlled by regions far upstream (53), whereas tissue and stage 
specificity is conferred by proximal gene control regions (54). The locus control region (LCR) is a 
dominant control region located far upstream of the globin structural genes (~ 6 - 18 kb) (55) 
characterised by four DNase I hypersensitive sites (HS 1, 2, 3 and 4) (53). It is thought that the 
hypersensitive regions of the LCR interact sequentially with the individual globin genes as a unit or 
'holocomplex' within the locus (56). Other HS activities include strong enhancer properties and a 
chromatin opening function (53). The LCR represents domains of altered chromatin structure, possibly 
due to the disruption or displacement of one or more nucleosomes by transcription factors (22, 57, 58), 
which is reminiscent of actively transcribed genes. The precise arrangement and spacing of the binding 
motifs present in the LCR (53, 59) affect DNA looping, which is mediated by transcription factors 
binding to both DNA elements within each HS site and other proteins at more proximal elements (53). 
DNA looping and protein-induced bending, and therefore proteins which function in the transcriptional 
regulation of globin gene expression during erythroid differentiation, may provide a mechanism whereby 
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multiple cis-elements (which are physically well separated along a stretch of DNA) can cooperate in the 
regulation of a downstream gene (60), possibly by direct interactions with the transcriptional machinery 
(61). Similar to other genes, the globin gene promoters have numerous sequence motifs recognised by 
various transcription factors, examples include the TATA motif, CCAAT, CACCC and GATA-binding 
sites (62). The speculation that these proteins may interact to form higher order protein-DNA structures is 
supported not only by the multiple occurrence of some regulatory sites in close association with each 
other (eg CACCC and GATA-1 sites, or GATA-1 and YY-1 elements (63)) but also by the finding that 
several protein-protein interactions occur amongst the associated transcription factors. For example 
GATA-1 (a zinc finger protein erythroid restricted protein (64, 65)) can self-associate (63, 66) and 
interact synergistically with other transcriptional activators (viz the Kriippel-like zinc finger protein 
EKLF and Spl) to activate transcription (62). Other interactions include TALl I SCL and RBTN2 (67). 
The process of gene switching may rely on the stable interaction between the promoters of individual 
globin genes and specific subdomains of the LCR. These interactions are probably facilitated by protein-
protein associations amongst lineage specific, ubiquitous and I or stage specific factors, possibly resulting 
in and stabilising DNA looping (62). 
Numerous other factors whose precise role in erythroid differentiation is unknown have been identified. 
Examples include Nuclear Factor-Erythroid 2 (NF-E2), a basic-leucine zipper which binds AP-1 like sites 
(52, 68), Nuclear Factor-Erythroid 4 (NF-E4) which functions by binding downstream of the p-globin 
genes (69), and TALliSCL and RBTN2, which are required for normal erythroid development (70, 71, 
72). More widely expressed factors which contribute to erythroid differentiation and development include 
GATA-2 (73) and Yin-Yang-1 (YY-1) (74). Erythroid cells also have several members of Kriippel-like 
factors, eg Spl, YY-1, EKLF and BKLF I TEF-2 (26). The Erythroid Kriippel-like factor (EKLF) is one 
of several proteins which binds the CACCC motif (in general 5 '-CCNCNCCCN-3 '), and is thought to be 
involved in gene switching (75). 
The chick adult P-globin gene promoter has been analysed extensively in an attempt to understand how 
chromatin structure relates to gene transcription. The proximal promoter is characterised by a nuclease 
hypersensitive domain (nt -260 to -60) (76) containing many small DNA elements which bind proteins. In 
particular this domain contains a G·C-rich region of 16 - 18 consecutive G residues (77), which, in 
supercoiled plasmids, is able to form unusual DNA structures (78). No functional role has been assigned 
to this G-string yet, however, it is postulated to have a role in gene regulation and it could function in 
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vivo as a conformational switch to aid 13-globin gene expression, since it is able to bind factors (eg BGP1, 
see section 1.3). The G·C-rich region can undergo DNA conformational changes, and the displacement I 
exclusion of a nucleosome is associated with this region, all of which are features associated with actively 
transcribed genes (11 ). 
1.3 Examples of G·C-Binding Proteins 
A variety of transcription factors have been reported which bind to G·C-boxes, these include both 
positive regulators and negative trans-acting factors. It is likely that various factors which have the same 
or similar sequence specificity can interact with G·C-rich target sites to elicit different functions, 
allowing flexibility in the regulation of transcription. Some examples of G·C-rich binding factors are 
listed below. 
The beta globin protein 1 (BGP1) is a well studied example of a G-binding factor which is thought to be 
involved in globin gene regulation (see section 1.3 and (11)). It is a protein with a characteristic 
molecular weight of 66 kDa, isolated from chicken erythrocytes. The minimum recognition sequence for 
BGP1 is a GTstring (11), and its DNA-binding ability has an absolute requirement for zinc. Specifically, 
the BGP1 binding site lies within the borders of the positioned nucleosome. The tissue-specific 
expression of the chick adult 13-globin gene correlates with the alteration in chromatin structure of the G-
string. While the gene is silent, a nucleosome is positioned over the G-string, however in the actively 
expressed gene the nucleosome is absent and BGP1 binds to the G-string instead (11). More recent 
evidence shows that BGP1 does not function to create a nucleosome-free promoter (69). BGP1 is a tissue 
and developmental stage specific factor which has been implicated in gene switching, however there is no 
evidence for its biological role. 
Analysis of the various cis-acting elements in the mouse a1(I) collagen gene promoter indicates that 
several factors may be involved in the coordinate regulation of these genes (79). In particular, it was 
shown that two transcriptional repressors, inhibitory factors 1 and 2 (IF-1 and IF-2), specifically bind to 
segments which have strong promoter activity. The factor IF-1 binds to a G7-string (similar to an Sp1 
target site) in the a1(I) and a2(I) collagen gene promoters, and is implied in mediating the developmental 
regulation of the respective genes (14). 
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The human late histone H4 gene-specific transcription factor, H4TF-1, is a DNA-binding protein thought 
to be involved in the promoter regulation of the histone gene H4 (80). Two H4 specific transcription 
factors, viz H4TF-1 and H4TF-2, were co-purified using ion exchange and affinity chromatography. 
H4TF-1 potentiates the expression of the target gene by interacting with G·C-rich sequences which are 
required for the maximal expression of the H4 gene (80). 
The BTE-binding proteins (BTEB and BTEB-2) have three repeated zinc finger motifs which are similar 
to Sp1 (81). BTEB is a ubiquitous protein, whereas BTEB-2 is found predominantly in the placenta and 
testis. (The latter was cloned from human placenta using the BTEB eDNA as a probe.) BTEB stimulates 
promoters with repeated G·C-box sequences, and BTEB-2, too, is a G·C-rich DNA-binding protein (81). 
The binding specificity of both proteins is identical to the Sp1 protein (see section 1.3.1). Indeed, the 
three amino acids within the classical zinc finger structure considered important for DNA sequence 
recognition are invariant in BTEB-2, BTEB and Spl. However, immunological supershift experiments 
can distinguish between the binding of the BTE-binding proteins and Sp1, since (apart from their DNA-
binding zinc finger domains, which exhibit a 72 % between Sp1 and BTEB and a 59 % similarity 
between Sp 1 and BTEB-2) these proteins have little or no similarity. 
BTEB-2 has been relatively well characterised. It is a 219 amino acid protein, containing three domains 
specific to transcriptional regulators. The DNA binding domain consists of three zinc finger domains at 
the protein's C-terminus (these are 59% similar to the Sp1 zinc finger domain (81)). BTEB-2 also has a 
basic region which partially identifies with the basic domain of proteins characterised by the helix-loop-
helix and leucine zipper motifs. This protein has a proline-rich region (16 out of 67 residues) between 
amino acids 44 - 110, which is very likely to constitute a transcriptional activation domain, as in other 
proline-rich DNA-binding proteins (82). Transient expression studies indicated that BTEB-2 is able to 
activate the expression of CAT (chloramphenicol acetyl-transferase) on G·C-box containing reporter 
plasmids, ie BTEB-2 is implied as a transcriptional activator (81 ). 
G·C-binding Factor (GCF) is a 91 kDa protein isolated from A431 cells (83). It has a characteristic basic 
region at its N-terminus which functions as the DNA-binding domain. The protein recognises G·C-rich 
sequences. (The binding site is 5'-GCGGGGC-3', which can also be recognised by Spl and ETF.) 
Cotransfection experiments imply that GCF acts as a sequence-specific repressor. It may function either 
by competing with various activators for DNA-binding sites, or alternatively, it may interact with other 
7 
proteins to achieve repression. This protein has an ~cidic C-terminus which is required for its full activity 
(83). It is also characterised by two leucine zipper motifs which are proposed to facilitate dimerisation 
and are common to DNA-binding proteins such as C/EBP, Myc, Fos, GCN4 and Jun (84). 
The trans-acting epidermal transcription factor (ETF) of 120 kDa binds to G·C-rich regions and has been 
found to specifically stimulate the transcription of the epidermal growth factor receptor (EGFR) gene 
(35). The promoter for this gene characteristically lacks a TATA-box and CCAAT box, yet it is highly 
G·C-rich. ETF (together with Spl) stimulates its transcription. The ETF protein is implied as a specific 
transcription factor for several promoters which do not contain TATA elements, since it appears that the 
presence of a TAT A element interferes with the functions of ETF (35). It recognises various G·C-rich 
sequences (including stretches of poly(dG).poly(dC)) with similar affinities. The core binding sequence 
of 5'-CCCC-3' was deduced from various binding sites. Otherwise it has a very loose sequence 
requirement, ie no rigorous consensus sequence has been derived for its binding. 
1.3.1 A Subfamily of Zinc Finger Proteins with G·C-Rich Binding Sites 
The Cys2/His2 class of zinc finger DNA-binding proteins is characterised by the particular sequence of 
amino acids which forms structural domain(s) that bind a zinc (II) ion. This domain has a J3--hairpin 
followed by an helix (85) and constitutes an important eukaryotic DNA-binding domain, usually 
characterised by tandem repeats of a conserved motif of 20 - 30 amino acids. The variation of the amino 
acid sequence within each zinc finger domain contributes individually to the DNA-binding affinity and 
specificity of the protein as a whole (ie the fingers appear to be modular in nature), which is one of the 
factors determining DNA-binding preferences and degeneracy of binding within target sites (86). The 
best understood members of this class of proteins belong to a subset of DNA-binding proteins which bind 
to relatively G·C-rich target DNA sequences, examples include Sp 1 (87), members of the Wilm tumour 
family (eg Zif268 or NGFI-A, Krox-20,24 and Efr21,2) and yeast ADRl (88). ADRl and Zif268 are two 
of the best studied members of this protein subfamily, and they have revealed much that is known about 
the zinc finger-DNA interaction. The ADRl protein has a DNA-binding domain which is characterised 
by two zinc fingers, and generally the protein binds DNA target sites as a dimer (89). The target sites 
have approximate dyad symmetry and the consensus binding site appears to be 5 '-TTGGAG-3 '. The 
three zinc finger domains of Zif268 (also called NGFI-A or egrl) preferably bind to a consensus 
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sequence 5 '-GCGGGGGCG-3 '. The Zif268 protein was bound to cognate oligonucleotides and, using a 
combination of altered amino acid sequences, as well as variations within the DNA target sequences, has 
provided much structural information regarding zinc finger protein-DNA interactions (90). For instance, 
it was determined that three particular amino acid positions within each zinc finger are the main 
contributors in determining the DNA site preference of the protein. This accounts for the DNA-binding 
site degeneracy of a single protein and the many aspects of variations in the known binding sites ofthe 
members of this class of DNA-binding proteins in general. 
The zmc finger DNA-binding protein Spl (stimulatory protein 1) is one of the first mammalian 
transcription factors that was characterised (87). It is a ubiquitous protein of about 100 kDa, which is 
abundant in most cell lines, but it varies substantially in different tissues during development (91). The 
protein binds G·C-rich target sites and related motifs (92) present in many cellular and viral promoters. 
The DNA-binding domain of this protein is characterised by three zinc fingers (87), and it binds in the 
major groove of the DNA target site (93). The G·C-rich target sites for Spl are variations of the 
sequences 5 '-GGGCGG-3' and 5 '-GGGGCGGG-3 '. Sp 1 binding sites often appear in promoter regions 
in clusters, allowing the Sp 1 protein to act synergistically through adjacent binding sites (94), ie enhanced 
promoter trans-activation results from the mediation of at least two binding sites (95). Sp 1 not only 
interacts with itself to form multimeric complexes (95), it has also been implicated in the interaction with 
other transcription factors, such as NF-KB (96), GATA-1 (the major erythroid transcription factor (62)), 
as well as select components of the basal transcription apparatus (98). It is therefore able to interact and 
cooperate with other proteins to direct expression. The promoters and enhancers of numerous genes 
contain multiple binding sites for the same or for several different sequence-specific proteins (located 
within several hundred base pairs of each other), allowing additive and even synergistic activation of 
transcription, as exhibited by distal and proximal Sp 1 sites (99). The ability of Sp 1 to self-associate ( 1 00) 
suggests a mechanism whereby distant DNA segments are joined by looping of the intervening DNA as a 
result of stabilising protein-protein interactions. These interactions amongst proteins from multiple 
binding sites confer transcriptional responsiveness. 
The Sp 1 protein is involved in both constitutive transcription and the regulation of several inducible 
genes (49, 101). It is an activator protein, whose transactivation function lies in the glutamine-rich N-
terminus, containing the A and B domains (102, 103). The two other domains (C, which is weakly basic, 
and D) are adjacent to the zinc finger region. They also influence the protein's transcriptional activation 
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function (103). In particular, it has been found that domain D plays a key role in the synergistic action of 
Sp1 mediation (95). 
As indicated above, many promoters contain elements which are capable of binding Sp1 in addition to 
other transcription factors. Sp 1 levels ate abundant in the cell, and the protein coordinately regulates 
many different genes, therefore the access of Sp 1 to the promoter must be regulated in order to ensure 
some specificity of control. Several mechanisms may be involved in these regulatory mechanisms, 
including phosphorylation or glycosylation (1 04, 1 05), regulation of the affinity of Sp 1 for DNA (1 06), 
alteration of its trans-activation potential (1 07), regulation of its nuclear levels (1 08) and regulation of its 
concentration relative to other transcription factors (93). 
More recently it was discovered that the DNA-target sites bound by Sp1 are bound with equal affinity by 
two human proteins, Sp3 and Sp4 (1 09). Sp4 is expressed in certain cells within the brain, and may have 
a role in the expression of certain genes within these cells, however the natural target genes of Sp4 in vivo 
have not been identified yet. Together, Sp 1, Sp3 and Sp4 represent a family of G·C-box binding proteins 
which have very similar structural features (110). They have very conserved zinc finger DNA-binding 
domains, which are close to the C-terminus. Their N-termini are characterised by stretches of glutamine-
and serine- I threonine-rich amino acids. The striking structural homology between Sp 1, Sp3 and Sp4 
does not reflect functional equivalence, though (11 0). Sp3 is a transcriptional inhibitor (11 0, 111) or an 
activator (112, 113), therefore the role of SP3 may be context- or cell-dependent. Studies on the 
transcriptional properties of Sp4 have revealed that it is an activator protein like Sp 1, but it does not act 
synergystically through adjacent binding sites (108) since it lacks the functionally active domain for this 
property. Sp4 exhibits various other unique properties with respect to Sp1, for instance it may be a target 
for Sp1 activation (110). 
The nerve growth factor-induced early response gene encodes a Cys2/His2 zinc finger protein of 50 kDa 
called NGFI-C (114), whose induction is very rapid but transient, as shown by induction of PC12 cells 
using NGF (Nerve Growth Factor). NGFI-C is a G-binding protein containing three zinc fingers, and 
characteristically binds to the site 5'-GCGGGGGCG-3' from which it is able to strongly activate 
transcription as shown by CAT reporter constructs (114). Three other proteins bind to the same target site 
(viz NGFI-A, Krox-20 and the Wilm's tumour gene product), and have considerable homology to NGFI-
C in the DNA-binding domain only. Similarly Sp1 also has a high homology over this region. Another 
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characteristic feature of NGFI-C is its unusually high proline composition (25 %) over 77 amino acids, 
which is reminiscent of a transcriptional activation domain as found in several other transcription_ factors, 
such as AP-2, Oct-2 and c-Jun (114), and hence this region may have an analogous function_ 
1.4 Sea Urchins: Model Systems Used to Study Developmental Regulation 
1.4.1 Regulatory Genes and Trmrs-ReguJatory Factors in Sea Urchin Embryogenesis · 
Sea urchin embryos share some basic characteristics with a wide variety of invertebrates (115, 116). They 
belong to the _echinoderms, which, of all the invertebrates, are considered to be most closely related to 
chordates and hence to vertebrates (117). The ready availability, structural simplicity and rapid 
development of sea urchin embryos have made them a model system for investigations regarding the 
mol<!cular mechanisms underlying differentiation, region specification, transcriptional regulation and 
morphogenesis by focusing on transcriptional regulators ( 118). Several sea urchin embryo trans-
regulatory factors (which may have a broader role within developmental control) have been identified as 
a result of characterising spatially and temporally controlled structural genes involved in development. 
1.4.2 Spatial Regulatory Systems in Sea Urchin Embryos 
Examples of putative regulatory elements controlling the timing and localisation of gene expression in 
sea urchins (reviewed by Maxson and Tan (1994) (118)) may restrict the expression of certain genes to 
the aboral ectoderm, the skeletogenic mesenchyme, as well as the vegetal plate (and its derivatives). 
Various regulatory factors which bind these elements have been identified. Some have been isolated and 
their cDNAs obtained. 
The Cyiiia actin gene is an example of an aboral ectoderm specific gene l,Vhose expression is spatially, 
temporally and quantitatively controlled in the embryo (119). It is activated during late cleavage stage 
and serves as a marker for aboral ectoderm specification. The cis~regulatory domain (divided into the 
proximal, middle and distal modules, which function separately but are quantitatively interdependent on 
each other) spans more than 2.3 kb and binds a minimum of nine transcription factors at more than 
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twenty randomly distributed sites (31 ). The proximal module activates early gene expression, while the 
middle module controls late spatial expression. The distal cluster contains a high occurrence of SpGCFl 
sites (these have G·C-rich sequences), which are thought to mediate a positive function (3). The Cyiiia 
target sites have been used to isolate several nuclear DNA-binding proteins, and the functional 
significance of most of the interactions (except that of the SpGCF1 protein, see section 1.4.4.2) are 
known. Examples of proteins which interact in this region include SpGCF1 (see section 1.4.4.2), SpP3A2 
(which has a basic helix-loop-helix DNA-binding domain (120)), and SpP3A1 (120), which is a zinc 
finger protein that binds to specific P3A sites. These sites probably have a negative spatial regulatory 
function throughout the regulatory domain (119), confining expression of Cyiiia to the aboral ectoderm 
( 121 ). They are also contained in the promoters of oth,er genes which have different expression patterns to 
Cyiiia actin, eg skeletogenic SM50 and L1 H2B histone genes (122). The P1 protein which binds to the 
Cyiiiaactin gene promoter is uncharacterised as yet, however the P1 target site is required for normal 
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functioning. SpRunt1 is another factor which provides a major positive input, whereas negatively acting 
factors SpP7II (which binds to the negative spatial regulator P7II (123)), and SpZ12-1 confine expression 
to the aboral ectoderm from gastrulation onwards (31 ). 
Another example of a gene whose expression is limited to the aboral ectoderm includes Spec2a (124). 
The promoter. elements which specify the temporal and spatial regulation of this gene include an 
upstream region and three orthodenticle (Otx) sites (the consensus binding site is TAATCC) which bind a 
group of homeoproteins (SpOtx) from sea urchin and which have counterparts in Drosophila and mouse. 
SpOtx may function in the activation of the Spec2a gene in the aboral ectoderm (124). 
The Endo 16 gene codes for a cell surface glycoprotein whose function is unknown, and its expression is 
restricted to the vegetal plate of the blastula stage embryo, continues throughout the archenteron (to 
which the vegetal plate gives rise) in gastrulation (125), and transcription is eventually shut down in all 
other regions except the midgut where it is increased. A 2.2 kb fragment upstream of the start site 
determined correct reporter gene expression (125) and the specific sites of protein-DNA interaction 
within the cis-regulatory domain have been mapped in order to elucidate which ones are necessary or 
sufficient for normal expression. The output of each module is not well defined yet, but it appears that the 
positive regulatory functions of the proximal and distal modules are curbed by negative interactions 
preventing incorrect expression in the adjacent skeletogenic and ectodermal territories (126). Studies 
show that a minimum of 13 factors (whose identities and functions have mostly not been determined yet) 
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bind to 30 discontinuously distributed target sites, including many SpGCF1 sites (31). Most of the 
modules also include SpGCF1 sites which could function in intermodule communication (see section 
1.4.4.2). 
The muscle cell lineage in sea urchin development may be regulated by SUM-1, a member of the Myo-D 
family of basic helix-loop-helix transcription factors (127). The temporal expression pattern of this factor 
coincides with the ability of a subset of secondary mesenchyme cells of the vegetal plate to differentiate 
into muscle cells during gastrulation (128). It is considered as one· of several influences which lead to the 
commitment of secondary mesenchyme cells into muscle cells, since it is able to bind and trans-activate 
muscle specific enhancer elements in sea urchin embryos, as shown by microinjection experiments. 
1.4.3 Temporally Regulated Sea Urchin Histone Genes 
The early sea urchin histone genes are tandemly repeated in the genome, ie there are multiple copies of a 
gene battery, each of which codes for one H1, H2A, H2B, H3 and H4 gene. During early embryogenesis 
the early histone genes are coordinately expressed in a distinct temporal pattern. However, after 
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blastulation, sea urchins express the late histones and the early genes are switched off, never to be 
expressed again. The expressed genes have nuclease hypersensitive intergenic spacers, whereas the 
shutdown of the genes correlates with the presence of a well defined nucleosome pattern. The control 
mechanisms governing this gene switch have not been elucidated yet. Several cis-elements have been 
defined for both the early {a.) and late ([3) histone genes {129). The early histone genes are expressed at 
very high levels from oogenesis through to blastula stage embryos, partially as a _result of positive 
regulatory elements, many of which have been identified in the promoters of (a.) H 1, H2A, H2B, H3 and 
H4 genes (130, 131, 132, 133, 134). Negative elements in the promoters of the H3 and H4 genes cause 
inactivation of expression of the early genes in late-stage embryos (135, 136) after the initiation of late 
histone gene expression which is characteristic of blastula to adult stages. 
Nuclear proteins which bind to these DNA regulatory s'equences have been implicated in the 
developmental regulation of the sea urchin histone genes. For instance, SpOct (a POU ll ciass gene (137)) 
is the major octamer binding protein in early sea tirchin embryos, and is able to bind the octamer site of 
the a.H2B gene which is essential for the correct timing of expression. Additional evidence implying that 
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this transcription factor may be a key regulator in the temporal control is suggested by the correlating 
temporal expression patterns for both SpOct and the aH2B gene. Several elements responsible for 
activating gene expression and candidate regulatory proteins have also been identified for the sea urchin 
late (13) histone genes (138, 139, 140, 141, 142). SSAP (stage specific activator protein) belongs to the 
class of RNA-binding proteins (118) and is a very strong candidate for the specific stimulation of 
transcription of the 13H1 gene in blastula stage embryos, since it is able to bind the 13H1 temporal 
enhancer, which is a stage specific enhancer (139). The L1 H2B gene is trans-activated by a 
homeodomain protein of the Abdominal B class which binds a 3' enhancer element (142), and may be 
encoded by a eDNA (Hbox4) which is similar to Hox-C9 (143). It may therefore also function in pattern 
formation, as do other homeobox gene products. The developmental profile for the Hbox4 mRNA closely 
resembles that of L1 H2B, reinforcing the association between them. The H2A-2 and H2B-2 histone 
genes have degenerate sets of elements in their promoters to which a putative temporal regulatory protein 
TSAP (tissue specific activator protein) binds (141). This protein has not been characterised further, 
however another protein, designated BSAP (B-cell specific activator protein) with identical DNA-binding 
specificity has been identified, which may function in B-cell specific gene expression and B-cell 
differentiation (144). The protein suGF1 (see section 1.4.4.1) binds a G·C-rich region in the H1-H4 
spacer in vitro, which can also be occupied by a nucleosome (145) and therefore may play a role in 
modulating the stability of the nucleosome, as well as in the regulation of the early histone genes. 
1.4.4 Examples of G-Binding Proteins in Sea Urchins 
1.4.4.1 suGFl: a Nuclear Sea Urchin DNA-Binding Factor 
Sea urchin G-binding factor 1 (suGF1) is a 59.5 kDa sea urchin DNA-binding protein which has been 
identified in 14 hour sea urchin (Parechinus angulosus) embryos (145). This factor is present in the early 
embryonic developmental stages. It has high binding affinity and specificity for G·C-rich DNA sequences 
and it binds to both poly(dG).poly(dC) and oligo(dG).oligo(dC) containing sequences by reproducibly 
forming two characteristic bands in electrophoretic mobility gel shift assays (1). The consensus 
recognition sequence was established as 5'-GGGNGGG-3' or 5'-GGGGGGC-3' (1), however it is possible 
that there is further degeneracy within the binding site. Both bands formed by electrophoretic mobility 
gel shift assays contain the suGF1 protein, however it has not been established whether the two bands 
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arise as a result of posttranscriptional modification or truncation of the protein. The formation of these 
bands is strongly dependent on ionic strength (optimal DNA-binding occurs at 175 mM KCl) and the 
binding is also dependent on divalent cations, since dialysis of suGF1 with EDTA partially abolishes 
DNA-binding (1). This originally suggested that suGF1 may belong to the zinc fmger class of DNA-
binding proteins. The divalent cations appear to be very· tightly complexed with the factor, as the 
purification buffers do not need to be supplemented with divalent ions such as Zn2+. suGF1 is able to 
. form sequence-specific multimers via suGF1-suGF1 interactions (145), and it is possible that the protein 
could be involved in looping DNA, thereby bringing distant regulatory regions into close proximity. 
1.4.4.1.1 suGFl Interacts with the Hl-H4 Intergenic Region 
The H1-H4 intergenic region of the early histone gene battery contains a run of 11 Gs, and provides a 
binding site for suGF1 in vitro. The interaction of suGFl with this region has been extensively studied 
and characterised (1, 2, 145). The sea urchin early histone gene battery is developmentally regulated and 
the genes are coordinately expressed in a distinct temporal pattern. Expression of the histone genes is 
associated with intergenic regions which are nuclease hypersensitive, whereas the shutdown of gene 
expression correlates with well-defined spaced nucleosomes (146). Thus alterations in chromatin 
structure of the early histone gene battery correlate with the temporal expression pattern of the early 
histone genes. Specifically, it has been established that there is a nucleosome positioned over the Hl-H4 
fragment in vitro, and the G11-string lies close to the dyad of the positioned nucleosome core. The 
nucleosome positioning signal lies over the sequence (GA) 16(G) 11 which, in vitro, has the ability to form 
an unusual DNA structure (triple helix), under conditions of negative superhelical stress and low pH (20, 
147). 
Using a combination of footprinting and methylation interference studies a model for the binding 
interaction ofsuGFl with the G11-string in the Hl-H4 intergenic fragment has been developed (1). It was 
shown that suGFl approaches the double helix mainly from one side, and is closely associated with the 
DNA over about 1.5 helical turns. A bulky structure of the protein protrudes into the major groove and 
contacts the central Gs located in this region, as well as the phosphate backbone bordering on the run of 
Gs (1). Both the free and the bound DNA are curved, which can be deduced from the periodic narrowing 
of the minor groove on one side of the DNA helix, and the periodic widening of the major groove on the 
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opposite side, as elucidated by hydroxyradical footprinting. The binding of suGF1 to the DNA is 
consistent with the direction of curvature of the free DNA when wrapped around a nucleosome core, and 
suGF 1 binding stabilises the curvature of the DNA fragment, implying that the protein' could play a role 
in the alteration of chromatin structure of the Hl-H4 intergenic fragment (145). It appears that suGF1 has 
a single preferential frame of binding to the intergenic fragment (2). The latter is able to form several 
distinct nucleosome core species which have different translational settings but very similar rotational 
placing, in that the octamer surface is positioned away from the suGF1 binding site. Despite the fact that 
the rotational setting of the nucleosome core maximally exposes the suGF1 binding site, the binding of 
suGF1 and a nucleosome core are mutually exclusive in most nucleosome species, due to steric 
hindrances (2). The more internal the recognition site is within the core DNA, the more the histone 
proteins ofthe positioned nucleosome sterically clash with the binding ofsuGF1 to its recognition site. It 
is therefore possible that the DNA binding site has to be exposed to the suGF1 protein in a regulated 
fashion, unless the transcription factor gains access to the DNA shortly after replication (2). 
1.4.4.1.2 suGFl Is Implicated In Gene Regulation 
There has been no direct evidence for a biological role for suGFl yet. However there is strong indirect 
evidence for its role as a transcriptional regulatory protein. It is possible that the protein may be involved 
in gene regulation of the sea urchin histone gene battery via alterations in chromatin structure within the 
pur.pyr region (145). suGF1 binds sequence-specifically and with high affinity to oligo(dG).oligo(dC) 
regions. The G6-string in the LpS1f3 gene promoter also provides a recognition site for suGFl. This G·C-
rich sequence is known to be a cis positive regulatory element, mutations within the G-string abolish 
transcriptional activity in functional assays (16). suGF1 interacts with the G6-string by forming the same 
characteristic bands as it does with the Gil sequence in the H1-H4 intergenic fragment. These complexes 
are very similar to the ones formed by the ectoderm G-string factor (16) when interacting with the same 
probe. Not only do these proteins have indistinguishable target site specificities, they also bind the probe 
under the same optimum ionic strength. The similarities observed between these proteins strongly suggest 
a structural or functional relationship between them. 
The chicken p globin gene promoter and the H1-H4 intergenic fragment also have several properties in 
common. For instance, the globin gene promoter contains a G-string (16- 18 Gs) which lies on the border 
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of a positioned nucleosome and the factor BGP1 (see section 1.3) binds in this region. Even though it is 
possible that there are several frames in which BGP1 binds to its recognition site in the 13-g1obin gene 
promoter, methylation interference studies established that the main interaction occurs with the central 7 
Gs. The binding of factors to the G-string appears to correlate with a conformational change in the DNA 
and the disappearance of the nucleosome (11 ), all of which are closely associated with the expression of 
the 13-globin genes. Similarly, the H1-H4 fragment contains a Gwstring, which lies within the positioned 
nucleosome and close to the dyad of symmetry, and the main interaction of suGF1 is with the centrally 
located Gs within the recognition site. The state of expression of the early histone genes is also correlated 
with a change in chromatin structure. suGFl is able to bind the G11 -string in the H1-H4 intergenic region 
and the 13-globin G-string with equal affinity. Indeed, suGF1and BGP1 produce identical footprints on the 
13-globin gene promoter. Hence it appears that the biochemical and DNA binding properties of the two 
factors are very similar, and it is possible that suGF1 and BGP1 are structurally or functionally related, 
despite the fact that there are several differences between them (such as distribution, size and requirement 
of zinc for DNA-binding). 
The implication of suGF1 as a transcription factor raises several issues. For instance it could be proposed 
that suGF1 may be a member of a family of G-string factors involved in developmental regulation of 
several unrelated genes in various organisms, possibly by functioning in the alteration of chromatin 
structure. It is possible that suGF1 may have a similar role in gene regulation as BGP1 (11), or it could be 
the Parechinus angu/osus homologue of one of several other sea urchin G-binding proteins, such as the 
ectoderm specific G-string factor (16), or SpGCF1 (3), since there is evidence that several unrelated sea 
urchin genes share upstream G·C-rich regions which may be involved in their regulation (16). 
1.4.4.2 Other G-Binding Proteins in Sea Urchin Embryos 
The Lps 113 gene is a sea urchin cell lineage specific gene (16). The gene promoter contains a G6-string, 
which is a positive cis-regulatory element. Functional assays have shown that mutations within the G·C-
rich sequence abolish cis activity (16) and therefore this region is postulated to be important in sea urchin 
development. The Lps 113 cis-regulatory domain is bound by different nuclear proteins, one of which is a 
G-string binding factor. This G-binding protein is an ectoderm specific factor present in the nuclear 
extracts of gastrula and blastula stage embryos (16), ie it is differentially localised in the embryo. EMSAs 
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performed with this protein and the G·C-rich promoter exhibit a characteristic slow mobility doublet. It 
has been suggested that the ectoderm specific factor may be similar to the mammalian IF-1 (see section 
1.3) factor which binds the a1 and a2 collagen gene promoters (14), or it could be a homologue ofsuGF1 
(see section 1.4.4.1 ). 
Another example of G·C-rich target sites in sea urchin genes which bind nuclear proteins is a C4 core 
element (referred to as either a "P8", "P2" or "SpGCF1" site) which has been identified to occur 
severalfold throughout the entire gene regulatory regions of both the Endo16 gene and the Cyiiia 
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cytoskeletal actin gene. These target sites occur on genes which are expressed in different embryonic 
territories (3). Most of what is known about the SpGCF1 protein derives from the Cyiiia actin gene, 
which contains clusters of SpGCF 1 sites in the distal regulatory domain in a variety of patterns, and often 
in close proximity to other DNA-binding sites (3). The biological function of the SpGCF1 sites has not 
been determined yet, however experiments using transgene chloramphenicol acetyl transferase (CAT) 
constructs and in vivo competition with excess target sites indicate that SpGCF1 sites have a positive 
transcriptional activating function (119, 148). The SpGCF1 sites are bound specifically by five proteins 
present in blastula-stage nuclear extracts isolated from Strongylocentrotus purpuratus as shown by 
EMSAs (3, 121). The protein which gives rise to the slowest migrating complex in the assay has been 
identified as a 55 kDa factor (SpGCF1), and from quantitative simulation studies it is predicted that the 
protein binds DNA as a dimer (149). 
Distinct transcription factors bind to several regulatory sites in both the Cyiiia and Endo16 gene 
promoters, and some are able to bind at multiple sites, for instance SpGCF 1, whose binding sites .occur in 
clusters and often lie close to binding sites for other transcription factors (3). The regulatory domain of 
the Cyiiia gene is divided into three distinct regions with separate functions, all of which are required for 
normal embryonic expression of the Cyiiia genes (123, 119). The proximal region regulates the spatial 
expression of the gene, whereas the distal region controls the level of expression, and the middle region 
controls spatial and temporal expression, but only in conjunction with portions of the proximal module 
(31 ). This implies that gene expression may be influenced by intercommunication between the regulatory 
sites, for instance via the interaction of positive and negative regulatory transcription factors which bind 
to target sites contained on the proximal and middle modules (31 ). EMS As and electron microscopy 
indicate that SpGCF1 molecules (which have target binding sites throughout the regulatory domain) may 
associate with each other to form multimers (149). If this reflects the in vivo situation, the DNA-bound 
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protein molecules could associate with each other, promoting the formation of loops in the intervening 
DNA (3). Thus SpGCF1 could function in bringing distant regulatory domains into close proximity, 
allowing stable functional complexes constituted of distal transcription factors and regulatory elements to 
form and intercommunicate, thereby increasing productive interactions and stimulating gene expression 
(31). SpGCF1 may be involved in developmental regulation of several urirelated genes, which could 
account for its prevalence in sea urchin embryos and for the positive function of the SpGCF1 target sites. 
1.5 Purification and Identification of Transcription Factors 
Characterisation and identification of a newly isolated protein is often reinforced by analysis of its 
primary structure, which aids in the cloning of the corresponding gene or eDNA (see section 1.6). It is 
estimated that DNA-binding proteins and transcription factors constitute about 0.001 % of total cellular 
protein (92). Calzone et al (1988) (150) estimate that the minimum prevalence of factors binding to the 5' 
CyiiiA cytoskeletal gene in the late cleavage-stage sea urchin embryo are as few as several hundred to 
thousand molecules per nucleus. Therefore the rarity of these transcription factors makes their 
purification to homogeneity a time-consuming and relatively difficult task, requiring enormous amounts 
- of starting material and highly selective purification strategies of high yield. Several sensitive techniques 
have been developed whereby sequence-specific DNA-binding proteins can be detected, characterised or 
monitored during their biochemical fractionation ( eg nitrocellulose filter binding, DNase 1 footprinting, 
and EMSAs (151)). The mobility gel shift assay is the most common technique used to detect the 
interaction of sequence-specific proteins with small amounts of a particular DNA fragment in solution 
(152). Tightly bound protein-nucleic acid complexes are stable during electrophoresis under non-
denaturing conditions, and even weak complexes can often be resolved because they are stabilised by the 
"cage effect" created by the gel matrix, ie the diffusion of the protein away from the DNA is hindered by 
the matrix, which in tum favours reassociation (153). The binding takes place in solution in the presence 
of nonspecific competitor DNA, and once subjected to electrophoresis through polyacrylamide, the 
mobility of the protein-DNA complex is retarded with respect to the unbound DNA. As the two 
populations of DNA (free and protein-bound) enter the gel matrix, they are separated physically, and the 
bound protein can no longer affect the mobility of the free DNA (154). This results in the formation of 
discrete bands by individual protein-DNA complexes which have lower mobility than the free DNA 
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fragment. The difference in mobility of the discrete populations of bands Is usually analysed by 
autoradiography of radiolabelled DNA (151 ). 
The development of sequence-specific DNA-affinity chromatography (92) has greatly facilitated the 
purification of low abundance transcription factors in general. This method was originally developed 
using nonspecific DNA attached to cellulose or agarose supports (155). However several variations 
(different combinations of specific or nonspecific DNA sequences linked to several types of resins) have 
been described and used successfully to isolate a variety of transcription factors, including Sp1, AP-1, 
AP-2, NF-KB, Pit-1 and CBP-1 (155). Several types of solid support resins can be used, eg cellulose 
(156) or agarose (92), and DNA can be linked to them using a variety of interactions, such as CNBr, 
biotin-avidin and streptavidin (155, 157). Commonly DNA affinity chromatography involves preparation 
of an agarose resin activated by cyanogen bromide, and subsequently the DNA (containing the relevant 
protein binding site) is covalently linked to the solid support (155). The linked DNA is generally one of 
two types. Either it is a plasmid containing multiple protein binding sites (156) or it constitutes a 
catenated, synthetic, double stranded oligonucleotide representing the high affinity protein binding site. 
Oligonucleotides are generally prepared for coupling to the resin by annealing complementary strands, 5' 
phosphorylation, and ligation of the oligonucleotides to form oligomers (158, 155, 159). 
A crude protein sample which is to be purified using DNA affinity chromatography needs to be nuclease-
free, therefore the purification of transcription factors is generally approached by partial purification of a 
crude protein extract using conventional chromatography. This enables the removal of nucleases and 
other contaminants in the sample (92). Usually the protein sample is pretreated with a nonspecific 
competitor DNA to which the protein of interest has very low affinity, and finally the mixture is applied 
to the affinity column at low ionic strength. The retained proteins (which are specifically bound) are 
eluted by increasing salt concentration (155), whereas proteins having little or no affinity for the DNA-
resin flow through the column. The expected enrichment for an affinity purified factor lies between 500-
to 1000- fold (155). Subsequent separation of the sample by SDS-PAGE will usually suffice to purify a 
protein for most applications, including protein sequencing. Several DNA-binding proteins have been 
isolated to homogeneity using above procedure, examples include SpP3A2 (120), SpOct (137) and 
SpGCFl (3). 
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Cloning a gene or eDNA coding for a transcription factor is usually achieved by producing sufficient 
protein sequence information to synthesise oligonucleotide probes in order to screen genomic or eDNA 
libraries (see section 1.6.1.1). Classical sequencing techniques (ie Edman degradation) involve the 
removal of one amino acid at a time from the N-terminus of the intact protein (or from internal peptides 
generated by proteolytic cleavage) by means of chemical ·reagents, with subsequent analysis of the 
released amino acid derivative (160). The traditional microsequencing technique sets the lower limit in 
sensitivity. Most protein purification strategies involve a combination of various fractionation techniques 
(chromatography, selective precipitation, dialysis, etc) yielding a highly purified protein sample which is 
often only available in minute and limited quantities (eg nanogram levels) and not always in a form that 
can be directly submitted for sequence ·analysis. Adsorptive losses make it difficult to handle low 
quantities of protein, which emphasises the need for highly sensitive analytical techniques in order to 
identify protein sequences (161). Mass spectrometry provides an alternative strategy to classical 
sequencing (162). In addition to detailed primary sequence information, the mass spectral results can 
yield purity evaluation, as well as molecular mass determinations of proteins (161). Two of the main 
advantages posed by mass spectrometry over classical sequencing are (i) mass spectrometry operates on 
picomole to femtomole sensitivities for both molecular mass determinations and partial to complete 
amino acid sequence information (163), and (ii) a mixture of peptides can be introduced into the mass 
spectrometer (164). Site specific proteolysis of the protein of interest generates small quantities of 
peptides which can easily be handled by combining microcolumn liquid chromatography (LC) with 
tandem mass spectrometry (MS/MS) (165). Electrospray ionization is used to introduce the peptide ions 
to the mass spectrometer, and ions of a single mass to charge ratio are targeted selectively for collision 
induced dissociation (CID) using an inert gas, which leads to the fragmentation of the peptides, 
generating a reproducible and generally predictable signal pattern characteristic of the specific amino 
acid sequence (161). The mass spectrometer approach has been successfully applied to both proteins and 
peptides ( 166) and the spectrum which is generated is used to search a protein database in order to 
identify the protein of interest, which involves correlating the predicted fragment ions from a database 
with the experimental data (166). This approach has only been possible by the development of computer 
programs which aid the interpretation of tandem mass spectra (166). The outcome of the search is a 
ranked list of the highest scoring amino acid identities from the database (161). The specificity of the 
database search is improved by taking several features of the protein into account, which, amongst others, 
includes the species of origin, mass of protein, inspection of non-assigned peaks in the peptide map, etc 
(166). 
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1.6 Strategies for Obtaining the eDNA of Transcription Factors 
1.6.1 eDNA Cloning by Screening Recombinant DNA Libraries 
DNA replication and the transcriptional regulation of gene expression is usually mediated by the 
interaction of DNA regulatory regions and DNA-binding proteins (ie by a combination of cis- and trans-
acting elements). The majority of cis-acting elements are localised to the 5' flanking and intronic regions 
of genes and they often constitute highly conserved sequence motifs which may be common to many 
genes (some examples include the Z-box, the X-box, theY-box, the octamer and the "TATA"box, which 
are all highly conserved sequence motifs among class II genes (167)). Investigating the functiomil role of 
the interaction of trans-acting factors with their cognate cis-elements relies largely on the ability of trans-
acting elements within crude nuclear extracts to bind DNA regulatory sequences. Although these proteins 
can be retrieved in a pure form (see section 1.5) it is often difficult and tedious to isolate them in 
sufficient quantities which allow further biochemical studies. Therefore isolation of the gene or eDNA 
encoding the DNA-binding activity can facilitate the analysis of the structural and functional 
relationships between cis- and trans-acting elements, merely by overproducing regulatory proteins using 
recombinant DNA clones of their encoding DNA (168). The molecular aspects of gene regulation and 
functional significance of these motifs can be explored further using transfection and transgenic studies. 
However these investigations rely on the use of recombinant DNA clones encoding the regulatory 
proteins. Thus in order to understand the molecular mechanisms underlying transcriptional regulation, it 
is important to isolate and analyse eDNA clones encoding DNA-binding proteins. 
The general approach for obtaining the sequence of a gene or mRNA is by screening a DNA library. The 
latter should be a faithful representation of the complexity, size and sequence of the genomic DNA or 
mRNA population it was derived from. This can however be a problem, especially if the DNA of interest 
represents a small fraction of the total target DNA, for instance when the gene is present as a single copy 
in the entire genome, or a rare eDNA needs to be isolated from a complex mRNA population (169). Since 
there is no technology available for the manipulation and propagation of RNA sequences the best 
alternative is to synthesise eDNA and prepare recombinant libraries. A variety of factors must be given 
careful consideration when screening a library. Firstly, the strategy for constructing a eDNA library is 
important. Factors which affect the quality, size and type of library include the integrity of the mRNA (it 
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must be undegraded and DNA-free), the abundance of the clone of interest (high cloning efficiency is 
required if the sequence of interest represents a small fraction of the total target DNA), and the screening 
method (this determines which type of vector the library is cloned into). optimally a eDNA library is 
made from a tissue or set of cells which express the highest mRNA levels to ensure that there is at least 
one eDNA clone for each mRNA present in the cell. Usually one aims to achieve a eDNA library which 
contains at least five times more recombinants than the lowest abundance of each mRNA. This ensures 
that even the rarest mRNA is represented, and it takes into account the screening efficiency (eg 
expression screening reduces the number of identifiable clones by 1/6th) (151). 
Screening methods vary from simply sequencing. several individual clones until the clone of interest is 
identified, through ordinary hybridisation methods, to more complex methods of expression screening. 
The method devised to isolate a clone of interest depends on each individual case, and is determined, 
amongst other factors, by the type of recombinant library and the frequency of the desired clone within 
that library {151). The usefulness of a recombinant library depends on the ability to screen a large number 
of clones at one time and to identify the correct one within the population. This can be achieved by 
spreading a library (or large numbers of colonies) on agar plates and preparing replica copies of the plates 
by transferring them onto filters. The latter can then be screened by a variety of methods, such as in situ 
hybridisation screening or by binding to antibodies, as well as using DNA ligands. 
1.6.1.2 Hybridisation Screening and Immunoscreening 
A pure protein (see section 1.5) can be used to generate a specific antiserum, or it can be analysed for its 
partial amino acid sequence, from which oligonucleotide primers can be designed. Both the antiserum 
and the primers in turn can be used to screen a eDNA library by expression or hybridisation respectively. 
This should generate the desired recombinant clone, either because it expresses a segment of protein 
which can be recognised by an antibody, or because it hybridises to a specific nucleic acid probe. Another 
way of identifying cDNAs coding for sequence-specific DNA-binding proteins is to use the filter binding 
protocol (see section 1.6.1.2) developed by Singh et al (1988) (170). 
Current protein microsequencing technology has made it convenient to isolate eDNA clones using 
degenerate oligonucleotide probes without raising antibodies against the purified protein. Taking codon 
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utilisation frequencies into consideration, the protein sequence is reverse-translated and a best-match 
DNA sequence is generated. An oligonucleotide is synthesised from the above information, which can be 
used to screen a eDNA library. The screening is normally performed on bacterial colonies containing 
plasmids or cosmids ( 151 ), or on bacteriophage plaques, using the in situ plaque hybridisation technique 
described by Benton and Davis (1977) (171 ). The phage are multiplied in host bacteria at high density 
within a thin layer of agarose which is spread onto agar plates. The phage particles and unpackaged DNA 
adsorb onto the filter which is applied to the agarose. Duplicate filter membranes are generated this way, 
they are treated with sodium hydroxide to destroy the phage particles and the denatured DNA remains 
fixed to the filter. The filter is prehybridised in a solution which saturates the filter's nonspecific DNA 
binding capacity, after which the desired clones can be detected by their ability to hybridise to a labelled 
DNA pro~e (the denatured DNAs reanneal with complementary strands approximately 25°C below the 
melting temperature Tm). It is critical that the DNA probe is unique (ie it may not contain any reiterated 
or vector sequences) to ensure that it correctly matches the sequence of interest. The nucleic acid probe 
may take several forms, eg a plasmid containing a previously cloned fragment, synthetic 
oligodeoxynucleotides, RNA or single stranded eDNA made from reverse transcribing inRNA (172). 
Excess probe, incorrectly matched sequences and non-sequence specific interactions are washed off the 
filter to reduce the signal to noise ratio in the ensuing autoradiography, which should identify authentic 
signals on duplicate filters ( 151 ). Autoradiography of the replica filters eliminates most artifacts, and 
often allows the identification of a single clone within a population of millions of other clones. The 
positive signals are matched with the corresponding regions on the agar plates and a plug of agar is 
picked from the correct area of the plate. The isolated positives are usually rescreened at a lower density, 
as the confluence of the agar surface in the first screening round does not allow the identification and 
isolation of an individual plaques or colonies (173). 
Using antibodies in the screening procedure is another method whereby clones encoding specific proteins 
can be identified in a recombinant library. This is analogous to hybridisation screening with radioactive 
DNA probes, except that the plaques are screened with antibodies specific to the desired proteins. The 
eDNA library is cloned in an expression vector ( eg A.GTll or A.ZAP), and the insert DNA is detected 
indirectly by the protein, which is generally induced to express from the cloned segment a~ part of a 
fusion protein. Expression of the particular recombinant is only initiated after the host's growth is firmly 
established, such that toxic proteins do not affect the growth (172). The immunological screening of 
fusion prot~ins produced either by plasmids or phage involves firstly the synthesis and immobilisation of 
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the antigenic material to the filter, and secondly the detection procedure using antibodies. Antibodies can 
either be visualised by labelling with 125! directly, or by applying secondary antibody conjugates (172). 
The quality of the antibody probe is important, and high titre antibodies produce better signals than low 
titre antibodies. Both monovalent and polyvalent antibody populations have been used to successfully 
isolate clones of interest (172). Polyvalent antibodies usually recognise more than a single epitope, which 
is advantageous. However, they also contain components which bind to antigens normally produced by E. 
coli. These components can be removed from the antibody preparation by incubation with bound 
bacterial lysate and subsequent elution of the antibody. It is important to note that demonstrating that a 
eDNA encodes an antigenic determinant does not prove that it codes for the protein of interest, since the 
eDNA may code for a sequence which is related only at the protein product structure. Therefore the 
desired sequence should be tested with at least one additional distinguishing property in order to identify 
the clone unequivocally {151 ). 
1.6.1.2 DNA Ligand Screening 
Both screening strategies described above (see section 1.6.1.1) depend on the availability of substantial 
amounts of starting material for purifying the protein (see section 1.5). A novel but similar screening 
strategy was developed by Singh et al (1988) (170) which is analogous to immunological screening, 
however it obviates purification of a sequence specific protein for the purpose of isolating its eDNA or 
gene since it relies on a selectable function in order to identify the desired clones. The DNA ligand 
screening technique is designed to directly detect clones which encode sequence specific DNA-binding 
proteins, by simply using a eDNA expression library and a labelled DNA recognition site probe. The 
feasibility of the screening strategy was tested using a model system where a A.GTU phage recombinant 
(A.EB), encoding a fusion protein of the DNA-binding domain of the Epstein-Barr virus nuclear antigen 
{EBNA-1), was detected with a DNA recognition site probe {170). The ease of isolation of this clone 
implied that this strategy could facilitate the isolation of genes for transcription factors and would be 
generally useful in the cloning and analysis of sequence-specific DNA-binding proteins (174). Since the 
initial application of the DNA ligand screening technique many mammalian eDNA clones encoding a 
variety of sequence-specific DNA binding proteins (with varying DNA-binding motifs) have been 
isolated; eg H2TF1/NF-KB, Oct-2, E12, Xbp, IRF-1, MLTF, and CREB, confirming that this method is 
indeed useful and not restricted to a particular subclass of DNA-binding domains. (Singh et al (1989) 
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(174) list many of the clones encoding transcriptional regulatory proteins which have been isolated from 
A.GT11 eDNA libraries using recognition site DNA probes.) Other examples include the cDNAs for YB3 
protein from Xenopus (175) and SpP3A1 from Strongylocentrotus purpuratus (122), and the cDNAs for 
YB-1 and dbpA were isolated independently by several groups (176, 177). It has been reported that even 
clones encoding proteins which bind DNA as homodimers can be detected via DNA ligand expression 
screening (174). Expression vectors such as A.GTll or A.ZAP allow insertion of foreign DNA into the 13--
gal structural gene, lacZ, and promote the expression of hybrid proteins. The hybrid proteins are then 
blotted onto duplicate nitrocellulose filters, and the screening procedure essentially involves the direct 
probing of the replica filters from the eDNA expression library with radiolabelled, sequence-specific 
binding site DNA. Several variables influence the successful identification of bacterially expressed DNA-
binding clones using radioactive DNA as ligand. The requirements or conditions that need to be fulfilled 
include the functional expression of the DNA-binding domain in E.coli as a 13-galactosidase fusion 
protein, a strong interaction between the DNA-binding domain and recognition site DNA (170), and the 
protein of interest must be able to bind the DNA independent of associations with other proteins or 
complexes. Several procedures greatly enhance the detection of cDNAs which encode sequence-specific 
DNA-binding proteins. For instance, it was demonstrated that the sensitivity of -detection was greatly 
improved by the use of a multisite DNA probe, as well as the use of nonspecific competitor DNA such as 
sonicated, denatured calf thymus DNA (178, 179). The inclusion of excess nonspecific competitor DNA 
reduces the background, as well as the detection of nonspecific DNA-binding proteins. Using a test 
system where the DNA-binding domain of an enhancer binding protein (C/EBP) was fused in frame to 
the 13-galactosidase gene of bacteriophage A.GTll, Vinson et al (1988) (168) determined that processing 
the nitrocellulose filters through a denaturation I renaturation regimen using 6 M guanidine hydrochloride 
increased the level of binding between the ligand and the recombinant fusion protein and enhanced the 
selectivity of the interaction. Bacterial expression of recombinant proteins often leads to deposition of 
insoluble protein precipitates which need to be exposed to chaotropic agents to be solubilised (168). 
Guanidine hydrochloride dissociates these protein aggregates, and it may also overcome the problem of 
incorrect protein folding in E.coli. Therefore the denaturation I renaturation protocol leads to improved 
detection signals by allowing more of the correctly folded protein molecules to access the DNA ligand. In 
this report the authors also tested the importance of using a catenated DNA probe as ligand, showing that 
the catenated probe (consisting of a higher density of protein binding sites) yielded an appreciably 
enhanced detection signal over the monomeric ligand. It is likely that a catenated probe is able to tether 
several immobilised, bacterially expressed DNA-binding proteins on a single DNA molecule, which may 
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alleviate rapid probe dissociation and increase the stability of the protein-DNA complexes (174). A 
comparison of the signals obtained when using a 32P-labelled DNA-binding site probe and a secondary 
antibody conjugate containing horseradish peroxidase shows that the DNA binding site probe has higher 
sensitivity, but the signal is probably comparative to that obtained when using an 125!-labelled antibody 
(174). 
1.6.2 eDNA Cloning by PCR 
The polymerase chain reaction (PCR) has promoted the development of a variety of analytical procedures 
which can be used for detection, measurement and characterisation as a result of its power to amplify 
extremely small amounts of DNA. Its versatility ranges from basic PCR amplification reactions, to 
mutagenesis and screening of libraries (180). Prior to the development of PCR library screening 
techniques mainly involved plating lambda based libraries on a lawn of E.coli, with subsequent transfer 
of the phage particles or their expressed recombinant proteins to nitrocellulose filters, which were then 
screened with DNA hybridisation probes, antibodies or DNA ligands (see section 1.6.1). This technique 
is relatively time-consuming, it often results in numerous false positives and sometimes it may not be 
sensitive enough to detect low abundance mRNAs. PCR, in combination with degenerate or specific 
primers can be used to isolate families of related clones from recombinant DNA libraries, within a short 
time and without the use of radioactive labels. Generally a eDNA or genomic library can be plated (at 
relatively low density) and the phage from each plate represent the starting material for PCR screening. 
Positive aliquots are identified and are replated at lower and lower densities with subsequent PCR 
screening until a single phage plaque can be identified as a positive. PCR-based eDNA screening 
techniques are applicable to both bacterial and phage libraries (180). 
eDNA amplification using 5' and 3' RACE (Rapid Amplification of eDNA Ends) is a technique which 
allows cloning of full-length cDNAs without the need to construct or screen a eDNA library. It relies on 
the simultaneous PCR amplification ofboth 5' and 3' eDNA ends performed on the same template (181), 
and is capable of amplifying large templates which have high fidelity with respect to the original RNA. 
The only requirement for successful application of 5' I 3' RACE is that a single short DNA sequence (at 
least 21 - 24 nt) must be known for the eDNA of interest, such that gene specific primers for both the 5' 
and 3' RACE reactions can be synthesised. In addition, the amplifications require a source of RNA in 
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which the transcript of interest is definitely present. Briefly, the technique involves synthesis of double -
stranded eDNA from either total or poly-A+ RNA using a combination of reverse transcriptase, E. coli 
polymerase I and RNase H. T4 DNA polymerase is used to create blunt-ended ds eDNA, which is ligated 
to adaptors with specific adaptor primer (AP) sites. The uncloned library of adaptor ligated ds eDNA can 
be used in combination with primers specific to the adaptor sequence and gene specific primers (a pair of 
antisense and sense primers) to amplify the respective 5' and 3' RACE fragments from the eDNA 
template· of interest. Exponential amplification is achieved by using a DNA polymerase which is suitable 
for long distance PCR, and the two separate fragments generated in this way can be combined to form a 
full length eDNA. Full length cDNAs can be achieved using various techniques, such as simple ligation 
and cloning of the two products, PCR amplification of the full length product or by a fusion reaction (in 
this case the 5' and 3' fragments are annealed and simultaneously act as template and primers in a 
thermal cycling reaction). The full length product can then be cloned and analysed to verify its nucleotide 
sequence. 
1.7 Aim of This Investigation 
In order to elucidate the biochemical mechanisms which govern gene transcription, factors regulating 
gene promoters must be purified and characterised, since they are central to the understanding of 
regulation and control of gene expression, replication and recombination. Many examples of G·C-rich 
promoter elements have been cited. These elements, together with the factors that bind them, are 
implicated in gene regulation. A detailed understanding of the structural and functional relationships 
· amongst factors which bind G·C-rich sequences may elucidate analogies in their biological roles and 
DNA recognition functions. 
suGFl is implicated as a member of a family of G-string factors with related functions. The main 
objective of this investigation is to purify and clone suGFl. This could possibly elucidate a functional 
significance for suGF 1 by identifying the factor via its primary protein structure and eDNA sequence. 
Analysis of the molecular structure of the protein may lead to the identification of characteristic motifs 
similar to those of previously identified transcription factors. This may enable the classification of suGFl 
as a possible member of a family of proteins which are related by their primary structure and DNA-
binding specificity. The strategies for purification and cloning of suGFl are developed concurrently in 
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this project, using the DNA recognition site as affinity probe in both approaches. Detection of the eDNA 
for suGFl is attempted by the direct cloning method developed specifically for DNA-binding proteins by 
Singh et al (1988) (170), with the aim to eliminate the need for isolating large amounts of native protein. 
A PCR strategy is employed as second cloning approach, in order to isolate a P.angulosus clone based on 
a S.purpuratus homologue, which potentially represents a suGFl clone. Identification of positive clones 
can be achieved by analysis of the DNA-binding specificities and affinities by expression of the putative 
positive clones. No information is available on the requirements of post-translational modifications or 
heterodimer formations regarding the suGFl-DNA interaction, therefore, despite the apparent ease ofthe 
direct cloning method by the DNA-ligand screening approach, it is not guaranteed to be successful with 
respect to every transcription factor. Therefore the cloning strategy and the protein purification of suGFl 
are addressed concurrently. The latter involves a combination of ion exchange and affinity 
chromatography, and SDS-PAGE as a final purification step before primary structure determination of 
the protein. Using both these approaches it should be possible to identify the protein sequence and eDNA 
sequence for suGF 1. 
By analysing the primary structure of suGFl several characteristic domains related to the functional 
properties of the factor may be elucidated. For instance the putative DNA-binding domain (eg zinc finger 
or homeodomain, amongst others), a possible dimerisation domain (which is often associated with 
leucine zipper proteins and helix-loop-helix functional motifs), and perhaps a transcriptional activation 
domain (this is usually characterised by regions which are serine I threonine-, glutamine I threonine- or 
proline-rich) are speculated to be present in the factor. The identification and isolation of the eDNA_ 
coding for suGFl should lead to recognition of domains within the protein via similarities in their 
primary structures, allowing comparisons to be drawn with other G-binding factors. In addition, a 
knowledge of the eDNA coding for the suGFl protein should allow verification of the developmental 
distribution of the factor, and expression of the eDNA using truncated DNA templates may enable further 
identification of the position of certain functional domains (eg the DNA-binding domain and a 
dimerisation domain) with respect to the primary protein structure. 
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CHAPTER2 
Materials and Methods 
2.1 Materials 
All chemical reagents and solvents used were analytical grade, unless otherwise stated. The source of 
the materials was not important unless specified. All solutions, glassware and plastics were sterilised 
by autoclaving or sterile filtering. All water was double distilled. 
2.2 Plasmid Propagation and Isolation 
2.2.1 Competent Cells 
Competent bacterial cells were either purchased from Pharmacia or they were prepared using a 
method described by Chung et al (1989) (182). The cells were grown to early log phase (OD600 = 0.3-
0.6) in Luria Bertani (LB) broth. They were pelleted by centrifugation (1000 X g for 10 minutes at 
4°C). The cell pellet was resuspended in 1110 volume of transformation and storage buffer (TSB) (LB 
broth (pH 6.1) containing 10% (w/v) PEG (MW = 4 000), 5% (v/v) DMSO and 20 mM Mg2+ (10 
mM MgCI2 and 10 mM MgS02)) at 4°C. They were then incubated on ice for approximately 10 
minutes, and either stored at -70°C in aliquots, or used immediately for the transformation procedure. 
2.2.2 Transformation of Competent Cells 
Competent cells (purchased commercially) were transformed according to the supplier's 
recommendations. JM109 High Efficiency Cells (Promega) were used to transform ligation reactions. 
Competent cells were mixed evenly and a 50 Jll aliquot of cells was combined with 2 Jll of ligation 
reaction and incubated on ice for 20 minutes. The cells were heat shocked for 45 - 50 seconds in a 
waterbath at 42°C, and placed on ice for 2 minutes. The transformed cells were supplemented with 
950 ml SOC medium (room temperature), and incubated for 1.5 hours at 37°C with shaking. An 
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aliquot of each transformation culture (iOO J.Ll) was plated onto LB plates containing ampicillin (SO 
J.Lg/J.Ll), IPTG {O.S mM) and X-Gal (80 J.Lg/ml). The plates were incubated at 37°C overnight. 
Competent cells (100 J.Ll) prepared by the method of Chung et al (1989) (182) (see section 2.2.1) were 
mixed with plasmid DNA and incubated on ice for 60 minutes. The cells were supplemented with 900 
J.Ll TSB containing 20 mM glucose, and incubated at 37°C for 60 minutes to express the antibiotic 
resistance gene. Transformants were selected by plating the cells on LB plates containing the relevant 
· antibiotic. 
2.2.3 Plasmid DNA Mini-Preparation by Boiling Method 
Single bacterial colonies containing plasmid DNA were picked from fresh agar plates and inoculated 
into 10 ml LB containing the appropriate antibiotic. Cells were grown overnight at 37°C, and 1.S ml 
of the culture was pelleted (12 000 rpm, 1 minute). The cell pellet was resuspended in 290 J.Ll STET (8 
% (w/v) sucrose. O.S %Triton X-100, SO mM EDTA (pH 8), 10 mM Tris.HCl (pH 8)) and 10 J.Ll 
lysozyme (20 mg/ml) was added to the cell suspension, which was incubated on ice for S minutes. 
The cells were lysed by boiling for 1 minute, and the cell debris was precipitated by centrifugation for 
20 minutes at room temperature (12 000 rpm). The sticky pellet was removed with a toothpick and the 
DNA was precipitated by addition of an equal volume of isopropanol. The DNA was recovered by 
centrifugation (12 000 rpm, 20 minutes, 4°C), and the pellet was washed with 70% ethanol. The dry 
DNA pellet was resuspended in 20 J.Ll TE and stored at -20°C. 
2.2.4 Large Scale Plasmid Isolation 
P1asmids were propagated in the appropriate E. coli strains which were grown in Luria-Bertani growth 
medium (LB) containing the relevant antibiotic. Plasmids were either isolated by the triton lysis 
I 
method (1S1), or using Wizard Midipreps DNA Purification System (Promega) according to the 
supplier's recommendations. 
2;2.4.1 Triton Lysis Method 
Briefly, 2 litres of bacterial culture were centrifuged for 30 minutes at S 000 rpm (JA 14 rotor, 
Beckman). The pellet was resuspended in 1S ml SO mM Tris.HCl (pH7.S), and the suspension was 
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incubated for 30 minutes with 1 mllysozyme (10 mglml), 10 minutes with I ml EDTA (0.5 M), 20 
minutes with 100 f..ll RNase A (20 mglml), 200 f..ll Triton (10% (vlv)) and centrifuged for 45 minutes 
at 20 000 rpm (JA20 rotor). The supernatant was extracted three times with an equal volume of 
neutralised phenol, and twice with an equal volume of chloroform. The sample was adjusted to 300 
mM sodium acetate and the DNA was precipitated with 2.5 volumes absolute ethanol for 30 minutes 
at -70°C. DNA was recovered by centrifugation at 20 000 rpm (JA20 rotor) for 20 minutes. 
The pellet was washed with 70 % (vlv) ethanol, dried and the plasmid was banded in a caesium 
chloride I ethidium bromide gradient (VTi 65 rotor (Beckman), 55 000 rpm, 16 hours, caesium 
chloride from Sigma). This step was performed twice if supercoiled plasmid only was required. 
Ethidium bromide was removed from the recovered plasmid by repeated extractions with isoamyl 
alcohol (151). The supercoiled plasmid was dialysed against TE (pH 7.5) and precipitated as above. 
Plasmid was stored in aliquots in TE (pH 7.5) at -20°C. 
2.2.4.2 DNA Isolation Using Wizard Midipreps Columns (Promega) 
Bacterial cultures (100 ml) were pelleted for 15 minutes at 4°C (14 000 rpm, JA14 rotor (Beckman)). 
JSV ~· (O 
The cells were resuspended in 3 rfil cell resuspension solution (fO mM Tris.HCl (pH 8), 10 mM 
EDTA (pH 8) and 100 f..lglml RNase A), and lysis was achieved by addition of~5~X!f cell lysis 
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solution (0.2 N NaOH, 1 % (wlv) SDS). P~smid was released from the lysed ~ells by gentle swirling, 
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and the mixture was supplemented with~neutralisation solution (1.32 M KOAc tpH 4.8)). Cell deoris ' 
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and chromosomal material were precipitated for 15'='minutes at 4°C (15 000 rpm, JA20.1 rotor 
(Beckman)). The supernatant was retained and supplemented with 10 ml Wizard Midipreps DNA 
Purification Resin (7 M Guanidine HCl), and passed directly over a Wizard Midipreps column. 
Elution of solvents was achieved by application of a vacuum to the column, which was subsequently 
washed twice with 15 ml column wash solution (8.3 mM Tris.HCl (pH 7.5), 83 mM NaCl, 2 mM 
EDTA and 58% (vlv) ethanol) and dried before the DNA was eluted with 300 f..ll TE (pH 8.0) at 65°C 
by spinning the column for 2 minutes. 
2.2.5 Recovery of Single Stranded DNA from pBluescript 
Single stranded DNA was isolated according to the Stratagene instr:Ic.tion manual for pBluescript Exo 
I Mung DNA Sequencing system. pBluescript vector containing the DNA fragment of interest was 
transformed into XL !-Blue cells, which were grown on LB I ampicillin I tetracycline plates. Single 
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colonies were picked and 10 ml starter cultures were grown overnight at 37°C in LB I ampicillin I 
tetracycline. LB (2 ml) containing 2 J.tl purified M13 phage was inoculated with 20 J.ll of the starter 
culture, and the mixture was incubated at 3 7°C for one hour. The culture was supplemented with 
kanamycin (230 J.l.glml final concentration) and the culture was grown at 37°C overnight. The cells 
were pelleted at 12 000 rpm for 5 minutes (4°C), and the phage-containing supernatant was mixed 
with 0.2 volume 15 % (wlv) PEG (8000) I 2.5 M NaCI. The mixture was vortexed gently and 
incubated at room temperature for 15 minutes. The phage were pelleted at 12 000 rpm for 5 minutes 
(4°C) and the supernatant was removed carefully. The pellet was resuspended in 100 J.ll TE (pH 8) by 
vortexing vigorously. The phage were extracted once with 50 J.ll phenol, followed by a chloroform 
extraction (50 J.tl). The DNA was precipitated with 0.1 volume 3M sodium acetate (pH 5.2) and 2.5 
volumes absolute ethanol. The mixture was incubated at room temperature for 15 minutes and the 
DNA was pelleted at 12 000 rpm for 10 minutes (4°C). The DNA was washed with 70 % ethanol, 
evaporated to dryness and resuspended in 20 J.tl TE (pH 8). 
2.3 Sanger Di-Deoxy DNA Sequencing 
Enzymatic sequence analysis was performed usmg the TaqTrac sequencing system (Promega), 
alternatively the DNA samples were sequenced using an Automated DNA Sequencer. 
2.3.1 Denaturation of Double Stranded DNA 
DNA (approximately 5 J.tg) was pipetted into a microfuge tube, the volume was adjusted to 18 J.ll with 
sterile water and 2 J.ll of a 2M NaOH solution was added. The mixture was incubated at 37°C for 6 
minutes. The reaction was neutralised with 4 J.tl of 3 M sodium acetate (pH 5.2), and 150 J.ll of 
absolute ethanol was added. The DNA was pelleted by centrifugation at 12 000 rpm for 30 minutes 
(4°C), and the pellet was washed with 70 % ethanol. The DNA was dried by evaporation and 
resuspended in 17 J.ll water. 
2.3.2 Sequencing Using the Two Step Extension I Labelling Procedure 
Primer (2 pmol) and single stranded or denatured doublestranded DNA (5 J.tg) were combined in 1 X 
Taq DNA polymerase buffer (50 mM Tris.HCl (pH 9) and 10 mM MgC}z) containing 2 J.ll extension I 
label mix (7 .5 J.1M of each dGTP, dTTP and dCTP), and annealed by incubation at 3 7°C for 11 
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minutes. The extension I labelling reaction was carried out at 3 7°C for 11 minutes by adding 1 fll [a.-
35S]dATP (approximately 10 flCilfll, Amersham) and 1 fll Taq DNA polymerase (2.5 Ulfll) to the 
DNA I primer mixture. For each set of sequencing reactions 1 fll of each ddNTP was aliquoted into a 
microcentrifuge tube and 6 fll of the extension I label reaction was added. The mixture was incubated 
at 70°C for 16 minutes and 4 fll of stop solution (1 0 mM NaOH, 95 % (vlv) formamide, 0.05 % (wlv) 
bromophenol blue and 0.05 % (wlv) xylene cyanol) was added to each tube. The reactions were 
heated to 90°C for 5 minutes before resolving them on a 6% sequencing gel (see section 2.3.3). 
2.3.3 Sequencing gels 
6 % sequencing gels (5.7 g acrylamide (Merck), 0.3 g bisacrylamide (BDH Biorad), 48 g urea 
(Merck), 10 ml of 10 X TBE, 40 ml water, 45 fll of 50 % AMPS and 45 fll TEMED) were pre-
electrophoresed for 30 minutes at 90 W. Samples were electrophoresed for 1 - 6 hours at 90 W 
depending on where the DNA sequence of interest was situated on the template DNA. 
2.4 Synthesis and Annealing of Oligodeoxyribonucleotides 
Oligodeoxyribonucleotides (oligonucleotides) were synthesised on a Beckman Systems 1+ DNA 
Synthesizer and purified by established procedures (151). Concentrations were determined 
spectrophotometrically. The molar extinction coefficient for each oligonucleotide was estimated from 
the extinction coefficients ofthe individual bases (151). Complementary strands of the specific and 
nonspecific oligonucleotides (see fig 2.1 for their respective nucleotide sequences) were annealed at a 
molar ratio of 1:1, by incubating at 88°C for 2 min, 65°C for 10 min, 37°C for 10 min, 25°C for 5 
min, and finally placing the sample on ice. 
2.5 Enzymatic Manipulations and Radioactive Labelling of DNA 
2.5.1 Restriction Enzyme Digests 
Typically restriction enzyme digests were performed with plasmid DNA containing 1 X reaction 
buffer, 1 - 2 units I f.!g of DNA of each restriction enzyme, and the final volume was adjusted with 
water. The mixture was incubated at 37°C for one hour or longer, followed by addition of 6 X loading 
buffer (0.25 %bromophenol blue, 0.25 %xylene cyanol, 30 % glycerol in water). The digests were 
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SPECIFIC OLIGO (Sp) 
5' gatcAGAGAGGGGGGGGGGGAGGGAGAATT 3' 
3' TCTCTCCCCCCCCCCCTCCCTCTTAActag 5' 
NONSPECIFIC OLIGO (NS) 
5' TCAGGTCATGGCCACTGTGACGTCTTctag 3' 
3' gatcAGTCCAGTACCGGTGAGAGTGCAGAA 5' 
Fig 2.1 Sequences of the Synthetic Oligodeoxyribonucleotides 
The sequences of the specific (Sp) and nonspecific (NS) synthetic double stranded 30 bp oligonucleotides are 
shown in capital letters. The oligos have 4 base single-stranded overhangs (small letters) to enable 
multimerisation. The specific oligo contains 26 bp of the Hl-H4 intergenic region of the early histone gene 
battery of P.miliaris (h22) (see fig 2.2), whereas the nonspecific oligo contains a random sequence. 
gaattctc atgtttgaca gcttatcatc gccctgactg agtcgagccc 
cttaagag tacaaactgt cgaatagtag cgggactgac tcagctcggg 
EcoRI 
-440 -430 -420 
aattcgagct cggtacccCA CGTAGAGGAA AAGAGAGTTA TACCACTCCT 
ttaagctcga cggatgggGT GCATCTCCTT TTCTCTCAAT ATGGTGAGGA 
-410 -400 -390 -380 -370 
GACATGAAAC ACACTCAATT CAACATATTT AGAGGAAGGG AGAGAGAGAG 
CTGTACTTTG TGTGAGTTAA GTTGTATAAA TCTCCTTCCC TCTCTCTCTC 
-360 -350 -340 -330 -320 
AGAGAGAGAG AGAGAGAGAG AGGGGGGGGG GGAGGGAGAA TTGCCCAAAA 
TCTCTCTCTC TCTCTCTCTC TCCCCCCCCC CCTCCCTCTT AACGGGTTTT 
-310 -300 -290 -280 -270 
CACTGTAAAT GTAGCGTTAA TGAACTTTTC ATCTCATCGA CTGCGCGTGT 
GTGACATTTA CATCGCAATT ACTTGAAAAG TAGAGTAGCT GACGCGCACA 
-260 -250 
ATAAGGATGA TTATAAGCTg gggatcctgt agagtcgacc tgcaggcatg 
TATTCCTACT AATATTCGAc ccctaggaga tctcagctgg acgtccgtac 
caagctgggc tcgacttagt cagggtcacc gataagctt Watson 
gttcgacccg agctgaatca gtcccagtgg ctattcgaa Crick 
Hind III 
Fig 2.2 DNA Sequence of the E/H Fragment 
Part of the sequence of plasmid pHP2 (shown in small letters) contains a 201 bp insert (capital letters) from the 
H1-H4 intergenic regi,on ofthe P.miliaris early histone gene battery (h22) (20). Numbering is with respect to the 
major cap site of the mRNA of H4 denoted + 1 (183). A 335 bp EcoRI I Hindiii fragment (E/H fragment) was 
prepared from pHP2 and radio labelled on one strand as described in the text. 
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analysed on agarose gels of appropriate concentration. When plasmids from minipreps were digested, 
1 J.Ll RNase A (20 mg/ml) was also added to the restriction digest reaction. 
2.5.2 ISolation and Radioactive Labelling of DNA Fragments 
A 335 bp Eco Rl I Hind III (EIH) fragment containing the binding site of suGFl was prepared from 
pHP2 (20). (This fragment includes 11 contiguous G residues on one strand, see fig 2.2.) Fragments 
obtained by restriction enzyme digestion were resolved on 1% agarose gels in TAE (0.04 M Tris-
acetate, 0.002 M EDTA) containing ethidium bromide. The relevant bands were visualised with a 
handheld UV lamp (A.= 315 nm) and excised from the gel. The DNA was purified from the agarose 
using the Wizard PCR Preps DNA Purification System (Promega). Agarose slices were transferred to 
microcentrifuge tubes and 1 ml Wizard PCR Preps DNA Purification Resin was added. The agarose 
was melted at 65°C and applied to a Wizard Minicolumn, which was washed with 2 ml of 80 % (v/v) 
isopropanol. The DNA was eluted from the dry column by applying 50 Jll TE (pH 8) and 
centrifugation at 12 000 rpm for 20 seconds. The sample was adjusted to 0.3 M sodium acetate and 
the DNA was precipitated by adding 2.5 volumes absolute ethanol for 30 minutes at -70°C. The DNA 
was recovered by centrifugation at 15 000 rpm (Beckman JA20.1) for 20 minutes, washed with 70% 
(v/v) ethanol and stored in TE (pH 8) at -20°C. The DNA concentration was determined 
spectrophotometrically or by ethidium bromide spotting. 
Restriction fragments were 3' end-labelled by a Klenow fill-in reaction. The Watson strand of the E/H 
fragment could be labelled selectively by filling in the Hindiii site using [a-32P]dCTP (10 J.LCiiJ.Ll, 
Amersham) as radioactive nucleotide. Specific activity of fragments was typically 12 000 to 50 000 
dpm/ng. 
2.5.3 Nick Translation of eDNA 
eDNA was labelled by nick translation with [a-32P]dCTP according to the protocol described by 
Maniatis et al (1982) (169). Typically an incubation was performed in 1 X Nick Translation Buffer 
(50 mM Tris.HCl (pH 7.5), 10 mM MgS04, 1 mM DTT, 0.05 mg/ml BSA) containing 1 J.Ll eDNA 
(0.5 mg/ml), 3 Jll nucleotide mix (2 mM each dATP, dGTP, dTTP), 3 Jll [a-32P]dCTP (10 J.!Ci/Jll), 1 
Jll DNasel (0.4 J.!U/ml) and 1 Jll DNA polymerase I (500 U/ml). The reaction was allowed to proceed 
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at l6°C for one hour, it was terminated by the addition of 2 Jtl of 0.5 M EDTA (pH 8). The specific 
activity of the labelled probes was 0.1 - 1.9 x 108 dpm/J.Lg DNA. 
2.5A Labelling of DNA Using the Amersham MegaPrime Kit 
DNA fragments were isolated from low melting point agarose gels as described above (see section 
2.5.2). The DNA template (25 ng) was combined with 5 J.Ll random primers (Amersham) and the 
mixture was denatured at 95°C - 1 00°C for 5 minutes. The reaction cocktail, including nucleotides ( 4 
J.!l of each dGTP; dTTP and dATP (10 mM)), 10 X reaction buffer (SJ.Ll), [a-32P]dCrP (5 .J.Ll) and 2J.Ll 
Klenow enzyme (2 U/J.Ll) was added to the denatured DNA at room temperature. The volume was 
adjusted to 50 J.Ll with water. The reaction was incubated at 37°C for 30 minutes and was terminated 
by addition of0.5 M EDTA (2 J.Ll). The volume was adjusted to 100 J.Ll with TE and the labelled DNA 
was separated from the unincorporated nucleotides by chromatography on a Sephadex G-50 spin 
column. Specific activity ofthe labelled DNA was typically- 1 X 109 dpm/J.Lg. 
2.5.5 Sephadex G-50 Chromatography 
The labelled DNA was passed over a 1 ml spirt column containingSephadex G-50 in TE solution (pH 
8) in order to remove the unincorporated nucleotides. The spin colurrtn was prepared by plugging a 
disposable 1 ml syringe with sterile glass wool and filling_ it with Sephadex G-50. The column was 
washed with three column volumes of TE (pH 8) and centrifuged on a benchtop centrifuge for 4 
minutes after each wash. The DNA sample was applied to the· column in a volume of 100 J.!l and 
eluted by centrifugation for 4 minutes. The labelled DNA was present in the void volume and the 
amount of radioactivity was measured by Cerenkov counting. 
2.6 RNA Isolation and Manipulations 
2.6.1.RNase-free Plasticware, Glassware and Solutions 
All glassware was baked at 260°C for four hours. Plasticware was soaked in a solution of 3 % (v/v) 
H20 2 for ten minutes and washed thoroughly with RNase-free water, unless sterile disposable 
plasticware was available. RNase-free water was double distilled Milli-Q water (passed through 
carbon, ion exchange and organic scavenger cartridges), filtered directly into a baked glass bottle and 
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autoclaved for 30 minutes. All RNase-free solutions were prepared using baked glassware, chemicals 
set aside for RNA work only and RNase-free water. Gloves were worn at all times when working with 
RNA and the accompanying solutions. 
2.6.2 RNA Isolation Procedure 
Total RNA was isolated using the Guanidinium thiocyanate I CsCl gradient technique proposed by 
Chirgwin et al (1979) (184). Guanidinium thiocyanate stock solution (4 M guanidinium thiocyanate, 
0.5% (w/v) sodium lauroylsarcosine, 25 mM sodium citrate (pH 7), 100 mM 13-Mercaptoethanol) was 
filtered through a 0.22 ).lm filter. Sea urchin eggs or embryos (grown for 4 hours, 9 hours, 14 hours, 
21 hours, 30 hours or 45 hours) were allowed to settle at 4°C. Adult tissue (testes, ovaries or muscle) 
was frozen in liquid nitrogen and ground to a powder using a mortar and pestle. Guanidinium 
thiocyanate stock solution (3.3 ml) was added to 1 ml of settled eggs, embryos or adult tissue. The 
cells were resuspended in the guanidinium thiocyanate solution using a Pasteur pipette. The lysed cell 
mix was transferred to a 5 ml handheld Dounce homogenizer and the suspension was homogenized 
for 25 - 30 strokes. Each homogenate was added to 1.32 g CsCl and shaken to dissolve the CsCI. The 
mixture was layered over a 1.2 ml cushion of 5.7 M CsCl solution (5.7 M CsCl, 0.1 M EDTA (pH 
7.5)) in a polyallomer tube. The RNA was pelleted by centrifugation at 36 000 rpm (105 OOOg) in a 
Beckman SW65Ti rotor for 16 hours at 20°C in a Beckman L-65 Ultracentrifuge. The supernatant 
was aspirated until approximately 500 ).11 remained. The centrifuge tube was cut above the level of the 
remaining solution and the latter was removed by inverting the centrifuge tube, so as not to disturb 
the RNA pellet. This method ensures the complete separation of RNA (found in the pellet) from 
contaminating DNA and protein. The pellet was resuspended in 300 ).11 RNase-free water, transferred 
to an Eppendorf vial and vortexed to mix. The solution was incubated at 65°C briefly and spun down 
in a microfuge. The RNA was subsequently precipitated by the addition of 0.1 volume 3 M sodium 
acetate (pH 5.2) and 2.5 volumes absolute ethanol and stored at -20°C. The RNA was recovered from 
the ethanol suspension by centrifugation for 20 minutes at 15 000 rpm and 4°C. The pellets were 
washed with 75% ethanol, air dried and dissolved in 100 ).11 RNase-free water. A260 in water was used 
to determine the RNA concentration, and a ratio of A26ofA280 = 2 was ensured. The RNA was stored 
as an aqueous solution at -20°C. 
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2.6.3 Selection of Poly-A+ RNA 
Oligo(dT)-cellulose (0.5 g) was swollen in 0.1 M NaOH. A 1 ml column was poured in a silanized 
pasteur pipette. The column was washed with 10 ml RNase-free water and 1 X column loading buffer 
(20 mM Tris.HCl (pH 7.6), 0.5 M NaCl, 1mM EDTA, 0.1% (w/v) SDS), until the pH of the column 
effluent was less than 8. Sea urchin embryo (14 hour) total RNA (2 mg) was resuspended in RNase-
free water and heated to 65°C for 5 minutes. An equal volume of 2 X loading buffer was added, the 
sample was cooled to room temperature and applied to the column. The flow-through was collected, 
heated again to 65°C, cooled and reapplied to the column. The eluate was reapplied twice in the same 
fashion. The column was washed with 10 column volumes ofloading buffer. The poly-A+ RNA was 
eluted with 4 column volumes of elution buffer (10 mM Tris.HCl (pH 7.5), 1 mM EDTA, 0.05 % 
(w/v) SDS). Fractions (1 ml) were collected and the A260 of each fraction was determined. The poly-
A+ RNA was selected again by oligo(dT)-cellulose chromatography, by adjusting the NaCl 
concentration of the eluted mRNA to 0.5 M and repeating the chromatography procedure. The poly-
A+ RNA was precipitated at -20°C by adding 0.1 volume 3M Na-acetate (pH 5.2) and 2.5 volumes 
absolute ethanol. The pellet was rinsed in 70 % ethanol, and resuspended in RNase-free water. 
2.6.4 RNA Gel Electrophoresis 
For RNA gels the electrophoresis apparatus was soaked in 3 % (v/v) H20 2 for 1 hour, rinsed with 
methanol and washed with RNase-free water. 
2.6.4.1 Denaturation of RNA by Glyoxal Method 
RNA was fractionated under denaturing conditions according to standard procedures (169). RNA 
samples were incubated in 1M glyoxal, 50% (v/v) DMSO, 10 mM NaH2P04 (pH 7) for 60 minutes 
at 50°C. The RNA samples were cooled to 4°C and 0.2 volumes sample application buffer (50 % 
(v/v) glycerol, 10 mM NaH2P04 (pi:I 7), 0.25 % (w/v) bromophenol blue) was added to them. The 
samples were fractionated through a vertical 1 % agarose gel in 10 mM NaH2P04 (pH 7), at 3 - 4 
V/cm with buffer recirculation. The gel was stained for 10 minutes with 33 Jlglml acridine orange in 
10 mM NaH2P04 (pH 7), and destained overnight in buffer only. 
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2.6.4.2 Denaturation of RNA by Formamide Method 
The integrity of RNA samples was checked on 1 % agarose I formaldehyde gels based on a 
modification of the method described in Ausubel et al (1987) (151 ). Gels were prepared as follows: 
0.5 g agarose, 5 ml 10 X MOPS (0.4 M morpholinopropanolsulfonic acid (pH7), 100 mM sodium 
acetate, 10 1mM EDTA) and 36 ml DEPC water. The agarose was heated, cooled to 55°C and 8.4 ml 
37 % (v/v) formaldehyde was added. The gel was poured in the fumehood and covered with 1 X 
MOPS buffer once it had set. The RNA samples were precipitated by ethanol and resuspended in 25 
J..ll1oading buffer containing 72 J..ll formamide, 16 J..ll10 X MOPS, 26 J..ll 37% (v/v) formaldehyde, 18 
J..ll water, 10 J..ll 80 % (v/v) glycerol and 8 J..ll saturated Bromophenol Blue. The RNA samples were 
electrophoresed at 3.5 V/cm for 3 hours in 1 X MOPS running buffer. 
2.6.5 Northern Analysis 
2.6.5.1 Northern Transfer Procedure 
A piece of Nylon membrane (Hybond N) was cut to fit the dimensions of the gel (see section 2.6.4) 
and floated on deionised water, it was then submerged and wet thoroughly. The membrane was 
soaked in transfer buffer (1 0 x SSC) until used. The gel was kept in low ionic strength buffer prior to 
the transfer. The RNA was transferred from the gel to the membrane by capillary action. A piece of 
Whatman 3MM paper was cut 10 - 20 em longer than the gel, saturated with transfer buffer and 
placed on a glass plate. The ends of the paper wick were draped into a buffer reservoir. The gel was 
laid onto the wick of chromatography paper, and the prewet nylon membrane was placed on it, 
followed by 2 - 3 pieces of gel blot paper cut to fit the gel. Any air bubbles trapped between the layers 
were removed by rolling a pipette back and forth over every layer. The sides of the gel were 
surrounded by clingwrap film to prevent the paper on top of the gel from coming into contact with the 
lower layer of gel blot paper. A stack of paper towels was placed on the gel blot paper, and the blot 
was secured with a light weight. The transfer was carried out overnight, and the transfer efficiency 
was checked by staining the gel with acridine orange (33 J..lg/ml). The membrane was washed with 5 x 
SSC for 5 minutes after the transfer was complete, and the RNA was crosslinked to the membrane 
under UV light (A = 254 nm). 
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2.6.5.2 Northern Hybridisation Procedure 
The membrane was placed in a heat sealable bag with 0.25 ml/cm2 prehybridisation buffer (50 % 
(v/v) forrnamide, 5 X Denhardt's reagent, 10 mM NaHzP04 (pH 7), 5 X sse, 0.1% SDS, 5 ing/ml 
denatured low molecular weight DNA) for 16 hours at 42°e with gentle agitation. The 
prehybridisation solution was removed from the blot and replaced with 0.1 ml/cm2 hybridisation 
solution (50% (v/v) forrnamide, 5 X Denhardt's reagent, 10 mM NaHzP04 (pH 7.0), 5 X sse, 0.1 % 
(w/v) SDS, 5 mg/ml denatured low molecular weight E.coli DNA) together with the relevant heat 
denatured, nick translated or MegaPrime labelled probe (5- 20 ng/ml). Hybridisation was carried out 
at 42°e for 12- 24 hours with gentle agitation. 
2.6.5.3 Washes and Autoradiography 
The blot was removed from the plastic bag and washed as follows: twice in 2 x sse, 0.1 % SDS for 5 
minutes at room temperature, twice in 2 X sse, 0.1 % SDS for one hour at 65°e, and the final washes 
were in 2 x SSC for 2 minutes at room temperature. The membrane was blotted slightly, sealed in a 
plastic bag and autoradiographed. 
2.7 Synthesis of eDNA by Reverse Transcription of RNA 
RNA-dependent DNA polymerase (reverse transcriptase) was used to transcribe mRNA into eDNA. 
Either total RNA or poly-A+ RNA (both 5 J.tg) was treated with 5 U DNase 1 (10 U/J.tl Boehringer 
Mannheim) in 1 X MMLV Reverse Transcriptase Buffer (15 mM Mgel2, 375 mM KCI, 250 mM 
Tris.Hel (pH 8) (Promega)), containing 0.5 J.i.l RNasin (40 U/J.tl, Boehringer Mannheim) for 30 
minutes at 37°C. The RNA was extracted once with phenol (pH 4) and once with chloroform. It was 
adjusted to 0.3 M Na-acetate and precipitated with 2.5 volumes absolute ethanol. The RNA was 
pelleted for 20 minutes at 14 000 rpm, washed with 70% ethanol and air dried before resuspending it 
in 15 J.tl RNase-free water. RNA (1 J.tg) was denatured at 70°e for 10 minutes, and placed on ice. 
Reverse transcription mix (1 J.tl dNTPs (10 mM), 4 J.tl 5 X reaction buffer (15 mM J\1'gelz, 375 mM 
KCl, 250 mM Tris.Hel (pH 8)), 0.5 J.i.l RNase inhibitor (40 U/J.tl), 1 J.tl random primer (200 J.tg/ml), 1 
J.i.l MML V Reverse Transcriptase (200 U/J.tl) was added to each RNA sample in a final volume of 20 
J.tl. The samples were stirred gently, incubated at room temperature for 10 minutes and placed at 37°C 
for 50 minutes. Finally they were heated to 70°C for 15 min. The synthesised eDNA was kept on ice 
until it was amplified by PCR or stored at -20°e. 
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2.8 eDNA Library Expression Screening Using a DNA Ligand 
2.8.1 Catenated DNA Probes 
Double stranded oligonucleotide probes used to expression screen the eDNA library were generated 
by annealing complementary synthetic DNA strands (see section 2.4). Each ds oligonucleotide was 
phosphorylated according to standard reaction conditions specified by the supplier. Typically a 
phosphorylation reaction contained 120 Jlg oligonucleotides, 1 X T4 polynucleotide kinase buffer (50 
mM Tris.HCl (pH 8.2), 10 mM MgC12, 0.1 mM EDTA, 5 mM DTT), 100 mM ATP, 50 J.1Ci [y-
32P]ATP, and 30 Jll T4 polynucleotide kinase (1 U/Jll, Boehringer Mannheim). The reaction was 
allowed to proceed at 37°C for 3 hours. The enzyme was inactivated by heating it to 70°C for 10 
minutes, and the DNA was purified by organic extraction. The DNA was precipitated by the addition 
of 0.1 volume 3 M sodium acetate and 2.5 volumes absolute ethanol. The DNA was pelleted (12 000 
rpm, 20 minutes, 4°C), washed with 70 % ethanol and resuspended in a final volume of 100 Jll, 
containing 66 mM Tris.HCl (pH 7 .5), 5 mM MgC12, 1 mM DTT, 1 mM ATP and 50 U T 4 DNA ligase 
(5 U/Jll). The ligation reaction was incubated for 16 hours at 15°C, and the catenated DNA attained a 
mean length of 180 bp. 
Radiolabelled probe was prepared using the Prime-a-Gene Labelling System (Promega). The DNA 
template (25 ng) was denatured at 95°C- 100°C for 2 minutes and combined with 1 X labelling buffer 
(50 mM Tris.HCl (pH 8), 5 mM MgC12, 2 mM DTT, 200 mM Hepes (pH 6.6) and 5 A260 units/ml 
random hexadeoxyribonucleotides), 20 JlM of each nonlabelled dNTP, 400 Jlg/ml nuclease-free BSA, 
5 Jll [a-32P]dCTP (50 J.1Ci, 3000 Ci/mmol) and 1 Jll Klenow enzyme (5 U/Jll). The volume was 
adjusted to 50 Jll with sterile water, and the reaction was incubated at room temperature for 60 
minutes. The reaction was stopped by heating it to 95°C - 1 00°C for 2 minutes and addition of 2 Jll 
0.5 M EDT A. The labelled DNA was separated from the unincorporated nucleotides by size exclusion 
on a Sephadex G-50 spin column (see section 2.5.5). Specific activity of the DNA template was 
typically 0.4- 1 X 108 cpm/Jlg. 
2.8.2 Preparation of Nitrocellulose Filter Replicas 
The DNA ligand screening method was carried out according to a protocol described by Singh et al 
(1989) (174). The E.coli host strain BB4 (Stratagene) was grown to saturation in LB medium 
containing 0.2 % (w/v) maltose and 10 mM MgS04.7H20 at 37°C. Aliquots of the culture (500 Jll) 
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were infected with 3 - 5 X 10
4 
pfu of a A.ZAP eDNA expression library (a gift from Prof. E. Davidson 
(Caltech)), which was derived from 24 hour Strongylocentrotus purpuratus embryos. The bacterial 
cells were incubated for 15 minutes at 37°C to allow phage adsorption. Top agarose (9 ml), 
equilibrated to 47°C, was added to each aliquot of infected cells. The mixture was inverted twice and 
spread on prewarmed LB I tetracycline plates (150 mm). The LB plates were incubated at 42°C for 
about 3 hours until tiny plaques were visible. Each LB plate was overlayed with a nitrocellulose filter 
(Amersham) which had been soaked in 10 mM IPTG for 30 minutes and air dried. The LB plates 
were incubated at 3 7°C for 6 hours. The position of the filter was marked on each plate. The filters 
were lifted off the plates, air dried for 15 minutes at room temperature and immersed in binding 
buffer (25 mM Tris.HCl (pH 7.9), 25 mM NaCI, 5 mM MgC12, 0.5 mM DTT) supplemented with 6 M 
guanidine hydrochloride (GuHCI). The filters were incubated with gentle shaking at 4°C for 10 
minutes. All filters were processed in the same petri dish. This step was repeated with fresh binding 
buffer containing 6 M GuHCI. The second wash was supplemented with an equal volume of binding 
buffer without GuHCI, and the filters were incubated for 5 minutes. The 100 % dilution step was 
repeated four times, and the final step was followed by 2 washes with unsupplemented binding buffer 
for 5 minutes at 4°C. The filters were blocked for 30 minutes at 4°C with a solution containing 3 % 
(w/v) BSA, 50 mM Tris.HCl (pH 7.5), 50 mM NaCI, 1 mM EDTA, 1 mM DTT and 0.05 % (v/v) 
Tween-20. This solution was replaced with binding buffer containing 0.15 % (w/v) BSA and 0.05 % 
(v/v) Tween-20, the filters were immersed for 1 minute at 4°C and then screened with radiolabelled 
probe. 
2.8.3 Screening of Nitrocellulose Filter Replicas 
Filters were screened in batches by incubating them in 25 ml binding buffer containing 107 cpm of 
radiolabelled specific DNA probe, and 150 Jlg poly[d(I-C)] (Boehringer Mannheim). The binding 
reaction was incubated for 1 hour at 4°C with gentle shaking. The filters were washed with 4 changes 
of binding buffer (7.5 minutes each wash, 4°C). The filters were air dried on blotting paper and 
autoradiography was performed overnight ( -70°C) with an intensifying screen. 
2.8.4 Identification and Purification of Sequence Specific Clones 
The presumptive positive plaques were identified by aligning autoradiographs of duplicate filters and 
identifying overlapping signals. Agarose plugs corresponding to positive signals were stabbed out of 
the plates with a pasteur pipette and secondary phage stocks were prepared according to Maniatis et al 
43 
(1982) (169). The agarose cores containing the positive plaques were placed in 1 ml suspension 
medium (100 mM NaCl, 0.2 % MgS04.7H20, 50 mM Tris.HCl (pH 7.5) and 2 % (wlv) gelatin) 
containing one drop of chloroform, and incubated at room temperature for 2 hours. The secondary 
phage stock were stored at 4°C indefinitely. The secondary phage stock (ca. 5 X 103 pfu) were mixed 
with an aliquot (200 Jll) of E.coli BB4 cells (overnight culture grown in LB, supplemented with 10 
mM MgS04.7H20 and 0.2% (wlv) maltose) and incubated for 15 minutes at 37°C. Top agarose (3 
ml) equilibrated to 47°C was added to the mixture and inverted twice before spreading· onto 
prewarmed LB I tetracycline plates (1 00 mm). The nitrocellulose filter replicates were prepared as 
above (see section 2.7.2). The secondary filters were screened with the wildtype recognition site DNA. 
probe (concatenated specific oligo), as well as a control DNA probe (nonspecific oligonucleotide) 
which lacks the DNA-binding site (see fig 2.1 for sequences). Phage which were detected specifically 
with the wild-type recognition probe but not the control DNA were plaque purified. 
2.9 Lambda Zap Automatic Excision Process 
The pBluescript vector (containing. the eDNA inserts of interest) was excised from the secondary 
phage stock according to the Stratagene ExAssist I SOLR System manual. The two E. coli host strains, 
SOLR™ and XL1-Blue, were revived by streaking them onto LB plates containing kanamycin (20 
Jlglml) and tetracycline (12.5 Jlglml) respectively, and incubating them overnight at 37°C. Single 
colonies were inoculated into 5 ml LB supplemented with 0.2% (wlv) maltose and 10 mM MgS04, 
and grown overnight at 30°C to prevent overgrowing. The cells were pelleted at 1000- 2000 X g for 
10 minutes, and gently resuspended in 0.5 volumes 10 mM MgS04 • The following components were 
combined in a test tube: 200 Jll XL1-Blue cells (OD600 = 1), 100 Jll isolated phage stock, and 1 J.!l 
ExAssist (Stratagene) helper phage (> 1 X 106 pfulml). The mixture was incubated at 37°C for 15 
minutes, 3 ml of 2 X YT medium (10 g NaCl, 10 g yeast extract, 16 g bactotryptone per liter) was 
added and the mixture was incubated at 37°C for 3 - 5 hours without shaking. The tubes were then 
heated at 70°C for 20 minutes and spun for 15 minutes at 4000 X g (Beckman JA20.1 rotor). The 
supernatant, containing the plasmid packaged as a filamentous phage particle, was decanted into a 
sterile tube and stored at 4°C for up to 2 months. The rescued phagemid was plated b)' aliquotting 200 
Jll of SOLR™ (Stratagene) cells (OD600 = 1) into separate tubes and adding either 1 J.!l or 50 J.!l of 
phage stock to each tube. The tubes were incubated at 37°C for 15 minutes, and the cells (100 Jll) 
were plated on LB I ampicillin plates and incubated at 37°C overnight. To maintain the pBluescript 
plasmid, colonies were restreaked onto new LB I ampicillin plates. Glycerol stocks for longterm 
storage were kept at -70°C. 
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2.10 Preparation of Genomic DNA from Sea Urchin Sperm 
Genomic DNA was isolated according to the method described by Ausubel et al (1987) (151). Adult 
sea urchins (P.angulosus) were induced to spawn by injecting them with 0.5 M KCl (5 ml). Sperm 
was collected (2 ml) and washed twice with PBS. The sperm was pelleted by centrifugation at 500 X 
g, and the supernatant was discarded. The sperm was resuspended in at least 2 volumes digestion 
buffer {100 mM NaCl, 10 mM Tris.HCl (pH 8), 25 mM EDTA {pH 8), 0.5% (w/v) SDS, and 0.1 
mg/ml proteinase K). Cell lysis was achieved by shaking the solution at 50°C for 12 - 18 hours. 
Genomic DNA was extracted by mixing the lysed sample with an equal volume of PCI 
(phenol:chloroform:isoamyl alcohol= 25:24:1, pH 8). The phases were separated by centrifugation at 
12 000 rpm for 2 minutes in a microfuge. The organic extraction step was repeated four times. The 
DNA was precipitated by addition of 0.5 volume of 7.5 M ammonium acetate and 2 volumes 100% 
ethanol (room temperature). DNA was recovered by centrifugation at 1 700 X g for 2 minutes, and 
washed with 70 % ethanol. The pellet was air dried and resuspended in TE. The DNA was stored at -
20°C. 
2.11 The Polymerase Chain Reaction (PCR) 
The polymerase chain reaction was used to amplify specific segments of DNA in vitro. Either 
genomic DNA, eDNA or plasmid DNA was used as a template for the amplification. Generally, a 
basic protocol (as described by Ausubel et al (1987) (151)) was applied. First the samples were 
denatured at 94°C, then the primers were annealed to the single-stranded DNA (annealing 
temperatures depend on primer sequence and length) and finally the extension reactions using Taq 
DNA polymerase were performed at 72°C or 68°C. The 3 steps were repeated 25 to 40 times in a 
Stratagene Robocycler Gradient 40. 
2.11.1 Amplification of Specific DNA-Fragments 
The polymerase chain reaction was carried out according to Ausubel et al (1987) (151) and was 
modified depending on the template DNA. PCR using genomic DNA or eDNA was performed in a 
final reaction volume of 50 J!l in 0.5 ml PCR tubes. The reaction mix was prepared by combining 
template DNA (100- 1000 ng), 5 J!l 10 X PCR reaction buffer {200 mM Tris.HCI (pH 8.4), 500 mM 
KCl, GibcoBRL), 1 J!l dNTPs (10 mM), 0.4 J!l Taq (5 U/J!l Taq DNA polymerase from Thermus 
aquaticus YTl, GibcoBRL), 1 J!l of each primer (20 pmol!J.Ll) and adjusting the final MgC}z 
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concentration to 0.5 - 4 rnM. Sometimes DMSO, formamide and I or glycerol were included in the 
reactions. The samples were adjusted to 50 J.!l with nuclease-free water and covered with 50 J.!l 
mineral oil. Thermal cycling took place in a Stratagene Robocycler Gradient 40. Generally the 
programme was set for 35 cycles; each cycle constituted an incubation at 94°C for 1 min, followed by 
a 55°C incubation for 1 min, and the final step was a 1 min incubation at 72°C or 68°C. The final step 
included a 10 min incubation at 72°C or 68°C. 
2.11.2 Colony Screening for Recombinant Plasmid by PCR 
For screening of bacterial colonies by PCR a single colony of a freshly plated transformed bacterial 
culture was placed into 20 J.!l of sterile water. Bacterial mix (5 J..Ll) was transferred 'into a 0.5 ml PCR 
tube and each screening reaction was prepared by adding 0.5 J.!l 10 rnM dNTP, 2 J.!l 10 X PCR buffer 
(200 rnM Tris.HCl (pH 8.4), 500 mM KCl), 0.6 J.!l 50 rnM MgCh, 0.4 J.!l Taq polymerase (5 UIJ.!l Taq 
DNA polymerase, GibcoBRL) and 1 J.!l of each primer (20 pmol). The final reaction volume was 
adjusted to 20 J.!l with water and samples were covered with 50 J.!l of mineral oil. Thermal cycling was 
performed as described above (the annealing temperature was 50°C instead of 55°C) in a Stratagene 
Robocycler Gradient 40. Glycerol stocks of each colony were made by adding of 1 ml LB containing 
50 mglml ampicillin to the remaining 15 J.!l of water (starter solution). The cell suspension was 
incubated overnight at 37°C with shaking and glycerol was added to a final concentration of 20 % 
(vlv). The bacterial glycerol stocks were stored at -20°C or at -70°C. 
2.11.3 Rapid Amplification of eDNA Ends (RACE) 
The eDNA amplification protocol outlined in the ClonTech Marathon RACE manual was followed 
for all reactions. Reactions were performed on ice unless otherwise indicated. 
2.11.3.1 First Strand eDNA Synthesis 
Total RNA (1 J..Lg) isolated from 14 hour sea urchin embryos (P.angulosus) was combined with 1 J.!l 
eDNA synthesis primer (10 J..LM). The volume was adjusted to 5 J.!l with nuclease-free water, and the 
contents of the tube was mixed and spun briefly. The mixture was incubated at 70°C for 2 minutes, 
and cooled on ice. First strand synthesis was performed by combining the RNA I primer mix with first 
strand buffer (1 X), 1 rnM dNTP mix, and 10 U MML V reverse transcriptase (all ClonTech) in a total 
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volume of 10 J.ll. The contents of the tube was mixed briefly and collected at the bottom of the tube. 
The reaction was incubated at 42°C for 1 hour. First strand synthesis was terminated by placing the 
tube on ice. 
2.11.3.2 Second Strand Synthesis 
First strand eDNA (10 J.ll) was combined with 48.4 J.ll sterile water, 1 X second-strand buffer 
(ClonTech), 1.6 J.ll dNTP mix (10 mM) and 5 X second-strand enzyme cocktail containing RNase H 
(0.25 UIJ.!l), E.coli polymerase I (6 UIJ.!l) and E.coli DNA ligase (1.2 UIJ.!l). The mixture was 
incubated at l6°C for 90 minutes. T4 DNA polymerase (10 units) was added to the reaction and the 
incubation was continued at l6°C for 45 minutes. Second strand synthesis was terminated by addition 
of 4 J.ll EDTA I glycogen mix (ClonTech) to the reaction. The DNA was extracted with 100 J.ll of 
phenol:chloroform:isoamyl alcohol (25:24:1), followed by a chloroform:isoamyl alcohol (24:1) 
extraction. The aqueous layer was removed and supplemented with 0.5 volume 4 M ammonium 
acetate and 2.5 volumes 96% (vlv) ethanol. The DNA was precipitated in a microfuge at 14 000 rpm 
(room temperature) for 20 minutes. The DNA pellet was washed with 300 J.ll 80% (vlv) ethanol, and 
the supernatant was removed. The pellet was air dried to evaporate the residual ethanol. The 
precipitate was dissolved in 10 J.ll water and the eDNA (2 J.ll) was analysed on an 1.2 % agarose I 
EtBr gel with suitable DNA size markers. 
2.11.3.3 Adaptor Ligation 
The double stranded eDNA (5 J.ll) was combined with 2 J.ll Marathon eDNA Adaptor (10 J.!M, 
ClonTech), 2 J.!l5 X DNA ligation buffer (25 mM Tris.HCl (pH 7.8), 5 mM MgC12, 0.5 mM DTT, 0.5 
mM ATP and 5 % (wlv) PEG (MW 8000)), and 1 J.ll T4 DNA ligase (1 UIJ.!l). The reaction was 
incubated at 16°C overnight, and the DNA ligase was inactivated by heating to 70°C for 5 minutes. 
The adaptor ligated eDNA was diluted 1:10 with Tricine I EDTA buffer, and heated to 94°C for 2 
minutes to denature the double stranded eDNA. The tube was cooled on ice and stored at -20°C. 
2.11.3.4 PCR Amplification of 5' and 3' eDNA Ends 
Each PCR reaction was performed in a final volume of 50 J.ll, and contained 5 J.ll diluted (1:100) 
adaptor ligated ds eDNA, 1 X KlenTaq PCR buffer (40 mM Tricine-KOH (pH 9.2), 15 mM KOAc, 
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3.5 mM Mg(OAc)2 and 75 Jlglml BSA, ClonTech), lJ.ll dNTP mix (10 mM), 1 X Advantage KlenTaq 
Polymerase Mix (1 %glycerol, 0.8 mM Tris.HCl (pH 7.5), 1 mM KCl, 0.5 mM (NH4) 2S04, 2 11M 
EDTA, 0.1 mM [3-mercaptoethanol, 0.005 % Thesit, ClonTech) and 1 Jll of the appropriate primers 
(1 0 JlM). The 5' and 3' RACE reactions were performed using a combination of adaptor primer 1 
(API, Clontech) and individual gene specific primers (SP2 and SPl respectively, see Appendix VII). 
Three negative control PCR reactions were performed using 5 Jll diluted adaptor ligated ds eDNA and 
one of the API, SPl and SP2 primers individually. The PCR reaction mixtures were overlayed with 
two drops of mineral oil and the thermal cycling was performed in an automatic thermocycler 
(Stratagene Robocycler Gradient 40). The programme was set for 30 cycles, each cycle involved a 30 
second denaturation at 94°C, a 60°C annealing step for 30 seconds, and the extension was a 4 minute 
incubation at 68°C. Finally the sample was incubated at 68°C for 10 minutes. Aliquots (5 Jll) of each 
sample were analysed on an 1.2 % agarose I EtBr gel. RACE products were subsequently 
characterised by Southern blot analysis (see section 2.12) and automated DNA sequencing. 
2.11.3.5 Fusion of 5' and 3' RACE Products to Form Full Length eDNA 
Full length eDNA was generated by fusion of the 5' and 3' RACE PCR fragments (see section 
2.11.3.4), as described in the ClonTech protocol. The 5' and 3' RACE PCR products were purified on 
an 1 % (wlv) low melting point agarose gel (Seaplaque) in TAE buffer with ethidium bromide (0.3 
Jlglml). The DNA was separated from the agarose using a Wizard PCR Preps Column (Promega) and 
resuspended in a final volume of 50 Jll. The 5' I 3' fusion reaction was performed in 0.5 ml PCR tubes, 
containing 50 ng of both 5' and 3' PCR products (see section 2.11.3.4), 1 X KlenTaq PCR buffer (40 
mM Tricine-KOH (pH 9.2), 15 mM KOAc, 3.5 mM Mg(OAc)2 and 75 Jlglml BSA, 0.5 Jll dNTP mix 
(10 mM) and 1 X Advantage KlenTaq Polymerase Mix (1 % (vlv) glycerol, 0.8 mM Tris.HCl (pH 
7.5), 1 mM KCl, 0.5 mM (NH4) 2S04, 211M EDTA, 0.1 mM J3-mercaptoethanol, 0.005% Thesit). All 
reagents were from ClonTech. The volume was adjusted to 20 Jll with water. The contents of the tube 
was overlaid with 2 drops of mineral oil and thermal cycling was performed in a Robocycler Gradient 
40 (Stratagene) at 94°C for 30 seconds and 68°C for 30 minutes. The program was set for 10 cycles. 
The fusion product was analysed on an 1 % (wlv) agarose gel in TBE. The fused full-length eDNA 
was diluted (1:100) with Tricine I EDTA (10 mM Tricine-KOH (pH 8.5), 0.1 mM EDTA) and 5 Jll of 
the dilution was used in a PCR amplification, containing 1 X KlenTaq PCR buffer, 1 J.ll dNTP (10 
mM), 1 )ll API (10 JlM), 1Jll eDNA synthesis primer (10 J.LM) and 1 X KlenTaq Polymerase Mix (all 
reagents from ClonTech). The final volume of the reaction was adjusted to 50 Jll with water. The 
mixture was overlaid with 2 drops of mineral oil, incubated at 94°C for 1 minute, and thermal cycling 
48 
was performed for 15 cycles. Each cycle was 30 seconds at 94°e, 30 seconds at 55°e followed by 
68°e for 5 minutes. The PeR amplification reaction was analysed on an 1 % (wlv) agarose gel in 
TBE. The full length product was purified on a preparative low melting point agarose gel (Seaplaque) 
in TAE, and the full length eDNA sample was recovered using a Wizard PeR Prep column 
(Promega). 
2.12 Southern Blot Analysis 
The Southern blotting procedure was performed as described in the Amersham Hybond booklet. DNA 
samples were electrophoresed in an 1 % (wlv) agarose I TBE gel. After electrophoresis the agarose 
gel was placed in denaturing solution (1.5 M Nael, 0.5 M NaOH) for 30 minutes at room temperature 
with gentle agitation. The gel was rinsed with water and placed in neutralisation buffer (1 .5 M NaCl, 
1 mM EDTA, 0.5 M Tris.Hel (pH 7.2) for 15 minutes at room temperature with gentle agitation. The 
water wash and the neutralisation step were repeated once. For the capillary blot a glass dish was 
filled with blotting buffer (20 X SSC). The platform was covered with a wick made from three sheets 
of Whatman 3MM filter paper saturated with 5 X SSe. The gel was placed on the wick and 
surrounded with cling wrap to prevent the blot from drying out. A sheet of Hybond N+ membrane 
(Amersham) was cut to the exact size of the gel and placed on the gel after wetting it in 5 X sse. The 
membrane was covered with three sheets of Whatman 3MM paper cut to size and wetted with blotting 
buffer. A stack of absorbent paper towels was placed on top of the 3MM paper (approximately 5 em 
high). A glass plate with a 1 kg weight was placed on top of the paper towels and the transfer was 
allowed to proceed for 16 hours. The blotting apparatus was dismantled and the membrane was 
marked with a pencil to allow later identification of the tracks. The membrane was washed briefly in 
2 X sse to remove any adhering agarose. It was then placed (with the DNA side up) on three layers 
of Whatman 3MM paper soaked in 0.5 M NaOH for 20 minutes in order to fix the DNA. The 
membrane was immersed in 5 X SSe for less than a minute. The membrane was placed in a 
hybridisation box with 80 ml of prehybridisation solution (6 X sse, 0.4 % (wlv) SDS, 5 X 
Denhardt's, 20 mM NaH2P04 (pH 7.5), 0.5 mglml denatured herring sperm DNA) at 60°e and was 
gently agitated for one hour. The prehybridisation solution was replaced with hybridisation buffer (6 
X SSC, 20 mM NaH2P04 (pH 7.5), 0.5 mglml denatured herring sperm DNA) containing the heat 
denatured labelled probe (50 ng at 0.5 X 106 dpm/ng). The membrane was incubated in hybrisation 
buffer for 3 hours at 60°e. It was washed three times in 6 X SSe I 0.1% SDS for 10 minutes at 42°e, 
three times in 1 X SSe I 0.1 % SDS for 10 minutes at 60°e, and three times in 0.1 X SSe I 0.1 % 
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SDS for 10 minutes at 65°C. The membrane was wrapped in plastic and autoradiographed overnight 
at -70°C. 
2.13 Cloning of eDNA into Plasmid Vectors 
2.13.1 Ligation ofPCR Products into T-Vectors 
PCR products were ligated into the pMOS BlueT-vector (Amersham) or pGEM-T vector (Promega) 
according to the supplier's recommendations. The pMOS Blue T-vector ligation reaction was 
prepared by combining 1 ~I ligase buffer (10 X), 0.5 ~I DTT (100 mM), 0.5 ~I ATP (10 mM), 1.0 ~I 
vector (50 ngi~I) and 0.5 ~I T4 DNA ligase (2 - 3 Weiss units) with the PCR products in a final 
volume of 10 ~1. All reagents were available in the Amersham pMOS BlueT-vector kit. Insert DNA 
was either purified by Wizard™ PCR preps (see section 2.5.2) or used directly in low melting agarose 
slices. The reactions were stirred gently with pipette tips and incubated at l6°C overnight. The 
ligation reactions were stored at 4°C until they were transformed into bacteria (see section 2.2.2) 
The pGEM-T vector system was used as outlined in the pGEM-T Vector Systems manual (Promega). 
PCR products were gel purified (see section 2.5.2) prior to the ligation reaction. Each ligation 
reaction contained 1 X T4 DNA Ligase Buffer (30 mM Tris.HCI (pH 7.8), 10 mM MgC12, 10 mM 
DTT and 1 mM ATP), 50 ng pGEM-T Vector, 3 Weiss units T4 DNA ligase, and 150 ng PCR 
product. The final volume was adjusted to 10 f.ll using nuclease-free water,. The reactions were mixed 
by pipetting, and they were incubated at l6°C for 2 - 18 hours, 2 ~I of the ligation mixture was 
transformed into bacteria (see section 2.2.2). 
2.13.2 Subcloning eDNA Inserts 
eDNA fragments obtained by DNA expression screening were subcloned into the prokaryotic 
expression vectors pET-29b(+) (Novagen), pGEX-3X (Pharmacia) and the eukaryotic expression 
vector pCIS (185). The eDNA fragments were released from pBluescript using restriction enzymes 
EcoRJ, BamHJ I Sa/1 or Sac] I Xhol, which did not cut the inserts. The prokaryotic expression 
vectors were linearised with the same combinations of enzymes. The eDNA insert cloned into the 
pCIS vector was released from the pET-29b(+) vector using the Xball Notl sites. eDNA inserts were 
separated from the original vector DNA by electrophoresis on 1 % (wlv) low melting point agarose I 
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TAE gels. The DNA fragments were excised from the gel with a sterile blade after visualisation of the 
bands using UV light (A. = _342 nm). DNA was purified from the agarose using the Gene-Clean 
protocol (USB). Essentially the DNA I agarose was dissolved in 3 volumes 6 M Nal at 55°C for 5 
minutes, and 5 J.tl glass powder suspension was added. The DNA was allowed to adhere to the glass 
powder by incubating the mixture on ice for 5 minutes. The suspension was centrifuged for 5 - 10 
seconds (12 000 rpm) and the glass powder pellet was rinsed with 50% ethanol rinse buffer. (A 50-
fold excess of buffer to glass powder was used.) The suspension was centrifuged for 5- 10 seconds, 
and the wash step was repeated twice. After . the final centrifugation, the glass powder was 
resuspended in 1 - 2 volumes TE and the DNA was eluted by incubation at 55°C for 2 - 5 minutes . 
. The DNA concentrations were estimated by comparison to DNA standards dotted onto agarose I 
ethidium bromide plates. Ligation reactions were performed according to the pMOSBlue T-vector kit 
(Amersham, and see section 2.13.1), ensuring a vector : insert ratio of 1 : 10. Vector (pET-29b(+), 
pGEX-3X or pCIS (see Appendix VIII)) was combined with the appropriate insert in a final ligation 
reaction volume of 10 J.tl and incubated at 16°C for 16 hours. The ligation mixture (5 J.tl) was used to 
transform competent JM109 or DHSa. cells (see section 2.2.2), which were then plated on LB plates 
containing the appropriate antibiotic. 
2.14 Bacterial Target Gene Expression 
2.14.1 Recombinant Protein Expression from pBluescript 
Pilot experiments were performed as described in the Stratagene manual in order to optimise 
expression of the 13-gal fusion protein from pBluescript. Several E.coli strains (eg XLI-Blue, JM109, 
DHSa. and SOLR ™ cells) containing the pBluescript plasmid with the insert of interest were grown 
to mid-log phase (OD600 = 0.2) at 37°C. IPTG (100 mM) was added to a final concentration of 1 mM. 
The cells were grown to stationary phase (OD600 = 1) and pelleted_at 1600 X g (Beckman, JA 20.1 
rotor) for 15 ininutes. The cell pellet was resuspended 1 : 4 (w: v) in lysis buffer (50 mM Tris.HCl 
(pH 8), 1 mM EDTA, 1 mM PMSF, 10 % (wlv) sucrose). Lysozyme was added to a final 
.. 
concentration of 1 mg/ml and the cells were incubated on ice for 10 minutes. ·The cells were 
supplemented with Triton X-100 (0.1 %final concentration) and the lysed cells were pelleted at 20 
000 rpm (Beckman, JA 20.1 rotor) for one hour. The supernatant contained the soluble protein and 
was stored at -70°C. Both the supernatant and the cell pellets were analysed on SDS gels, which were 
either Coomassie stained or silver stained (see section 2.24) . 
. 
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2.14.2 Recom_binant Protein Expression from pET-29b(+) 
The recombinant pET-29b(+) plasmids were established in a variety of E.coli strains (viz HB101, 
JM109 and DH5a) by transforming the respective cells and allowing them to grow on LB I 
kanamycin plates at 3rC. The plasmids were isolated from these hosts and transformed into two 
different expression hosts, viz BL21DE3 or BL21DE3(pLysS) (both Novagen). 
Pilot experiments establishing the optimum conditions of recombinant protein expression were 
performed according to the pET System Manual (Novagen). Expression conditions were optimized by 
varying several conditions, eg E.coli hosts in which the plasmid was established, expression host, 
culture volume, length of induction and temperature of induction (16°C - _37°C). Single bacterial 
colonies were picked from fresh LB I kanamycin plates, and grown to saturation in 10 ml LB I 
kanamycin overnight. Fresh LB I kanamycin (1.8 ml) was then inoculated with 200 Jll of starter 
cultUre and grown for 2 hours until Ob600 = 0.4- 0.6. The cells were induced to express recombinant 
protein with a final concentration of 1 mM IPTG. The induction was allowed to .proceed between 1 
and 6 hours. Protein induction was assayed by removing 200 Jll of cell culture and electrophoresing 
the cell pellet by SDS-..PAGE. 
2.14.3 Purification ofRecombinant Proteins Expres_sed frompET-29b(+) 
2.14.3.1 Isolation of Soluble Protein Fraction 
Isolation of the soluble protein fraction from E.coli cells was performed according to a method for 
recombinant protein isolation from bacteria (Stratagene manual). A 10 ml culture of BL21DE3 cells 
(00600 = 0:6) containing the recombinant pET-29b(+) vector was induced to express recombinant 
protein (see section 2.14.2). Cells were pelleted (6 000 X g, 15 minutes, JA20.1 rotor (Beckman)), 
and the supernatant was removed. All subsequent steps were performed on ice. The cell pellet was 
resuspended in 2 mllysis buffer (50 mM Tris.HCl (pH 8), 1 mM EDTA, 1 mM PMSF and 10% (wlv) 
sucrose). The cells were lysed by the addition oflysozyme (1 mg/ml final concentration). The mixture 
. was incubated on ice for 10 minutes, and supplemented with Triton X-100 (final concentration 0.1% 
(v/V)). The mixture was incubated on ice for 10 minutes and the cell debris was pelleted by 
centrifugation (18 000 rpm, 50 minutes, JA20.1 rotor (Beckman)). Part of the supernatant was 
retained and stored in aliquots at -70°C, the remaining supernatant was dialysed against dialysis 
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buffer (20 mM Tris.HCl (pH 8), 100 mM KCl, 0.2 mM EDTA, 20% (v/v) glycerol, 4 mM MgC12 and 
2 mM ZnC12), divided into aliquots and stored at -70°C. 
2.14.3.2 Affinity Purification of Soluble Recombinant Protein Using a Ni2+ Column 
Recombinant prot~in was induced to express as described above (see section 2.14.2), and proteins 
were extracted in binding buffer (40 mM imidazole, 4 M NaCI, 160 mM Tris.HCl (pH 7.9)) 
supplemented with 4 mM PMSF and 20 ).lg/ml leupeptin. The cells were placed in an icebath and 
sonicated in small bursts until the suspension was no longer viscous. The preparation was centrifuged 
for 20 minutes (39 000 X g) to remove the cell debris. The protein extraction procedure was 
sometimes varied by the addition of lysozyme (1 mg/ml final concentration) and Triton X-100 (0.1% 
final concentration), and the length of sonication was also varied. All steps were performed at 4°C. 
The soluble protein extract was then subjected to affinity chromatography over a 2.5 ml Ni2+NTA 
agarose column which had been washed with 3 column volumes of sterile water, 5 column volumes of 
1 ~charge buffer (50 mM NiS04), and 3 column volumes of 1 X binding buffer (5 mM imidazole, 
0.5 M NaCl, 20 mM Tris.HCl (pH 7.9)). The bacterial cell extract was loaded onto the column and the 
flow rate was adjusted to 420 ).ll/min. The column was washed with 25 ml of 1 X binding buffer, 15 
ml of 1 X wash buffer and the protein was eluted with 15 ml of 1 X elution buffer (1 M imidazole, 0.5 
M NaCI, 20 mM Tris.HCl (pH 7 .9)). The eluate was collected in 1 ml fractions, which were stored at 
-70°C. Aliquots of each fraction were TCA precipitated and analysed by 12 % SDS-PAGE (see 
section 2.24). 
2.14.3.3 Inclusion Body Isolations 
Several methods were applied in order to isolate expressed recombinant protein from inclusion 
bodies. 
Cells (1 00 ml of culture) were induced to express recombinant protein as outlined in the pET Manual. 
The cells were pelleted (5000 X g, 5 minutes) and the supernatant was drained completely. The ce!ls 
were resuspended in 4 ml 1 X binding buffer (5 mM imidazole, 0.5 M NaCl, 20 mM Tris.HCl (pH 
7.9)). The resuspended cell pellet was sonicated in brief bursts to shear the DNA. The nonviscous 
lysate was centrifuged at 20 000 X g for 15 minutes to remove the debris. The 'supernatant was 
removed and the pellet was resuspended in 20 m1 of 1 X binding buffer (sonication was necessary. to 
resuspend the pellet). The inclusion bodies were pelleted as above and the centrifugation I 
. 
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resuspension I sonication step was repeated several times in order to release more trapped protein. 
The supernatant from the final centrifugation was removed and the pellet was resuspended in 5 ml 1 
X binding buffer containing 6 M guanidine HCI. The mixture was incubated on ice for one hour to 
completely dissolve the protein. The remaining insoluble material was removed by centrifugation at 
39 000 X g for 20 minutes. The supernatant was either stored at -70°C for further analysis and column 
purification, or it was dialysed into dialysis buffer and then stored at -70°C. A similar isolation 
procedure was followed where the guanidine hydrochloride in the binding buffer was replaced with 6 
Murea. 
Alternatively cells were induced to express recombinant protein as above, and the cell fractions were 
analysed according to Hoog et al (1991) (122). The cells were pelleted at 5000 X g for 5 minutes. 
The supernatant was discarded and the pellet was resuspended in 1/50 volume of Buffer Z (20 mM 
Hepes (pH 7.4), 40 mM KCl, 0.1 mM EDTA, 1 mM DTT, 20% (v/v) glycerol). Lysozyme was added 
(final concentration 2 mg/ml). The cells were incubated for 2 hours on ice and 1 mM PMSF was 
added to the mixture. The cell lysis was completed by 4 - 5 bursts of sonication. The suspension was 
supplemented with 1 mM DTT, 0.5 % (v/v) NP-40 and 5 % (w/v) sucrose. The insoluble material was 
removed by centrifugation at 10 000 X g for 15 minutes and the soluble supernatant was 
supplemented with 0.1 volume 4 M ammonium sulphate and glycerol (20 % (v/v) final 
concentration). The mixture was centrifuged at 100 000 X g to remove ribosomes and other particles, 
· and the soluble supernatant was either stored at -70°C or dialysed into dialysis buffer (20 mM 
Tris.HCl (pH 8), 100 mM KCl, 0.2 mM EDTA, 20% glycerol (v/v), 4 mM MgC12 and 2 mM ZnCh) 
and then stored at -70°C. 
A third method of inclusion body isolation was performed according the method outlined by Lin and 
Cheng (1991) (186). A 20 ml cell culture (OD600 = 0.4 - o:6) was induced to express recombinant 
protein by supplementing it with 1 mM IPTG. The induction was allowed to proceed for 3 hours at 
3 7°C. The cells were harvested by centrifugation at 5 000 rpm for 15 minutes. The cell pellet was 
frozen at -70°C and subsequently thawed on ice, it was then resuspended in 1 ml Buffer A (20 mM 
Tris.HCl (pH 7.5), 20% (w/v) sucrose and 1 mM EDTA). The suspension was incubate,~ on ice for 10 
minutes. The cells were pelleted at 4 000 X g for 20 minutes· and resuspended in ice cold water to 
release spheroplasts, which were then pelleted at 8 000 X g and resuspended in 250 J..Ll Buffer P (1 X 
PBS, 5 mM EDTA, 1 J..Lg/mlleupeptin, 20 J..Lg/ml aprotinin and 0.5 mM PMSF). The cell membranes 
were lysed by sonication (3 high intensity bursts for 10 seconds) and RNase A (100 J..Lg/ml) and 
DNase 1 (400 J..Lg/ 10 ml) were added to the lysate. The mixture was Incubated at room temperature 
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for 10 minutes and 800 J.Ll of Buffer P was added. The inclusion bodies were pelleted at 13 000 X g 
for 30 minutes (4°C) and resuspended in 800 J.Ll Buffer W (1 X PBS, 25 % (wlv) sucrose, 5 mM 
EDTA and 1 % (vlv) Triton X-100). The suspension was incubated on ice for 10 minutes and the 
inclusion bodies were pelleted for 10 minutes at 25 000 X g. The inclusion body wash procedure was 
repeated twice and finally the inclusion bodies were resuspended in 250 J.Ll Buffer D (50 mM 
Tris.HCI (pH 8), 5 M guanidine HCl, and 5 mM EDTA). The protein aggregates were sonicated for 5 
second pulses in order to solubilise them. The proteins were incubated on ice for one hour and 
centrifuged for 30 minutes at 12 000 X g. The supernatant was added to 2.5 ml Buffer R (50 mM 
Tris.HCl (pH 8.0), 1 mM DTT, 20 % (vlv) glycerol, 1 J.Lglml leupeptin, 20 J.Lglml aprotinin and 0.5 
mM PMSF). The mixture was gently stirred overnight to renature the recombinant proteins and the 
supernatant was clarified by centrifugation at 13 500 X g for 30 minutes. The supernatant (containing 
soluble protein) was analysed by SDS-PAGE and aliquoted to store at -70°C. 
2.14.4 Recombinant Protein Expression from pGEX-3X 
The procedure outlined in the GST Gene Fusion System Manual (Pharmacia) was used in order to 
screen recombinants for the expression of fusion proteins. pGEX-3X recombinant plasmids were 
transformed into different E.coli hosts (MC1061 and DH5a.), and several colonies from each host 
were picked into separate tubes containing 10 ml LB I ampicillin. Liquid cultures were grown at 37°C 
overnight. The starter culture (200 J.ll) was used to inoculate 1.8 ml LB I ampicillin. Cells were grown 
at 37°C for 1 hour until OD600 = 0.4- 0.6. Recombinant protein expression was induced by addition 
of 20 J.Ll IPTG (100 mM). Cells were incubated for 3 hours at 37°C, they were then pelleted for 1 
minute in a microfuge and the pellet was resuspended in 200 J.Ll SDS sample application buffer (1 X). 
The samples (20 J.Ll) were analysed by 12% SDS-PAGE. 
2.15 Eukaryotic Recombinant Gene Expression in COS-1 Cells 
(All reagents were at 37°C before use.) HBS buffer (pH 7.1) was 137 mM NaCI, 5 mM KCl, 0.7 mM 
NaH2P04, 21 mM Hepes. Hepes-DMEM was 10 mM Hepes in DMEM (Dulbecco's Modified Eagle's 
Medium). The DEAE Dextran stock solution was 3 mglml in HBS buffer, filter sterilised and stored 
at 4°C. The chloroquine stock solution (10 mM) was made freshly· and filter sterilised. The 
chloroquine DMEM solution was 200 J.lM chloroquine and 2 % fetal calf serum in DMEM. 
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COS-I cells were plated at a cell density of 7 X 106 cells per flask. They were supplemented with 25 
ml DMEM and 10% fetal calf serum (FCS), and allowed to grow at 37°C for 24 hours. The HBS I 
DEAE dextran (3 mglml) was diluted 10-fold in DMEM I P-5 and 80 Jlg DNA sample (pCIS vector 
only or vector containing insert) was added to 10 ml HBS I DEAE dextran I DMEM I P-5. The 
medium was aspirated from the cells and 15 ml Hepes I DMEM I P-5 was added to each flask, which 
was also aspirated from the cells. The DNA solution (as prepared above) was added to the cells and 
they were incubated at 37°C for 4 hours in a 10% C02 incubator. The medium was aspirated from the 
cells and 20 ml of chloroquine I DMEM solution was added to each flask. The cells were incubated at 
37°C for 50 minutes. The medium was aspirated from the cells, and the cells were washed gently 
using 15 ml serum-free DMEM I P-5. The medium was aspirated from the cells and replaced with 20 
ml DMEM I 10% FCS I P-5. The flasks were incubated at 37°C for 18- 24 hours and processed into 
cell extracts and nuclear extracts using a method described by Jiang et al (1995) (187). Cells were 
placed in Buffer H (140 mM NaCl, 4 mM KCl, 20 mM Hepes, 1 mglml BSA, 8.3 mM glucose, 1 mM 
DTT and 0.5 mM PMSF) containing 1 mM EDTA for 10 minutes at 37°C. The cells were scraped 
from the dishes using a rubber policeman and pelleted. The cell pellet was washed in 10 ml PBS, and 
resuspended in 2 X Buffer H containing 20 % (vlv) glycerol. The cells were exposed to 4 cycles of 
rapid freezing (dry ice) and thawing. The cellular debris and nuclei were separated from the cellular 
extract by centrifugation at 12 000 rpm for 15 minutes (4°C). The whole cell extract was aliquoted 
and stored at -70°C. Nuclear pellet was resuspended in 50 J.!l of 2 X Buffer H I 40 % (vlv) glycerol, 
and an equal volume 2 M KCl was added to the suspension dropwise, whilst mixing. The mixture was 
rolled at 4°C for 60 minutes and the extracts were centrifuged for 20 minutes at 12 000 rpm. The 
supernatant was removed and stored in aliquots at -70°C. 
2.16 In Vitro Coupled Transcription I Translation 
Eukaryotic in vitro translations were performed using either the TNT T3 Coupled Reticulocyte Lysate 
System or the TNT T7 Quick Coupled Reticulocyte Lysate System (both Promega). The kits were 
used according to the supplier's recommendations. All components were stored at -70°C. The lysate 
was stored in aliquots and never frozen and thawed more than twice, All reactions were performed 
using RNase-free glassware, plasticware and chemicals. The DNA templates were pBluescript or 
pGEM-T vectors containing the eDNA inserts of interest. "Translational grade" 35S-methionine (15 
mCilml, Amersham) or Trans 35S-label™ (- 10 mCi/ml, ICN) was used when radiolabelling the 
protein products. Sometimes an amino acid mixture containing no radiolabel was used. The reaction 
components (25 Jll TNT Rabbit Reticulocyte Lysate, 2 J.!l TNT Reaction Buffer, 1 J.!l TNT RNA 
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Polymerase, 1 Jll amino acid mixture Minus Methionine (1 mM), 4 Jll 35S-methionine (15 mCi/ml), 1 
Jll RNasin Ribonuclease Inhibitor (40 U/Jll, Promega), and 1 Jlg of DNA template) were assembled in 
a 1.5 ml microcentrifuge tube. The volume was adjusted to 50 Jll with RNase-free water. The reaction 
was incubated for 2 hours at 37°C and the samples were stored at -20°C. Samples were analysed by 
SDS-PAGE (see section 2.24) and EMSA (see section 2.21). 
2.17 Growth of Sea Urchin Embryos 
Sea urchins (P. angulosus) were collected in rock pools on the West Coast of the Cape Peninsula, at 
Melkbos Beach. The sea urchins were induced to spawn by injecting them with 5 ml 0.5 M KCl. The 
eggs were collected and filtered through two layers of cheesecloth, after which they were washed 
three times with filtered sea water. (Sea water was filtered through Whatman 3MM paper.) 50 ml 
sperm (1:500 dilution) was added per litre of 4 % (v/v) egg suspension which contained 100 mg/1 
penicillin and 50 mg/1 streptomycin in sea water. The cultures were shaken at 180 rpm (21°C) for 14 
hours. All subsequent steps were performed at 4°C. The cultures were allowed to settle, centrifuged 
(4 000 rpm, 1 sec, JA14 rotor) and washed three times with 0.5 M KCl. The embryos were either 
frozen at -70°C in 2 to 3 volumes nuclear storage buffer (Buffer A containing 25 % (v/v) glycerol) or 
processed immediately after washing once with 2- 3 volumes 0.25 M sucrose, 10 mM Tris.HCl (pH 
8), 0.1 mM EDTA. (Buffer A is 15 mM Tris.HCl (pH 8), 65 mM KCl, 15 mM NaCl, 0.15 mM 
spermine, 0.5 mM spermidine, 0.2 mM EDTA, 0.2 mM EGTA, 10 mM B-mercaptoethanol and 0.1 
mMPMSF.) 
2.18 Preparation of Nuclei 
Nuclei were prepared using several different methods. 
2.18.1 Method by Morris and Marzluff (1983) (188) 
All steps were performed at 4°C. The embryos were washed three times with 4 volumes 0.5 M KCl 
and once with 0.25 M sucrose in 10 mM Tris.HCl (pH 8), 0.1 mM EDTA, after which they were 
resuspended in Buffer A containing 0.32 M sucrose. The suspension was homogenised with a tight 
dounce for twenty strokes and cell breakage was monitored by light microscopy. The homogenate 
was adjusted to 1.8 M sucrose by adding the required volume of 2.3 M sucrose in Buffer A. The 
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homogenous suspension was centrifuged at 90 _ 000 g (Beckman ultracentrifuge) for 50 minutes. The 
nuclei were either processed directly or frozen in nuclei storage buffer at -70°C. 
2.18.2 Hexylene Glycol Method 
A method based on several procedures was followed (1). All steps were carried out at 4°C. Embryos 
were washed once with Hexylene glycol in Buffer A (HexA), resuspended in the same buffer and 
rolled for two hours. The suspension was homogenised for twenty strokes with a tight dounce and the 
cell breakage was monitored by microscopy. The intact nuclei were pelleted at 5 000 rpm for one 
minute, after which they were washed with HexA buffer and resuspended in the minimum volume of 
the same buffer. The suspension was adjusted to 1.8 M sucrose by adding the required volume of 2.3 
M sucrose in Buffer A. The nuclei were pelleted by centrifugation at 90 000 g (Beckman 
Ultracentrifuge) for 50 minutes. The nuclei were processed directly. 
2.18.3 Method by Calzone et al (1991) 
Preparation of nuclei was carried out essentially as described (120). The fresh embryos were washed 
with 1 M glucose, after which they were resuspended in buffer D I 0.36 M sucrose. Buffer D was 10 
mM Tris.HCl (pH 8), 1 mM EDTA, 1 mM EGTA, 1 mM spermidine, 1 mM PMSF. At this stage the 
embryos were frozen at -70°C. The frozen embryos were crushed and uniformly thawed for further 
processing. The nuclei were collected by centrifugation at 2 500 g for 40 minutes and washed in 
Buffer D three times. The nuclei were subsequently washed three times in Buffer D containing 0.1 % 
(v/v) NP-40. The nuclei were resuspended in 3 - 3.7 pellet volumes lysis buffer (10 mM HEPES (pH 
7.9), 1 mM EDTA, 1 mM EGTA, 1 mM spermidine-Tris-HCl, 1 mM DTT and 10% (v/v) glycerol). 
The nuclei were processed directly. 
2.19 Preparation of Nuclear Extracts 
All steps were performed at 4°C. Nuclei from 1 litre of fourteen-hour culture were resuspended in 32 
mllysis buffer (15 mM Tris.HCl (pH 8), 100 mM KCl, 3 mM MgCh, 0.1 mM EDTA, 1 mM DTT, 
and 0.1 mM PMSF). Ammonium sulfate (4 M) was added dropwise and with immediate mixing to a 
concentration of0.4 Mover a period of 10 minutes. The solution was rolled for 30 minutes at 4°C and 
centrifuged at 90 000 g for 45 minutes. The pellet was discarded and 0.25 g/ml solid (NH4) 2S04 was 
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added to the supernatant. The suspension was rolled for 45 minutes and centrifuged at 90 000 g for 15 
minutes. The pellet was resuspended in 2 ml dialysis buffer (20 mM Tris.HCl (pH 8), 2 mM MgClz, 
0.2 mM EDTA, 20 % (v/v) glycerol, 1 mM DTT and 0.5 mM PMSF) for every litre of original 4 % 
(v/v) culture. The extract was dialysed for 5 hours against 200 volumes of the same buffer, 
centrifuged for 20 minutes at 15 000 rpm and the supernatant ("nuclear extract") stored in aliquots at -
70°C. The prqtein concentration typically ranged between 5 and 15 mg/ml. 
2.20 Protein Determination with the Folio Ciocalteu Reagent 
Working standards were prepared from bovine serum albumin (Boehringer) by making a series of 
solutions containing 0 - 10 J.lg of BSA. Assays were performed in triplicate for the standard protein 
solutions and in duplicate for the unknown protein. 
The protein solutions were adjusted to 1 ml with water and 10 111 sodium deoxycholate (1.76% (w/v)) 
was added to each solution. Dilutions were mixed well and incubated for 15 minutes at room 
temperature. Proteins were precipitated by the addition of 333 111 TCA (24 % (w/v)) and 
centrifugation at 18 000 rpm (Beckman, JA 20.1 rotor) for 50 minutes at 4°C. The supernatant was 
removed carefully and each protein pellet was resuspended in 1 ml Lowry reagent C (100 volumes 
Na2C03 (2 % (w/v)) in 0.1 N NaOH, 1 volume Cu2S04 (1 % (w/v)), and 1 volume disodium tartrate 
(2% (w/v))). This was followed by the addition of 100 111 Folin-Ciocalteu phenol reagent (Merck) to 
each solution with rapid mixing. The reactions were allowed to proceed for 75 minutes in the dark, 
after which the optical density readings were determined at /.. = 660 nm. 
2.21 Electrophoretic Mobility Gel Shift Assays 
Electrophoretic mobility shift assays (EMSAs) were carried out essentially as described by Fried and 
Crothers (1984) (153) and Gamer et al (1981) (189)). In the standard EMSA, 1 ng of end-labelled 
DNA restriction fragment was incubated with variable amounts of protein for 30 minutes at 4°C in 
EMSA incubation buffer (16 mM Tris.HCl (pH 8), 175 mM KCl, 1.6 mM MgClz, 1 mM EDTA, 16% 
(v/v) glycerol, 0.8 mM DTT, 0.4 mM PMSF, 0.5 Jlg p[d(I-C)] (Boehringei') and 1J.!g BSA (Molecular 
Biology Grade, Boehringer) in a total volume of 25 111. 
Nondenaturing 4 %polyacrylamide gels (acrylamide Merck, bisacrylamide Biorad) (22 em X 18.5 
em X 0.15 em) were pre-electrophoresed at 30 rnA for 2 hours. The electrophoresis buffer was 
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changed and the EMSA incubation mixtures were loaded directly onto the gels. Electrophoresis was 
overnight at 30 rnA per gel. A buffer system consisting of TGE (50 mM Tris.HCl (pH 8), 380 mM 
glycine (Merck), 2 mM EDTA) was employed. Gels were dried and exposed to a preflashed X-ray 
film with an intensifying screen at -70°C. 
The binding specificity of protein for the E/H fragment was determined by using double stranded 
DNA deoxyoligonucleotides (oligos) containing a G·C-rich region and mutations thereof as 
unlabelled competitors in the mobility gel shift assay. The E/H fragment was used as radiolabelled 
probe. The mobility gel shift incubations were carried out as above, however the DNA competitors 
(present in various ratios to unlabelled DNA) were included in the reaction cocktail (see individual 
experiments, Chapter 3). Gels were dried and analysed by autoradiography or by Instant Imager 2024. 
The data provided a measure of the relative affinity and specificity of DNA-protein-binding which 
could be evaluated by Scatchard analysis. 
2.22 Synthesis of Poly( dG).Poly( dC)-Affinity Matrix 
A trace of poly(dG).poly(dC) (Boehringer) was labelled with [y-32P]dATP and T4 Polynucleotide 
Kinase (Boehringer) after removal of 5' phosphates with Calf Intestinal Phosphatase ( 151 ), and mixed 
with the unlabeled poly( dG).poly( dC). Approximately 1.3 mg of this homopolymer preparation was 
coupled to approximately 20 ml Sepharose CL-4B (Pharmacia) by the cyanogen bromide method, 
essentially as described by Kadonaga (1990) (158) and Kadonaga and Tjian (1986) (92). 
Sepharose CL-4B (15 ml settled bed volume) was washed with 900 m.J H20 in a 60 ml scintered glass 
funnel, transferred to a 25 ml cylinder and adjusted to 20 ml with H20. The slurry was transferred to a 
150 ml beaker in a 15°C waterbath over a magnetic stirrer in a fume cupboard. CNBr (1.1 g, Riedel-
de Haen) dissolved in 2 ml N,N-dimethylformamide was added dropwise over 1 minute to the stirring 
slurry. Sodium hydroxide (30 f.!l, 5 M) was immediately added, followed by another addition of 30 fll 
every 10 seconds for 10 minutes, to a final volume of 1.8 ml. Ice-cold H20 (100 ml) was immediately 
added and the mixture was poured into a 60 ml scintered glass funnel under suction. Care was taken 
not to suck the resin to a dry cake. The resin was washed three times with 100 ml ice-cold H20 and 
once with 100 ml ice-cold 10 mM potassium phosphate (pH 8), and the thick slurry was immediately 
transferred to a silanized SS34 tube (Sorvall). The DNA (1.5 ml) was added immediately, and the 
slurry was rolled at room temperature for 16 hours. 
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The resin was transferred to a scintered glass funnel and washed with 2 x 100 ml H20, 1 X 100 ml 1 
M ethanolamine (pH 8), and rolled in 4 ml ethanolamine solution for 6 hours at room temperature to 
inactivate the unreacted CNBr-activated Sepharose. The resin was finally washed with 100 ml each of 
10 mM potassium phosphate (pH 8), 1 M potassium phosphate (pH 8), 1 M KCl, H20 and column 
storage buffer (10 mM Tris.HCl (pH 7.5), 1 mM EDTA, 0.3 M NaCl, 0.04% (w/v) sodium azide. The 
resin was stored at 4°C in column storage buffer. 
The coupling efficiency was estimated to be approximately 90 % by comparing the level of 
radioactivity in the first few millilitres of the wash (after the overnight coupling step) with that of the 
washed resin. 
2.23 Purification of Native suGFl 
Column buffers containing different concentrations of potassium chloride are referred to as "O.X 
buffer C", where O.X buffer Cis 20 mM Tris.HCl (pH 8.0), 2 mM MgCl2, 0.2 mM EDTA, 20% (v/v) 
glycerol, 0.5 mM PMSF, 1 mM DTT and containing O.X M KCl. All chromatographic steps were 
performed at 4°C and all fractions were stored at -70°C between manipulations. 
2.23.1 Pll Phosphocellulose Chromatography 
P11 phosphocellulose chromatography was based on a method described by Dailey et al (1988) (190). 
P11 phosphocellulose (Whatman) was swollen in a large volume of distilled water. The resin was 
stirred in 5 volumes 0.5 M NaOH for 30 minutes and rinsed with water until the eluate reached pH 8. 
The resin was stirred in 5 volumes 0.5 M HCl for 30 minutes, followed by a wash with water until the 
eluate reached pH 4. The resin was resuspended in 2 volumes 0.05 M Tris.HCl (pH 7.9) and stirred 
for 15 minutes. The suspension was adjusted to pH 7.9 with 6 M KOH. The resin was packed in a 
column of radius 2.2 em and a bed volume of approximately 180 ml was ensured (1 column volume). 
The column was equilibrated overnight with 0.1 Buffer C containing no MgC12• The flow rate was 
always 60 mllhour. Nuclear extract (protein concentration between 5 and 15 mg/ml) was loaded onto 
the column and washed with 2.4 column volumes of0.1 Buffer C (containing no MgC12). The bound 
protein was eluted stepwise with 3 column volumes 0.3 Buffer C lacking MgC12, 3 column volumes 
0.5 Buffer C and 1 column volume 0.8 Buffer C. The eluate was collected in 15 ml fractions and the 
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elution was monitored spectrophotometrically at A. = 280 nm. The fractions (1 J.tl aliquots) were 
monitored for suGFl activity by EMSA in 250 mM KCI. The column was regenerated by washing it 
with 10 column volumes of 2.5 M KCl until the resin was white. When not in use, the column was 
stored in 50 mM Tris.HCl (pH 8), 100 mM KCl and 0.04% (w/v) sodium azide. 
2.23.2 Poly(dG)·Poly(dC) Affinity Chromatography 
The poly(dG)·poly(dC) affinity matrix was packed in a column of radius 4.75 mm and bed volume 
approximately 9 mi. The flow rate was 0.5 ml/min and 9 ml fractions were collected at 4°C. Column 
buffers containing different concentrations of potassium chloride are referred to as "O.X buffer C", 
where O.X buffer Cis 20 mM Tris.HCl (pH 8), 2 mM MgC12, 0.2 mM EDTA, 20% (v/v) glycerol, 0.5 
mM PMSF, 1 mM DTT and containing O.X M KCI. All buffers were supplemented with 0.01 % (v/v) 
NP-40. The column was equilibrated in 0.35 buffer C. Pll column fractions exhibiting suGFl activity 
in EMSAs were pooled and adjusted to 0.35 buffer C by addition ofO.O buffer C (and 0.01% NP-40), 
incubated with 400 J.ll p[d(I-C)] (1 mg/ml) for 10 minutes and loaded onto the column. The flow-
through was collected in a single fraction, and the column was washed with 5 column volumes of 0.35 
buffer C. Bound proteins were eluted in a stepwise fashion with 8 column volumes of 0.55 buffer C, 5 
column volumes of 0.7 buffer C, and 3 column volumes of 1.0 buffer C. Aliquots (5 J.tl) of each 
fraction were monitored for suGFl activity in EMSAs. The fractions were stored at -70°C between 
manipulations. The column was regenerated at room temperature by washing with 300 ml column 
regeneration buffer (CRB) (10 mM Tris.HCl (pH 8), 1 mM EDTA, 2.5 M NaCI, 1 % (v/v) NP-40) 
followed by 300 ml column storage buffer (CSB) (10 mM Tris.HCl (pH 8), 1 mM EDTA, 0.3 M 
NaCI, 0.04% (w/v) sodium azide). The matrix was stored at 4°C. 
2.23.3 TCA Precipitation of Proteins 
Protein solutions were adjusted to a volume of 500 J.ll with water, and TCA (final concentration 20 % 
(v/v)) was added. The samples were placed on ice for 60 min and centrifuged for 30 min at 15 000 
rpm, 4°C. The supernatant was discarded and the pellet was resuspended in cold 1 ml acidified 
acetone (0.05 % (v/v) HCl). The samples were centrifuged as above. The protein pellet was washed 
with 1 ml acetone by spinning at 15 000 rpm and 4°C for 20 min, resuspended in 1 X SDS sample 
application buffer (see section 2.24) and neutralised with NaOH, if necessary. The samples were 
boiled in the presence of a reducing agent and analysed by SDS-PAGE. 
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2.24 SDS Polyacrylamide Gel Electrophoresis and Silver Staining 
Samples were boiled in SDS sample application buffer (0.0625 M Tris.HCl (pH 6.8), 2 % (w/v) SDS 
(Sigma), 10 % (v/v) glycerol, 5% (v/v) B-mercaptoethanol, 0.001 % (w/v) bromophenol blue) and 
loaded onto a 10% or 12% SDS gels (acrylamide (Merck) : bisacrylamide (Sigma)= 30 : 0.8). The 
gels were electrophoresed at constant voltage (180 V) until the ion front reached the end of the gel. 
The gels were fixed in 50 % (v/v) methanol containing 10% (v/v) acetic acid for a minimum of 45 
minutes. They were either stained in Coomassie Brilliant Blue or silverstained. Silver staining was 
performed in clean glass dishes, and all solutions were made up freshly. The gels were washed with 
deionized water and soaked in 100 ml DTT (5 Jlg/ml) for 30 minutes followed by a further 30 minutes 
in 0.1 % (w/v) silver nitrate. The gel was briefly rinsed in a small amount of deionized water before 
washing it twice with carbonate developing solution (3% (w/v) Na2C03 containing 0.5 ml 37% (v/v) 
formaldehyde per litre of developing solution). The gel was covered with 100 ml developing solution 
and agitated slowly until it reached the desired level of staining. The .reaction was stopped by adding 
5 ml 2.3 M citric acid to the gel in developer solution. 
2.25 Mass Spectral Protein Sequencing 
2.25.1 In Gel Digestion 
The Coomassie-stained protein band representing suGF1 was precisely excised from the acrylamide 
gel (see 2.24), cut into small cubes and rinsed twice with 100 J..ll water for 5 - 10 minutes to remove 
the SDS and acid. The pH was ensured to be 6- 7. The same volume of acetonitrile I water (1:1) was 
added to remove the Coomassie dye and incubated for 10 - 20 minutes. This step was repeated three 
times. The residual water was extracted from the gel with pure acetonitrile by incubating for 10 
minutes. The acetonitrile was removed and replaced with 30 - 50 J..ll digestion buffer (NH4C03, 
NMM) containing 0.5 Jlg trypsin. The digestion was performed at 37°C for 6 - 12 hours. The 
supernatant was recovered and the gel pieces were extracted twice with 0.1 % TFA (2o"·- 30 minutes). 
The volume of the combined extracts was reduced to 5 J.1l in a speed-vac. · 
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2.25.2 LC-MS Analysis 
LC-MS (microcolumn liquid chromatography) and MS/MS (tandem mass spectrometry) spectra were 
recorded on a Finnigan LCQ ion trap mass spectrometer equipped with an electrospray (ESI) ion 
source. LC separation of the peptides was performed on a 300 J..tm X 12 em C18 column at a flow rate 
of 4 J!l/min. The peptides were eluted by a gradient of acetonitrile (10- 40 %) in 0.05 % TFA (40 
min) and on line introduced into the ESI source. Full scan MS spectra (m/z 350 to mlz 1700) were 
collected continuously and production of MS/MS spectra (collision induced dissociation (CID) of 
individual peptides) was triggered by a peptide signal intensity above a preset threshold (3.0E4 ions). 
The signal switched the instrument to isolate the parent ion, to perform CID fragmentation and to 
scan the product ions. This sequence of scan events (full scan- MS/MS scan) was repeated every 4 · 
seconds. 
2.25.3 Computer Analysis of MS/MS Spectra 
Cross correlation analysis of the data was performed by using the "Sequest" program ( 166) package 
and the OWL database {147 000 entries). 
2.26 Autoradiography 
Sequencing gels, SDS gels and nondenaturing PAGE gels (gel mobility shift assays) were vacuum 
dried onto Whatman 3MM blotting paper before they were exposed to X-ray films. Either Cronex 4 
X-ray film or MP™-Film were used in X-ray cassettes. For gels containing the isotope 32P, the films 
were preflashed twice on either side and exposed to the gel in the presence of an intensifying screen at 
-70°C. The intensifying screens were not necessary if 35S was used and exposure was performed at 
room temperature. Exposure times ranged from overnight to one week. 
Gels were either analysed by autoradiography or Instant Imager 2024. The Instant Imager 2024 is an 
electronic alternative to autoradiography on film or phosphor screens. It is a fully automated system 
which quantifies radioactivity distributed on flat samples using the microchannel array detector. 
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CHAPTER3 
Cloning the eDNA for suGFl 
3.1 Introduction 
Since at the start of the project there was no sequence information available on either the suGF1 
protein or the eDNA coding for it, the DNA ligand screening procedure was an obvious choice in the 
cloning strategy of this protein. This choice was supported by the fact that suGF1 not only binds to 
the G·C-rich H1-H4 intergenic spacer with high affinity and specificity, but also by the ease with 
which native suGF1 can be denatured and subsequently renatured to regain its specific DNA-binding 
ability when subjected to Southwestern analysis (1, 191), indicating that suGF1 may be an ideal 
candidate for cloning by the DNA ligand screening approach. suGF1 is proposed to be one of several 
sea urchin G-binding proteins (such as SpGCF1 or the ectoderm specific factor) involved in the 
regulation of unrelated sea urchin genes, implying that it could be a member of a family of G·C-rich 
DNA-binding proteins (see section 1.4.4). Given the similarities between suGF1 and SpGCFl with 
·· respect to their size and DNA-binding specificity (see sections 1.4.4.1 and 1.4.4.2, respectively), it 
was of interest to investigate whether these two proteins are possibly homologous. Therefore a second 
cloning approach, viz a PCR screening strategy (see section 1.6.2), was used at a later stage in order 
to clone a eDNA representing the P.angulosus homologue of SpGCF1 (see section 1.4.4.2). 
3.2 DNA Binding Properties of suGFl 
In order to establish the conditions for isolating the eDNA of suGF1 using the DNA ligand screening 
approach, the affinity and specificity of the interaction between suGF1 and the G·C-rich E/H 
fragment (see fig 2.2) derived from the H1-H4 intergenic region was investigated using mobility gel 
shift assays, which result in the formation of two characteristic suGF1-DNA complexes, B1 and B2 
(fig 3.1). EMSAs were performed using suGFl in crude nuclear extract (isolated from 14 hour 
P.angulosus embryos) and the labelled E/H fragment prepared from the histone gene battery (20) in 
the presence of various amounts of unlabelled oligonucleotide and DNA competitors (fig 3.1). The 
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Fig 3.1 suGFl Interacts Sequence-Specifically wjth G.C-Rich DNA 
Electrophoretic mobility shift assays were performed with suGF1 (2 11g nuclear extract) in the presence of 
oligonucleotide or DNA competitors. The formation of the suGF1 complexes (B1 and B2) is competed away by the 
specific (Sp) oligonucleotide (a) and the E/H fragment (c), but not by the nonspecific (NS) oligonucleotide (b). The 
competition assays (see (a), (b) and (c)) were performed both in the absence of competitors (lanes 1 and 2) and using 
increasing amounts (5 - I 0 fold molar excess) of each competitor (lanes 3 - 8). F is free labelled DNA probe, B 1 and B2 
are suGFI- DNA complexes. 
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(fig 3.1 (a)), or a random mutation of the binding site (nonspecific oligo) (fig 3.1 (b)). The nucleotide 
sequences of the oligonucleotides and the E/H fragment are shown in fig 2.1 and fig 2.2 respectively. 
The oligos were used in a 5- to 50- fold molar excess in the competition gel shift assays. EMSAs 
performed with unlabelled specific oligonucleotide competitor (fig 3.1 (a), lanes 2 - 8) show that 
formation of complexes B1 and B2 is competed away efficiently, even at low molar ratios of 
competitor with respect to labelled probe (5 - 10 M excess, fig 3,1 (a), lanes 3 and 4). The extent of 
the competition compares favourably with a similar assay using unlabelled E/H fragment as DNA 
competitor (fig 3.1 (c), lanes 2- 8). Binding is competed for at very low molar excess of unlabelled to 
labelled E/H fragment (5 M excess, fig 3.1 (c), lane 3). In contrast, the same amounts of unlabelled 
nonspecific oligo do not compete for complex formation at all (fig 3.1 (b), lanes 2 - 8), showing that 
suGFl interacts in a highly specific manner with the G·C-rich region of the specific oligo. 
Above findings were reinforced by a quantitative competition gel shift assay performed with the 
specific and nonspecific competitors in a 2 - 10 fold molar excess with respect to the labelled E/H 
probe (fig 3.2). A constant amount of suGFl (2 J.lg nuclear extract) was incubated with 1 ng EIH 
fragment, in the presence of increasing amounts of competitor oligonucleotides. The amount of free 
DNA and the protein-DNA complexes formed at each different concentration of competitor were 
quantified by Instant Imager 2024 (table 3.1). The specific oligonucleotide exhibits more than 50% 
competition at a 5- 10 fold molar excess (fig 3.2, lanes 5 - 7 and table 3.1), whereas the nonspecific 
competitor (fig 3.2, lanes 8- 13 and table 3.1) does not compete for the formation of complexes B1 
and B2 at all. These results show that suGF1 binds with very high specificity to G·C-rich DNA, since 
binding can be competed away at very low molar excess of G·C-rich competitor, whereas suGF1 has 
no affinity for random DNA sequences. 
The kinetic and equilibrium constants for protein-DNA interactions in solution imply that only 
proteins with relatively high binding constants will complex the DNA long enough to withstand the 
wash protocols. Therefore the kinetics of the suGF1-DNA interaction was investigated using 
Scatchard analysis. The end-labelled E/H probe (1 ng) was incubated with a constant amount of 14 
hour nuclear extracts (2 J.lg) in the presence of increasing amounts of unlabelled E/H fragment as 
competitor (fig 3.3). The competitor DNA was present in a 1- to 35- fold molar excess relative to the 
radiolabelled E/H fragment. The amount of radioactive DNA present in complexes B 1 and B2 in each 
lane was quantitated using an Instant Imager 2024 (table 3.2). A Scatchard analysis of this data is 
shown in Appendix I. The dissociation constant (K!) was determined to be 3.6 X 10"10M, confirming 
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Fig 3.2 Quantitative Competition EMSA Usin~: Specific and Nonspecific Oli~:onucleotide Competitors 
The amount of suGFI binding in each lane in the presence of increasing amounts (2 - 10 fold molar excess) of 
specific and nonspecific oligonucleotide competitors (Janes 3 - 7 and 8 - 13 respectively), was quantified by Instant 
Imager 2024 (see table 3.1 ). Both the specific and nonspecific competitors were unlabelled. F is free labelled probe, 
B I and B2 are suGF I-DNA complexes. 
free labelled E/H fragment protein-DNA complexes unlabelled DNA competitor 
(cpm) (cpm) (fold Molar excess) 
(Specific oligo competitor) 
69.761 1.268 0 
33.179 24.134 0 
39.733 16.721 2 
58.712 5.996 4 
62.112 4.282 6 
63.437 3.727 8 
58.734 3.735 10 
(Nonspecific oligo competitor) 
42.403 23.446 0 
37.001 24.569 2 
27.443 17.674 4 
37.784 24.341 6 
40.582 22.017 8 
35 .899 14.943 10 
Table 3.1 Ouantitation of the Amount of Labelled DNA in the Unbound and Protein-Bound Fractions in 
the Presence of Different Concentrations of Unlabelled Specific and Nonspecific Oligonucleotide 
Competitors 
Gel shift reactions were performed in the presence of increasing amounts of both specific and nonspecific 
competitor oligonucleotides (2 - 10 fold molar excess) and the amount of labelled probe in the unbound and 
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Fig 3.3 The Dissociation Constant of suGFl with Respect to the G-String in the Hl-H4 Intergenic Region 
was Determined by Quantitative Competition EMSA 
Labelled E/H fragment (I ng) was incubated in the absence of protein (lanes I and 2) and with a constant 
amount of suGFI (2 11g nuclear extract) in the presence of increasing amounts (I - 35 fold molar excess) of 
unlabelled G-string competitor (lanes 3 - 15). The suGFI-bound DNA was separated from the free DNA by 
electrophoresis, and both were quantified by Instant Imager 2024, as indicated in table 3.2. B I and B2 are the 
suGFI-DNA complexes, F is free labelled DNA. 
69 
free labelled protein-DNA total counts of labelled unlabelled E/H fragment 
E/H fragment) complexes (81 and 82) E/H fragment 
(cpm (cpm) (cpm) fold Molar [M] error [M] 
excess 
360.419 5.420 366 0 O.OOE+OO O.OOE+OO 
372.706 5.995 379 0 O.OOE+OO O.OOE+OO 
44.536 117.211 162 0 O.OOE+OO O.OOE+OO 
40.932 97.977 139 0 O.OOE+OO O.OOE+OO 
116.268 71.791 188 I 1.7E-IO 4.86E-11 
142.372 48.478 191 2 3.4E-IO 9.72E-ll 
168.918 24.226 193 3 5.12E-IO 1.46E-l 0 
184.950 28.449 213 4 6.8E-IO 1.94E-IO 
194.173 17.298 211 6 1.02E-9 2.92E-IO 
216.307 10.869 227 8 1.36E-9 3.89E-IO 
230.372 12.091 242 10 I.7IE-9 4.86E-IO 
243.155 6.194 249 15 2.56E-9 7.29E-IO 
260.504 5.625 266 20 3.41E-9 9.72E-IO 
259.504 5.579 265 25 4.26E-9 1.22E-9 
201.143 9.464 211 35 5.97E-9 1.70E-9 
234 1. 7E-I o• 
67 0.5E-10b 
a) In a 25 J.ll reaction volume, I ng of the 335 bp E/H fragment represents 234 cpm and the reaction is I. 7 X I 0'10 M in the 
labelled DNA fragment. 
b) The error for the total counts is 67 cpm, and therefore the error for the molarity of the E/H fragment in the reaction is 0.5 
X 10'10 M. . 
Table 3.2 Ouantitation of the Amount of Labelled DNA in the Unbound and Protein-Bound Fractions in 
the Presence of Increasing Amounts of Unlabelled E/H Competitor DNA 
The amount of labelled DNA present in the unbound and the suGFl-complexed fractions (in the presence of 
increasing amounts of unlabelled E/H fragment as shown in fig 3.3) was quantified by Instant Imager 2024, in 
order to determine the dissociation constant for suGFl via Scatchard analysis (see Appendix 1). 
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Formation of the suGF1-DNA complex was investigated in the presence of various amounts and types 
of nonspecific competitor DNA, viz calf thymus DNA, E.coli DNA and poly[d(I-C)] (fig 3.4). Even at 
low concentrations (0.5 - 2 Jlg) both E.coli DNA (lanes 1 - 3) and calf thymus DNA (lanes 4 - 6) 
compete substantially for the formation of suGF1-DNA complexes B1 and B2. In contrast, higher 
amounts of poly[d(I-C)] can be included in the incubation without competing for the specific DNA 
complexes (fig 3.4, lanes 7 and 9). Generally, calf thymus DNA has been used to isolate several 
clones encoding DNA-binding proteins successfully, and it is the preferred nonspecific competitor 
DNA used in the DNA ligand screening procedure (174). However, given the fact that it competes so 
easily for the formation of complexes B1 and B2 in the suGF1-DNA interaction, the preferred 
nonspecific competitor DNA used in combination with the suGF1 protein is poly[d(I-C)], since it has 
a low capacity for competing for the formation of specific complexes B 1 and B2, and it prevents the 
formation of nonspecific protein-DNA complexes (see fig 3.4, lanes 7- 9). 
3.3 DNA Ligand Screening a Sea Urchin Embryonic eDNA Library 
A eDNA expression library is a crucial starting material for the DNA ligand screening procedure. 
Attempts to have a Parechinus angulosus eDNA expression library produced commercially from 14 
hour poly-A+ or total RNA (see section 3.5) were unsuccessful (Clontech), since the recombinant 
inserts repeatedly contained small inserts(< 2 kb) and only about 300 000 independent clones, which 
is a low yield and does not comprise a representative library. Therefore an alternative source (viz a 
eDNA library derived from a different species of sea urchin) was used. Professor E. Davidson 
(Caltech) kindly provided a custom synthesised A.ZAP eDNA library from 24 hour (late blastula I 
early gastrula) Strongylocentrotus purpuratus embryos for which 1.3 X 106 independent clones were 
obtained (see Appendix II). This library was constructed using both oligo(dT)- and random-primed 
synthesis. The inserts were cloned into the EcoRJ site of the A.ZAPII vector and their sizes ranged 
from 1.0 to 4- 5 kb. 
An outline of the steps involved to identify suGF1 eDNA clones from the recombinant expression 
library using the DNA ligand screening strategy is depicted in fig 3.5. The first stage involved the 
identification of recombinant clones which detect the binding site DNA probe. These initial positive 
clones were subjected to a second round of screening in which the hybrid proteins were blotted onto 
duplicate filters and individual filters were probed with either the specific binding-site DNA probe, or 
with a DNA probe that lacks the binding site. The second screening procedure selectively identified 
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The suitability of several nonspecific DNA competitors was investigated by incubating suGFI in nuclear 
extract with labelled E/H fragment in the presence of varying amounts of E. coli DNA (lanes I - 3), sonicated 
calf thymus DNA (lanes 4 - 6) and poly[ d(l-C)) (lanes 7 - 9). The amounts of the competitors are indicated in 
the individual lanes. F is free labelled DNA, Bl and B2 are suGFI-DNA complexes. 
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Fig 3.5 An Outline of the Steps Involved in the DNA Ligand Screening Strategy 
The DNA ligand screening strategy allows cloning of sequence-specific DNA-binding proteins from a 
bacteriophage eDNA expression library. The specific oligo represents the recognition site probe, whereas the 
non-specific oligo is a control probe which lacks the recognition site, or contains a mutant version thereof. 
In order to improve the efficiency of detection of prospective eDNA clones, both the specific and 
nonspecific oligonucleotide probes (see fig 2.1) were catenated extensively using DNA ligase (151). 
The mean length of the catenated oligonucleotides was - 200 bp. Both the catenated DNA probes 
were labelled to a specific activity of- 108 dprn!Jlg with [a.-32P]dCTP. Using a DNA probe with 
above specific activity, and assuming a 1:1 stoichiometry for the protein-DNA complex, it should be 
possible to detect 1 0"2 fmol of protein in a plaque, considering that the level of expression of the lacZ 
fusion gene in a single phage plaque exceeds these amounts (174). A standard E. coli host strain (BB4) 
was used throughout the screening procedure to produce a fusion protein between the products of the 
!3-galactosidase gene and the cloned cDNAs. The amplified library was plated at a density of 1 X 103 
pfu/plate and the plates were overlaid with nitrocellulose filters saturated with IPTG to induce the 
expression of the fusion proteins. A total of 6 X 105 plaques was screened. The filters were subjected 
to a denaturation I renaturation protocol using 6 M guanidine hydrochloride, which facilitates the 
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correct folding of a larger fraction of the bacterially expressed fusion proteins (168, 174). The filters 
were subsequently incubated with radio labelled recognition site probe In the presence of poly[ d(I-C]) 
to prevent nonspecific binding. 
The screening procedure was performed as outlined by Singh et al (1989) (174) (see section 2.8 and 
fig 3.5). Typical signals generated by the DNA-binding site probe in the first round of screening are 
illustrated in fig 3.6 (a). The recombinant hybrid proteins were blotted onto duplicate nitrocellulose 
· filters, and the resulting autoradiographs were superimposed in order to identify presumptive positive 
DNA-binding signals. The first round of screening resulted in the identification of 19 putative 
positive plaques, from screening a total of 6 X 105 plaques. The autoradiographs were aligned with 
the original LB plates to identify the presumptive positive plaques, which were then plaque purified , 
according to standard procedures (169). The secondary phage stocks generated in this way were used 
to identify sequence specific clones by blotting the expressed fusion proteins onto replica filters. One 
filter was screened with the recognition site probe (specific oligo) whereas the other filter was 
screened with the DNA probe lacking the binding site (nonspecific oligo) (see fig 3.5). A typical 
result of a sequence specific clone identified by the second round of screening is shown in fig 3.6 (b). 
Binding is specific with respect to the recognition site probe, whereas there is no interaction with the 
DNA probe lacking the G·C-rich binding site, thereby satisfying the criteria depicted in fig 3.5. In this 
manner the number of putative positive clones was finally reduced to four (referred to as Clones 2, 6, 
11 and 16). 
A.ZAP recombinants, unlike those derived from A.GTll, do not easily form lysogens, therefore the 
cloned proteins are not usually isolated in the form of extracts derived from induced lysogens of 
E.coli cells. Instead it is recommended that the pBluescript phagemids (containing the cDNAs of 
interest) are excised from A.ZAP and that the eDNA inserts are cloned into an expression vector for 
further analysis of the protein products. The four positive plaques generated by the DNA ligand 
screening procedure were plaque purified, the Bluescript plasmid (containing the eDNA insert) was 
excised from A.ZAP and analysed by restriction enzyme digestion with EcoRJ. The individual DNA 
fragments were separated by electrophoresis on an agarose gel in order to determine the size of each 
insert by comparing it to a lambda EcoRJ I Hindi/! digest (fig 3.7). The insert sizes are estimated to 
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Fig 3.6 DNA Ligand Screening the eDNA Library Yielded Positive Signals from Several Clones 
(a) The 24 hour S.purpuratus eDNA library was plated at a density of 1 x 103 pfu I plate in the first round of 
the DNA ligand screening process. The recombinant hybrid proteins were blotted onto duplicate 
nitrocellulose filters and screened with radiolabelled specific oligonucleotide. The duplicate blots were 
exposed to autoradiography and presumptive positive plaques were identified by superimposing duplicate 
autoradiographs. An example of a putative positive plaques is marked by the arrow. 
(b) Phage stocks generated from the putative positive plaques identified in the first round of screening (a) 
were screened for sequence specific clones by blotting the fusion proteins onto replica filters and screening 
one filter with the recognition site probe (specific oligo) and the other with the DNA probe lacking the 
binding site (nonspecific oligo). Several clones (four) revealed sequence specific binding to the recognition 
site probe, whereas they did not interact with the DNA probe lacking the G.C-rich binding site thereby 
satisfying the criteria outlined in fig 3.5. 
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3.4 DNA Sequence Analysis of the Putative Positive Clones Generated by the DNA Ligand 
Screening Procedure 
The 5' and 3' termini of each clone (see section 3.3) were subjected to several rounds (between 4 and 
7) of manual sequencing (occasionally automated DNA sequencing was used), in order to obtain 
DNA sequence information (see Appendices III - VI). Analyses of the partial DNA sequences of the 
four clones and subsequent homology comparisons using algorithms such as Bestfit (from the GCG 
program) revealed that each clone represents an independent isolate of a different eDNA. Additional 
homology searches were performed with programs such as FastA (GCG) (this compares the query 
sequence to nucleotide sequences in the GenEMBL database), BLASTN and BLASTP (192), as well 
as BLASTX (193) which perform comparisons on the public sequence databases. The BLASTN 
program is optimised to find nearly identical nucleotide sequences, whereas BLASTX is used for 
database similarity searches of protein coding regions. The query sequence for each search was 
filtered . This process eliminates low complexity regions and thereby avoids nonspecific pairwise 
alignment. A summary of the analysis of each of the clones is presented in table 3.3. 
eDNA Clone 2 Clone 6 Clone 11 Clone 16 
length (bp) 2 200 850 900 2 400 
5' ntsequence 236 nt 655 nt 519 nt 622 nt 
3 ' nt sequence 223 nt 159 nt 301 nt 156 nt 
total length 459 nt 764 nt 820 nt 778 nt 
sequenced 
5 ' ORF yes 3 partial ORFs yes 3 partial ORFs 
3' ORF partial ORF yes yes yes 
database search 3' untranslated Kriippel-like mRNA of a G-box basic-helix-loop-
result region of Zinc-fmger binding factor helix-leucine zipper 
S.purpuratus protein in (GBF) in transcription factor 
Cyllb actin gene Caenorhabditis Dictyostelium in Caenorhabditis 
elegans discoideum e/egans 
%homology 96 % 63 % 56% 64% 
length of overlap 205 nt 96 nt 166 nt 14 amino acids 
reference Lee et al (1984) Srni th et al (1994) Schnitzler et al Wilson et al (1994) 
(194) (195) (1994) (196) (197) 
Table 3.3 Summary of the Analysis of Clones 2. 6. 11 and 16 Isolated by the DNA Ligand Screening 
Method 
The table lists the insert size of each clone, the length of its known DNA sequence, an indication whether either 
eDNA end has an open reading frame and the most relevant database homology score for each clone. 
Clone 2 has a 2.2 kb eDNA insert (fig 3.7, lane 5) of which 459 nt were sequenced. Partial DNA 
sequences of the 5' and 3' termini (236 and 223 nt respectively) are shown in Appendix III (a) and (b) 














lane 2 3 4 5 6 7 8 9 10 11 
EcoRI digest + + + + + 
sample A. Bluescript Clone 2 Clone 6 Clone 11 Clone 16 
Fig 3.7 Restriction Analysis of the Clones Isolated by the DNA Li2and Screenin2 Method 
eDNA inserts isolated by the DNA ligand screening method (section 2.8) were released from the Bluescript 
plasmid using EcoRJ. Supercoiled and EcoRJ digested Bluescript (lanes 2 and 3 respectively), and 
supercoiled Clones 2, 6, 11 and 16 (lanes 4, 6, 8 and 1 0) and their respective EcoRI restriction digests (lanes 
5, 7, 9 and 11) were separated by electrophoresis on an 1 % agarose gel. The size of each insert was estimated 
by comparison to a lambda EcoRJ I HindiiJ digest (lane 1). The insert sizes are estimated to be 2.4 kb (Clone 
2, lane 5), 0.85 kb (Clone 6, lane 7), 0.9 kb (Clone 11, lane 9) and 2.2 kb (Clone 16, lane 11 ). 
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using the 'MAP' algorithm in the GCG program, which revealed three putative ORFs for the 5' 
terminal sequence (see Appendix III (c)), one of these (reading frame "b") has a putative start codon 
at nt 59, the other two reading frames (beginning at nt 85 and nt 146) do not start with methione 
residues. The ORFs code for 59, 50 and 27 amino acids respectively, and they continue to the end of 
the known sequence for the 5' terminus, however their full lengths were not established since the 
eDNA was only sequenced partially. The 3' terminus of Clone 2 (see Appendix III (d)) has a single 
ORF of significant length (nt 4 - 174), however it is interrupted (this could be due to erroneous 
sequencing results, or it could indicate the end of the ORF for this clone). The 5' and 3' DNA 
sequences were both subjected to FastA searches in the GCG program, as well as BLASTN searches. 
The 236 nt sequence obtained for the 5' terminus shows a striking and significant homology to the 3' 
untranslated region of the Strongylocentrotus purpuratus Cyiib actin gene (194). The homology 
extends over 205 nt and has 96% identity. Several other scores are listed in both the nucleotide and 
protein homology searches. For instance, the former shows a 73% homology between the 5' terminus 
of Clone 2 and a zinc finger protein (CEZF) in C.elegans (198). The homology ranges over 49 nt (in 
the translated region of Clone 2) of which 36 nt are identical. The homology searches performed with 
the 223 nt 3' terminal sequence of Clone 2 revealed no significant homologies using either nucleotide 
or protein database searches. One interesting score was a 56 bp overlap of 64 % identity with a 
posttranslationally regulated Drosophila chorion transcription factor, CF2 (199). The homology exists 
between the 3' untranslated region of the transcription factor and the 3' terminus of Clone 2, however 
the sequences lie in opposite orientation with respect to the each other. 
The insert size of Clone 6 is 850 bp (see fig 3.7, lane 7). Almost the entire clone was sequenced (764 
bases in total, see Appendix IV (a) and (b)). The MAP algorithm (GCG) was used to analyse the 
clone for ORFs, as shown in Appendix IV (c) and (d). The 5' terminus (655 nt) of Clone 6 does not 
appear to have a single continuous ORF, however three individual ORFs overlap partially. One of 
these (nt 54- 237) codes for 61 amino acids, a second one (nt 286- 478) codes for 64 amino acids, 
and a third ORF codes for 42 amino acids (nt 392 - 518) which partially overlaps with the second 
ORF (see Appendix IV (c)). None of the ORFs begin with putative ATG start codons, nor do any of 
them continue to the end of the known DNA sequence for the 5' terminus. Protein database homology 
searches revealed no substantial scores for the amino acid sequences corresponding to the 5' region of 
this clone, whereas the most interesting score for the nucleotide searches showed a 96 nt overlap 
(within the first ORF described above) of 63 % identity with a Kriippel-like Zinc finger protein in 
C.elegans (195) using FAST A (GCG). The 3' terminal DNA sequence of Clone 6 shows an ORF of 
49 amino acids spanning nt 34 - 181, and potentially represents the end of the coding sequence for 
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this clone. Neither the protein nor nucleotide database homology searches showed scores which were 
either significant, or relevant with respect to DNA-binding proteins. 
Clone 11 contains an insert of 900 bp (see fig 3.7, lane 9). About 820 nt of the entire clone were 
sequenced (see Appendix V (a) and (b)). The 5' terminal DNA sequence (519 nt) has a putative ATG 
start codon positioned at nt 72, which continues into a single long ORF to the end of the known DNA 
sequence of the 5' terminus (Appendix V (c)). The 3' terminal nucleotide sequence (301 nt) was also 
analysed for ORFs, of which three were identified. These code for 51, 4 7 and 21 amino acids, they all 
overlap with each other and continue to the end of the known DNA sequence for the 3' terminus (see 
Appendix V (d)). It appears that Clone 11 represents a full length eDNA clone, which has a 5' 
untranslated region (72 nt), a coding region of about 680 nt and a 3' untranslated region (- 150 nt). 
Nucleotide and protein database homology searches revealed that the 5' terminal nucleotide sequence 
scored low homologies to several DNA-binding proteins, for instance 36 amino acids had a 44 % 
identity with heat shock protein 70 from Chlamydia trachomatis (200), whereas 166 nt within the 5' 
ORF of this clone had a 56 % identity with the mRNA of a G·C-box binding factor {GBF) in 
Dictyostelium discoideum (196). Another score includes the engrailed-like homeodomain protein 
(smox-2) mRNA from Schistosoma mansoni (201), which has an identity of75% with 53 nt ofthe 5' 
ORF of Clone 11. 
A total of 778 nt were sequenced for Clone 16, which has a 2.4 kb insert (fig 3.7, lane 11). The 5' 
terminal (622 nt) and 3' terminal (156 nt) sequences for this clone are shown in Appendix VI (a) and 
(b). The 'MAP' algorithm (GCG) was used to establish the ORFs for both the 5' and 3' termini. There 
is a long 5' untranslated region followed by an ATG codon at nt 285 (see Appendix VI (c)), which 
may be indicative of a putative start codon. The nucleotide sequence codes for three separate 
discontinuous ORFs which are interleading. This could imply that there may be one continuous ORF, 
taking into account that DNA sequencing is subject to several artifacts. Alternatively it is possible 
that protein translation only starts at nt 501, which represents the beginning of the last ORF, however 
this does not continue to the end of the known DNA sequence of the 5' terminus. The 3' terminus also 
has an ORF, which lies between nt 13- 156 (see Appendix VI (d)), and may therefore be indicative of 
the end of the coding region for this clone. The nucleotide and protein database homology searches 
revealed no relevant scores for the 5' terminal sequence, however the 3' terminus has an 18 amino 
acid overlap of 44 % identity with the human NF-KB TF subunit (202). In addition there is a 64 % 
identity (over 14 amino acids) with the eDNA of a basic-helix-loop-helix leucine zipper transcription 
factor in C.elegans (197). 
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The DNA ligand screening technique yielded four independent isolates of different cDNAs based on 
the ability of their recombinant proteins to preferentially interact with the specific recognition site 
probe instead of the mutant nonspecific probe (see section 3.3). Partial DNA sequence analysis 
confirmed that at least three of the clones (2, 11 and 16) potentially encoded recombinant proteins of 
substantial length, as these clones had ORFs at their 5' ends. Database homology studies indicated 
that three of the clones (6, 11 and 16) were unique cDNAs which scored homologies to other DNA-
binding proteins. The DNA-binding specificities of the recombinant proteins encoded by these clones 
required further investigation to verify whether any of them correlated with suGFl (see Chapter 4). 
3.5 A PCR Cloning Strategy Was Used to Amplify a eDNA Sequence Potentially Encoding 
suGFl 
A PCR strategy was used to amplify the eDNA sequence encoding the P.angulosus homologue for 
SpGCFl (a transcription factor present in S.purpuratus embryos, see section 1.4.4.2), which 
represents a candidate homologous protein to suGFl. Genomic DNA prepared from sea urchin sperm 
(section 2.10), as well as eDNA generated from 14-hour sea urchin embryo RNA (section 2.6.1), were 
used as templates for the PCR amplifications. The integrity of the RNA was verified on an agarose I 
formaldehyde gel (section 2.6.4.2) as shown in fig 3.8 (a). Both the 14-hour poly-A+ RNA (lane 1) 
and the 14-hour total RNA (lane 2) are undegraded. The poly-A+ RNA, as expected, has a slight 
smear associated with it, and the 28S and 18S ribosomal bands in the sample are faint. There is no 
smear apparent for the total RNA (fig 3.8 (a), lane 2) and the intensities of the 28S and 18S ribosomal 
RNA bands are present in a ratio of about 1.5 : 1. eDNA was produced by using 2 J.lg of either poly-
A+ RNA or total RNA. The integrity of the genomic DNA isolated from P.angulosus sea urchin 
sperm (section 2.10) was verified on an agarose gel (fig 3.8 (b), lane 2) and was judged to be intact 
since it forms a sharp band in the region of 21 kb. 
PCR amplification (see section 2.11.1) was performed on both genomic DNA and eDNA from 14 
hour P.angulosus sea urchin embryos using three different combinations of two degenerate primer-
pairs. The design of degenerate PCR primers (see Appendix VII) was based on the SpGCFl eDNA 
sequence (3). Degenerate primers IS and lA were designed by Zeller et al (1995) (3), whereas 
degenerate primers 2S and 2A were designed by J. Hapgood (personal communication). Specific 
primers SPl, SP2, SP3 and SP4 were based on the DNA sequences ofPCR products amplified from 
P.angulosus genomic DNA and eDNA. Amplification with primer-pair 1S/1A is predicted to result in 
a fragment of 106 bp, a combination of the primers 2S/2A should give a 372 bp fragment, and the size 















Fig 3.8 Analysis of the Inte2rity of RNA and Genomic DNA Isolated from Sea Urchin (P.an~ulosus) 
RNA isolated from 14 hour sea urchin embryos (P.angulosus) (a) and genomic DNA (b) isolated from sea 
urchin sperm were used as starting material in the PCR reactions. (a) Total RNA (lane 1) and poly-A+ RNA 
(lane 2) from 14 hour embryos were analysed (1 f.lg each) on an 1 % agarose I formaldehyde gel. The 28S and 
18S ribosomal RNA bands are marked. (b) Genomic DNA (1 f.lg) (lane 2) was intact as indicated by its high 
molecular weight as compared to an EcoRI I HindiJ/ digest of lambda (lane 1 ). 
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amplifications using genomic sea urchin DNA as template and primer-pair lS/lA resulted in the 
successful amplification of a 106 bp DNA fragment (see fig 3.9, lanes 8 and 9), showing firstly that 
the P.angulosus genome contains a gene homologue to SpGCFl, and secondly that there is no intron 
present between primers IS and lAin this gene. The 372 bp fragment using primer pairs 2S/2A could 
not be amplified from genomic DNA using similar conditions (fig 3.9, lanes 10- 13), implying that a 
large intron may be present between primers 2S and 2A. Attempts to optimise PCR reactions using 
genomic DNA as template and primer pairs 1S/2A and 2S/2A respectively, by varying the 
concentrations of MgC12 and DMSO, did not result in products of the predicted size. Amplification of 
eDNA, generated from 14 hour sea urchin embryo RNA, using the primer pair 1S/2A was 
unsuccessful, however the primer-pairs lS/lA and 2S/2A both generated PCR products of the correct 
size (viz 106 bp and 372 bp), implying that the sea urchin P.angulosus expresses a protein homologue 
to SpGCF I. The 106 bp and 3 72 bp DNA fragments generated by PCR were gel purified, cloned into 
the pMOS Blue T-vector (see Appendix VIII (b)), and transformed into host bacteria. Several 
colonies generated by the ligation I transformation procedure were checked for positive insertion by 
direct PCR screening of the bacterial cells (section 2.11.2). The cloned PCR products were replicated 
in bacterial cultures, followed by plasmid isolation (section 2.2.4.2) using Wizard Midipreps. Plasmid 
inserts were analysed by DNA sequencing (section 2.3) using the T7 and U19 primers from the 
vector. Several clones from each PCR product were sequenced automatically, all of them revealed the 
same respective sequences for PCR products generated from the primer combinations lS/lA and 
2S/2A. The DNA sequences of the two individually amplified fragments from P.angulosus were 
compared to the DNA sequence coding for SpGCFl as published by Zeller et al (1995) (3) using a 
computer programme (GCG). The comparison of the sequences shows a very high homology (- 94 % 
and 92% respectively) between the two sea urchin species (see Appendix X (a) and (b)). 
Gene specific primers SPl and SP2 (see Appendix VII) were designed from the P.angulosus DNA 
sequences obtained for the 106 bp and 372 bp PCR products respectively (see Appendix X) in order 
to amplify the full length eDNA by application of 5' and 3' RACE (Rapid Amplification of eDNA 
Ends, see section 1.6.2). The integrity of the specific primers was verified by PCR amplification of 
the overlap region between SP1 and SP2 (see Appendix X), which generated a DNA fragment with a 
predicted size of 421 bp from P.angulosus eDNA and genomic DNA (see fig 3.10 (a), lanes 4-7 and 
(b), lanes 3 - 7 respectively). Both these PCR products were isolated from a preparative low melting 
point agarose gel and cloned into the pMOS-T vector (see Appendix VIII). Plasmid DNA was 
isolated and the 421 bp insert was sequenced from several colonies. All were found to contain the 
same sequence, which was used in a homology comparison with respect to the SpGCF1 sequence (see 
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Fig 3.9 PCR Amplifications from Sea Urchin Genomic DNA Using Degenerate Primers 
PCR amplification conditions using genomic DNA (isolated from P.angulosus sea urchin sperm) were 
optimised by varying the MgCI2 and DMSO concentrations (lanes 4 to 13). The I 06 bp fragment (see lanes 8 
and 9, marked by an arrow) was amplified with primer pair ISIIA (lanes 4- 9), whereas the expected 372 bp 
fragment could not be amplified using the primer pair 2SI2A (lanes I 0 - 13). Negative PCR controls without 
DNA (lanes 2 and 3) were performed with primer pairs ISIIA and 2SI2A, respectively. A 123 bp ladder 
(lane I) was used as molecular weight marker. The different conditions under which the PCR amplifications 
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Fig 3.10 Amplification of a 421 bp fra2ment from P.an~ulosus eDNA and Genomic DNA Usin2 Specific 
Primers SP1 I SP2 
(a) The primer pair SPJ/SP2 was used to PCR amplify a 421 bp fragment (lanes 2- 7) from the eDNA of 14 
hour P.angulosus embryos. The different MgC12 concentrations used in each reaction are indicated (see 
individual lanes). Negative and positive controls (without eDNA (lane 2) and with eDNA (lane 3) 
respectively) were performed with degenerate primers 1SIIA. PCR products (421 bp) are indicated with an 
arrow (lanes 4, 5 and 6). A Pst/ digest of lambda was used as molecular weight marker (lane 1 ). 
(b) PCR amplification of the 421 bp fragment from genomic DNA (isolated from sea urchin sperm) using 
primer pair SP1 /SP2 (lanes 3 - 7) was optimised by using different concentrations of genomic DNA, MgC12 
and DMSO, as indicated in each lane. A negative control (without genomic DNA) is shown in lane 2. A Pstl 
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Fig 3.11 Analvsis of eDNA Generated from Sea Urchin Embryo Total RNA 
eDNA obtained by reverse transcription of total RNA (from 14 hour sea urchin embryos) using MML V 
reverse transcriptase was analysed on an 1 % agarose gel (lane 2). The molecular weight marker (Jane 1) is an 
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Fig 3.12 RACE Generates Multiple 5' and 3' DNA Fra~;:ments 
The DNA fragments generated by 5' and 3' RACE reactions (see section 2.11 .3) using sea urchin eDNA (fig 
3.11) were analysed on an I % agarose gel (lanes 2 and 3 respectively). The 421 bp product (lane 4) generated 
by amplification of eDNA with primer pair SPI/SP2 (see fig 3.10) served as a positive control, whereas 
negative controls (lanes 5, 6 and 7) represent PCR reactions using the three respective primers SP I, SP2 and 
API (Clontech) individually, under the same amplification conditions. The molecular weight marker (lane 1) 
is an EcoRI I Hindiii digest of phage lambda. 
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has a major band in the expected region (viz - 1.3 kb), and there is an additional strong signal in the 
region of 3 kb. The two bands probably arose as a result of different polyadenylation sites (see section 
6.1.3). 
The two major fragments resulting from the 5' and 3' RACE reactions (marked by the arrows in fi g 
3.13) were recovered from a low melting point agarose gel, and the fragments were purified using 
Wizard PCR Preps columns (section 2.5.2). The fragments were identified further by sequencing 
them automatically. The isolated 5' RACE product was sequenced with the T7 primer (an annealing 
site is situated on the adaptor ligated to the eDNA, see Appendix IX) and the 3' RACE fragment was 
sequenced with a gene specific primer (SPl). Homology comparisons established that the two 
fragments resulting from 5' and 3' RACE have a very high identity with the SpGCFl eDNA 
sequence, viz 74 % for the 5' RACE product and 92 % for the 3' RACE product (see Appendix XI). 
This indicates that together these fragments represent the P.angulosus homologue of SpGCFl from 
S.purpuratus. Comparing the combined length (- 2.1 kb) of the 5' and 3' RACE fragments to the 
SpGCFl DNA sequence reveals that it is likely that the full length P.angulosus clone has been 
amplified, since the 5' RACE product extends at least 50 bp further into the 5' untranslated region 
than the eDNA for SpGCFl (see Appendix XI), and judging from its complete length(- 1.3 kb) the 3' 
RACE product extends at least 300 bp beyond the 3' end of the open reading frame of SpGCFl . Thus 
the 5' and 3' RACE products were characterised by Southern blot analysis and their correct identity 
was confirmed by sequencing the fragments. 
The generation of a - 2.1 kb full length clone potentially encoding suGFl involved fusing the 5' and 
3' RACE fragments (see section 2.11.3 .5) which was facilitated by the region of overlap between the 
fragments (the sense and the antisense primers are separated by 421 bp (see Appendix VII)). The final 
product of the fusion I amplification reaction was analysed by agarose gel electrophoresis (fig 3.14, 
lane 2). The full length product was isolated from a low melting point agarose gel, purified using a 
Wizard PCR preps column and the fragment was cloned into pGEM-T (a T/A type PCR cloning 
vector, see Appendix VIII (c)) using the A overhang incorporated by Taq polymerase on the PCR 
products. DNA from several colonies was isolated to confirm the correct size of the insert and 
subsequently the plasmids containing inserts were sequenced (see section 3.6). 
3.6 DNA Sequence Analysis of the PCR-Generated eDNA Clone 
A consensus DNA sequence was derived for the full length P.angulosus clone by automatic 
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Fig 3.13 Southern Analysis of the 5' and 3' RACE Products 
.... 
.... 
The 5' and 3' RACE products as weJJ as the control reactions were separated on an I % agarose gel and 
blotted onto a nitroceJJulose filter (see section 2.12). Southern analysis was performed using the radioactively 
labelled 421 bp fragment representing the region between the gene specific primers (SPI and SP2}, which 
were used in the amplification reactions. Multiple RACE products (lane 1 (5' RACE) and Jane 2 (3 ' RACE}}, 
as well as the 421 bp fragment (Jane 3) hybridised to the probe. The main RACE products (see lanes 1 and 2) 
with correctly predicted sizes are marked by arrows. The negative control reactions performed with primers 
SP I, SP2 and AP 1 individuaJJy (lanes 4, 5 and 6 respectively) did not hybridise to the probe. The molecular 








Fig 3.14 Fusion of the 5' and 3' RACE Fra2ments Yielded a Full Len2fh Clone 
The 5 ' and 3 ' RACE products were fused in their region of overlap and extended by a thermal cycling 
reaction in which both products simultaneously acted as primer and template. The resultant full length 
product of- 2.1 kb (lane 2) was PCR amplified, gel purified and cloned into the pGEM-T vector. The 
molecular weight marker (lane I) is a Hindi// digest of phage lambda. 
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sequenced in both directions, using the T7 and Sp6 primers of the pGEM-T vector (see Appendix X). 
In addition, internal sequencing was achieved by primer walking, ie internal gene specific primers 
were designed (primers SP3 and SP4, see Appendix IX and fig 3.15) in order to obtain continuous 
sequence information. Several nucleotide positions in the sequences showed degeneracy within the 
three clones. These regions were resequenced on two additional independent clones in order to 
eliminate any. errors in the consensus sequence for the entire full length clone (fig 3.15). A homology 
comparison between the P.angulosus clone identified by the PCR strategy and the eDNA sequence 
coding for SpGCFl (3) using the GCG computer programme, revealed that the full length 
P.angulosus clone includes the entire coding region, as well as some 5' (~ 300 nt)and 3' (~ 500 nt) 
untranslated sequence information. An alignment of the two sequences (see Appendix XIV) shows an 
84 % identity over a region of 1989 nt. The P.angulosus eDNA has a single open reading frame of 
1542 nt, which can be translated into a protein of 514 amino acids (see fig 3.15), with a molecular 
weight of 57 kDa. 
In conclusion, several clones potentially encoding suGF1 were generated using a combination of a 
PCR strategy (see section 3.5) and DNA ligand screening a eDNA expression library (see section 
3.4). Further determination of the DNA-binding specificity of all the recombinant proteins encoded 
by the putative positive clones was necessary in order to establish whether any of the eDNA clones 
isolated by both these methods correctly represent the eDNA coding for suGF1 (see Chapter 4). 
Fig 3.15 Sequence Analysis of the Full Length P.angulosus eDNA Clone Isolated by the PCR Strategy 
A full length clone potentially encoding suGFl was isolated from P.angulosus using a PCR strategy (see section 
3.5). The consensus sequence for the clone was derived by sequencing a minimum of three independent 
colonies. The specific primer pair (SPl I SP2) was used to PCR amplify the 3' and 5' ends of the eDNA 
respectively, whereas primers SP3 and SP4 were used to obtain internal DNA sequence information. (All 
primers are shown in bold print.) The 5' untranslated region has three stop codons (bold print) in frame with a 
single open reading frame, which codes for a 514 amino acid protein. TheN-terminus is rich in proline residues 
(marked by asterisks), and contains several methionine residues (bold print) which may present alternate 
translation start sites. The protein is characterised by nine pentapeptide repeats (N/SVSMP), which are 
underlined. It also has a basic domain representing a putative DNA-binding domain, which is double underlined 
and it has heptad repeats which are marked by the broken lines. 
ttacgccaagctatttaggtgacactatagaatactcaagctatgcatccaacgcgttgg 
1 ---------+---------+---------+---------+---------+---------+ 60 
aatgcggttcgataaatccactgtgatatcttatgagttcgatacgtaggttgcgcaacc 
gagctctcccatatgggtcgacctgcaggcggccgcactagtgattccatcctaatacga 




121 ---------+----~----+---------+---------+---------+---------+ 180 
gagtgatatcccgagctcgccggcgggcccgtccacaggcaagtacgctgttaactattt 
tttactggattttggagcttaatattgcttttcatcaatcataacgattgaaaaatttac 
181 ---------+---------+------~--+---------+---------+---------+ 240 
aaatgacctaaaacctcgaattataacgaaaagtagttagtattgctgactttttaaatg 
cattttgtgtgtaccttgtgagttgaggagactcctccatagaagaagaaggagtgaggt 
241 ~--------+---------+---------+---------+---------+---------+ 300 
gtaaaacacacatggaacactcaactcctctgaggaggtatcttcttcttcctcactcca 
atgtccactctgccccagcccctgtcccattgcctgctgaaccaggtgaacactgcagcc 
301 ---------+---------+---------+---------+---------+---------+ 360 
tacaggtgagacggggtcggggacagggtaacggacgacttggtccacttgtgacgtcgg 
M S T L P* Q P* L S H C L L N Q V N T A A 
1---~----------------1 
atcaacctaccacatcaacaacctggactcatcacagacatcaaaccaatgattagtaac 
361 --------~+-------~-+---------+---------+---------+-~-------+ 420 
tagttggatggtgtagttgttggacctgagtagtgtctgtagtttggttactaatcattg 
I N L P* H Q Q P G L I T D I K P* M I S N 
1---------------------1 1----------------------1 
aaaccccctcctactcaggaggtcaaaccaaacatcttagctgcggctgctgctggcttg 
421 ·--------+---------+---------+---------+---------+-~----·-~+ 480 
tttgggggaggatgagtcctccagtttggtttgtagaatcgacgccgacgacgaccgaac 
K P* P* P* T Q E V K P* N I L A A A A A G L 
acctaccctccactcaacgtgcctagcctacctgcaatgcccaacgtgtcgatgcctaat 
481 ---------+---------+---------+---------+---------+---------+ 540 
tggatgggaggtgagttgcacggatcggatggacgttacgggttgcacagctacggatta 
T Y P* P* L N V P* S L P* A M P* N V S M P* n__ -
gtgtcattgcccaacgtgtcaatgcctaatgtgtctatgcccaatgtgtctatgccaacc 
541 ---------+---------+---------~---------+--------·+---------+ 600 
cacagtaacgggttgcacagttacggattacacagatacgggttacacagatacggttgg 
V S L P* N V S M P* N V S M P* N V S M P* I__ -
agcgtttcaatgccgagtgtgtccatgcccagcgtttctatgccgagtgcgtccatgcca 
601 ---------+---------+---------+---------+---------+---------+ 660 
661 
tcgcaaagttacggctcacacaggtacgggtcgcaaagatacggctcacgcaggtacggt 
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agtttcactgccgaagctgcagagctggccgatcggagacgcctttggaggcggcggaag 
1261 ---------+---------+---------+---------+---------+---------+ 1320 
tcaaagtgacggcttcgacgtctcgaccggctagcctctgcggaaacctccgccgccttc 
S F T A E A A E L A D R R R L W R 'R R K 
-----1--------------------l--------------------l 
gagaacaaccgaaagagacggaagcgcatggagaaacaacttgaaaaaattgagcagcga 
1321 ---------+---------+---------+---------+--~----~-+---------+ 1380 
ctcttgttggctttctctgccttcgcgtacctctttgttgaacttttttaactcgtcgct 
E N N R K R R K R M E K Q L E K I E Q R 
tcttgcgagcttctctttcacatcacatcacggggggcgtacgacagggtgcgttcccac 
1381 ---------+---------+---------+---------+---------+---------+ 1440 
agaacgctcgaagagaaagtgtagtgtagtgccccccgcatgctgtcccacgcaagggtg 
S C E L L F H I T S R G A Y D R V R S H 
cctgagatgcctcgcatcggacccagcgaggtgaacacagacatgttaaatgggattaaa 
1441 ---------+---------+---------+---------+---------+---------+ 15·00 
ggactctacggagcgtagcctgggtcgctccacttgtgtctgtacaatttaccctaattt 
P E M P R I G P S E V N T D M L N G I K 
tccaaatcagaagtgaggcctctaatgcatctactgagtaaaggttacatgactccaggt 
1501 ---------+---------+---------+---------+---------+---------+ 1560 
aggtttagtcttcactccggagattacgtagatgactcatttccaatgtactgaggtcca 
S K S E V R P L M H L L S K G Y M T P G 
gcgatggaaatggtctcgcaaaagattcagaaactagaatgtggtattaagactgaagct 
1561 ---------+---------+---------+---------+---------+---------+ 1620 
cgctacctttaccagagcgttttctaagtctttgatcttacaccataattctgacttcga 
A M E M V S Q K I Q K L E C G I K T E A 
caccaacaggcaacccaggtcggtatcaactctctggccatcaacaaaatgccagttcct 
1621 ---------+---------+---------+---------+---------+---------+ 1680 
gtggttgtccgttgggtccagccatagttgagagaccggtagttgttttacggtcaagga 
SP4 CATAGTTGAGAGACCGTTAG 
H Q Q A T. Q V G I N S L A I N K M P V P 
gcttccagaattaaatccatactgcctcctgctcctcctccagtcactggcgttgcctca 
1681 ---------+---------+---------+---------+---------+---------+ 1740 
cgaaggtcttaatttaggtatgacggaggacgaggaggaggtcagtgaccgcaacggagt . 
A S R I K S I L P P A P P P V T G V A S 
tccactatgatctcatcaaccatggtgtcgtcagtaaactctgctgcccctgttacacag 
1741 ---------+---------+---------+---------+---------+---------+ 1800 
aggtgatactagagtagttggtaccacagcagtcatttgagacgacggggacaatgtgtc 
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caatcagtgcccaccgttaatctcaatactcagctagcaaagtaacaccaaacagaccat 
1801 ---------+---------+---------+---------+---------+---------+ 1860 
gttagtcacgggtggcaattagagttatgagtcgatcgtttcattgtggtttgtctggta 
Q S V P T V N L N T Q L A K 
gtaacctttccatacttctgagtgttgatagttatactctatactgtaatttcaagcaac 
1861 ---------+---------+---------+---------+---------+---------+ 1920 
cattggaaaggtatgaagactcacaactatcaatatgagatatgacattaaagttcgttg 
attttatgatgtctaatcatgctccaatgtgagaaaagtatacatttattgtataaacag 
1921 ---------+---------+---------+---------+---------+---------+ 1980 
taaaatactacagattagtacgaggttacactcttttcatatgtaaataacatatttgtc 
gaatgtagcaaattttaaaatgatttagctactaaattgtagaattacttgttgtttgga 
1981 ---------+---------+---------+---------+---------+---------+ 2040 
cttacatcgtttaaaattttactaaatcgatgatttaacatcttaatgaacaacaaacct 
taaacatgtagcttgtactggatgtaaatgtaaattttacccagtacaaataactgcttt 
2041 ---------+---------+---------+---------+---------+---------+ 2100 
atttgtacatcgaacatgacctacatttacatttaaaatgggtcatgtttattgacgaaa 
attcttctagtcaatgatgtatgacttttgcagtattacattagttgtatgctgttatac 
2101 ---------+---------+---------+---------+---------+---------+ 2160 
taagaagatcagttactacatactgaaaacgtcataatgtaatcaacatacgacaatatg 
attgcctaaaaattgtaggtttatatgtatatgatttaataacttgcctttgctcaacaa 
2161 ---------+---------+---------+---------+---------+---------+ 2220 
taacggatttttaacatccaaatatacatatactaaattattgaacggaaacgagttgtt 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaagcggccgctgaattctagaaaatcccgcggc 
2221 ---------+---------+---------+---------+---------+---------+ 2280 
tttttttttttttttttttttttttttttcgccggcgacttaagatcttttagggcgccg 
catggcggccgggagcatgcgacgtcgggcccaattcgccctatagtgagtcgtattaca 
2281 ---------+---------+---------+---------+---------+---------+ 2340 
gtaccgccggccctcgtacgctgcagcccgggttaagcgggatatcactcagcataatgt 
attcactgccgt 
2341 ---------+-- 2352 
taagtgacggca 
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3.7 Developmental Distribution of the mRNA Transcript Corresponding to the PCR-Generated 
eDNA in P.angulosus 
To determine the developmental distribution of the RNA transcript corresponding to the PCR-
generated clone (see section 3.5), total RNA was isolated from P.angulosus eggs, several 
d~velopmental embryonic stages (4, 9, 14, 21, 30 and 45 hour embryos), as well as adult tissue 
(muscle, ovary and testis). The RNA was analysed by Northern blotting and reverse-transcriptase 
(RT) PCR. Fractionation of RNA under denaturing conditions (see section 2.6.4.1) followed by 
acridine orange staining showed that the RNA was intact, as determined by the presence of distinct 
undegraded 28S and 18S ribosomal bands. Northern blotting of the fractionated RNA was performed 
with a radiolabelled probe containing part of the putative suGF1 eDNA (viz the overlap region 
between specific primers SP1 and SP2 (see Appendix IX, and fig 3.15)). Hybridisation signals 
resulting from Northern blots were uninterpretable as the probe appeared to bind over a wide range of 
molecular weights for each RNA sample (data not shown). An alternative approach using RT-PCR 
was followed. Briefly, this technique involved treating the RNA samples with DNase 1 and 
subsequently with MMLV reverse transcriptase (see section 2.7). eDNA generated from each RNA 
sample was amplified in a PCR reaction using specific primers SP1 and SP1, generating the 
characteristic 421 bp fragment described above. PCR amplifications were analysed on an agarose gel, 
revealing that the putative suGF1 RNA is present in P.angulosus eggs, embryonic stages (4- 45 hour 
embryos), as well as adult muscle and testis tissue (see individual lanes in fig 3.16). In contrast, ovary 
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Fig 3.16 Analysis of the Distribution of the mRNA Transcript Corresponding to the PCR-Generated 
Clone 
mRNA isolated from sea urchin eggs, embryos (4 - 45 hours) and adult tissue (muscle (M), ovaries (0) and 
testes (T)) was reverse transcribed using MML V reverse transcriptase (see section 2.7). The resulting eDNA 
was used in PCR amplifications in combination with specific primers SP1 and SP2 to amplify the 
characteristic 421 bp fragment. The mRNA transcript of interest is present in eggs (lane 4), 4 - 45 hour 
embryos (lanes 5 - 10), testes (lane 12) and muscle tissue (lane 13). The transcript is absent in ovaries (lane 
11). Control PCR amplifications performed in the absence of eDNA (lane 2), and with 14 hour mRNA not 
treated with reverse transcriptase (lane 3) did not yield DNA products. A molecular weight marker (EcoRI I 





RECOMBINANT PROTEIN EXPRESSION 
4.1 Introduction 
Biologically important eukaryotic proteins are often cloned and overexpressed to produce large 
amounts of material. Commonly, the expression of large quantities of proteins encoded by cloned 
genes can be achieved in E.coli, since this system is easy to manipulate, inexpensive to maintain, 
grows quickly and represents one of the best understood organisms in nature (151, 204)~ Several other 
systems such as yeast, mammalian cells, baculovirus, plants, transgenic animals and eukaryotic in 
' vitro transcription I translation systems are also available for recombinant protein expression (205). 
These systems generally rely on a similar basic approach. A foreign gene is inserted into an 
·expression vector (eg bacteriophage, plasmid or virus), which has several characteristic features 
including (i) a selectable marker to actively maintain the foreign gene, (ii) a transcription promoter 
(eg lac, trp, tac, T7, etc) whose induction is tightly controlled and maximises the efficiency of 
transcription, (iii) translational control signals, eg a ribosome binding site and signals for the 
initiation of translation, and (iv) a poly linker which simplifies the insertion of a foreign gene into the 
vector (151 ). The choice of the expression vector is often determined by its promoter (promoters may 
be controlled by various mechanisms, eg temperature shift, chemical induction or metabolic response, 
etc) (151 ). Expression constructs are transformed into appropriate expression systems, which, ideally, 
should facilitate both the expression and purification of foreign target peptides. However, 
recombinant protein expression is often associated with problems such as instability, insolubility and 
inactivity of the target protein. These problems may be overcome by conditions determined for each 
target protein individually, such as the synthesis of hybrid proteins, the use of host strains with 
decreased proteolytic capacity, or exploitation of the formation of inclusion bodies, which may 
sometimes be solubilised and renatured to gain functional activity by use of denaturing agents. 
Unfortunately there are no set methods or rules which guarantee the successful expression of cloned 
proteins in a useful form, and each new gene presents its own unique expression problems. This 
means that the expression of each gene has to be tested and optimised individually, possibly using 
several host expression systems and varying the expression conditions for each. Therefore, since the 
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expression of recombinant proteins is an inexact science, a trial. and error approach was used to 
investigate the expression of the isolated eDNA clones (see Chapter 3) potentially encoding suGFl. 
4.2 Expression of Clones Obtained by the DNA Ligand Screening Approach 
4.2.1 Recombinant Protein Expression Using the Prokaryotic Expression Systems pBluescript, 
pETandpGEX 
Recombinant protein expression of Clones 2, 6, 11 and 16 in Bluescript (see Appendix VIII (a)) was 
induced by addition of IPTG to mid log phase cells, which were grown to stationary phase and 
subsequently assayed for recombinant protein expression by comparison to uninduced cells using 
SDS-PAGE (see section 2.24). Various techniques (see section 2.14.1) were used in attempts to detect 
recombinant protein expression from the bacterial cells. The most direct assay involved lysis of the 
induced stationary phase cells (which were pelleted by centrifugation) in SDS loading· dye with 
subsequent analysis by SDS-PAGE. A second method involved lysis of induced stationary phase cells 
using a combination of lysozyme and Triton X-100, and the bacterial lysate (separated from the cell 
debris by centrifugation) was analysed by SDS-PAGE for the presence of recombinant proteins. A 
third method promoted the release of proteins from the periplasmic space by high speed 
centrifugation of induced stationary phase cells. Again the supernatant was analysed by SDS-PAGE 
after TCA precipitation of the proteins. Each method involved protein induction using several 
different E.coli host strains, eg SOL R' JM109, XL-1 Blue and DH5a, and analysis was performed on 
multiple colonies derived from each host strain. Various other parameters were optimised, such as 
varying the temperature and length oflnduction, and using different volumes of culture, ranging from . 
2 ml to 50 mi. In addition, protein extracts were separated by various percentages SDS-PAGE (the 
gels were stained using both Coomassie Brilliant Blue and silver). Analysis of protein extracts was 
also attempted by EMSA and DNase 1 footprinting, which are highly sensitive techniques used to 
detect DNA-binding proteins. However, none of the strategies outlined above resulted in the detection 
of induced recombinant proteins (data not shown), despite the fact that target proteins from Bluescript 
inserts should be reasonably stable, since they are expressed as fusion proteins to the amino terminus 
(- 20- 50 amino acids) of the a-complementing portion of the J3-galactosidase gene (206). 
The four clones (2, 6, 11 and 16) were subsequently subcloned from pBluescript SK into pET-29b(+) 
(see Appendix XIV (a) for details on the pET system and Appendix XIV (b) for details on the 
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subcloning strategy). Several parameters were varied in order to obtain and optimise expression of 
these constructs. For instance, the inserts were subcloned using several unique restriction sites, the 
resulting pET constructs were established in various different E.coli host strains (JM109, HB101 and 
DH5a) and subsequently induced to express in two different host strains BL21DE3 and pLysS (see 
Appendix XIV for details). Multiple colonies from each expression strain were analysed for 
expression, the conditions were also altered with respect to temperature and length of induction, as 
well as volume of culture. A plasmid referred to as the "induction control", which codes for the 13-
galactosidase protein and has matching elements (ie promoter, selective marker, etc), wasprovided 
with the pET-29b(+) vector (see Appendix VIII). This plasmid allowed convenient testing of 
induction. Optimisation of expression (see Appendix XIV (b) for experimental details) resulted in the 
expression of a single clone only. Clone 11 was expressed successfully as a- 25 kDa protein in the 
BL21DE3 expression host, as depicted by the arrow in fig 4.1. Expression was independent of both 
the restriction site used in the subcloning procedure (data not shown) and the host strain the construct 
was originally established in (fig 4.1, lanes 4 - 6 (DH5a), lanes 7 - 9 (HB101) and lanes 10 - 12 
(JM109)). Both uninduced (lanes 4, 7 and 10) and induced cells (lanes 5, 6, 8, 9, 11 and 12) were 
harvested after 3 hours, resuspended in SDS sample application buffer and analysed by SDS-P AGE 
(silver stained). Protein molecular weight standards are indicated (lane 1), and uninduced and induced 
total cell protein from the induction control plasmid were analysed, too (lanes 2 and 3, respectively). 
The asterisk indicates the position of the induced 13-gal protein, which, although expressed very 
strongly, was not always easily distinguishable from the background, as it often discoloured into a 
light yellow band upon silver staining. Expression of Clone 11 was analysed by a time course of 
induction at various temperatures (16°C, 20°C, 30°C and 37°C, see Appendix XVI (b) for details), 
which established that the recombinant protein is maximally induced at 3 7°C after 3 - 4 hours of 
induction and at 30°C after 5 - 6 hours of induction. Recombinant protein expression could not be 
detected for any of the other clones (2, 6 and 16), irrespective of the conditions used to optimise 
induction (eg changes in temperature, time, volume of culture), the cloning site used and initial or 
expression host. However expression of the j3-gal protein from the control plasmid was always 
detected successfully in these assays (data not shown). 
In order to confirm the DNA-binding ability of Clone 11 several strategies were attempted to generate 
recombinant protein in a soluble form (see section 2.14.3 and Appendix XIV (c)). For the first 
method,, induced cells were lysed using a combination of lysozyme and Triton X-100, the cellular 
debris was separated from the soluble proteins in the supernatant and analysed by SDS-PAGE (see 
Appendix XIV (c) for details), showing that Clone 11 can be induced as a soluble protein, however 
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Fig 4.1 Clone 11 Expresses a 25 kDa Recombinant Protein 
..__ 
Bacterial cell extracts containing recombinant protein product generated from the pET-29b(+) I Clone 11 
expression construct were analysed by I 0 % SDS-P AGE (silver stained). The BL21 DE3 expression host was 
induced to express the recombinant protein , after establishing the expression construct in various E.coli host 
strains, viz DH5a (lanes 4 - 6), HB I 0 I (lanes 7 - 9) and JM I 09 (lanes I 0 - 12). Uninduced cell extracts are 
shown in lanes 4, 7 and 10, whereas the induced extracts are in lanes 5 and 6 (DH5a), 8 and 9 (HBIOI) and 
II and 12 (JM I 09) . The arrow shows the position of the induced recombinant protein expressed by Clone II. 
Extracts from cells containing the induction control plasmid (I/C) are shown in lanes 2 (uninduced cells) and 
3 (induced cells), the position of the induced ~-gal protein is marked by the asterisk. The protein molecular 
weight standards are indicated (lane I) . 
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EMSAs using the E/H fragment as labelled DNA probe (see section 2.21), indicating that the induced 
recombinant protein was inactive with respect to DNA-binding activity (data not shown), despite 
attempts to improve recombinant protein folding by dialysis of the bacterial extracts into dialysis 
buffer (see section 2.19) containing 4 rnM MgC12 and 2 rnM ZnCh. (Prokaryotic gene expression may 
lead to incorrect folding of eukaryotic proteins or loss of their biological activity (151 ).) Further 
attempts to improve the method of soluble recombinant protein isolation were unsuccessful (see 
Appendix XIV (c) for details). 
Purification of soluble recombinant protein was approached using a second method, which exploits 
the fusion of cloned inserts to the His-Tag on the pET plasmid (see Appendix VIII) by subsequent 
Nickel column chromatography of protein extracts. Cells were induced, pelleted and resuspended in 
column binding buffer (see section 2.14.3.2) containing protease inhibitors. The protein sample was 
processed by a combination of sonication, washing the pellet and differential centrifugation (for 
experimental details see Appendix XIV (c)). Protein extracts containing recombinant protein from 
Clone 11 were subjected to Nickel chromatography, however the recombinant protein could not be 
discerned in the elution profile resulting from the column, implying that insufficient protein may have 
been released into the supernatant for subsequent detection. Similarly when above procedure was 
repeated with induced f3-gal protein from the induction control plasmid, the f3-gal protein could also 
not be detected in the elution profile (see Appendix XIV (c) for details). These results imply that 
either insufficient protein was released by the sonication steps, and therefore was not detectable in the 
elution profile, or that the Nickel column was prone to ion leaching during the wash steps, leading to 
the loss of the protein-metal complexes. Alternatively these complexes may have leached out 
gradually over several of the eluting fractions. Thus Nickel chromatography did not appear to enrich 
the recombinant proteins, and therefore it was decided to approach the protein purification by first 
denaturing the insoluble recombinant protein using denaturin~ agents, in order to release greater 
amounts of protein. 
It appeared that insoluble inclusion bodies (ie dense aggregates of highly concentrated expressed 
target protein) contained the major fraction of the expressed protein. These were used as a source for 
further purification of the recombinant protein. Several methods involving inclusion body isolations 
and renaturation of recombinant protein were examined (see Appendix XIV (d) for experimental 
details). Briefly, one method (pET System Manual and section 2.14.3.3) involved resuspension ofthe 
induced cells in binding buffer, followed by brief bursts of sonication, several washes and subsequent 
resuspension in binding buffer (see section 2.14.3.2) supplemented with 6 M guanidine HCl or 6 M 
urea. Resuspension of protein was aided by repeated sonication and subsequently it was dialysed into 
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dialysis buffer (see section 2.19) in order to remove the guanidine HCI. A second inclusion body 
isolation method (described by Cal zone et al (1991) (120), and see section 2.14.3 .3 ), involved lysis of 
induced cells using lysozyme (aided by sonication), and the suspension was supplemented with NP-
40 and sucrose. Soluble proteins were selectively precipitated and the resuspended proteins were 
dialysed into dialysis buffer (see section 2.19). Inclusion body isolation using a third method 
(outlined by Lin and Cheng (1991) (186) and see section 2.14.3.3) required formation ofspheroplasts 
from induced cells. Lysis was achieved by sonication, and nucleic acids were removed enzymatically. 
Crude inclusion bodies were pelleted and washed several times, resuspended by sonication and 
denatured in 5 M guanidine HCI. Proteins were renatured overnight by dilution of the denaturant, and 
subsequently dialysed into the buffer of choice (dialysis buffer). Despite several attempts to solubilise 
expressed recombinant protein by means of extensive sonication combined with denaturation agents 
such as urea and guanidine HCl, none of the methods outlined above (see Appendix XIV (d) for 
experimental details) successfully dissociated the inclusion bodies containing the recombinant protein 
expressed from Clone 11. The recombinant protein was continuously present in the pelleted fractions 
rather than the solubilised fractions (data _not shown). Therefore, it appears that inclusion body 
isolations in combination with denaturation I renaturation techniques are not compatible with the 
isolation of the recombinant protein expressed by Clone 11. Overall, the above experiments indicate 
that the expression of the isolated sea urchin clones (see section 3.4) is not successful in combination 
with the pET-29 system, since firstly only one clone was successfully expressed (at very low levels) 
and secondly the respective recombinant protein could not be solubilised or renatured. 
The expression of the four clones (2, 6, 11 and 16) was therefore attempted in the pGEX expression 
system. The clones were subcloned from pBluescript into the pGEX-3X vector (see Appendix VIII) 
using the EcoRJ site in order to retain the same original reading frame. The correct orientation of the 
inserts was confirmed by restriction enzyme analysis. Recombinant protein expression was induced 
chemically by means of IPTG and induction was performed in several hosts, eg JM109, DH5a and 
MC1061. Several colonies of each clone (originating from different expression hosts) were analysed 
for recombinant protein production by SDS-PAGE, however only the characteristic 26 kDa 
glutathione S-transferase (GST) protein was expressed and no fusion proteins were generated,, 
implying that none of the constructs were expressed successfully in the pGEX-3X vector (data not 
shown). Despite its eukaryotic origin GST is generally expressed at very high levels in E.coli as a 
soluble homodimeric protein with a MW of 26 kDa (207). Expression is induced chemically and is 
controlled by the tac promoter. 
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4.2.2 Eukaryotic Protein Expression in Mammalian Cells 
Transient transfection studies were performed with Clone 11 subcloned into the pCIS plasmid (see 
Appendices XV). The expression construct was transfected into COS-I cells (derived from African 
green monkey kidney cells) using the DEAE-dextran method (see section 2.15). Cells were allowed to 
express for 24 - 48 hours after which they were harvested and processed into whole cell extracts and 
nuclear extracts (see section 2.15), which were analysed by SDS-PAGE (see Appendix XV for 
details). No difference was observed between untransfected and transfected cells for either the nuclear 
or whole cell extracts, implying that recombinant protein expression may have been unsuccessful. 
Analysis of the extracts via EMSA using the labelled E/H probe revealed no DNA-binding activity in 
any of the extracts either (data not shown). The results imply that either the mammalian expression 
system is inefficient in this case (possibly due to low transfection success), such that the expression of 
the recombinant protein could not be ascertained or, alternatively, the protein could not be expressed 
in this host environment. Generally eukaryotic genes or cDNAs should express efficiently in 
eukaryotic systems, resulting in the proper translation and processing of the expressed product (208). 
Instead of performing a detailed trouble shooting analysis (see Appendix XV for a discussion of the 
possible underlying problems associated with the system), the problem of eukaryotic expression was 
readdressed using a different eukaryotic system, viz in vitro coupled transcription I translation (see 
section 2.16 and 4.2.3). 
4.2.3 In Vitro Eukaryotic Transcription I Translation 
Recombinant proteins from Clones 2, 6, 11 and 16 in the Bluescript plasmid (see Appendix VIII) 
were expressed in conjunction with a rabbit reticulocyte lysate transcription I translation system (see 
section 2.16). Transcription was effected from the T3 promoter in all the clones, including the 
luciferase control plasmid which was provided with the system. Eukaryotic translation of the proteins 
was generally performed in the presence of translational grade 35S-methionine. The resultant protein 
products were analysed by SDS-PAGE with subsequent autoradiography (fig 4.2). Protein molecular 
weight markers are indicated in the margin, a control reaction was performed in the absence of a 
plasmid (lane 1), and the control plasmid resulted in translation of the 61 kDa luciferase protein (lane 
2). Protein products from Clones 2, 6, 11 and 16 are shown in lanes 3, 4, 5 and 6 respectively. Clone 2 
(2.2 kb) resulted in a protein of molecular weight about 48 kDa (lane 3), the protein arising from 
Clone 11 (0.9 kb) is about 25 kDa (lane 5), and Clone 16 (2.4 kb) has a protein of about 45 kDa (lane 
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Fig 4.2 In Vitro Transcription I Translation Yielded Recombinant Proteins from the Clones Isolated by the 
DNA Li2and Screenin2 Procedure 
A rabbit reticulocyte lysate system (see section 2.16) was used to express recombinant proteins from Clones 2, 6, 
11 and 16 in the presence of translational grade 35S-methionine. Transcription was effected from the T3 promoter 
on the Bluescript plasmid, as well as the luciferase control plasmid which was provided with the system 
(Promega). The resultant protein products were analysed by 10 % SDS-PAGE with subsequent autoradiography. 
A negative control was performed without plasmid DNA (lane !), and the luciferase control protein (LC) forms a 
clear product at about 61 kDa (lane 2). Protein products from Clones 2, 6, 11 and 16 are shown in Janes 3, 4, 5 
and 6 respectively. Clone 2 (2.2 kb) encodes a protein of molecular weight- 48 kDa (lane 3), the protein arising 
from Clone II (0.9 kb) is- 25 kDa (lane 5), and Clone 16 (2.4 kb) has a protein of- 45 kDa (lane 6) as shown by 
the arrows. No unique protein bands corresponding to a protein encoded by Clone 6 (0.85 kb) could be identified 
(lane 4). Standard protein molecular weight markers are indicated in the margin . 
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them. No unique band corresponding to a protein encoded by Clone 6 (0.85 kb) could be identified 
(lane 4). This correlates with previous indications that this clone may not have an open reading frame 
(see section 3.4 and Appendix IV). Alternatively the recombinant protein may have a very low 
methionine content, such that insufficient 35S label was incorporated, thereby preventing visualisation 
of the product (see also section 6.2.2). The amounts of protein produced from the four clones by the 
in vitro transcription I translation application appear to be relatively low when compared to the 
luciferase control protein (fig 4.2, lane 2). Expressed target proteins were titrated in EMSAs in order 
to assay for protein-DNA interactions, however it appears that either insufficient protein was 
expressed to discern a detectable shift in the mobility of the labelled DNA, or the expressed target 
proteins do not have DNA-binding activity (data not shown). 
4.3 Expression of the PCR-Generated eDNA Clone and its S.purpuratus Homologue 
A pRSET expressiOn construct coding for the SpGCFl protein (which represents a candidate 
homologue to suGFl) was obtained from Professor E. Davidson (Caltech) prior to the isolation of the 
full length P.angulosus homologue (see section 3.5). The integrity of this expression construct was 
confirmed by a restriction enzyme digest using BamHI and Bgl/1, which resulted in the release of a -
1.7 kb insert from the pRSET vector (see Appendix VIII) (data not shown). Expression of the 
SpGCFI construct was attempted in bacterial expression hosts BL21DE3 and pLysS, in order to 
correlate the identity of native suGFI and recombinant SpGCFl. Induction of recombinant SpGCFl 
expression was performed according to conditions outlined by Zeller et al (1995) (3). Expression of 
the recombinant protein could not be observed by comparing total protein from uninduced and 
induced cells as analysed by SDS-PAGE (fig 4.3, compare lanes 6 with lanes 7 and 8). However, 
when recombinant proteins were isolated from inclusion bodies (see section 2.14.3.3), induced cells 
appeared to have a stronger expression pattern in the region of 42 kDa marked by the arrow (fig 4.3, 
compare lanes 2 with lanes 3 and 4), which corresponds to one of the expected sizes of the SpGCFl 
protein (3). This suggested that expression of SpGCFl may have been successful. The DNA-binding 
activity of induced proteins was analysed by EMSA using the E/H fragment, however the pattern of 
protein-DNA complexes was not unique for the induced extract with respect to the uninduced protein 
fraction (data not shown), implying that either recombinant SpGCFl was not being expressed or it 
was expressed in both uninduced and induced cells as a result of a leaky promoter. Therefore the 
specificity of the protein-DNA complexes was investigated using EMSAs performed with specific 
and nonspecific ds oligonucleotides and E/H fragment (see fig 2.1 and fig 2.2, respectively) as cold 
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Fig 4.3 Inclusion Bodies Were Isolated from Bacterial Cells Induced to Express Recombinant SpGCFl 
The induced protein pattern obtained from two different expression hosts containing the SpGCF1 expression 
construct was analysed by 10% SDS-PAGE. The protein pattern of uninduced BL21DE3 pLysS cells before the 
purification of inclusion bodies is shown in lane 6, whereas lanes 7 (BL21DE3) and 8 (BL21DE3 pLysS) show a 
lysate of induced total bacterial proteins. Inclusion bodies were isolated from uninduced (lane 2 (BL21 DE3 
pLysS)) and induced bacterial hosts (lane 3 (BL21DE3 pLysS) and lane 4 (BL21DE3)). A stronger expression 
pattern was observed in the region of 42 kDa for induced inclusion body fractions (lanes 3 and 4), as indicated 
by the arrows. Standard protein molecular weight markers are marked (lanes 1 and 5). 
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extracts contained protein-DNA complexes which were sequence-specifically competed for by the 
G·C-rich competitors. This, together with the fact that none of the protein-DNA complexes were 
unique to the induced fraction, implies that recombinant expression of SpGCF1 was unsuccessful, and 
therefore comparisons between recombinant SpGCF1 and native suGF1 were impeded. Expression of 
the PCR-generated P.angulosus clone was not attempted in a bacterial system, since neither the 
SpGCF1 construct, nor Clones 2, 6, 11 and 16 had expressed successfully in bacteria. 
Instead, both the PCR-generated P.angulosus clone, and its SpGCF1 homologue were successfully 
expressed using in vitro eukaryotic coupled transcription I translation (see section 2.16). Transcription 
of both the P. angulosus and S.purpuratus constructs (cloned into pGEM-T and pRSET respectively) 
was directed by the T7 bacteriophage promoter present in the respective plasmids (see Appendix 
VIII), whereas translation was achieved with eukaryotic signals in the rabbit reticulocyte lysate, 
which was supplemented with 35S-methionine. Both constructs were used in supercoiled and linear 
conformations. The pGEM-T vector was linearised using the restriction enzyme Sac!, whereas the 
pRSET vector was linearised with Bg/JI. The protein products were analysed by SDS-PAGE (see fig 
4.4), and visualised by subsequent autoradiography of the dried gel. The protein molecular weight 
markers are indicated in the margin, a transcription I translation reaction was performed in the 
absence of DNA (lane 1 ), and the luciferase protein was translated from a positive control plasmid 
with a T7 promoter (lane 2). The 61 kDa luciferase protein represents the clear band of highest 
molecular weight (lane 2), and several lower molecular weight bands (with lower intensities) can be 
observed in the same lane. Proteins expressed from both the supercoiled and linearised P.angulosus 
clone (see section 3.5) show the same pattern of protein bands (fig 4.4, compare lanes 3 and 4, 
respectively), however the intensities of the bands differ, indicating that transcription I translation is 
more efficient from a supercoiled plasmid (lane 3). The protein band of highest molecular weight for 
the P.angulosus clone (lanes 3 and 4) represents a- 55- 57 kDa protein. This correlates both with the 
predicted size (57 kDa) of the translated clone (see section 3.5), and previous estimates of 59.5 kDa 
for native suGF1 as analysed by SDS-PAGE (191). Several other unique protein bands are present in 
the region of 36 - 66 kDa (fig 4.4, compare lanes 3 and 4 with lane 2), implying that this clone may 
code for several protein isoforms which could arise from internal translation start sites present in the 
eDNA (see section 3.5 and fig 3.15). Using the Peptidesort program in GCG, analysis of the multiple 
putative start sites coded for by the eDNA reveals that the first ATG start codon correlates with a full 
length protein of 57 kDa, whereas N-terminally truncated protein isoforms of molecular weights 53 
kDa, 45 kDa, 42 kDa and 39 kDa may potentially be formed from alternative ATG start codons 
further downstream in the eDNA (see fig 3.15). These protein sizes correlate with several bands 
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Fig 4.4 Recombinant Proteins from the PCR-Generated Clone and Its S.,purouratus homolo~ue were 
Expressed by In Vitro Transcription I Translation 
The expressed protein products resulting from in vitro transcription I translation of the PCR-generated clone 
(lanes 3, 4) and its S.purpuratus homologue (lanes 5, 6) were analysed by 10% SDS-PAGE. Expression from 
supercoiled (lane 3) and linearised (lane 4) plasmid containing the PCR-generated clone, as well as 
supercoiled (lane 5) and linearised (lane 6) SpGCFI constructs, resulted in several unique protein products, as 
marked by the dots. Protein molecular weight standards are indicated in the margin, an incubation without 
plasmid DNA (lane I) and the luciferase positive control plasmid (LC) (lane 2) were analysed, too. 
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2 in order of decreasing molecular weight. Expression of the supercoiled and linearised SpGCF1 
constructs was analysed in a similar manner (fig 4.4, lanes 5 and 6 respectively). The high~st 
molecular weight protein obtained for SpGCF1 was also in the vicinity of - 55 - 57 kDa, which 
corresponds to the predicted molecular weight of 55 kDa for this factor (3). Similarly to the 
P.angulosus homologue, several unique protein bands of lower molecular weight are observed for 
recombinant SpGCFl (marked by dots in lane 5, fig 4.4). These correspond in molecular weight (viz 
55 kDa, 50 kDa, 43 kDa, 40 kDa and 37 kDa) to the multiple protein products observed for SpGCFl 
as a result of alternate internal translational start codons present in the eDNA (3). 
The in vitro generated expression products described above (derived from homologous sea urchin 
clones) were analysed by standard EMSA conditions (see section 2.21) using the E/H fragment as 
labelled DNA probe (fig 4.5). Native suGFl (nuclear extract) exhibited the characteristic doublet (B 1 
and B2) when bound to the E/H fragment (fig 4.5, lanes 2 and 3). Free DNA (F) is shown in lane 1. 
Different amounts (1.5 ).ll and 3.5 ).ll) of the in vitro translated protein from the P.angulosus clone 
were used in EMSAs (fig 4.5, see lanes 4 and 5 respectively) forming several protein-DNA 
complexes (marked by asterisks). These complexes appear in an approximate ratio of 4 : 3 : 1 : 2 : 2 
(in order of increasing mobility) which is reminiscent of the pattern of the protein isoforms discussed 
above (see fig 4.4, lane 3). Therefore, it appears that the in vitro translation system is able to produce 
several protein isoforms from the P.angulosus eDNA. The two protein-DNA complexes of lowest 
mobility correspond to complexes Bland B2 formed by native suGFl protein (fig 4.5 , compare lanes 
4, 5 with lanes 2, 3), showing that the PCR-generated P.angulosus eDNA clone is a likely candidate 
coding for the suGFl protein. Complexes C2 and C3 present in nuclear extract (fig 4.5, lanes 2 and 3) 
are two of three complexes which have been observed in nuclear extract preparations on numerous 
occasions, apart from the specific complexes Bl and B2 (see section 5.2.3.2). Three higher mobility 
complexes are also observed in the in vitro translated protein sample (fig 4.5, lanes 4 and 5), and two 
of these may correspond to complexes C2 and C3 in nuclear extract, as they have very similar 
mobilities. This implies that in vivo, suGFl may be expressed as a transcription factor with several 
isoforms which differ in their N-termini. The in vitro generated protein forms virtually identical 
complexes to native suGF1, indicating that the native protein probably does not undergo post-
translational modifications. The SpGCF 1 protein was also titrated in EMS As using the E/H fragment 
as labelled DNA probe (fig 4.5 , lanes 6 and 7). Several prominent protein-DNA complexes are 
formed. They are present in a ratio of 5 : 2 : 1 : 2 in order of increasing mobility and appear to 
correspond to the protein bands observed by SDS-PAGE analysis (see discussion above and fig 4.4, 
lanes 5 and 6). The protein-DNA complex formed by the full length SpGCF1 protein (marked by an 
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Fig 4.5 Expression Products from the PCR-Generated eDNA Clone and Its S.purpuratus Homoloeue 
Form Multiple Protein-DNA Complexes 
In vitro translated expression products from the PCR-generated clone (lanes 4, 5) form several distinct protein-
DNA complexes when analysed by EMSA (marked by the asterisks). Similarly, the expression products from 
the S.purpuratus homologue (lanes 6, 7) also generate multiple protein-DNA complexes (the lowest mobility 
complex is marked by an arrow). Native suGFl (lanes 2, 3) from nuclear extract (NE) forms a characteristic 
doublet (Bl and B2), and other complexes, C2 and C3, are commonly observed in nuclear extract, too. F is free 
labelled DNA (lane 1). 
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however it does not form a doublet. Three higher mobility protein-DNA complexes are also observed 
for the SpGCFI translated protein, which probably correspond to truncated isoforms of the SpGCFI 
protein as a result of internal translation start sites in the eDNA (3). Two of the higher mobility 
protein-DNA complexes of SpGCFl (fig 4.5 , lanes 6 and 7) correspond in mobility to some of the 
protein-DNA complexes formed by the homologous P.angulosus recombinant protein, however the 
highest mobility protein-DNA complexes of the homologous clones differ substantially in mobility 
(fig 4.5 , compare lanes 4, 5 with lanes 6, 7). Another obvious difference between the two homologous 
recombinant proteins is that their isoforms are not expressed in the same ratios, which is reflected by 
both SDS-PAGE analysis (fig 4.4, compare lanes 3 and 5), as well as EMSA (fig 4.5 , compare lanes 4 
and 6). 
Clearly, the pattern of protein-DNA complexes formed by the P.angulosus recombinant protein is 
virtually identical to the protein-DNA complexes (B I and B2) formed by native suGFl (fig 4.5 , 
compare lanes 2, 3 with lanes 4, 5) . Therefore, it is appears that the PCR-based cloning strategy has 
resulted in the successful isolation of a P.angulosus clone encoding the suGFI protein, which is likely 
to be an orthologue of SpGCFI from S.purpuratus. 
4.4 DNA-Binding Analysis of In Vitro Expressed Truncated Proteins from the PCR-Generated 
Clone 
DNA fragments, coding for different sized truncated protein products, were amplified from the full 
length PCR-generated clone and cloned into the pGEM-T vector (see Appendix VIII) . The 
recombinant plasmids were used to express the truncated proteins by in vitro transcription I 
translation in the presence of 35S-methionine (see section 2.16), and the protein products were 
analysed by SDS-PAGE and subsequent autoradiography (see fig 4.6). Primers SP31SP4 (see fig 3 .15) 
amplified a 963 bp DNA product, encoding a protein of -31 kDa (fig 4.6, lane 3), whereas primer SPI 
in conjunction with the pGEM-T vector primer SP6 (see Appendix VIII) amplified a DNA fragment 
of 1.2 kb encoding a- 41 kDa protein (fig 4.6, lane 4). The DNA fragments code for single unique 
protein products, as shown by the arrows (fig 4.6). These protein products differ mainly in the length 
of their C-terminus (see fig 3.15). In vitro transcription I translation control reactions were performed 
in the absence of plasmid DNA (fig 4.6, lane 1), and using the luciferase control plasmid provided 
with the system, which codes for the 61 kDa luciferase protein (lane 2). Standard protein molecular 
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Fig 4.6 Individual DNA Fragments Amplified from the PCR-Generated Clone Encode Two Different Size 
Truncated Proteins 
The PCR-generated clone was used as a template in separate PCR reactions to generate a 963 bp fragment using 
gene specific primers SP3 and SP4, and a 1.2 kb fragment using gene specific primer SPI and the pGEM-T 
plasmid primer Sp6. The DNA fragments were cloned into the pGEM-T plasmid (see Appendix VIII) and 
proteins were expressed from them by in vitro transcription I translation. The in vitro expression products (5 ~I) 
were analysed by 12% SDS-PAGE and subsequent autoradiography. The 963 bp fragment yielded a protein of-
31 kDa (lane 3), whereas the 1.2 kb resulted in a protein of- 41 kDa (lane 4) as indicated by the arrows. Control 
reactions included an incubation in the absence of plasmid DNA (lane I), and translation of the 61 kDa Juciferase 
protein (lane 2) from the control plasmid provided in the system. 
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EMSAs of the individual truncated proteins show that both the 41 kDa and the 31 kDa products are 
able to form distinct single lower mobility protein-DNA complexes with the E/H fragment (fig 4.7, 
lanes 1, 2 and lane 6 respectively) as indicated by the arrows. This suggests that the DNA-binding 
domain of the PCR-generated clone is located centrally in the protein. DNA-binding analysis of a 
combination of both truncated protein products (fig 4. 7, lanes 3 - 5) results in the formation of two 
distinct protein-DNA complexes corresponding in mobility to the protein-DNA complexes formed by 
the individual protein products (compare lanes 3 - 5 with lanes 1 and 6). The absence of an 
intermediate protein-DNA complex suggests that the two different sized proteins do not associate 
with each other in this assay, and are able to bind DNA 'as monomers, ie this protein does not 
homodimerise in order to recognise the DNA-binding site. 
lane 
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Fig 4.7 The Protein Encoded by the PCR-Generated Clone Has a Centrally Located DNA-Bindin2 
Domain and Reco2nises DNA as a Monomer 
In vitro expressed truncated protein products (see fig 4 .6) were analysed by EMSA with 1 ng of E/H 
fragment. Reactions performed with either protein individually show that both the 41 kDa protein (lanes 1 and 
2, 4 ~I and 5~1 of protein respectively) and the 31 kDa protein (lane 5, 1 ~I protein) form single protein-DNA 
complexes with distinct mobilities, as indicated by the arrows. When analysed together (lanes 2 - 4, see 
individual lanes for amounts of respective proteins used), the truncated proteins retained their individual 
protein-DNA complexes without forming a protein-DNA complex of intermediate mobility. Nuclear extract 
(lane 7, NE) forms the characteristic suGFI-DNA doublet (B 1 and B2). F is free labelled DNA. 
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CHAPTERS 
PURIFICATION AND SEQUENCING OF suGFl 
5.1 Introduction 
The characterisation of sequence specific DNA-binding proteins and ultimately the identification of 
genes which code for them, is hampered by the rarity of these factors in biological samples, which 
bears several implications on the purification strategy, since enormous amounts of starting material 
are required if the pure protein is used for techniques such as sequencing. Therefore the protein 
purification strategy needs to be highly selective, and should have as high a yield as possible. The 
purification of suGFl followed a general approach for transcription factors, ":hereby the crude 
nuclear protein extract was partially purified using conventional chromatography, enabling the 
removal of nucleases and other contaminants in the sample. This procedure was combined with a high 
enrichment affinity chromatography step, which required pretreatment of the protein sample with a 
nonspecific competitor DNA to which suGFl has very low affinity. Specifically bound suGFl was 
eluted by increased salt concentration, followed by separation of the protein using SDS-PAGE. This 
sufficed to purify suGF1 for protein sequencing. Several other DNA-binding proteins have been 
isolated to homogeneity using similar procedures, examples include SpP3A2 (120), SpOct (137) and 
SpGCF1 (3). 
Identification of suGFl was achieved by analysis of its primary structure using the mass spectrometer 
approach, which provides detailed primary sequence information and identified the protein of interest 
by correlating the experimentally generated spectrum with predicted fragment ions from a protein 
database search ( 166), thereby generating a search outcome in the form of a ranked list of the highest 
scoring amino acid identities from the database. 
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5.2 Isolation of Native suGFl 
5.2.1 Electrophoretic Mobility Gel Shift Assays 
suGFI binds sequence-specifically to oligo(dG).oligo(dC) sequences as analysed by EMSA (see 
section 3 .2). This assay was used after each step of the purification procedure to monitor the presence 
of suGFl. The ease with which the assay can be performed allows many samples to be analysed 
simultaneously in a rapid and highly sensitive fashion (femtomole quantities of DNA-binding 
proteins can be detected routinely ( 151) ), which makes the technique particularly suitable for 
monitoring the purification of this DNA-binding protein. Assaying suGF1 activity by gel shift 
analysis during the purification was not quantitative, it merely served as a qualitative confirmation 
that the protein was present. Generally, accurate quantitation of the relative activity of a DNA-
binding protein present at each purification step is complicated by several factors. For instance it is 
known that the optimal binding conditions of a protein can vary considerably during the purification 
procedure (159), crude and pure protein preparations often differ with respect to their increased 
sensitivity to oxidative or chemical damage (209) and the pure protein has increased tendencies to 
adhere to surfaces ( 159) even in the presence of carrier proteins or detergents. 
5.2.2 Lowry Protein Concentration Measurements 
Protein concentrations of nuclear extracts were measured by the micro modified Lowry method (21 0). 
Using this method, the protein concentration is proportional to the absorbance at A.= 660 nm in the 
range of 1 - 50 J.Lg, even in the presence of interfering chemicals such as sucrose, Tris, Tricine, 
glycerol and EDTA, since the method utilises a quantitative precipitation step by combining Na-
deoxycholate with TCA and subsequent quantitation by the standard Lowry procedure. The micro 
modified Lowry method is highly sensitive, but nonspecific (210). Generally, the nuclear extracts 
measured in this way had a protein concentration ranging from 5 - 15 mg/ml, which agrees well with 
previous observations for the purification of suGFl (1) and other DNA binding proteins, such as 
SpP3A2 (120). 
5.2.3 Fractionation of suGFl 
Although the suGF1-DNA interaction has been characterised in detail (145, 2), the structure of the 
protein has remained unknown. Isolating the pure protein is the most direct approach to the 
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biochemical characterisation of the factor. The development of DNA affinity chromatography makes 
the purification of transcription factors relatively straightforward, despite the low prevalence of these 
factors in the cell (92, 156). suGFI had previously been isolated on a small scale (191), however 
several changes were introduced to this purification method, including changes to the method of 
nuclei isolation, reduction in the number of affinity chromatography passes, and isolation of the 
protein from an SDS gel. An application like protein sequencing sets several constraints (such as 
volume and buffer composition) on the protein sample (211), and these were taken into account 
during the purification procedure. 
5.2.3.1 Optimisation of Nuclear Protein Extraction 
Sea urchin embryo cultures present an ideal system in which large amounts of material can be grown 
easily in a synchronised fashion. The resultant embryos can (for most purposes) be regarded as cells 
in suspension. For the purposes of isolating suGFl, sea urchin embryos (P.angulosus) were grown for 
14 hours, the embryos were harvested and processed for nuclei, from which nuclear proteins were 
extracted. This served as a starting material in the purification of suGFI. 
The isolation of nuclei is a critical step in the preparation of nuclear extracts which contain active 
DNA-binding proteins. Nuclei should be intact and relatively clean. Several methods have been 
described whereby nuclei are obtained from intact cells (212, 188, 141). Most commonly these 
methods involve the isolation of nuclei using either a nonionic detergent, or resuspension of cells in a 
hypotonic medium combined with homogenisation. Several methods described for the isolation of 
nuclei from sea urchin embryos involve a variation of the latter method (I, 120, 188). Resuspension 
of the cells I embryos in a hypotonic medium serves to swell the cells and increases their fragility, 
which facilitates cell breakage by homogenisation (151). Homogenisation is the most critical step in 
the preparation of nuclei: too extensive homogenisation will result in the premature rupturing of the 
nuclei, which may result in leaching of nuclear proteins, whereas insufficient homogenisation may 
lead to very dirty preparations which have cytoplasmic or other contamination. Hence the conditions 
of nuclei I nuclear extract preparation were determined for optimum ease of handling large amounts 
of embryos without compromising the quality of the extracts. 
Several methods for isolating nuclei were compared (see section 2.18 for experimental details). 
Generally, the buffer conditions for all three methods were very similar, and contained a combination 
of multivalent cations such as Mg2+, Ca2+, spermine and I or spermidine. All buffers contained 
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chelating agents (either EDTA or EGTA), as well as one or several protease inhibitors. Briefly, the 
first method (188) involved washing the embryos with 0.5 M KCl, followed by a wash with a 
hypotonic sucrose solution. The embryos were lysed by homogenisation in an isotonic sucrose 
solution containing multivalent cations which prevent the swelling_ of chromatin and hence the 
premature rupturing of the nuclei. The purified nuclei were collected by centrifugation over a sucrose 
bed, and resuspended in a low ionic strength buffer. The second method (I) involved a similar 
procedure, however the embryos were washed with a- buffer containing hexylene glycol, the cells 
were swollen for an extended time in the same buffer, followed by disruption of the cells by 
homogenisation. The nuclei were purified by centrifugation through a high density sucrose solution. 
The third method (120) involved washing the embryos with a cold glucose solution, a subsequent 
wash with an isotonic sucrose solution and then the embryos were frozen. The frozen embryos were 
crushed before thawing, and the nuclei were collected by centrifugation, followed by 2 - 3 washes 
with a buffer containing NP-40. 
Nuclear extracts were prepared from nuclei by two ammonium sulphate fractionation steps, which 
firstly involved the preparation of an ammonium sulphate fraction from lysed nuclei and extraction of 
soluble protein from chromatin by centrifugation. Secondly, the soluble proteins were differentially 
precipitated by increased salt concentration. Resuspension of the protein pellet was followed by 
dialysis to remove excess salt and the remaining insoluble proteins were precipitated by 
centrifugation. The soluble fraction (nuclear extract) contained suGFl. The protein concentration of 
each nuclear extract preparation was determined by the Lowry protein determination method (see 
sections 2.20 and 5.2.2), and was within a range of 3 - 15 mg/ml for all three methods used to 
generate nuclei, indicating that each method yielded comparable total amounts of protein. The quality 
of the nuclear extracts was assessed by titrating the protein concentration in EMSAs (fig 5.1). 
Although the latter assessment was not intended as a quantitative measure of the DNA-binding 
activity present (it seems that other contaminating proteins in the extracts relative to suGFl affect the 
amount of sequence specific binding (191)), nevertheless these assays provided an indication of 
which extraction method yielded the clearest results with respect to suGFl activity. Nuclei prepared 
by high speed centrifugation of embryo homogenates through concentrated sucrose solutions 
generally have higher purity nuclear extracts with distinctive suGFl binding activity (fig 5.1, lanes 1 -
8) compared to nuclear extracts generated from nuclei released by crudely crushing the embryos 
(lanes 9 - 12). At higher protein concentrations (4 - 10 J.lg total protein), suGFl binding activity is 
masked by a high molecular weight smear (lanes 1, 2, 5, 6, 9 and 10), whereas at lower concentrations 
(0.5 - 1.5 J.lg of total protein) the binding activity shows two characteristic protein-DNA complexes, 
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Fig 5.1 Nuclear Proteins Isolated from Three Different Nuclei Preparations were Compared by EMSA 
Nuclear extracts from 14 hour P.angulosus embryos were generated from nuclei isolated by three different 
methods (see section 2.18). The protein concentrations in the nuclear extracts (lanes 1 - 4, method by Morris 
and Marzluff(1983) (188), lanes 5-8, modified hexylene glycol method (1), lanes 9- 10, method by Calzone 
et al (1991) (120)) were titrated in order to assess the distinct protein-DNA complexes (see individual lanes 
for final amounts of protein used in each incubation). 
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appears to have much less suGF1 activity compared to the other preparations (compare lanes 3, 4, 8 
and 9 to lanes 11 and 12), which implies that the suGF1 protein was inefficiently extracted from the 
nuclei, or that the nuclear extract contains an excessive amount of nonspecific inhibitory proteins 
which were extracted alongside the nuclear proteins. 
In 1.3 - 1.8 M sucrose nuclei are sufficiently dense and large enough to sediment under the centrifugal 
forces which are applied, whereas unbroken cells and subcellular organelles float to the top of the 
centrifuge tube and form a pellicle - most of the cytosolic material can be removed from the nuclei in 
this way, leaving very pure nuclei from which a high quality nuclear extract can be derived (see fig 
5.1, lanes 1 - 8). It was therefore decided that the extraction of nuclear proteins was best achieved 
using homogenised nuclei isolated by high speed centrifugation, and as there was no qualitative 
difference between nuclei isolated in buffers containing sucrose (188) and those containing hexylene 
glycol (fig 5.1 compar6lanes 1, 2, 3 and 4 with lanes 5, 6, 7 and 8), it was decided to use the sucrose 
isolation procedure, as this was more cost-effective. 
5.2.3.2 Pll Phosphocellulose Chromatography 
The P11 cation exchange column was chosen as a first step in the chromatography of suGF1 because 
of its superior yield and enrichment compared to other columns, and because it is able to separate 
suGF1 from several contaminating activities which bind to the E/H fragment (191). 
Sea urchin embryo nuclear extracts from a total of about 120 liters of 14 hour cultures were prepared 
using the method by Morris and Marzluff (1983) (188) (see section 5.2.3.1 and section 2.18.1). The 
nuclear extracts were prepared in batches, and each batch was applied individually to a 180 ml Pll 
phosphocellulose column (see section 2.19). Briefly, the column was washed with 450 ml of 0.1 
buffer C, and the proteins were eluted by increasing the ionic strength in a stepwise fashion to 0.3, 0.5 
and 0.8 M KCl respectively. Fractions of 15 ml were collected. Protein elution was monitored by 
absorbance readings at 280 nm against a reagent blank (151) in order to obtain an elution profile (fig 
5.2). The profile shows that a large proportion of the protein was not retained by the ·column at 100 
mM KCl, and with each stepwise increase in the KCl concentration more protein was eluted, usually 
within about 12 fractions Gust over one column volume), implying that fractionation took place 
efficiently. The profile of suGF1 elution (as monitored by EMSA) is shown in fig 5.3. EMSA 
incubations with 5 J.Ll aliquots of the P11 column fractions were performed at 250 mM KCl in order to 
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Fig 5.2 Pll Phosphocellulose Protein Elution Profile 
Nuclear extracts from 14 hour P.angulosus embryos were loaded onto a P11 phosphocellulose ion exchange 
column (bed volume 180 ml). The column was washed with 2.5 column volumes 0.1 buffer C, and bound 
proteins were eluted stepwise with increasing KCl concentration, viz 3 column volumes 0.3 buffer C (starting 
after fraction number 40), 3 column volumes 0.5 buffer C (starting after fraction number 70) and 1 column 
volume 0.8 buffer C (starting after fraction number 107). The proteins were collected in 15 ml fractions, and the 
absorbance at 280 run of each fraction was measured against a reagent blank. An elution profile of absorbance 
reading at 280 run (ordinate) vs fraction number (abscissa) was plotted. The fractions containing suGF1 binding 
activity (fractions 85 - 1 07) are labelled by the bracket. These fractions were pooled for further purification. 
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fraction eluted from the P11 column was monitored for suGF1 activity by EMSA. Within the 0.5 
buffer C elution range (fractions 72 - 108), where suGF1 was expected to elute (191) every second 
fraction was tested by EMSA (fig 5.3, lanes 17, 20 - 33). This established which fractions could be 
pooled for further purification. 
A standard nuclear extract incubation (fig 5.3, lane 1) was always analysed by EMSA in parallel to 
the column fractions in order to gage the specific suGF1-DNA complexes, B1 and B2, in the elution 
profile. In addition to these specific complexes, generally three other factor-DNA complexes could be 
distinguished (they are referred to as complexes C1, C2 and C3 (fig 5.3, lane 1)). These complexes 
have been observed in numerous nuclear extract preparations (J. Hapgood, D. Patterton - private 
communication, and (191)). It appears that these complexes are fractionated out by P11 
phosphocellulose chromatography. Initially it was speculated that these factors either bind the E/H 
fragment nonspecifically or bind to other sequences in the E/H fragment. Later evidence suggested 
· that some of the higher mobility complexes could represent N-terminally truncated isoforms of suGF1 
(see section 6.2.3). Further analysis of the nature of these complexes was, however, not within the 
scope of this project. 
Several features were observed in the EMSA elution profile of the P11 column (fig 5.3). For instance, 
no suGF1 activity could be detected in the flow-through. A protein exhibiting some DNA-binding 
activity elutes during the application of 0.3 buffer C to the column (fig 5.3, lane 12). However this 
protein does not correspond to suGF1, rather it appears to correlate with complex C3. suGF1 elutes in 
the 0.5 buffer C range, which corresponds to fractions (~72- 108), and in this region every second 
fraction was monitored by EMSA. suGF1 activity can first be detected in fraction 85, it increases 
from fraction 89 onwards, and it continues through to fraction 107 (fig 5.3, lanes 22 - 33), but is no 
longer present during the elution of 0.8 buffer C (fig 5.3, lanes 34 - 36). Other protein-DNA 
complexes are formed in the 0.5 buffer C elution range, too. For instance complex C1 can be 
observed in fractions 91 - 99 (fig 5.3, lanes 25 - 29), whereas complex C2 elutes in fractions 85 - 89 
(fig 5.3, lanes 22 - 24). There also appears to be a high molecular weight smear of shifted probe in 
fractions 83 and 85 (fig 5.3, lanes 21 - 22), as well as an additional complex C4 in fraction 83 (fig 5.3, 
~·. 
lane 21). It was decided to pool fractions 89- 107 (which contain the bulk suGF1 activity), in order to 
eliminate most of the contaminating factors which can bind the E/H fragment, and yet maximise the 
amount of suGFl retained. 
Fig .5.2 and fig 5.3 are representative elution profiles obtained for P11 chromatography of suGFl. 
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I 0 15 20 25 30 35 40 
0.1 buffer C 
11 12 13 14 15 16 17 18 
45 50 55 60 65 70 75 80 
0.3 buffer C 0.5 buffer C 
Jane 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 35 36 
fraction no NE 81 83 85 87 89 91 93 95 97 99 101 103 105 107 110 115 
buffer 0.5 buffer C 0.8 buffer C 
Fig 5.3 Elution Profile of the DNA-Bindin2 Activities from the Pll Phosphocellulose Column 
An elution profile of the DNA-binding activities eluted from the P11 cation exchange column was generated by 
incubating aliquots (5 ~I) of every fifth fraction eluted with 0.1, 0.3 and 0.8 buffer C (lanes 2- 16 and lanes 34, 35) 
and every second fraction eluted with 0.5 buffer C (lanes 17, 18 and 20- 33) with 1 ng of labelled E/H fragment in 
EMSA incubation buffer containing 250 mM KCI. The fraction numbers refer to the same fractions as in fig 5.2. 
Nuclear extract (NE, 2 ~g) is present in lanes 1 and 19. F is free labelled DNA probe, B1 and B2 are suGF1-DNA 
complexes. C I, C2 and C3 are factor-DNA complexes distinct from B 1 and B2. 
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minor differences in the positions of elution of the various complexes described above (see fig 5.3). 
Occasionally some fractions would exhibit smearing when analysed by EMSA, these fractions were 
analysed using a lower concentration of the eluted protein, in order to resolve and identify the DNA-
binding complexes. 
5.2.3.3 Poly( dG).Poly( dC)-Affinity Chromatography 
Active fractions from P11 cation exchange chromatography (as determined by EMSA and described 
in 5.2.3.2) were pooled and diluted to a final concentration of 0.35 M KCl in buffer C. The solution 
was supplemented with p[d{I-C)], which is an excellent nonspecific competitor for suGF1-binding 
(see section 3.2.1), and incubated briefly before being applied to a 9 ml poly(dG).poly(dC)-affinity 
column which was pre-equilibrated in 0.35 buffer C. Two factors, viz the use ofp[d(I-C)] and loading 
of the sample at high ionic strength, dramatically increase the capacity of the affinity column, and 
greatly impede nonspecific binding {155). The flow-through (FT) was collected separately, the 
column was washed with 5 column volumes of0.35 buffer C and bound proteins were eluted from the 
column with sequential washes of 0.55, 0.7 and 1.0 buffer C (see section 2.23.2). The eluate was 
collected in 9 ml fractions and 1 J..tl aliquots were analysed by mobility gel shift assays in order to 
trace suGF1 activity (fig 5.4). 
The flow-through contained no suGF1 activity (fig 5.5, lane 2), although complexes Cl, C2 and C3 
can be observed both in the flow-through and fraction 1 (fig 5.4, lanes 2 - 3). These contaminants did 
not bind to the affinity column. suGF1 was eluted in 0.7 buffer Cas shown in fractions 14, 15 and 16 
(fig 5.4, lanes 16- 18). The fractions containing suGF1 activity were pooled for further analysis. 
5.2.3.4 TCA Precipitation and SDS Gel Electrophoresis 
Active fractions eluted from each single affinity chromatography run were pooled, small aliquots of 
the pooled fractions were TCA precipitated (see section 2.23.3) and analysed by SDS-PAGE with 
subsequent silver staining in order to estimate both the amount of protein eluted from each column 
run and the level of contamination of each pooled sample. A typical example of an aliquot of suGF1 
precipitated from a single affinity column is shown in fig 5.5 (lane 5). The amount of suGF1 (-50 
ng) was compared to several BSA standards (50 - 200 ng) run concurrently on the gel (fig 5.5 (a), 
lanes 2 - 4). Active fractions eluted from the poly(dG).poly(dC) affinity column still contain minor 












2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
NE FT 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
0.35 buffer C 0.55 buffer C 0.7 buffer C 1.0 buffer C 
Fig 5.4 Elution Profile of the DNA-Binding Activities from the Poly(dG).Poly(dC)-Affinity Column 
An elution profile of the DNA-binding activities eluted from the poly(dG).poly(dC)-affinity column was 
generated by incubating aliquots (1 i!l) of the flow-through {FT) and each fraction collected with 1 ng of 
labelled E/H fragment in EMSA incubation buffer containing 175 mM KCI. Fraction numbers and elution 
buffers are indicated. Nuclear extract (NE, 2 i!g) is present in lane 1. F is free labelled DNA, B 1 and B2 are 
suGFl-DNA complexes. Cl, C2 and C3 refer to the same complexes as in fig 5.3, and are distinct from B1 and 
B2. 
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silver staining of larger amounts of the pooled active fractions (data not shown). Proteins 
contaminating the suGF1 preparation had to be eliminated in order to identify the (partial) amino acid 
sequence of suGFl. Therefore the final step in the purification procedure involved electrophoretic 
separation of the pooled, precipitated affinity column fractions containing suGF1 on a denaturing 
SDS gel. SDS gel electrophoresis is the final chromatographic step in the purification of several 
DNA-binding proteins, since this provides the protein in a form pure enough for direct use in 
applications such as sequencing (3, 137, 120). 
The active fractions eluted from several individual affinity column runs were pooled and TCA 
precipitated by incubating the proteins in a final concentration of 20 % (w/v) TCA for 60 minutes on 
ice. The precipitated proteins were washed first with acidified acetone (0.02 % (v/v) HCl), followed 
by a wash with pure acetone. The protein pellet was dried and then dissolved in 30 Jll SDS sample 
application buffer containing ~-mercaptoethanol. After heat treating the protein sample for 5 minutes 
at 100°C it was loaded onto a 10 % SDS gel and separated by electrophoresis for 2.5 hours at 180 V. 
The SDS gel was Coomassie stained in order to visualise the separated proteins. The final purified 
suGF1 protein product is shown in fig 5.6 (lane 8), and appears to be a single pure band when stained 
by Coomassie. The amount of suGF1 loaded on the gel was estimated to be 300 ng compared to a 
series of BSA standards (20 - 500 ng) (fig 5.6, lanes 2 - 7). The Coomassie-stained suGF1 protein 
band was excised precisely from the acrylamide gel and rinsed twice in water, before further 
treatment for mass spectrometric analysis (see section 5.3). 
5.3 Mass Spectrometric Protein Sequencing 
5.3.1 Sample Preparation for Mass Spectral Analysis 
suGFl was excised from a Coomassie-stained SDS gel, and its primary structure was analysed by Dr 
R.W. Frank (Zentrum fiir Molekulare Biologie, Universitat Heidelberg) using mass spectrometry (see 
section 5.3.2). The protein sample was prepared for mass spectroscopic analysis as described in 
section 2.25.1. Briefly, the acrylamide slice containing the excised protein band was cut into small 
cubes and rinsed with water in order to remove the SDS and to ensure a pH between 6 and 7. The 
Coomassie dye was removed by repeated addition of 100 Jll acetonitrile I water (1 : 1) and incubation 
for 20 minutes. Excess water was extracted from the gel by addition of pure acetonitrile, which was 
subsequently replaced by digestion buffer containing 0.5 Jlg trypsin. Trypsin is a protease which 





















Fig 5.5 Chromatographic Fractionation Results in an Enriched Preparation of suGFl 
The suGF1-containing fractions eluted from each poly(dG).poly(dC) column were pooled, precipitated with TCA 
(20 % final concentration) and resuspended in a small amount of water (1 0 - 20 ).Ll), an aliquot of which was 
separated by SDS-PAGE (lane 5) and compared to BSA standards (20 - 100 ng, lanes 2 - 4) in order to estimate the 
amount of suGF1 eluted from each fractionation . The protein standards are indicated (lanes 1 and 6). The gel was 
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BSA suGFl 
Fig 5.6 Preparative SDS-P AGE of suGFl Prior to Mass Spectral Sequence Analysis 
The pooled, TCA precipitated fractions containing suGF1 (lane 8) were subjected to a final chromatographic step 
using SDS-PAGE. The gel was Coomassie stained. The amount ofsuGFl (- 300 ng) was estimated by comparison to 
BSA standards (20 - 500 ng) as indicated in the individual lanes (lanes 2 - 7). The protein was excised from the gel 
precisely and processed further for mass spectral sequence analysis (see section 2.25) . The protein molecular weight 
standards are indicated in lanes 1 and 9. 
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arginine-proline linkages. Trypsin is often the preferred protease smce it results in complete 
enzymatic digestion of the protein (due to its high specificity) and it is able to digest insoluble as well 
as adsorbed proteins (213). The trypsin digestion was allowed to proceed for 6- 12 hours at 37°C, and 
the supernatant containing the resultant peptides was recovered. The volume was reduced to 5 ~1 in a 
speed-vac. 
5.3.2 Mass Spectrometry and Sequence Assignment 
The trypsin digested protein sample was analysed by LC-MS and MS/MS (microcolumn liquid 
chromatography mass spectrometry and tandem mass spectrometry, respectively) . The spectra were 
recorded on a Finnigan LCQ ion trap mass spectrometer equipped with an electrospray (ESI) ion 
source (214) . LC separation of the peptides was performed on a C18 column, and the peptides were 
eluted by a gradient of acetonitrile (10- 40 %) in 0.05 % TFA. The separated peptides were on line 
introduced into the ESI source. Full scan MS spectra were collected continuously, and the production 
of MS/MS spectra was triggered by peptide signal intensity above a preset threshold of 3.0E4 ions . 
The signal induced the instrument to isolate the parent ion, which was subsequently fragmented by 
collision induced dissociation (CID) and the product ions were scanned. 
A mass analyser scan of the HPLC gradient identified several of the trypsin generated peptides from 
the gel slice. The mass spectrometric peptide map is shown in fig 5. 7. In total 10 peptides were 
analysed by MS/MS, three peptides could not be identified, whereas four of the peptides were 
identified as trypsin (these are marked "TRY" on the mass spectrum, fig 5.7). The other three, marked 
by an asterisk in fig 5. 7, were identified as peptide derivatives of suGF 1. These peptide fragments 
were detected as sequence specific ions in the MS/MS analysis, as shown by the mass spectra of 
figures 5.8, 5.9 and 5.10 (panel (a)). The spectra were generated by collision induced dissociation of 
the parent ions to produce daughter ions, and the tandem mass signals observed were generated by 
recording the mass to charge ratio of the fragment ions ( 166). The low mass ions are characteristic of 
the amino acids present in the peptides and the mass difference between the signal of each sequence 
ion is proportional to the mass of the following amino acid residue in the sequence. The sequence can 
therefore be interpreted relatively easily by identifying the N-terminal amino acid fragment and 
counting the mass difference between the subsequent sequence ions. This is illustrated in figures 5.8, 
5.9 and 5.10 (panel (b)) where the primary structure of each individual peptide is listed, as interpreted 
from the mass spectra in panel (a) of the same figures. The three peptides each constitute 18, 18 and 
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suGFl was excised precisely from a SDS-gel, the gel slice containing the protein was washed and treated with 
trypsin to generate peptides. These were isolated by reverse HPLC and a mass analyzer scan of the HPLC 
gradient revealed four peaks which were subsequently assigned to trypsin peptides (marked "Try" in the scan), 
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250 500 750 1000 1250 1500 
Seq Name None Seq Length 18(0) 
Composition C82 HllS N28 025 
Exact Mass 1915.03906 Avg Mass 1916.17273 
Bull&Breese 1190 Charge: 1 HPLC Index 27.7 
Specl Name brandt Spec2 Name myco 
Mass Modify 0.0 Derivatize None 
N-terminal Free Amino C-terminal Free Ac:id 
No. Seq A 8 8' Bo y• y• Yo 
1 val 72.1 100.1 83.0 82.1 1916.0 1899.0 1898.0 
2 His 209.1 237.1 220.1 219.1 1811.0 1800.0 1799.0 
3 Asn 323.2 351.2 334.2 333.2 1679.9 1662.9 1661.9 
4 Leu 436.3* 464.3* 447.2 446.3 1565.9 1548.9 1547.9 
5 Leu 549 .4• 577.P 560.3* 559.3 1452.8 1435.8 1434.8 
6 Ile 662.4* 690 .4• 673 .4• 672.4 1339. 7• 1322.7 1321.7 
7 Asn 776.5 B04 .s• 787 .4• 786.5 1226.6* 1209.6* 1208.6 
a Pro 873.5 901.5 884.5 883.5 1112. 6* 1095.6 1094.6 
9 Asn 987.6 1015.6* 998.5 997.6 1015. 5* 998.5 997.5 
10 ser 1074.6 1102.6 1085.6 1084.6 901.5 884.5 883.5 
11 Gly 1131.6 1159.6 1142.6 1141.6 814.5 797.4 796.4 
12 val 1230.7 1258.7* 1241.7* 1240.7 757.4 740.4 739.4 
13 Ala 1301.7 1329.7 1312.7 1311.7 659.4* 641.3 640.4 
" Gln 1429.8 1457.8 1U0.8 1439.8 587-3 570.3 569.3 15 Asn 1543. a 1571.8 1554.8 1553 .a 459.3 442.2 441.3 
16 Val 1642.9 1670.9 1653.9 1652.9 345.2 329.2 327.2 
17 Ala 1713.9 1741.9* 1724.9 1723.9 246.2 229.1 228.1 
18 Arg 1870.0 1898.0 1891.0 1890.0 175.1 158.1 157.1 
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(a) The tandem mass spectrum for the peptide was generated by recording the mass to charge ratio of the fragment ions. The 
peaks at low masses are characteristic of the amino acids present in the peptide, whereas the high group masses result from 
R-group loss from the intact protein. The peaks between the low and the high mass ions result from sequence specific 
fragmentation of the peptide. The mass difference between the signal of each low mass sequence ion is proportional to the 
mass of the following amino acid residue in the sequence. (b) The primary structure of the peptide is interpreted and 
compiled from the fragment ions of the mass spectrum in (a). (c) The outcome of the comparison between the tandem mass 
spectrum generated by the peptide of interest and the OWL protein database is presented as a ranked list of candidates and 
the highest priority score is the closest identity to the unknown protein. As can be seen from the highest ranking score, the 
original linear sequence of the peptide identifies with the SpGCFl protein from the sea urchinS. purpuratus (3). 
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I ' I I ' I 250 500 750 1000 12SO 
Seq Name None Seq Length 15(0} 
Corr;:~osition C67 Hll4 Nl8 025 Sl 
Exact Mass 1602.79224 Avq Mass 1603.81201 
Bull'-Breese 220 Charge: 1 HPLC Index 6.0 
Specl Name brandt Spec2 Name myco 
Mass Modify 0.0 Derivatize None 
N-terminal Free Amino c-terminal Free Acid 
No. Seq A B .. Bo y• yo Yo 
1 Ile 86.1 114.1 97.1 96.1 1603.8 1586.8 1585.8 
2 G1y 143.1 171.1 154.1 153.1 1490.7 1473.7 1472.7 
3 Pro 240.2 268.2* 251.1 250.2 1433.7 1416.7 1415.7 • ser 327.2 355.2 338.2 )37 .2 1336.6* 1319.6 1318.6 5 G1u 456.2 484.2 467.2 466.2* 1249. 6* 1232.6 1231.6 
6 Val 555.3 58).)• 566.3 565.3 1120. 6* 1103.5 1102.6 
7 Aan 669.4 697 .4• 680.3 679.3 1021. s• 1004.5 1oo3 .s• 
' Thr 770.4 798.4 781.4 780.4 907. s• 890.4• 889.4 • Asp 885.4 913 .4• 896.4 895.4• 806.4 789.4 788.4 10 Hso 1032.5 1060.5 1043.4 1042.5 691.4 674.4 673.4 
11 Leu 1145.6 1173.5 1156.5 1155. s 544.3 527.3 526.3 
12 Asn 1259.6 1287.6 1270.6 1269.6 431.3• 414.2 413.3 
13 Gly 1316.6 1344.6 1327.6 1326.6 317.2 300.2 299.2 
14 Ih 1429.7 1457.7 1440.7 1439.7 260.2 243.2 242.2 
15 Lya 1557.8 1585.8 1568.8 1567.8 147.1 130.1 129.1 
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(a) The tandem mass spectrum for the peptide was generated by recording the mass to charge ratio of the fragment ions. The 
peaks at low masses are characteristic of the amino acids present in the peptide, whereas the high group masses result from 
R-group loss from the intact protein. The peaks between the low and the high mass ions result from sequence specific 
fragmentation of the peptide. The mass difference between the signal of each low mass sequence ion is proportional to the 
mass of the following amino acid residue in the sequence. (b) The primary structure of the peptide is interpreted and 
compiled from the fragment ions of the mass spectrum in (a). (c) The outcome of the comparison between the tandem mass 
spectrum generated by the peptide of interest and the OWL protein database is presented as a ranked list of candidates and 
the highest priority score is the closest identity to the unknown protein. As can be seen from the highest ranking score, the 
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Seq NUie None Seq IAnqth 11(01 
Coq:JOS.I.tion ClOD HUt N24 OU Sl 
Ex.act Maaa 2225.00977 Avv ..... 222fi.UUO 
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ttaaa Modify 0.0 Oeriv•tize Hone 
N•taraina1 rr .. Allino C·Uraina1 rr .. Acid 
No. Seq " a a• 8o y• yo Yo 1 Cln 101.1 129.1 112.0 111.1 2226.0 l2ot. 0 2201.0 
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(a) The tandem mass spectrum for the peptide was generated by recording the mass to charge ratio of the fragment ions. The 
peaks at low masses are characteristic of the amino acids present in the peptide, whereas the high group masses result from 
R-group loss from the intact protein. The peaks between the low and the high mass ions result from sequence specific 
fragmentation of the peptide. The mass difference between the signal of each low mass sequence ion is proportional to the 
mass of the following amino acid residue in the sequence. (b) The primary structure of the peptide is interj,reted and 
compiled from the fragment ions of the mass spectrum in (a). (c) The outcome of the comparison between the tandem mass 
spectrum generated by the peptide of interest and the OWL protein database is presented as a ranked list of candidates and 
the highest priority score is the closest identity to the unknown protein. As can be seen from the highest ranking score, the 
original linear sequence of the peptide identifies with the SpGCFl protein from the sea urchinS. purpuratus (3). 
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peptides was subjected to a database comparison by computer analysis. The data were cross-
correlated using the "Sequest" program package (166) in conjunction with the OWL database (147 
000 entries). This is a development whereby the uninterpreted tandem mass spectra ofpeptides can be 
.correlated with amino acid sequences in a database. The protein database is searched for linear amino 
acid sequences whose predicted mass-to-charge ratios correlate within a certain mass tolerance to the 
fragment ions observed experimental data of the tandem mass spectrum (166). This approach 
conveniently interprets the tandem mass spectrum with respect to known sequences in a protein 
database. The result of the comparison between the tandem mass spectra (generated by the protein 
peptides of interest) and the OWL protein database is shown in figures 5.8, 5.9 and 5.10 (panel (c)). 
The outcome of the database comparison is presented as a ranked list of candidates, and the highest 
priority score is the closest identity to the unknown protein. The database comparison confirms that 
the three peptides which originate from suGF1 unambiguously identify with the single protein 
SpGCFl, which is a transcription factor isolated from the sea urchin Strongylocentrotus purpuratus (3 
and see section 1.4.4.2)). The suGF1 peptides, whose identities were established by mass 
spectrometry, were aligned with the protein sequence of SpGCF1, as illustrated in fig 5.11, showing 
that the peptides from suGF1 correlate with the amino acid sequence of SpGCF1 (3). In addition, a 
comparison of the amino acid sequences of these peptides shows full agreement with the amino acid 
sequence deduced for the eDNA clones isolated by means of PCR-RACE from P.angulosus mRNA 
(see section 3.5). These results not only confirm that the protein suGF1, isolated from Parechinus 
angulosus, is an orthologue of SpGCF1 (as speculated in Chapter 3), it also confirms that the eDNA 
generated by the PCR strategy (see section 3.5) codes for the transcription factor suGFl. 
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1 50 
SpGCFl MSTLPQPLSH CLLNQVHPAL NLPQTGVITD IKPMISNKPP TQEVKPNILA 
51 100 
SpGCF1 TGLPYPPLNV PRLPVMPNVS LPSVSMPSVS MPNVSMPNAS MPSVSMPNVS 
101 150 
Peptide 1 . . . . . . . .. . .. . . . . . . . . . . . . . . . . . . . . .......... .... QLFYND 
SpGCF1 MPSIPHHNLQ GNLGQLLNNS NSQKMSQMKK CPNEFLHQNP QSERQLFYND 
151 200 
Peptide 1 V.AMQLYNSDF NK •......• . . . . . . . . . . . . . . . . . . . . .......... 
SpGCFl VAMQLYNSDF NKFASKKGFH GYLLEQQKWR WDTHSYIGNL ETRVHNLLIN 
Peptide 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .......... ... VHNLLIN 
201 250 
SpGCF1 PNSGVAQNVA RYRSVPIKCK SEDVKRCKAT SKELENMATR IASVRQQLLH 
Peptide 2 PNSGVAQNVA R ......... 0 ••••••••• . . . . . . . . . . . . . . . . . . . . 
251 300 
SpGCFl KKGTLLTSSD NSVIVWQNEL AYIEQLFDRT DQMYNEVLST LASVNQTFSH 
301 350 
SpGCF1 LQTSFTAEAA ELADRRRLWR RRKENNRKRR KRMEKQLEKI EQRSCELLFH 
351 400 
SpGCFl ITSRGAYDRV RSHPEMPRIG PSEVNTDMLN GIKSKSEVRP LMHLLSKGYM 
Peptide 3 . . . . . . . . . . ........ IG PSEVNTDMLN GIK ....... .......... 
401 450 
SpGCFl TPGAMEMVSQ KIQKLECGIK TEAHQQATQV GINSLSINKI TAPASELNSI 
451 486 
SpGCFl LPPVTGIASS NMVSSVNSAV TQQSVPTVNL NTQLAK 
Fig 5.11 AJignment of the Three suGFl Peptides Identified by Mass Spectral Analvsis with SpGCFl 
The amino acid sequences of three peptides originating from suGFl were identified by MS/MS spectral analysis 
(see figures 5.8, 5.9 and 5.10). Alignment of the peptide primary structures with the corresponding amino acid 
sequence of SpGCFl from Strongylocentrotus purpuratus (3), using the programme "Bestfit" (GCG), shows that 




6.1 Cloning the eDNA for suGF1 
6.1.1 DNA Binding Properties of Native suGF1 
The ability of a transcription factor to distinguish between its cognate DNA-binding site and an 
unrelated sequence is an important requirement for the identification of clones using the DNA ligand 
screening approach (see fig 3.5, and (170)). suGFl discriminates specifically between its cognate 
G·C-rich DNA binding site and random mutations thereof. The results of the Scatchard analysis (see 
section 3.2) show that suGFl in nuclear extract exhibits a very low dissociation constant(~~ 3.6 X 
10"10 M) with respect to the G11 -string in the Hl-H4 intergenic fragment. The DNA-binding 
properties of suGFl (as established by analysis with EMSA) satisfy the criteria for this transcription 
factor to be identified using the DNA ligand screening approach, since the expressed protein binds the 
recognition site with high specificity and should be able to withstand the wash protocol without a loss 
in signal as a result of its low dissociation constant. In addition, the identification of sequence-
specific suGFl-DNA complexes is selectively enhanced by using the nonspecific DNA competitor 
poly[d(I-C)], the use of which in the probe solution should reduce both nonspecific protein-DNA 
interactions and the overall background. 
Mobility gel shift assays performed with several competitor DNAs show that suGFl has similar 
affinity for the native DNA binding site present in the E/H fragment and the specific oligo containing 
the G11-string (see section 3.2), since both these DNA probes are able to compete for the formation of 
the suGFl-DNA complex when present in very low concentrations. In contrast, suGFl has no affinity 
for random DNA sequences, as can be seen by the competition EMSA performed with the nonspecific 
oligo. The high affinity site oligonucleotide (specific oligo) is therefore an appropriate recognition 
site probe for the DNA ligand screening method. 
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It is unclear whether the equilibrium and kinetic constants of a protein-DNA interaction are the same 
in solution as they are for the binding of a DNA probe to a matrix of protein immobilised on a filter, 
however it may be possible to isolate recombinants encoding proteins with binding constants of 1 o·9 
M or lower (174). Even though the functional screening of expression libraries using a DNA ligand is 
not restricted to a particular subclass of DNA-binding domains, the successful screening of 
recombinants may be restricted to proteins with relatively strong binding constants, since only these 
have the ability to form complexes with half-lives long enough to withstand the 30 minute wash 
protocol (174). 
Poly[d(I-C)] is an excellent nonspecific competitor which can be used in combination with suGFl-
DNA interactions to reduce the formation of nonspecific protein-DNA complexes, since even 
relatively high amounts of this competitor do not compete for the formation of the specific suGFl-
DNA complexes (see fig 3.4). This is in contrast to other nonspecific competitors, such as sonicated 
calf thymus DNA and E.coli DNA, which compete with high affinity for the formation of suGF1-
DNA complexes at substantially lower concentrations. Therefore it was advisable to use poly[d(I-C)] 
as nonspecific competitor in the DNA ligand screening procedure. 
6.1.2 Analysis of the eDNA Clones Generated by DNA Ligand Screening 
The DNA ligand screening technique yielded four unique putative positive bacteriophage plaques, 
whose inserts were excised in the pBluescript phagemid. This facilitated subcloning, restriction 
analysis and DNA sequencing of the four clones. The inserts were also analysed for their ability to 
express recombinant protein products (see section 6.2). A total of 6 X 105 phage in the eDNA library 
were screened, which yielded 19 positive phage in the first round of screening, and 4 remained 
positive after the second round of screening for specific DNA-binding signals. The DNA sequences 
and their respective translated amino acid sequences were subjected to database homology searches 
. using either FAST A (GCG) or the BLAST search engines. The characteristic features of the clones 
and the most interesting homology scores are listed in table 3.3. The homology scores implied that 
most of the clones (viz Clones 6, 11 and 16) are novel sequences which may potentially encode DNA-
binding proteins. Some of the clones had partial open reading frames. Sequencing errors may have 
masked the presence of continuous open reading frames, as these clones were mainly sequenced 
manually. Since the identification of the clones relied on the sole requirement that the expressed 
proteins identify the target DNA-binding site with high specificity, it could be postulated that the 
isolated clones share a certain structural I functional motif with each other and possibly with suGFl. 
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It was therefore pertinent to gain further insight into these clones by analysing their expressed protein 
products (see Chapter 4 and section 6.2). 
The cDNAs isolated by the DNA ligand screening procedure were not suGF1 clones. The reasons for 
the lack of success with the screening method are discussed below. A transcription factor like suGF1 
represents a very small fraction of the total target RNA, therefore it is fundamentally important for 
the recombinant library to completely represent the· original mRNA population in terms of sequence, 
size and complexity (ie it must contain at least one eDNA clone representing each mRNA in the cell). 
The abundance of the mRNA of interest, and the chosen screening method determine the size of the 
library, which is larger than the number of clones that will be screened (the number of identifiable 
clones is reduced by at least 1/61h in the case of suGF1 since reading frames must be considered in the 
DNA ligand screening procedure). A representative mammalian eDNA library would contain about 
106 - 107 independent recombinants from 100 ng of eDNA (151). Sea urchins are lower eukaryotic 
organisms with a less complex mRNA population, therefore the number of independent clones may 
be less. Thus, a cloning efficiency of 1.3 X 106 for the 24 hour S.purpuratus eDNA library is 
indicative of a representative library, and the number of putative positive clones (four) obtained from 
this library compares favourably with several results outlined in the literature. For instance, Singh et 
al (1988) (170) screened 2.5 X 105 plaques in total, of which two were identified as true positives, 
Hasegawa et al ( 1991) ( 177) screened a total of 6 X 105 clones, five of these proved to be independent 
isolates of identical clones. Didier et al (1988) (167) screened a total of 1 X 107 plaques, where the 
initial screening yielded 34 positive plaques and three remained positive after two rounds of 
screening. Singh et al (1988) (170) estimate that the frequency of a positive phage clone is about 1 : 
105, which correlates well with the results obtained in this investigation. The failure to pick up the 
clone of interest by the ligand screening method may have been due to the absence of the relevant 
transcript in the eDNA library. However from the size of the library and the considerations above this 
is unlikely, unless the RNA transcript of interest was lost during amplification of the 24 hour 
S.purpuratus eDNA library. Representation of the SpGCF1 transcript in this library was not certain, 
as the eDNA encoding SpGCF1 was originally obtained by hybridisation screening a different 
S.purpuratus library derived from 4 hour embryos (3). However the presence or abs~nce of the 
SpGCF1 eDNA could have been verified by PCR amplification using the degenerate primers (see 
Appendix VII and section 3 .5). 
The DNA ligand screening method provides a powerful means for isolating eDNA clones (174). 
However it has several limitations associated with it. For instance, this technique relies on the 
expression of functional fusion proteins in bacteria, which implies that the recombinant protein may 
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not rely on any form of post-translational modification or association with other distinct subunits (the 
problem of heterodimer formation can only be overcome if the subunit of interest binds the DNA 
probe with detectable affinity by itself (174)). Furthermore, the protein must be folded in the correct 
configuration when expressed in the host. The lacZ promoter in the A.ZAP vector drives the 
expression of inserts as fusion proteins to the amino terminal part of the f3-galactosidase gene. 
Although the carrier protein in this case is usually only 20 - 50 amino acids, it is possible that it could 
inhibit the correct folding of the protein encoded by the insert, thereby preventing access of the DNA-
binding domain to the cognate DNA-binding site. Hence, incorrect folding of recombinant suGF1 or 
conformational constraints with respect to its DNA-binding domain as a result of fusion to the j3-gal 
protein could potentially explain the unsuccessful cloning of the suGF1 eDNA. It is well known that 
some clones cannot be expressed in ari active configuration in E.coli (174), as they may preferentially 
form insoluble protein aggregates preventing access of the DNA probe. Exposing expressed 
recombinant proteins to a guanidinium hydrochloride denaturation I renaturation protocol may 
renature the binding specificity of a fraction of the expressed proteins (168), provided the proteins are 
amenable to renaturation. It is possible that expressed proteins (such as C/EBP (168)), which were 
used to develop the conditions for the DNA ligand screening procedure, are unusually amenable to 
renaturation. Previously, Southwestern analysis of suGF1 indicated that the DNA-binding ability of 
this protein is easily renatured from the unfolded protein (1), suggesting that suGF1 would be a 
suitable candidate for the DNA ligand expression screening technique. However, it is possible that 
recombinant suGF1 in the form of a fusion protein may not be as amenable to renaturation as the 
native protein. For instance, two recombinant sea urchin proteins (SpGCF1 and SpP3A2), which are 
known to be expressed in the form of inclusion bodies, could only be restored to about 0.1 % of their 
DNA-binding activity (3, 120), showing that renaturation of the recombinant protein may be a 
limiting factor in the detection of its respective eDNA. Our own unsuccessful attempts to express 
recombinant SpGCF1 in bacterial hosts (see section 4.3) indicate that the clone of interest may not 
have been expressed in the eDNA library at all. 
The bacteriophage expression vector A.ZAP has a high cloning efficiency, with a cloning capacity of 
inserts up to 10 kb in length and it directs very high levels of fusion protein expression in 
recombinant phage (about 1 %of total protein mass) (174). Together with a high specific activity 32P-
labelled recognition site probe this implies a high detection limit, which should result in the positive 
identification of clones encoding DNA-binding proteins by application of the DNA ligand screening 
procedure. However, another limitation associated with the DNA-ligand screening method pertains to 
the kinetics of interaction between a DNA ligand and a protein immobilised on a filter, which have 
not been defined rigorously. Therefore one cannot be sure that all expressed DNA-binding proteins 
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will be able to withstand the wash protocol in the screening method (174). One would assume that 
proteins which exhibit strong binding may be suited to this cloning procedure. suGF1 is able to 
recognise its DNA binding site sequence-specifically and with high affinity, which allows the factor 
firstly to distinguish between the binding site and a random mutation, and secondly to form a stable 
interaction with the binding site. Therefore suGF1 should have been suitable for cloning via the DNA 
ligand screening procedure. The stability of the protein-DNA interaction and the sensitivity of the 
screening methodology should have been enhanced further by the use of multisite, catenated 
recognition DNA site probes which can simultaneously interact with several immobilised proteins. 
A possible reason for the detection of false positives obtained for suGF1 screening was the presence 
of p[d(I-C)]. Nonspecific competitor DNA was included in the probe screening solution in order to 
reduce the background signal from the filters and to block the interaction (and hence minimise the 
detection) of nonspecific protein with the labelled DNA probe. Binding to either double or single 
stranded DNA is an undesirable feature of the DNA ligand screening procedure, which may be 
enhanced by the presence of p[d(I-C)] (174). However it is also possible that the probe itself can 
undergo structural alterations (eg formation of ss DNA) during processing of the filters (174) which 
may also result in the detection of false positives. 
6.1.3 Analysis of the PCR-Generated Clone 
Successful amplification of DNA fragments (106 bp and 421 bp) from Parechinus angulosus genomic 
DNA showed conclusively that a gene homologue for SpGCF1 is present in the P.angulosus genome. 
In addition, PCR amplification of DNA fragments (1 06 bp, 327 bp and 421 bp) from eDNA showed 
that RNA for the SpGCF1 homologue is transcribed in 14 hour P.angulosus embryos, implying that 
the protein homologue is expressed in early embryonic stages. A PCR strategy, using a combination 
of 5' and 3' RACE, was used to amplify two individual fragments representing the full length eDNA 
coding for the homologue. The correct identity of these fragments was confirmed by Southern 
analysis and by the high DNA sequence homology to SpGCF1 eDNA (73% and 92% for the 5' and 
3' RACE fragments respectively). The full length clone(- 2.1 kb), generated by fusion of the two 
individual fragments was sequenced automatically, allowing a consensus eDNA sequence to be 
derived for the clone. The full length homologous cDNAs from P.angulosus and S.purpuratus showed 
84 % homology. The high conservation of this factor amongst the two sea urchin species, together 
with the fact that the respective proteins are expressed in the developing sea urchin embryos, implies 
that this transcription factor could have an important function in the regulation of genes during the 
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development of sea urchin embryos. Further, the primary structure of the P.angulosus clone was 
derived from the single open reading frame (1542 nt) of the eDNA, showing that it codes for a 514 
amino acid protein, of molecular weight 57 kDa. This protein is unique, apart from its 94 % 
homology to SpGCFl. 
The successful application of the RACE technique relies on very limited DNA sequence information 
with respect to the template of interest (such that gene specific primers for both the 5' and 3' RACE 
reactions can be synthesised) and a source of RNA in which the transcript of interest is definitely 
present. These requirements were all met by the P.angulosus homologue of SpGCFl as confirmed by 
the PCR strategy described above. Application of RACE resulted in the formation of multiple 
products for both reactions, which is not unusual. Possible reasons for multiple products generated by 
5' RACE include the presence of alternative transcription start sites, whereas some of the multiple 
products generated by 3' RACE may stem from different polyadenylation sites. Both the 5' and 3' 
RACE reactions may generate multiple products arising from alternative splice sites, or the 
amplification of related genes, which would give rise to several homologous cDNAs. The latter is not 
a very likely situation for the P.angulosus PCR-generated clone, as it was previously found that 
SpGCFl is a single copy gene (3). The products generated by the RACE reactions were characterised 
further in order to distinguish whether they were real or artifactual results. The latter are classified as 
either incomplete or nonspecific, which can be ascribed to a variety of factors. Artifactual results may 
arise as a result of premature termination of first strand synthesis, ie pausing of the reverse 
transcriptase, which causes multiple 5' RACE fragments, or because degraded RNA is used as a 
starting material (usually this results in multiple 5' products). Other reasons include nonspecific 
priming during RACE-PCR, as well as high G·C content of the template. The amplification products 
of interest were identified by Southern hybridisation which revealed that both the 5' and 3' RACE 
products contained bands of the expected sizes. A larger 3' RACE product (- 3 kb) was also observed 
and can probably be attributed to a product with a longer poly-A+ tail, ie the oligo(dT) priming may 
have taken place at different mRNA sites during the synthesis of the eDNA. The isolated 5' and 3' 
RACE products were further characterised by sequence analysis, which proved that the fragments 
were highly homologous to the SpGCF1 eDNA(- 73% for the 5' RACE product and- 92% for the 
3' RACE product). This confirmed that the fragments of interest with the correct sizes had been 
identified. The two separate fragments were then combined to form the full length - 2.1 kb eDNA 
representing the P.angulosus homologue ofSpGCFl. 
The full length, double stranded products were finally amplified and cloned, and three independent 
clones were sequenced completely (using automated techniques), enabling a consensus sequence to 
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be derived for the PCR amplified clone. Nucleotide positions which showed sequence degeneracies 
within the P.angulosus eDNA were resequenced from several independent clones to confirm the 
consensus sequence and eliminate any sequencing errors. The degeneracies may have arisen due to 
inaccurate nucleotide incorporations as a result of the PCR amplification reactions, since it is well 
known that Taq polymerase is prone to misincorporations. Alternatively, the differences in the clones 
could result from differences in the original mRNA templates, which may have arisen as a result of 
transcription products from different alleles. It appears that SpGCFl is coded for by a single gene (3), 
therefore the sequence degeneracy is unlikely due to transcription products resulting from different 
gene members. 
6.2 Recombinant Protein Expression 
6.2.1 In Vivo Recombinant Protein Expression of eDNA Clones Isolated by the DNA Ligand 
Screening Technique 
The four clones which were isolated by the DNA ligand screening technique (see section 3.3) were 
not compatible with most of the expression systems employed, as judged by the lack of detectable 
recombinant protein products in the bacterial pBluescript and pGEX systems, as well as the 
eukaryotic COS cell expression system. This may be attributed to a variety of reasons. Since none of 
the recombinant protein products were detectable in either the pBluescript or the pGEX systems, nor 
the pET system's pLysS strain (which is not protease deficient) it is possible that the target proteins 
are very protease-sensitive and their stability is easily compromised in a foreign host environment. 
Both the pBluescript system and the pGEX system should offer enhanced stability to recombinant 
proteins, since they express target proteins as fusion products of the truncated !3-galactosidase protein 
and the glutathione S-transferase protein respectively. Conditions such as altering the expression host 
in order to reduce host proteolytic activity did not improve the lack of detection of the recombinant 
proteins in these systems, implying that other problems could also have affected the expression. For 
instance, it is possible that the codon usage in these clones is not ideally suited to bacterial 
expression, or the translational signals were not optimal, or possibly the mRNA was very unstable. 
Alternatively, mRNA secondary structure formation could have blocked transcription, or detection 
may have been impeded by very low expression levels or instability of the target protein. Most of 
these factors can be addressed by the choice of the expression system, as well as the choice of the 
expression vector. Another impeding factor in the analysis of the four clones was that the eDNA 
sequence encoding suGFl (which was ultimately what I was looking for) was unknown, therefore the 
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identification and characterisation of the clones relied solely on the basis of the DNA-binding activity 
they displayed. Hence, from the tentative analysis of the DNA sequences of the four clones, the 
cDNAs could not be characterised fully and it was not obvious whether the cDNAs included long 
regions of 5' and 3' untranslated sequences, which could pose potential problems with the expression 
of fusion proteins. 
Despite trying to optimise expressiOn of the four clones by investigating them in a variety of 
expression environments, only a single clone (Clone 11) responded positively to the expression 
conditions. Clone 11 was expressed as a 25 kDa protein from the pET-29b(+) expression construct in 
BL21DE3 cells. Optimal expression conditions ranged from 3 - 6 hours at 30°C- 37°C. Isolation of 
the recombinant protein product was attempted using several procedures ( eg soluble protein 
extraction, Nickel column chromatography and inclusion body isolations), however the protein was 
generally expressed as an insoluble protein precipitate in the form of inclusion bodies, whose 
solubilisation proved unsuccessful despite a variety of denaturation conditions using _ potent 
denaturing agents. 
A variety of systems are available for recombinant protein expression, such as bacteria, yeast, 
mammalian cells, baculovirus, plants, transgenic animals and eukaryotic in vitro transcription I 
translation systems (151, 205). However the cloning of eukaryotic proteins does not always result in 
high level expression, and some systems may not result in any expression of desired clones at all 
(151), therefore one often needs to experiment with recombinant protein expression using a trial and 
error approach by individually testing a variety of expression systems and optimising their conditions. 
Several bacterial expression systems differing in their promoter systems were employed to investigate 
expression of the four clones isolated by the DNA ligand screening approach. These included the 
pBluescript lacZ promoter, the tac promoter in the pGEX system, and the T7lac promoter system 
present in pET. The different expression plasmid systems all potentially provided enhanced stability 
to the target protein, as expression is in the form of fusions to proteins such as the E.coli ~­
galactosidase protein (pBluescript), glutathione S-transferase (pGEX) or a histidine tag (pET-29). 
Over and above providing enhanced stability of expressed proteins, these fusions should improve the 
solubility, extraction and purification ·of expressed target proteins. For optimisation of expression of 
the four clones (2, 6, 11 and 16) attention was also given to other factors, such as the choice of 
expression hosts (stringency of host requirement is usually determined by the type of expression 
vector employed), and expression was investigated under different conditions of temperature, 
induction time and volume of culture. Further, an eukaryotic expression system (a pCIS expression 
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construct in COS cells) was also used to analyse recombinant protein expression, however it, too, was 
unsuccessful. 
6.2.2 In Vitro Recombinant Expression of eDNA Clones Generated by the DNA Ligand 
Screening Technique 
A rabbit reticulocyte lysate system was used to successfully express 35S-labelled recombinant proteins 
from Clones 2, 11 and 16. Analysis of the protein products by SDS-PAGE and autoradiography 
showed that Clone 2 (2.2 kb) codes for a protein of molecular weight about 48 kDa, the protein 
arising from Clone 11 (0.9 kb) is 25 kDa (which was verified by expression in the pET system) and 
Clone 16 (2.4 kb) encodes a protein of about 45 kDa. The protein sizes are in approximate agreement 
with the sizes of the eDNA fragments encoding them. These results strongly suggest that the eDNA 
clones did contain open reading frames. However they were masked by only partial sequence analysis 
of the clones, and also by erroneous sequencing (mainly for· Clone 16), possibly due to manual 
sequencing techniques. No unique protein band corresponding to a protein encoded by Clone 6 (0.85 
kb) could be identified, implying that either this clone does not have an open reading frame coding 
for a protein (as implied by the analysis of the eDNA sequence), or it has a very low methionine 
content, such that insufficient 35S label was incorporated into the protein product, thereby preventing 
its detection. Analysis of the in vitro generated recombinant proteins by EMSA did not exhibit any 
gel shift activity, suggesting that the proteins were either inactive in this respect, or that the protein 
translation efficiency was so low that the DNA-binding activity could not be visualised. Low 
translation efficiency may arise due to low quality of mRNA, RNase contamination, the presence of 
inhibitors in the reaction, or suboptimal Mg2+ concentrations. 
6.2.3 In Vitro Expression of the PCR-Generated eDNA Clone 
The PCR-generated clone was expressed using an eukaryotic in vitro transcription I translation 
system, generating a full length protein of 57 kDa, which correlates in size with the protein predicted 
to arise from the single long open reading frame of the eDNA, and also with the size of 59.5 kDa for 
native purified suGF1 previously estimated by SDS-PAGE (1). In addition; analysis of the expressed 
recombinant protein by EMSA proved to have the same characteristic protein-DNA doublet 
(complexes B1 and B2) as observed for suGF1, indicating that the PCR generated clone encodes the 
suGF1 protein. SDS-PAGE analysis of the in vitro expressed protein mixture revealed several other 
unique protein bands of approximate molecular weights 53 kDa, 45 kDa, 42 kDa and 39 kDa, which 
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may represent several N-terminally truncated protein isoforms arising from alternative internal 
translation start sites present in the eDNA (see section 3.5). Analysis of the in vitro expressed 
recombinant proteins by EMSA revealed five protein-DNA complexes (present in a similar ratio to 
the multiple protein products revealed by SDS-PAGE analysis), confirming the presence of several 
protein isoforms encoded by the eDNA. It is likely that these isoforms result from the degradation of 
RNA or protein in the transcription I translation reaction, or they could arise as a result of premature 
termination. However, it is also possible that the in vitro production of multiple protein isoforms 
reflects the in vivo situation. Evidence for this is gleaned from the pattern of protein-DNA complexes 
formed by sea urchin nuclear extracts, which reveal at least two protein DNA-complexes of higher 
mobility than the suGFl complexes, Bl and B2. The higher mobility complexes formed by native 
proteins compare favourably in both mobility and intensity with the higher mobility complexes 
formed by the in vitro translated protein products. In vitro translation systems do not provide any 
form of post-translational modifications, which suggest that native suGFl is unlikely to be subject to 
post-translational modifications either, since the in vitro expressed suGFl protein forms virtually 
identical complexes to native suGFl, as exhibited by formation of the characteristic protein-DNA 
doublet, and the similarity in both the mobilities and intensities.ofthe respective complexes. 
Expression of the homologous SpGCFl construct was analysed in a similar manner. A full length 
protein of- 55 kDa was generated, which corresponds to the predicted size for this factor (3). Several 
unique protein bands of lower molecular weight (viz 50 kDa, 43 kDa, 40 kDa and 37 kDa) can be 
observed for SpGCFl, representing truncated protein products resulting from alternative internal 
translational start codons present in the eDNA (3). Analysis by EMSA resulted in the formation of 
several prominent protein-DNA complexes, also present in a similar ratio to the multiple protein 
bands observed by SDS-PAGE. The single protein-DNA complex formed by the full length SpGCFl 
protein corresponds in mobility to the doublet formed by native suGFl. Three higher mobility 
protein-DNA complexes were observed for the SpGCFl translated protein, corresponding to 
truncated isoforms of the SpGCFl protein. Two of these complexes correspond in mobility to protein-
DNA complexes formed by the homologous P.angulosus recombinant protein, showing that the 
homologous proteins are translated in a similar fashion, although analysis by SDS-PAGE and EMSA 
"· 
reflects that the isoforms of the respective homologues are ·not expressed in the same ratios. In 
addition, the highest mobility protein-DNA complexes of the homologous clones differ substantially 
in mobility. 
Expression of recombinant suGFl was achieved by application of eukaryotic in vitro coupled 
· transcription I translation in preference to bacterial expression, as the latter was unsuccessful with 
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both recombinant SpGCFl and the clones generated by the DNA·lig~nd expression screening method. 
This suggested that bacterial expression may not be suited to clones encoding G·C·rich binding 
factors. In comparison, the in vitro translation system resulted in successful expression of most of the 
clones isolated by the DNA·ligand screening technique, as well as recombinant SpGCFl. Therefore, 
in vitro translation using a cell free protein synthesising system posed an attractive alternative to in 
vivo recombinant expression for the suGFl clone. Not only did it avoid complicating artifacts related 
to prokaryotic expression of eukaryotic genes, it also produced sufficient recombinant suGF1 for 
verification of the clone's open reading frame, and successful identification of recompinant suGFl-
DNA interaction as analysed by EMSA. 
6.3 Protein Purification of Native suGFl 
6.3.1 Purification Strategy 
The suGFl protein was purified to homogeneity on a large scale from P.angulosus embryos. The 
generation of high quality nuclear extracts was the first step in the purification procedure, and it was 
found that nuclear extracts obtained from nuclei which were isolated by centrifugation through dense 
sucrose gradients consistently showed least contaminating proteins relative to suGF1, as judged by 
EMSA. Therefore this was the method of choice when generating the starting material for subsequent 
fractionation of suGFl. Previous observations showed that contaminating proteins may affect the 
amount of sequence-specific binding which can be observed in nuclear extracts (191). The isolation 
procedure for suGF1 followed a general approach outlined for transcription factor purification (96). 
Nuclear extracts were fractionated by P11 chromatography (cation exchange), which promoted the 
removal of nucleases and other contaminants in the sample. Conventional ion exchange 
chromatography was combined with DNA affinity chromatography, which exhibits a very high 
enrichment for suGFl (191) and generally for many other sequence·specific DNA-binding proteins 
(3, 120, 96, 155). The cation exchange purification step exhibited only a 10-fold enrichment (191), 
however it represented a crucial step in the fractionation of suGFl. Nuclear extracts which were only 
fractionated by affinity chromatography and SDS-PAGE reflected numerous protei11. contaminants 
with respect to suGF1 (data not shown), making it impossible to identify the protein band of interest. 
Thus, despite proteins only requiring low purity in order to establish their sequence from SDS gels 
(120), in practice extensive enrichment may be needed, depending on the sample of interest. SDS gel 
electrophoresis was the final chromatographic step in the purification of suGFl, since it has 
successfully provided several other DNA-binding proteins in a pure enough form for applications 
such as sequencing. Examples of DNA-binding proteins which have been isolated by similar 
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procedures include SpP3A2 {120), SpOct (137) and SpGCFl (3). In total, about 600 ng of suGF1 was 
purified by the method outlined above, of which about 300 ng was separated by SDS-PAGE and 
subjected to further analysis by mass spectrometry. 
6.3.2 Identification of suGFl by Mass Spectral Analysis 
Purified suGFl (- 300. ng) was excised from a Coomassie-stained SDS gel and subjected to trypsin 
digestion, which generated peptides by the cleavage of suGF1. The resulting peptides were subjected 
to tandem mass spectrometry. Three of the ten peptides on the mass spectral peptide map (see fig 5.7) 
were identified unambiguously as derivatives of the SpGCF1 protein, as can be seen from the ranked 
list of database homologies in figures 5.8, 5.9 and 5.10. (Four of the ten peptides were. identified as 
derivatives of trypsin, whereas the other three could not be identified.) The three suGF1 peptides had 
lengths of 18, 18 and 15 amino acids respectively and their primary sequences identified 100 % with 
the sequence of SpGCFl over the corresponding primary structure. This confirms that the isolated 
protein suGFl is the P.angulosus homologue of SpGCFl from S.purpuratus, and that the eDNA 
sequence of the clone generated by application ofRACE (see section 3.5) encodes suGFl. 
The development of mass spectrometry with regard to the sequence analysis of proteins and peptides 
poses several advantages over classical Edman degradation, since it is more sensitive and it enables 
the sequencing of peptides in mixtures, which reduces the number of manipulations required. This is 
particularly advantageous for the identification of a transcription factor such as suGFl, as this protein 
is present in minute quantities in vivo and requires vast amounts of biological starting material for 
purification to homogeneity. Mass spectral analysis substantially reduced the amount of material 
required for protein sequencing of suGF1, as it only requires picomole to femtomole quantities. The 
purification strategy for suGF1 involved a combination of selective precipitation, dialysis and several 
chromatographic manipulations, yielding a purified protein sample available in very low quantities. 
Adsorptive losses make it difficult to handle low quantities of proteins; therefore it was advantageous 
using a highly sensitive technique in order to identify the suGFl protein sequence. Another advantage 
of mass spectral analysis (in conjunction with computer manipulation) is that the signal patterns 
resulting from the peptides of interest are. correlated directly with the predicted fragment ions from a 
database. Thus the sequencing data is interpreted and analysed in context with other known protein 
sequences in a specific manner which may be more precise than conventional database comparisons. 
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6.4 Analysis of suGFl Primary Structure 
6.4.1 Characteristic Features of the suGFl eDNA and Protein Sequence 
The length of the eDNA coding for suGF1 (as isolated by 5' and 3' RACE) is about 2.1 kb, ofwhich 
300 bp represent 5' untranslated region, the coding region has 1542 bp and the 3' untranslated region 
has about 250 bp. The short 3' untranslated region presumably originates from a eDNA with a longer 
poly-A+ tail (as judged from the SpGCF1 homologue), and probably arises due to alternate priming of 
the mRNA by the oligo( dT) primer during synthesis of the eDNA. Thus, no distinguishing features 
can be attributed to the 3' untranslated sequence of the suGF1 eDNA. The 5' upstream region 
contains three stop codons which are in frame with the predicted open reading frame of the suGF1 
eDNA. The lack of strong -initiation signals is often a feature associated with eDNA sequences 
containing several alternative start sites within the protein coding region (42). Indeed, the eDNA for 
suGF1 exhibits several internal ATG codons positioned at nt 409, 655, 733 and 808 (see fig 3.15). It 
has been proposed that ribosomes which fail to initiate at the first ATG start codon can begin 
translation downstream at alternate start sites (this is referred to as the "ribosome scanning 
mechanism" as described by Descombes and Schibler (1991) (215)), and may result in the formation 
of truncated protein products arising from a single mRNA species. As predicted from the eDNA 
sequence, the N-terminal suGF1 protein sequence is characterised by the presence of multiple 
methionine residues. In vitro translation of suGF1 indicates that some of these methionine residues 
are associated with the formation of several translation products which retain their DNA-binding 
ability (see section 6.3). This implies that in vivo, suGF1 may be translationally regulated at the 
initiation level, more specifically, it is possible that the mRNA may be scanned by the ribosomal 
complex to select one of several translation initiation codons (9). It is possible that the characteristic 
doublet formed by native suGF1 when analysed by EMSA results from N-terminally truncated 
protein isoforms, which have a very similar molecular weight and therefore cannot be differentiated 
by SDS-PAGE under the conditions described in this project. Several other examples of proteins 
which differ in their N-terminal lengths and are transcribed from a single mRNA include C/EBP 
(216) and antagonists LIP and LAP (215). Similarly, it has been suggested that several truncated 
SpGCFl proteins appear to be formed in this way (3). 
suGFl has an open reading frame of 1542 bp (nt 301- 1843, see fig 3.15) which codes for 514 amino 
acids, comprising a full length protein of molecular weight 57.2 kDa. The predicted molecular weight 
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of suGF1 correlates well with the previously predicted molecular weight of 59.5 kDa (1). suGF1 is 
characterised by a very high proline content (41 proline residues in total, which constitute 8% of the 
overall amino acid composition). More than half of the proline residues (25) occur in the N-terminal 
region. Proline-rich domains are reminiscent of transcription factor activation domains, and are 
postulated to have an important function in the activation potential of DNA-binding proteins. There 
are several examples of proline-rich domains which are implicated in certain classes of transcriptional 
activation domains, such as NGFI-C (114), CTF/NF-I and BTEB (82), and NF-E2 (217). Other 
examples include c-Jun (114) and C/EBP (218) _and the mammalian transcription factors AP-2, OCT-
2 and the serum response factor. Therefore, by analogy, this implies that part of the proline-rich N-
terminus of suGF1 could represent an activation domain. 
The N-terminus of suGF1 is further characterised by a tandem repeat of nine pentapeptides (see fig 
3.16), which contain many of the methionine and proline residues as discussed above. Database 
searches show that these repeats (N/SVSMP) are unique to the suGF1 and SpGCF1 protein (3), and 
no function can be ascribed to them at this point. 
6.4.2 DNA-Binding of In Vitro Translated suGFl 
The structural features important for the DNA recognition of suGF1 are contained in the central 
region of the protein, as shown by expression of a truncated suGF1 polypeptide of 31 kDa coded for 
by nt 699 - 1662 (see fig 3.15), which retained its DNA-binding activity when analysed by EMSA. 
Previously it was speculated that suGF1 is a zinc finger protein, as evidence from EMSAs indicates 
that .this protein has a requirement for divalent cations (191). However, the primary sequence of 
suGF1 shows no evidence for a zinc finger structure in the DNA-binding domain. Instead, the region 
containing the DNA-binding domain comprises a region with 17 amino acids which are highly basic 
residues (underlined in fig 3.15). Basic amino acids are often associated with DNA-binding domains 
(219, 220), and probably form part of the DNA-binding domain for suGFl. Several other G·C-
binding proteins are associated with basic DNA-binding domains. Examples include, amongst others 
GCF (83), CTF/NF-1 (82) and NSEP-1 (221). suGFl is also reminiscent of the transcription factor 
BTEB-2 whose basic region partially identifies with the basic domain of proteins characterised by the 
helix-loop-helix and leucine zipper motifs (82). 
The N-terminal region of the suGF1 basic domain is a combination of hydrophobic residues, which 
may constitute two potential heptad repeats of 22 and 63 amino acids each (aa 251 - 273 and 275 -
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328). suGF1 also has a third potential heptad of repeats located in theN-terminus (aa 13 - 37) (see fig 
3.15). Although no function has been assigned to these repeats either, it appears that they are 
commonly found in proteins which can adopt the coiled-coil structure, such as myosin (222) and the 
leucine zipper class of DNA-binding proteins (84). The latter is characterised by both a very basic 
DNA-binding domain and a strict heptad of leucine residues, which constitute the leucine zipper and 
mediate dimerisation, a feature which is central to DNA-binding within this family of transcriptional 
regulators. This leads to the speculation that the potential heptad repeats in the suGF1 protein may 
form a dimerisation domain which participates either in the formation of homodimers of suGFl 
molecules, or may assist in the interaction of suGF1 with accessory proteins. Previous results showed 
that suGF1 forms discrete multimers in EMSAs in the presence of excess protein (145) and several 
other transcription factors are also known to form multimeric complexes (eg Sp1). Indeed, Zeller et al 
(1995b) (149) suggest that SpGCF1 is a transcription factor which binds DNA as a homodimer, and 
using electron microscopy studies this group predicts that SpGCF1 molecules associate with each 
other. Therefore direct and implicative evidence suggests that multimerisation may be inherent to the 
function of suGFl. This was investigated by EMSAs using a combination of two different sized 
truncated suGF1 proteins. The results indicate that suGF1 does not bind DNA as a homodimer. The 
two polypeptides ofMW 31 kDa (described above) and 41 kDa (nt 762- 1842) differ in the length of 
their C-termini, and both contain the putative dimerisation domain, as well as an active DNA-binding 
domain. Individually these proteins exhibit distinct electrophoretic mobilities when bound to DNA, 
however when they are co-analysed in EMSAs, no intermediary electrophoretic mobility can be 
observed. This shows that the differently sized suGF1 polypeptides do not associate with each other 
in the assay, indicating that the region comprising aa 153 - 455 is devoid of a dimerisation domain, 
and that DNA-sequence recognition functions independently of the putative dimerisation domain. 
These results suggest that native suGF1 protein binds DNA as a monomer, and that DNA-sequence 
recognition of suGF1 is not determined by homodimerisation. However, this does not exclude the 
possibility that suGF1 may either associate with itself or other accessory proteins. Previous results 
(145) show that purified suGF1 does form multiple protein-DNA complexes, most likely via protein-
protein interactions. It is possible that part of the function of suGF1 occurs via its interaction with 
accessory proteins (and therefore the formation of heterodimers). However, if so, these accessory 
proteins are not required for DNA-binding, since the same gel-shift pattern is observed for the native 
suGF1 in crude nuclear extract and expressed full length recombinant suGFl. The formation of 
heterodimers between the in vitro generated recombinant suGFl and sea urchin accessory proteins 
would not take place in the rabbit reticulocyte lysate in vitro cell free extract. In addition, native 
suGF1 purified by DNA-affinity chromatography shows only one protein band of 59.5 kDa when 
analysed by SDS-PAGE (1 ). However it is possible that heterodimer formation which is not necessary 
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for DNA-binding, but necessary for some other function, does occur in vivo but the in vitro DNA-
binding conditions are not suitable for their detection. Although further experiments are required to 
show whether suGFl does indeed dimerise, our results indicate that suGFl recognises DNA as a 
monomer. Our results do not support the dimer model developed by Zeller et al (1995b) (149), 
whereby quantitative simulation of gel shift results with recombinant protein were used to predict that 
SpGCFl binds DNA in the form of homodimers only. This model excludes the formation of 
monomeric SpGCFl complexes. However these authors did not show conclusive experimental 
evidence for heterodimer formation.· 
6.4.3 Comparison Between suGFl and Other Sea Urchin Transcription Factors 
suGFl does not show any significant homology of its DNA or protein sequence to other sea urchin 
transcription factors, apart from SpGCF1 (3). A comparison between the full length cDNAs coding 
for suGFl and SpGCF1 (protein homologues from sea urchin species P.angulosus and S.purpuratus) 
shows that they exhibit 84% identity over a region of 1989 nucleotides, which partially includes the 
5' and 3' untranslated regions, as well as the entire coding regions. suGF1 exhibits a longer 5' 
untranslated region (- 100 bp), however its poly-A+ tail is truncated with respect to SpGCFl. The 
greatest homology (about 89 %) is present in the coding regions of the homologues, both the 5' and 3' 
untranslated regions exhibit less conservation of nucleotide sequence than the coding regions. 
A comparison between the derived amino acid sequences for suGF1 and SpGCFl (3) reveals an 
extremely conserved primary structure of 94 % identity between the proteins. All the essential 
features of suGFl (see section 6.4.1) are reflected in the SpGCFl homologue (3). This implies that 
the homologous proteins are functionally probably iden?cal. The 94 % identity between the two 
proteins shows that the DNA homology of 89 % between the analogous cDNAs can mainly be 
attributed to nucleotide base substitutions in degenerate positions. suGFI codes for a protein of 
molecular weight 57 kDa and contains 514 amino acids, whereas SpGCFl comprises 486 amino acids 
with a molecular weight of 55 kDa. The difference in the molecular weights between the homologues 
can mainly be attributed to the 28 amino acid difference in their primary structure. The two proteins 
exhibit highest identity in the central region, which contains the DNA-binding domain. In this region 
there is a single amino acid residue difference between the proteins. The remaining C-terminal and N-
terminal domains are less conserved, for instance the C-terminus exhibits differences between 9 of the 
amino acid residues, and the suGF1 protein contains 11 additional amino acids in this region. TheN-
termini show even more variation amongst the homologues, for instance, suGFl contains two 
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additional pentapeptide repeats with respect to SpGCF1, and overall the N-termini have 25 non-
identical amino acids, of which 1 substitution has preserved its charge, and 9 others have retained 
their neutrality (see Appendix XIII). Interestingly, three of the amino acids which have undergone 
changes are pro lines within the putative activation domain of SpGCF1. In the suGF1 homologue these 
positions are represented by two alanine residues and a tyrosine residue respectively. However 
overall, suGF1 is characterised by five more proline residues than SpGCFl. There is evidence from 
deletion experiments performed with C/EBP (223) that activation resulting from prolines is not 
necessarily restricted to a specific domain or local region, in which case the activation potential of 
some proteins may rather depend on overall proline content. In total, suGF1 contains five additional 
proline residues (two in the N-terminus and three in the C-terminus) with respect to its SpGCF1 
homologue (3), implying that suGFl may have a higher activation potential than SpGCFl. 
6.4.4 suGFl and Other G·C-Binding Factors 
suGFl may exist in several N-terminally truncated protein isoforms, possibly resulting from 
translational control at the initiation level. All the isoforms are able to bind G·C-rich DNA (see 
section 6.2.3). If native suGF1 protein translation is initiated from the internal ATG start codons 
situated within the eDNA, it may result in the formation of several suGFl polypeptides which differ 
in the length of their activation domains and therefore in their ability to activate. It could be proposed 
that the shorter proteins may compete for binding with the longer proteins, and therefore effectively 
act as competitive repressors, as has been shown for C/EBP and c-Myc. For instance, all species of c-
Myc examined exist in two protein isoforms (224) which differentially regulate transcription (225). 
The difference in their trans-activation abilities is ascribed to the differing amino termini. Only the 
longer protein contains the trans-activation domain which is proposed to undergo a conformational 
change, possibly allowing differential interaction with other proteins (such as the transcriptional 
machinery), which could explain the functional difference between the two protein isoforms. 
Similarly, the C/EBP family consists of several transcription factors important in the regulation of 
growth and differentiation of a number of cell types (226). A single mRNA species serves as template 
for the translation of two protein isoforms of C/EBP, viz a full-length and N-termiiially truncated 
isoform (216, 215) which differentially modulate transcriptional activity. The full length protein is a 
potent activator, whereas the truncated isoform is a repressor or an activator with low activity, 
depending on the promoter context. The ratios of the two isoforms may be regulated by the activity of 
the translation initiation factor eiF-2 (9). SpGCFl also appears to give rise to several truncated 
proteins present in different ratios, most of which are able to bind DNA (3). 
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suGF1 has a characteristically high proline content. More than half of the proline residues (25) occur 
in the N-terminal region. Proline-rich domains are a characteristic feature of certain classes of 
transcriptional activation domains and are implicated in the functional activation potential of several 
DNA-binding proteins. Examples of transcription factors which have proline-rich activation domains 
include NGFI-C, which has an unusually high proline composition of 25 % over 77 amino acids 
(114), CTF/NF-1 and BTEB-2 both have proline-rich regions (the latter has 16 pralines over a region 
of 67 residues) (82), and NF-E2 has a N-terminal proline-rich transactivation domain which is 
required to activate globin gene expression (217). Further examples include c-Jun (114), the 
mammalian transcription factors AP-2, OCT-2 and the serum response factor, as well as C/EBP 
(218). Therefore, by analogy, suGF1 is implied to have an activation domain at its N-terminus which 
is proline-rich, although the overall proline content of suGF1 may also act as an important contributor 
to functional activation potential, since evidence from deletion experiments performed with C/EBP 
(223) implies that activation resulting from pralines is not necessarily restricted to a local region, but 
may depend on overall proline content of the transcription factor. 
Structural features important for the sequence-specific binding of suGF1 are contained in the central 
region of the protein which contains a characteristic domain of highly basic amino acid residues (aa 
332- 349, underlined in fig 3.15). Basic amino acids are often associated with DNA-binding domains 
(219, 220). Several G·C-binding proteins contain basic DNA-binding domains, too. For example 
BTEB-2 has a basic region which partially identifies with the basic domains of proteins characterised 
by the helix-loop-helix and leucine zipper motifs (82), and GCF is characterised by the basic region at 
its N-terminus which functions as the DNA-binding domain (83). This protein also has two leucine 
zipper motifs, which are proposed to facilitate dimerisation and are common to DNA-binding proteins 
such as the fos/jun system (227), C/EBP (228), CREB (229), Myc and GCN4 (84). Other examples of 
proteins which have basic DNA-binding domains (but are not associated with the leucine zipper 
motifs) include CTF/NF-1 (82) and NSEP-1 (221). 
6.5 Developmental Distribution ofthe suGFl mRNA Transcript 
The finding that suGF1 binds in vitro to the G·C-rich region in the spacer between H1 and H4 histone 
genes of the early histone gene battery, which is developmentally regulated in sea urchins, raises the 
question whether suGF 1 functions as part of a set of mechanisms ensuring tight regulation of these 
genes. Binding of suGF1 to this element in vitro does not necessarily correlate with the protein(s) that 
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functionally interact with the element in vivo. The early histone gene battery is coordinately expressed 
in a distinct temporal pattern during early embryogenesis. It is expressed up to late blastula stage 
embryos. In P.angulosus embryos the switch from the early to the late set ofhistones occurs between 
9 and 12 hours after fertilisation (230). Co-expression of suGFl with transcription of these genes 
would support an important regulatory role for suGFl in the controlled expression of the histone 
genes. Therefore the similarity between the temporal pattern of suGFl mRNA and the expression 
pattern of the histone genes was investigated by Northern analysis and RT-PCR. 
The RT-PCR experiment showed that mRNA transcripts for suGFl are present in P.angulosus eggs, 
4 - 45 hour embryos, muscle and testis tissue. However they are absent in ovaries. RT-PCR gives 
qualitative insight about the location of the RNA transcripts of interest, however this experiment 
cannot give a quantitative indication about the relative differences in the amounts of transcripts 
amongst the different tissues I embryonic stages. The experiment was not performed in a 
semiquantitative manner either, since no suitable internal standard could be found. Candidate genes 
which generally serve as internal controls, eg actin genes, histone genes etc, are developmentally 
regulated in the sea urchin embryo. Further, the RT-PCR experiment cannot be used to extrapolate in 
which tissue I embryonic stages the functional protein (translated from the RNA transcript of interest) 
is expressed. It simply serves to indicate the presence of the RNA transcripts. 
Analysis of P.angulosus sea urchin RNA by Northern blotting resulted in uninterpretable signals, as 
the radioactive probe appeared to hybridise over a wide range of molecular weights for each RNA 
sample. This implies that the probe may have had homology with some other abundant transcripts, 
which may have masked authentic signals from the suGFl transcripts. Zeller et al (1995) (3) used 
quantitative RNase protection assays to measure the transcript prevalence of SpGCFl. Absence of 
Northern analysis for S.purpuratus RNA may indicate that this group encountered similar problems 
with Northern blotting of SpGCFl transcripts. (suGFl transcripts we_re not analysed by RNase 
protection assays due to consistently inadequate incorporation of the radiolabel into the antisense 
probe.) RNase protection assays detected the presence of the SpGCFl transcript in S.purpuratus 
ovaries and about 5000 copies of the transcript in unfertilised eggs. Transcript prevalence reached 
maximum levels in 9 hr embryos and steadily decreased to about 1500 copies per embryo at 72 hours 
(3). Adult S.purpuratus tissue (other than ovaries) was not analysed for the presence of SpGCFl 
transcripts. Analysis of the presence of suGFl transcripts in P.angulosus embryos by RT-PCR 
correlates with the distribution of SpGCFl transcripts in Spurpuratus as analysed by RNase 
protection assays. (Note that the P.angulosus and S.purpuratus embryos are grown under different 
conditions and their rates of development differ, viz P.angulosus embryos develop at almost twice the 
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rate with respect to S.purpuratus embryos.) Unfortunately analysis of suGFl transcripts was not 
quantitative, therefore no comparisons can be drawn about the relative abundance of suGF 1 and 
SpGCFl transcripts. Distribution of suGFl and SpGCFl transcripts does, however, not correlate with 
respect to ovaries (suGFl transcripts are absent in this tissue). It is possible that SpGCFl transcripts 
were located in the ovaries of S.purpuratus embryos as a result of incomplete depletion of eggs from 
this tissue. 
The presence of suGFl transcripts in both early and late embryonic stages, as well as adult tissue 
suggests that the functional suGFl protein is unlikely to have a role in the temporal regulation of the 
early histone gene battery as was speculated previously (see section 1.4.3). The early histone genes 
are switched off in blastula stage embryos (9 hours after fertilisation, 230). However, the wide 
distribution of the suGFl rnRNA transcript throughout several embryonic stages and adult tissues 
implies that it could indeed play a role in transcriptional regulation of several unrelated genes with 
G·C-rich promoters. Thus suGFl may have a role as a gep.eral transcriptional regulatory protein. 
6.6 Conclusions and Perspectives 
Although there is no direct evidence for the biological role of suGFl it appears that it may function as 
a general transcriptional regulator of several unrelated genes in sea urchin development. The presence 
of suGFl rnRNA transcripts in the early sea urchin embryonic stages, as well as adult muscle and 
testis tissue cannot be taken as direct evidence that the functional protein is expressed tn these stages I 
tissues. However, previous evidence shows that suGFl is a prevalent nuclear transcription factor in 
embryonic tissue (1). It has been implicated as a transcription factor with respect to its functional 
abilities (it binds sequence specifically to G·C-rich DNA sequences which have been shown by others 
to function as cis-regulatory elements) and as a result of its similar DNA-binding specificity to other 
G·C-rich DNA-binding factors, such as BGPl (11), the ectoderm specific factor (16) and its 
S.purpuratus homologue SpGCFl (3), which have all been implicated as transcriptional regulators. 
Several genes in different organisms have upstream G·C-rich regions, hence suGFl may be a member 
of a family of G-binding factors which is involved in the regulation of unrelated genes. 
The eDNA encoding suGFl was successfully cloned using a PCR-strategy, based on the homology of 
suGFl to a G·C-binding protein present in S.purpuratus embryos. The integrity of the clone was 
confirmed by eukaryotic in vitro expression of the recombinant protein, which showed identical 
DNA-binding properties to native suGFl in crude nuclear extracts suggesting that native suGFl does 
not undergo post-translational modifications. In addition, the true identity of the eDNA sequence was 
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confirmed by partial identification of the primary structure of native suGFl. Functional eDNA 
cloning of suGF1 using the DNA-ligand screening technique proved unsuccessful, either as a result of 
enhanced detection of false positives by use of p[d(I-C)] in the protocol, or more likely because 
recombinant suGF1 protein is not compatible with expression in a bacterial system. 
Analysis of the primary structure of the suGF1 protein has given further support towards the proposed 
biological role for suGF1 as a regulator in gene expression. The region of sequence-specific DNA-
binding has been identified in the suGF1 primary structure (nt 762- 1662). A truncated suGF1 protein 
corresponding to this DNA region retains its DNA-binding ability. Many G·C-rich binding proteins 
are classified as zinc-finger proteins, however suGF1 does not have a Zinc finger DNA-binding 
domain, despite its requirement for divalent cations in order to bind DNA (191). The suGF1 DNA-
binding domain contains highly basic amino acid residues which is a feature common to several 
transcription factors. A putative proline-rich transcriptional activation domain has been identified in 
theN-terminus of suGF1, implying a functional activity for this protein over and above its DNA-
interaction. Activation domains may function in contacting other proteins, which could present 
another feature in the function of suGF1, since this protein has been shown to form discrete suGF1-
suGF1 multimers (1), similar to transcription factors like Spl. The results show that recognition of 
the cognate DNA-binding site of this protein does not rely on obligate homodimerisation or 
heterodimerisation. However the suggestion that suGFl does potentially form associations with 
accessory factors can be gleaned from its primary structure, which comprises several potential heptad 
repeats reminiscent of a class of proteins which form "coiled-coil" conformations, and also leucine 
zipper proteins. The heptad repeat motif is closely associated with protein-protein interactions (ie 
homodimer or heterodimer formations), and thus it ties in with a putative dimerisation domain for 
suGF1, potentially allowing suGF1 to interact with different general transcription factors or with 
subunits of the transcriptional machinery. The inability to detect such putative interactions may have 
been due to the in vitro assay conditions. 
Analysis of the primary structure of suGF1 implies that different isoforms of this protein may exist, ie 
the suGF1 protein may be translationally regulated by the ribosome scanning mechani~m (215). This 
form of transcription factor regulation (ie translational control) and how it regulates the activity of 
transcription factors is not well understood at this stage, and still requires future attention. However, it 
could be proposed that suGF1 may be a promoter selective regulator which modulates the activity of 
promoters via interactions of the different protein isoforms, which could either act as activators with 
differing activational strength, or the truncated forms could act as competitive inhibitors. 
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Identification of suGF1 and determination of its primary structure has provided several insights about 
its mechanism of action. However, several questions remain to be answered. For instance, does 
suGFl function by forming contacts between distant DNA elements, and does multimerisation with 
itself or other factors result in looping of DNA in vivo? Does the formation of stable complexes 
increase productive interactions which may stimulate expression? Can suGFl interact with 
nucleosomes or with the basal transcription apparatus to effect transcriptional regulation? By making 
use of the cloned eDNA of suGFl and application of in vitro functional assays, many of the above 
suggestions and questions could be explored and addressed further, to elucidate the biological role 
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The model used to investigate the receptor-ligand (or protein-DNA) competition studies is analogous to the Michaelis-Menten 
Competitive Inhibition Rate Law which describes enzyme inhibition (231 ). 




R·I + L 








Kd I+- +(L]) 
KI 
(I) 
The relative affinities of a ligand and an inhibitor may therefore be determined by dividing equation (I) in the presence of 
inhibitor with that in the absence of inhibitor: 





When this ratio is 0.5 (50 %) inhibition, the competitor concentration is referred to as [I50]. • 





solving equation {2) for K1 results in 
(3) in (2): 
Ko = [Is0]- [L] 
where I = L, and I = unlabelled EIH_ fragment 
L = free labelled EIH fragment 
(3) 
where [I50] =concentration of unlabelled EIH fragment at 50% competition 
[150] = (4 :1: 2) X 10"
10 M (see graph) 
[L] =the corresponding concentration of free labelled E/H fragment 
~at 50% competition [L] = (4 :1: 2) X 10"11 M (53 cpm) 
since (234 :!: 67) cpm corresponds to (I. 75 :!: 0.5) X I o-to M (see Table 3.2) 
~ K0 = (4:!: 2) XI0-
10 M- (0.4:!: 0.2) X 10"10 M 
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Fig (i) Binding of suGFl to the E/H Fragment 
The amount of radioactivity in the unbound DNA and suGFl-DNA complexes (see fig 3.3) was determined by Instant Imager 
2024 (see table 3.2). The amount of radioactivity in the suGF-DNA-complexes was plotted against the amount of radioactivity in 
the unbound fraction in order to determine the dissociation constant of suGFl (in nuclear extract) with respect to the G-string in 
the EIH fragment, using Scatchard analysis. · 
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Appendix II 
Stro11gyloce11trotus purpuratus eDNA library 
DATE: April 7, 1993 
TO: DR. ROBERT ZELLER, Caitech 
FROM: Or. Kenneth Fong, Director of Custom Ubrary Synthesis Dept. 
Performed by:. Cynthia Chang Ph.D., Research Scientist m 
SUBJECT: Custom synthesis of eDNA library in Lambda Zap II 
oligo ciT-primed (x ), random-primed <x ). 
TITER & VOLUME: 10 ca 10 /ml ( 4 xl ml) 
STORAGE: 
SOURCE OF mRNA: @ 
CLONING VECTOR: 
CLONING SITE: Eco Rl 
4°C or -70°C when aliquoted for long-term storage 
after adding 7% DMSO or 50% sterile glycerol. 
Lambda Zap II (See map on reverse side) 
SELECTION CRITERIA: Clear from blue (parental) plaques* 
% OF CLEAR PLAQUES: 85% 
NUMBER OF INDEPENDENT 
CLEAR PLAQUES (Clones): L3 x 106 
INSERT SIZE RANGE: LO to 4-5 Kb · (as revealed on an autoradiogram before 
eDNA was cloned Into Zap II arms) 
Average: L9 Kb · · 
(see PCR data -.n insert sizes) 
USAGE: For lmmunoscreenlng or probe screCinlng, plate an .._ ""'roprtate dilution of the 
library on E. coli strain BB4 as described In theUibrary Protocol Handbook enclosed. 
* Clear plaques are recombinant phage clones and blue plaques are parental lambda 
Zap II phage. Occasionally, particular recombinant phage plaques produce a small but 
detectable blue color. The detection of blue plaques can be achieved by adding 35 pJ of 
40 mwml X -Gal (Cat. ## 8060) to 2.5 ml of LB soft agar before plating. 
(X-Galls NOT soluble In water. It can be dissolved In Dimethylformamide (OM F). DMF 




DNA Sequence Analysis of Clone 2 
Clone 2 (a 2.2 kb insert) was sequenced with primers T3 and T7 from the Bluescript plasmid giving partial sequence information 
for (a) the plus strand and (b) the minus strand, respectively. Analysis of putative open reading frames for the plus strand (c) and 
the minus strand (d) was performed using the 'MAP' algorithm in the GCG program. 
(a) plus strand (primer T3) 
length sequenced: 236 nt 
1 ttatatttgt ttgtatatga aatatataca ataccttgtg agagcttcaa 
51 acatataaat gttaaggatt cgttcaagtt atgaagaaaa aataatcttt 
101 caaggttttt tgaaggattt cctagcattc aggttaacaa ttttgaaaaa 
151 tatgatttgt ggcaattttg gcatccaatt tgtttacgaa acgtgttcag 
201 aaacaatatg ccaggcacat ttatcacact ctacta 
(b) minus strand (primer T7) 
length sequenced: 223 nt 
1 tcgaattccg gaccattttt tttctatcgc tgcctgatta gctgtaggtt 
51 taatgatagt tttgatgagt agtttagttc tcgtatcgac caacaaatgt 
101 cctaaaaaca gtggtctttt ttctgaaaaa tcgcctggtg ttgccgctaa 
201 agcgtttgaa attaaatcgg cca 








a R K N N L S R F F E G F 




a P S I Q V N N F E K Y D L W Q F W H P I 
b L A F R L T I L K N M I C G N F G I Q F 
c FVAILASNL 
tgtttacgaaacgtgttcagaaacaatatgccaggcacatttatcacactctacta 
181 ---------+---------+---------+---------+---------+------ 236 
acaaatgctttgcacaagtctttgttatacggtccgtgtaaatagtgtgagatgat 
a C L R N V F R N N M P G T F I T L Y 
b V Y E T C S E T I C Q A H L S H S T 
c F T K R V Q K Q Y A R H I Y H T L L 












E S F D G P T A A L A S F F N S K Q * T 
caactgtttcgtttaccacaagcgtttgaaattaaatcggcca 
181 ---------+---------+---------+---------+--- 223 
gttgacaaagcaaatggtgttcgcaaactttaatttagccggt 
L Q K T * W L R K F N F R G 
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Appendix IV 
DNA Sequence Analysis of Clone 6 
Clone 6 (an 850 bp insert) was sequenced with primers T3 and T7 from the Bluescript plasmid giVIng partial sequence 
information for (a) the plus strand and (b) the minus strand, respectively. Analysis of putative open reading frames for the plus 
strand (c) and the minus strand (d) was performed using the 'MAP' algorithm in the GCG program. 
(a) plus strand (primer T3) 
length sequenced: 655 nt 
1 cattttcctc tctaaagaaa attgctcata aggacagctt catacacact 
51 taagttttta tttggaatat tacaatcttt aaaaatatca aaatagggct 
101 actcaatcca ttgtattcaa agaaattggc atcctttcga tctaggagaa 
151 agggatccgc tcagttttta gaagtcataa aatttgaatt tttcctaaac 
201 tttaagaaac aacccatgaa tattcatatc aataggtaaa atttggtata 
251 atcgcaagta aactacatcc agattgcaat gaatgagtga tcacagtttt 
301 ctggccatat gttgagatac acctcgaaac caattttaag tcggtacatt 
351 gcatagatgg aatcgacata acacatcaac atgctagtgt gaggttctct 
401 cttgagaaaa agaacagtac ttgtatcgtg tgtgggggat ttggtctgtt 
451 acctcaaagt ctggcggcat tcattggtta agttttcact ctcccacata 
501 cttcaaaggt ttctgatata atgtcaaggg aggcaaagag ataatcgttt 
551 gcatttattg gttaaaagat ggtttcataa ctctatgacc tttgaccttt 
601 gaggtgaaag gttaaacgca ctcaactatg ctgttctatg ccacacctaa 
651 gaccc 
(b) minus strand (primer T7) 
length sequenced: 181 nt 
1 aaaaaaaaaa ttctcattcc aatgttctct taaaagagac cactgatatt 
51 agatatgctt ctttcgactc ttgtcgacct ttgacctagc tgccatattt 
101 tgaaagaaat tctatgtgtg ataaaagcag tttgttggat agtgtttatt 
151 tcaatcgttt tataccgagc gggtcttagg t 






























b I D I T H Q H A S V R F S L E K K N S T 




b C I V C G G F G L L P Q S L A A F I G 









601 ---------+---------+---------+---------+---------+----- 655 
ctccactttccaatttgcgtgagttgatacgacaagatacggtgtggattctggg 












I F A T Q Q I T N I E I T K Y R A P R L 
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Appendix V 
Sequence Analysis of Clone 11 
Clone II (a 900 bp insert) was sequenced with primers T3 and T7 from the Bluescript plasmid g1vmg partial sequence 
information for (a) the plus strand and (b) the minus strand, respectively. Analysis of putative open reading frames for the plus 
strand (c) and the minus strand (d) was performed using the 'MAP' algorithm in the GCG program. 
(a) plus strand (primer T3) 
length sequenced: 514 nt 
1 cccggctgat atcaagaata gaaacaaagt ttaacaaaga atgtgcgaac 
51 tgtgttctta tcttgaatgt tcatgacgac gacgacgagg acgaaaatga 
101 tgatgatgtt aatgatagtg ggtggtggtg gtgattgtga caatgttgag 
151 gatgttgatg gtgatgatat tgttgatggt gcattcatta tgactgtaat 
201 gacggcaacg gtcaatgatg atgttggtga taatgacgat ggtgataatg 
251 atgatcattg cggcgacaat tatattggtg atgaggaaaa ggagactaat 
301 gacgggtccc atccacaact tgtacaaaca attggcctcg tcgaactagg 
351 tggtatactc gggaaatcat caaaagatct aactgtttta aaggttcgtt 
401 cagatatgac actgtataaa ccgccgcgaa aagaaagcca cctctgtttc 
451 acttacgagt taaaaggaac ttttagattt acacgacgag aacgttggac 
501 cgccacgtgt gaca 
(b) minus strand (primer T7) 
length sequenced: 183 nt 
1 tttaatacat aaaaacagat ttgtttacgc cttacagatg ttacagtctt 
51 gtaaatgatt attatgtgtg taatatacca tgatggctaa tcgtacagaa 
101 attgtgcaat tatagagttg aatttcgatg taaaacaatt accttttatg 
151 ccttttcgtc agatagtgac gcggcaagtc tcg 
































K P P R K E S H L C F T Y E L K G T F R 
gatttacacgacgagaacgttggaccgccacgtgtgaca 
481 ---------+---------+---------+--------- 519 
ctaaatgtgctgctcttgcaacctggcggtgcacactgt 
F T R R E R W T A T C D 
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R V E 
E L N 
F R 
F D 
C K T 
V K Q 
I T 
L p 
F Y A 
F M P 
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S S D 
R Q I 
S D A 




G K S R G V F L R V D R R Y A C T M F L 
A S L A A F F C V S I D V T R A R C S C 
Q V S R R F S A C R S T L R V H D V P 
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Appendix VI 
DNA Sequence Analysis of Clone 16 
Clone I 6 (a 2.4 kb insert) was sequenced with primers T3 and T7 from the Bluescript plasmid giving partial sequence information 
for (a) the plus strand and (b) the minus strand, respectively. Analysis of putative open reading frames for the plus strand (c) and 
the minus strand (d) was performed using the 'MAP' algorithm in the GCG program. 
(a) plus strand (primer T3) 
length sequenced: 622 nt 
1 gggatctcta ggagaaatga aagatggtta agcaagcttt aaacttatca 
51 gggattttgc attctcacat ggtacaaaat tgtgtattgc tttctctgtt 
101 gctgctaaag gagcgataca ttgtacctat atttcactcc tatattcatc 
151 acggcaaatt tatactccaa acttgagaca cgatttcgta gccgtagacc 
201 gcagccaaaa ttttgtctat tattgatcac ttgtgttcat cttgcacttc 
251 tgctgttttg taattcttgt gctattaatt tcaaatgtgt tttctgtttg 
301 tggtgctgct caaaattgta atcgatctac atatfcttaa agtgaaggtt 
351 acgattttta taatctatct gtacaaacaa aatgaagggt gaaagtatct 
401 tgttgtatag gcatattatg tatgatcgta taaatgtaaa aaagcacaca 
451 cagaaaaaaa atctcaaaat gttatttatt tgtgtgtatg gccatctaag 
501 atgtactatg tacatgtttt ctgtaccaat ctggaaagga ccatggggaa 
551 agaattacta cttcccaccc tcccaccaag tttaacggcc caacataata 
601 tttgaaaaaa aaactattaa cc 
(b) minus strand (primer T7) 
length sequenced: 156 nt 
1 ttttccttta caacgcacag gatatttcac ttcccgtatc ttcatcccca 
51 tccaaggatc ctgttatatg aaatggatga cttgggtgtg gtacatgtac 
101 gtcatttttt aaacagaaat caacagatac agtacctcca cagaatgtaa 
151 aacatg 




































M K G E S I L L Y R H I M 











a C V Y G H L R C T M Y M F S V P I W K G 
b 




a P W G K N Y Y F P P S H Q V 
b 
c M G K E L L L P T L P P S L T A Q H N I 
tttgaaaaaaaaactattaacc 
601 ---------+---------+-- 622 
aaactttttttttgataattgg 








G T I H F P H S P H P V H V D N K L C F 
caacagatacagtacctccacagaatgtaaaacatg 
121 ---------+---------+---------+------ 156 
gttgtctatgtcatggaggtgtcttacattttgtac 
D V S V T G G C F T F C 
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Appendix VII 
Primers Designed for PCR Amplification of the SpGCFl Homologue in P.angulosus 
The double stranded eDNA sequence coding for recombinant SpGCFI protein in S.purpuratus embryos (3) is aligned with the 
predicted amino acid sequence. TheN-terminal region is a proline rich domain and the pralines are marked with asterisks(*). The 
sequence corresponding to the minimum DNA binding domain (3) spans from amino acids 223 - 353 (printed bold) and is 
contained in square brackets. Several degenerate primer pairs, viz IS/lA (3) and 2S/2A (J. Hapgood, personal communication) 
have been designed corresponding to this eDNA (shown in bold above the sequence). The specific primer pair SP1/SP2 and 





















V S M P* N V S M P* N A S M P* S V S M P* N 




V S M P* S I P* H H N L Q G N L G Q L L N 
gagcaacagtaattctc specific primer SP1 catc 
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Nth I EcoR V BmnH l~prr I Sac I .EcoR I ------
CATATCCATATCCCATCCCCCCCTACCCACCTCCAATTCACTCCCCCTCCTTTTACAACCTCCTCACTCCCAAAACCCT 
l T-•eaor doniog U-19mcr primer 
attggat-
Ttagcaa._ 
















Sac I 94 
BstX I 103 
Nsil 112 




T7 promoter primer #69348-1 
T7 promoter lac operator Xlla 1 
AGATCGATCTCGATCCCGCG~AATTAATACG~CTCACTATAGGGG~ATTGTGAGCGGATAAC~ATTCCCCTCTAGAAATAATTTTGTTT 
~ Nde 1 S•Tag"' Nso V .M.!!_ .:Ke!!l_ 
AACTTTAAGAAGG~G~TATACATATGAAAGAAACCGCTGCTGCTAAATTCGAACGCCAGCAC~TGGACAGCCCAGATCTGGGTACCCTG 
"etlysGiuThrAioAiaAiolysPheGiuArgGinHis"etAspSerProAspLeuGiyThr~ 
.. pET·29al•l .. Eagl 
























• Multiple cloning sites in three different reading 
frames for insertio-n of the gene of interest in frame 
with the Xpressn.~ N-tenninal peptide. ·. 
• Simplified analysis with a monoclonal antibody 
_ specific for the Xpressn.~ peptide (page 62). 
• Fl origin. for rescue of ssONA which binds the n 
primer (sense strand). For convenient generation 




Adaptor Primer (API) 
Marathon eDNA synthesis primer (52·mer) 
Ecci I Noll 
5'-TTCTAGAA TTCAGCGGCCGC(TIJ0N. 1N-3' 
Marathon eDNA Adaptor 
~N.J•G,A,orC;N•G,A,C,orT 
Deg.n•ate nucleolidea ond-
primer al bo .. ol pofy-A loil 





Adaptor primer 1 (AP J; 27 ·merl ··,,,Nested adaptor primer 2 (AP2; 23·mer) 
5'-cCATCCTAATACGACTCACTATAGGGC-3' 5'-ACTCACTATAGGGCTCGAGCGGC-3' 
.... 
Positive control primers 
5'·RACE TfR primer (24·mer) 
5'-GTCAATGTCCCAAACGTCACCAGA-3' 
l'·RACE TfR primer (29·mer) 
5'-A ffiCGGGAATGCTGAGAAAACAGACAGA-3' 
Sequences of the Marathon eDNA Synthesis primer, the Marathon eDNA Adaptor, and the API and AP2 primers, and the positive 
control TFR primers (all ClonTech). 
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Appendix X 
Sequence Analysis of PCR-generated DNA Fragments 
DNA sequences from P.angulosus (P.ang) corresponding to (a) the 106 bp fragment amplified using the degenerate primer pair 
I S/1 A, (b) the 3 72 bp fragment amplified using the degenerate primer pair 2S/2A and (c) the 421 bp fragment amplified using the 
specific primer pair SP1/SP2, were compared to the DNA sequence for SpGCF1 from S.purpuratus (S.purp) using a computer 
program (GCG). The numbers for the nucleotide sequence of the P.angulosus clone were aiiocated with respect to the numbering 
of the fu111ength clone (see fig 3.15), whereas the numbers for the nucleotide sequence ofthe S.purpuratus clone correspond to 
the numbers a11ocated to the fu111ength eDNA for SpGCF1 shown in Appendix VII and Ze11er et al (1995) (3). The degenerate 
primers 1 S/lA and 2S/2A used to amplify the respective fragments in (a) and (b) were not included in the sequence comparison. 
The P.angulosus sequences are printed in small letters, whereas the S.purpuratus sequences are printed in capital letters. The 
percentage similarity between the individual PCR fragments and the S.purpuratus clone are shown above each alignment 
respectively. 
(a) Percentage Similarity: 93.877 
S.purpuratus 520 AGAATCCACAAAGTGAGCGACAGCTTTTCTACAACGACGTAGCCATGCAA 569 
1111111111111111111 IIIII 11111111111 111111111111 
P.angulosus 763 agaatccacaaagtgagcgtcagctattctacaacgatgtagccatgcaa 812 
(b) Percentage Similarity: 91.912 
S.purpuratus 796 CGTCCAAAGAGCTTGAGAACATGGCAACCCGTATTGCCAGTGTACGGCAG 845 
1111 II IIIII IIIII 111111111 1111111111111111 Ill 
P.angulosus 1040 cgtcaaaggagctggagaatatggcaaccggtattgccagtgtacgacag 1089 
846 CAGCTGCTACACAAAAAGGGCACCTTGCTGACATCCAGCGATAACAGCGT 895 
11111111 11111111111111111111 II II 111111111 II I 
1090 cagctgctgcacaaaaagggcaccttgctaacat.cagcgataatagtg. 1137 
896 TATAGTGTGGCAGAATGAGCTAGCCTACATAGAACAGCTGTT 937 
111111 11111111111111 111111111111111 II 
1138 tatagt ... gcagaatgagctag.ctacatagaacagctatt 1175 
(c) Percentage similarity: 91.640 
S.purp 546 TTCTACAACGACGTAGCCATGCAACTGTATAACAGTGACTTCAACAAGTT 595 
11111111 II 11111111111 11111111111111111111111111 
P.ang 790 ttctacaatgatgtagccatgcagctgtataacagtgacttcaacaagtt 839 
596 TGCTTCCAAG.AAGGGATTTCATGGCTACCTGTTAGAGCAACAGAAGTGG 644 
1111111111 1111 111111111111111111111111 111111111 
840 tgcttccaagaaaggaatttcatggctacctgttagagcagcagaagtgg 889 
645 AGGTGGGATACCCACAGCTACATAGGTAACCTGGAGACTAGAGTACATAA 694 
II 11111111111111111111111111111111111 I: Ill IIIII 
890 agatgggatacccacagctacataggtaacctggagaccanagtccataa 939 
695 CTTGCTCATTAATCCAAACAGTGGGGTTGCACAGAATGTTGCTCGCTACC 744 
111111111 11111111111111111111 II II 11111111 II I 
940 cttgctcatcaatccaaacagtggggttgcccaaaacgttgctcgatatc 989 
745 GCAGTGTCCCCATCAAATGTAAAAGTGAGGATGTGAAGCGATGTAAAGCC 794 
II II IIIII 11111111111111 II ::1111111111111 IIIII 
990 gcagcgtcccaatcaaatgtaaaagcgaanntgtgaagcgatgtgaagcc 1039 
795 ACGTCCAAAGAGCTTGAGAACATGGCAACCCGTATTGCCAGTGTACGGCA 844 
IIIII II IIIII II: II 11111111 1111111111111111: II 
1040 acgtcaaaggagctgganaatatggcaacgcgtattgccagtgtacnaca 1089 
845 GCAGCTGCTACA 856 
111111111 II 
1090 gcagctgctgca 1101 
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Appendix XI 
Partial Sequence Analysis of the 5' and 3' RACE Products 
The DNA sequences obtained for the- 900 bp 5' RACE product (a) and the- 1.5 kb 3' RACE product (b) amplified from 
P.angulosus (P.ang) eDNA have 74% and 92% identity to the SpGCFI (3) sequence from S.purpuratus (S.purp) respectively. 
The homology comparisons were performed using the computer program GCG. The numbering of the nucleotide sequences for 
both SpGCFI and the P.angulosus sequences correspond to the numbering allocated to the respective full length clones (see 
Appendix VII and see fig 3.15). 
(a) 5' RACE fragment: Percentage Identity 73.626 
S.purp 5 TTTGGGGGCATAATTTTGCTATTGATCAAGGATAGCGGGCCCGAATTTAC 54 
Ill II II 1111 IIIII II IIIII Ill I II II 
P.ang 190 ttttggagcttaatattgcttttcatcaatcataactactgaaaaattta 239 
55 TCATTTT ........ TTAGTGACTTGACGAGGATCCAACA.GAGGTGAGT 95 
111111 I II I I II Ill Ill II II II 
240 ccattttgtgtgtcccttgttagtggaggagactcctccatgaaagaagg 289 
96 GAGGAGTGAGGTATGTCCACTCTGCCCCAGCCCCTTTCCCACTGCCTGCT 145 
11111111111 IIIII 1111111111111111 IIIII 11111111 
290 aaggagtgaggtttgtccgctctgccccagcccctgtcccattgcctgct 339 
146 GAACCAGGTACAC ... CCCGCTCTCAACCTGCCC ...... CAGACAGGGG 186 
1111 Ill II I II 1111111 Ill II 1111 
340 gaacgtggtgaacactgcagccatcaacctaccccatcaacaaccaggac 389 
187 TCATCACAGACATCAAGCCCATGATCAGTAATAAACCTCCTACACAGGAG 236 
1111111111111111 II IIIII IIIII IIIII Ill I Ill 
390 tcatcacagacatcaaaccaatgattagtaacaaaccccctcctactgag 439 
237 G ..... TCAAACCAAACATCCTAGC ........... AACTGGCTTGCCCT 270 
I II 1111 Ill II 1111 11111111 II 
440 ggaggttccaacccaacttcttagcctgcggctgcttgctggcttgaccc 489 
271 ATCCTCC 277 
I IIIII 
490 accctcc 496 
(b) 3' RACE fragment: Percentage Identity: 92.063 
S.purp 561 GCCATGCAACTGTATAACAGTGACTTCAACAAGTTTGCTTCCAAGAAGGG 610 
11111111 II 1111111111111111111111111111111111111 
P.ang 805 gccatgcagctctataacagtgacttcaacaagtttgcttccaagaagga 854 
611 ATTTCATGGCTACCTGTTAGAGCAACAGAAGTGGAGGTGGGATACCCACA 660 
111111111111111111111111 11111111111 1111111111111 
855 atttcatggctacctgttagagcagcagaagtggagatgggatacccaca 904 
661 GCTACATAGGTAACCTGGAGACTAGAGTACATAACTTGCTCATTAATCCA 710 
1111111111111111111111 IIIII 11111111111111 111111 
905 gctacataggtaacctggagaccagagtccataacttgctcatcaatcca 954 
711 AACAGTGGGGTTGCACAGAATGTTGCTCGCTACCGCAGTGTCCCCATCAA 760 
11111111111111 II II 11111111 II IIIII IIIII IIIII 
955 aacagtggggttgcccaaaacgttgctcgatatcgcagcgtcccaatcaa 1004 
761 ATGTAAAAGTGAGGATGTGAAGCGATGTAAAGCCACGTCCAAAGAGCTTG 810 
111111111 II 111111111111111 1111111111 II IIIII I 
1005 atgtaaaagcgaagatgtgaagcgatgtgaagccacgtcaaaggagctgg 1054 
811 AGAACATGGCAACCCGTATTGCCAGTGTACGGCAGCAGCTGCTACACAAA 860 
1111 11111111 11111111111111111 11111111111 111111 
1055 agaatatggcaacgcgtattgccagtgtacgacagcagctgctgcacaaa 1104 
861 AAGGGCACCTTGCTGACATCCAGCGATAACAGCGTTATAGTGTGGCAGAA 910 
11111111111111 11111111111111 II II 11111111111111 
1105 aagggcaccttgctaacatccagcgataatagtgtcatagtgtggcagaa 1154 
911 TGAGCTAGCCTACATAGAACAGCTGTTT 938 
111111111111111111111111 Ill 
1155 tgagctagcctacatagaacagctattt 1182 
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Appendix XII 
DNA Homology Comparison Between the PCR-generated 
P.angulosus Clone and the eDNA Encoding SpGCFl 
The consensus DNA sequence representing the full length SpGCFl homologue present in P.angulosus was aligned and compared 
to the SpGCFl DNA sequence (3) using the computer programme GCG. The P.angulosus sequence (P.ang) is printed in small 
letters and the S.purpuratus (S.purp) sequence is shown in capital letters. The numbers for the nucleotide sequence of the 
S.purpuratus clone correspond to the numbers allocated to the full length eDNA as shown in Appendix IX and Zeller et al (1995) 
(3), and the numbers allocated to the consensus DNA sequence for the P.angulosus homologue correspond to the nucleotide 
position as determined by sequence analysis. 
Percentage Similarity: 83.763 
P.ang 190 atttggagcttaatattgcttttcatcaatcataacgactgaaaaattta 239 
II II II 1111 IIIII II IIIII Ill II II II 
S.purp 5 TTTGGGGGCATAATTTTGCTATTGATCAAGGATAGCGGGCCCGAATTTAC 54 
240 ccattttgtgtgtaccttgtgagttgaggagactcctccatagaagaaga 289 
111111 I 1111 1111 Ill Ill II II II 
55 TCATTTT ........ TTAGTGACTTGACGAGGATCCAACAGAGGTGAGTG 96 
290 aggagtgaggtatgtccactctgccccagcccctgtcccattgcctgctg 339 
1111111111111111111111111111111111 IIIII 111111111 
97 AGGAGTGAGGTATGTCCACTCTGCCCCAGCCCCTTTCCCACTGCCTGCTG 146 
340 aaccaggtgaacactgcagccatcaacctaccacatcaacaacctggact 389 
11111111 II I II 1111111 II II I II I 
147 AACCAGGTACAC ... CCCGCTCTCAACCTGCC ...... CCAGACAGGGGT 187 
390 catcacagacatcaaaccaatgattagtaacaaaccccctcctactcagg 439 
111111111111111 II IIIII IIIII Ill 11111111 1111 
188 CATCACAGACATCAAGCCCATGATCAGTAATAAA ... CCTCCTACACAGG 234 
440 aggtcaaaccaaacatcttagctgcggctgctgctggcttgacctaccct 489 
11111111111111111 II II 111111111111 111· 
235 AGGTCAAACCAAACATCCTA ......... GCAACTGGCTTGCCCTATCCT 275 
490 ccactcaacgtgcctagcctacctgcaatgcccaacgtgtcgatgcctaa 539 
11111111111111111 IIIII I 11111111 IIIII 111111 
276 CCACTCAACGTGCCTAGGCTACCCGTCATGCCCAATGTGTCTCTGCCTAG 325 
540 tgtgtcattgcccaacgtgtcaatgcctaatgtgtctatgcccaatgtgt 589 
I II II IIIII I 111111111111111111 I 
326 T ............... GTCTCTATGCCGAGTGTGTCTATGCCCAATGTCT 360 
590 ctatgccaaccagcgtttcaatgccgagtgtgtccatgcccagcgtttct 639 
I IIIII I I I 11111111111 IIIII 
361 CCATGCCCAAC .................. GCATCCATGCCCAGTGTTTCG 392 
640 atgccgagtgcgtccatgccaagtgttactcttcacaaccaacagggaaa 689 
IIIII I II 1111111111111 II Ill 1111111 111111 II 
393 ATGCCCAATGTGTCCATGCCAAGTATTCCTCATCACAACTTACAGGGTAA 442 
690 caatagcca ... actgagcaacagtaattctcaacggctgtcccaaatga 736 
I 1111 Ill I 111111111111 Ill 111111111111 
443 CTTAGGCCAATTACTCAACAACAGTAATTCCCAAAAAATGTCCCAAATGA 492 
737 agaaatgccccaatgagtttctccatcagaatccccaaagtgagcgtcag 786 
I II 11111111 111111 I 11111111111 11111111111 Ill 
493 AAAAGTGCCCCAACGAGTTTTTACATCAGAATCCACAAAGTGAGCGACAG 542 
787 ctattctacaatgatgtagccatgcagctgtataacagtgacttcaacaa 836 
II 11111111 II 11111111111 11111111111111111111111 
543 CTTTTCTACAACGACGTAGCCATGCAACTGTATAACAGTGACTTCAACAA 592 
837 gtttgcttccaagaaggaatttcatggctatctgttagagcagcagaagt 886 
11111111111111111 111111111111 11111111111 1111111 
593 GTTTGCTTCCAAGAAGGGATTTCATGGCTACCTGTTAGAGCAACAGAAGT 642 
191 
887 ggagatgggatacccacagctacataggtaacctggagaccagagtccat 936 
II II lllllllllllllllllllllllllllllllllll IIIII Ill 
643 GGAGGTGGGATACCCACAGCTACATAGGTAACCTGGAGACTAGAGTACAT 692 
937 aacttgctcatcaatccaaacagtggggttgcccaaaacgttgctcgata 986 
I I II I I Ill J I llllll I I lllllllllll I II II I I I IIIII II 
693 AACTTGCTCATTAATCCAAACAGTGGGGTTGCACAGAATGTTGCTCGCTA 742 
987 tcgcagcgtcccaatcaaatgtaaaagcgaagatgtgaagcgatgtgaag 1036 
IIIII IIIII llllllllllllll II lllllllllllllll Ill 
743 CCGCAGTGTCCCCATCAAATGTAAAAGTGAGGATGTGAAGCGATGTAAAG 792 
1037 ccacgtcaaaggagctggagaatatggcaacgcgtattgccagfgtacga 1086 
lllllll II IIIII IIIII llllllll lllllllllllllllll 
793 CCACGTCCAAAGAGCTTGAGAACATGGCAACCCGTATTGCCAGTGTACGG 842 
1087 cagcagctgctgcacaaaaagggcaccttgctaacatccagcgataatag 1136 
lllllllllll llllllllllllllllllll llllllllllllll II 
843 CAGCAGCTGCTACACAAAAAGGGCACCTTGCTGACATCCAGCGATAACAG 892 
1137 tgtcatagtgtggcagaatgagctagcctacatagaacagctatttgaca 1186 
II llllllllllllllllllllllllllllllllllllll lllllll 
893 CGTTATAGTGTGGCAGAATGAGCTAGCCTACATAGAACAGCTGTTTGACA 94.2 
1187 gaacggatcagatgtacaacgaggtcttgtccacacttgcaagtgttaac 1236 
I II llllllllllllll IIIII II II II II llllllll Ill 
943 GGACTGATCAGATGTACAATGAGGTGTTATCTACCCTGGCAAGTGTCAAC 992 
1237 caaactttctcccaccttcagactagtttcactgccgaagctgcagagct 1286 
II II lllllllllllllllll II IIIII II llllllllllll I 
993 CAGACCTTCTCCCACCTTCAGACAAGCTTCACAGCAGAAGCTGCAGAGTT 1042 
1287 ggccgatcggagacgcctttggaggcggcggaaggagaacaaccgaaaga 1336 
Ill IIIII II Ill I 111111 II I 11111111111111 II II 
1'04 3 GGCAGATCGTAGGCGCTTGTGGAGGAGGAGAAAGGAGAACAACCGCAAGA 10 92 
1337 gacggaagcgcatggagaaacaacttgaaaaaattgagcagcgatcttgc 1386 
1111 11111111111111111111111111 11111111111111111 
1093 GACGCAAGCGCATGGAGAAACAACTTGAAAAGATTGAGCAGCGATCTTGT 1142 
1387 gagcttctctttcacatcacatcacggggggcgtacgacagggtgcgttc 1436 
11111111111111 11111111 IIIII II II Ill 1111111111 
1143 GAGCTTCTCTTTCATATCACATCCCGGGGAGCATATGACCGGGTGCGTTC 1192 
1~37 ccaccctgagatgcctcgcatcggacccagcgaggtgaacacagacatgt 1486 
111111 11111111111 II 1111111111111111111111111111 
1193 CCACCCAGAGATGCCTCGTATTGGACCCAGCGAGGTGAACACAGACATGT 1242 
1487 taaatgggattaaatccaaatcagaagtgaggcctctaatgcatctactg 1536 
1111111111111111 IIIII 11111111111111 IIIII IIIII 
1243 TAAATGGGATTAAATCTAAATCCGAAGTGAGGCCTCTTATGCACCTACTC 1292 
1537 agtaaaggttacatgactccaggtgcgatggaaatggtctcgcaaaagat 1586 
IIIII 11111111111 II IIIII IIIII 11111111 11111111 
1293 AGTAAGGGTTACATGACCCCTGGTGCAATGGAGATGGTCTCTCAAAAGAT 1342 
1587 tcagaaactagaatgtggtattaagactgaagctcaccaacaggcaaccc 1636 
II 11111111 llllllllllllllllllll llllllllllllllll 
1343 CCAAAAACTAGAGTGTGGTATTAAGACTGAAGCGCACCAACAGGCAACCC 1392 
1637 aggtcggtatcaactctctggcmatywacaaaatgccagttcctgcttcc 1686 
1111 lllllllllll Ill I ll::lllllll Ill 11111111 
1393 AGGTTGGTATCAACTCCCTGTCGATCAACAAAATTACAGCACCTGCTTCA 1442 
1687 agawttaaatccatactvcctcctgctcctcctccagtcactggygttgc 1736 
I II llllllll:llllll 11111111 1111 
1443 GAGCTAAACTCCATACTGCCTCCT ............ GTCACTGGAATTGC 1480 
1737 ctcatccactatgatctcatcaaccatggtgtcgtcagtaaactctgctg 1786 
11111111 11111111 II 11111111 I 
1481 ............... CTCATCAAATATGGTGTCATCTGTAAACTCAG ... 1512 
1787 cccctgttacacagcaatcagtgcccaccgttaatctcaatactcagcta 1836 
1111 IIIII 11111111111111 II IIIII II IIIII II 
1513 ... CTGTGACACAACAATCAGTGCCCACAGTAAATCTTAACACTCAATTA 1559 
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1837 gcaaagtaacaccaaacagaccatgt ...... aacctttccatacttctg 1880 
II 111111 II 1111 II II II Ill I I I I 
1560 GCGAAGTAAAGACATTTTAACCAAGTCACAGCGACTTTGCCACATTGCCG 1609 
1881 agtg.ttgatagt ............. tatactctatactgtaatttcaag 1916 
1111 1111 I I I IIIII I 1111 Ill II 
1610 AGTGTTTGACATTGAGTAGGCTGTACTCTACTCCACACTG ... TTTTAAC 1656 
1917 caacattttatgatgtctaatcatgctccaatgtgagaaaagtatacatt 1966 
1111111 Ill 1111 I I Ill Ill I II I Ill I 111111 
1657 CAACATTGTATTATGTATGAGCATACTCTTACATG.GCAAAATGTACATT 1705 
1967 tattgta.taaacaggaatgtagcaaattttaaaatgatttagctactaa 2015 
1111 II II 111111111 Ill II I Ill II I I I 
1706 TATTATATTATGCAGGAATGTTGCATCAGTTTA ... GATCTAACCAAAAC 1752 
2016 attgtagaattacttgttgtttggataaacatgtagcttgtactggatgt 2065 
I I I 1111111111 Ill II Ill I Ill 
1753 AGTTTTAGATTACTTGTTCTTT .............. TTTTTACCAGGTGT 1788 
2066 aaatgtaaattttacccagtacaaat 2091 
I llllllllllll I II II I 
1789 ACATGTAAATTTTAACTGGTGAAATT 1814 
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Appendix XIII 
Comparison Between suGFl and SpGCFl Primary Sequence 
The predicted amino acid sequences corresponding to the full length suGFI clone from P.angulosus (P.ang) and the SpGCFl 
clone from S.purpuratus (S.purp) (3) were aligned using GCG. They show a homology of94 %. Identical amino acid residues in 
both sequences are connected with a solid line, those which differ between the two proteins aie marked in bold type, and are 
connected by a colon (conservation of charge), or by a single dot (charge is not retained). Nonidentical amino acids are shown in 
bold type. The numbering of the SpGCFl amino acids corresponds to the numbering allocated in Appendix VII and Zeller et al 
(1995) (3). 
Percentage Similarity: 94.227 
P.ang 1 MSTLPQPLSHCLLNQVNTAAINLPHQQPGLITDIKPMISNKPPPTQEVKP 50 
1111111111111111: :1:111 1-1=11111111111 11111111 
S.purp 1 MSTLPQPLSHCLLNQVH.PALNLP •. QTGVITDIKPMISNK.PPTQEVKP 46 
51 NILAAAAAGLTYPPLNVPSLPAMPNVSMPNVSLPNVSMPNVSMPNVSMPT 100 
Ill 1-11-1111111-11-11111:1-.11:1-1111111111 
47 NIL .•• ATGLPYPPLNVPRLPVMPNVSLPSVSMPSVSMPNVSMPN ..... 88 
101 SVSMPSVSMPSVSMPSASMPSVTLHNQQGNNSQ.LSNSNSQRLSQMKKCP 149 
-11111111-·1111=· II Ill =I 1-11111==1111111 
89 ...... ASMPSVSMPNVSMPSIPHHNLQGNLGQLLNNSNSQKMSQMKKCP 132 
150 NEFLHQNPQSERQLFYNDVAMQLYNSDFNKFASKKEFHGYLLEQQKWRWD 199 
I II II II I I I Ill I II 1111 I I I Ill 111111 II I = II II IIIII II II I 
133 NEFLHQNPQSERQLFYNDVAMQLYNSDFNKFASKKGFHGYLLEQQKWRWD 182 
200 THSYIGNLETRVHNLLINPNSGVAQNVARYRSVPIKCKSEDVKRCEATSK 249 
I I 1111 II I I I I II I II I I II IIIII II 111111111 1111 Ill I · 1111 
183 THSYIGNLETRVHNLLINPNSGVAQNVARYRSVPIKCKSEDVKRCKATSK 232 
250 ELENMATRIASVRQQLLHKKGTLLTSSDNSVIVWQNELAYIEQLFDRTDQ 299 
I I II I II I I I I I Ill II II I I II II !" I II II II II II II 111111 II II I 
233 ELENMATRIASVRQQLLHKKGTLLTSSDNSVIVWQNELAYIEQLFDRTDQ 282 
300 MYNEVLSTLASVNQTFSHLQTSFTAEAAELADRRRLWRRRKENNRKRRKR 349 
11111111111111111111111111111111111111111111111111 
283 MYNEVLSTLASVNQTFSHLQTSFTAEAAELADRRRLWRRRKENNRKRRKR 332 
350 MEKQLEKIEQRSCELLFHITSRGAYDRVRSHPEMPRIGPSEVNTDMLNGI 399 
I I 1111 II Ill I II II Ill II I I Ill Ill II 1111 II 1111111111 Ill 
333 MEKQLEKIEQRSCELLFHITSRGAYDRVRSHPEMPRIGPSEVNTDMLNGI 38 
400 KSKSEVRPLMHLLSKGYMTPGAMEMVSQKIQKLECGIKTEAHQQATQVGI 449 
I I I II II I I I II II IIIII I I II 1111 111111 IIIII 111111 IIIII I 
383 KSKSEVRPLMHLLSKGYMTPGAMEMVSQKIQKLECGIKTEAHQQATQVGI 432 
450 NSLAINKMPVPASRNKSILPPAPPPVTGVASSTMISSTMVSSVNSAAPVT 499 
111-111=··111 -Ill 11111=1 11-11111111 II 
433 NSLSINKITAPASELNSIL •••. PPVTGIA .•••• SSNMVSSVNSA .. VT 471 
500 QQSVPTVNLNTQLAK 514 
111111111111111 
472 QQSVPTVNLNTQLAK 486 
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Appendix XIV 
Recombinant Protein Expression in pET 
(a) Description of the pET Expression System 
The pET system provides translation vectors which can generally be used for expression of eukaryotic target genes (232). These 
vectors are available in three different reading frames with respect to the BamHJ site in the polylinker. In addition to a versatile 
multiple cloning site, pET vectors have several other features such as peptide "tags" to which the target protein can be fused. 
These are useful for detection and purification. The pET-29b(+) plasmid contains sequences coding for the His-Tag (an 
oligohistidine domain) which, when fused to the C-terminus of the target protein, can be used for convenient purification of the 
recombinant protein. The His-Tag can be released from the target protein by cleavage at the thrombin site. Another "tag" available 
on the pET-29b(+) vector is the S-Tag peptide (this forms anN-terminal fusion with the target protein) and an antibody generated 
against this region is available, allowing quantitation, detection and affinity purification of the expressed protein. Stop signals, as 
well as a downstream T7 transcription terminator, are available in all three reading frames on the plasmid. The plasmid codes for 
the kanamycin resistance gene, which is read in the opposite direction to the target gene, preventing read-through transcription 
from the T7 promoter. This tum prevents the accumulation of the kanamycin gene product (pET System Manual). Finally the 
presence of an fl origin of replication on the plasmid allows for the production of ss plasmid DNA. 
Expression constructs are first established in a host which does not contain T7 RNA polymerase. This ensures plasmid stability by 
preventing potentially toxic genes from being expressed. Several cloning hosts are suitable, three of which (viz HBIOI, JMI09 
and DHSa) were used to establish the expression constructs for Clones 2, 6, II and 16 (see section 4.2.1 ). The absence of a T7 
RNA polymerase source in the cloning host reduces the background target protein synthesis because the host enzymes do not 
recognise (or initiate from) the T7 promoter (232). Target genes remain transcriptionally inactive in the uninduced state until they 
are transferred to an expression host containing T7 RNA polymerase. Generally these are lysogens of the DE3 bacteriophage, 
which is a A. derivative, and as a result these host cells have a DNA fragment containing the lad gene, the lacUVS promoter and 
the gene for T7 RNA polymerase (232). The T7 RNA polymerase gene is under control of the inducible lacUVS promoter which 
can be induced by addition of IPTG to the growth medium. Induction results in the expression of T7 RNA polymerase, which in 
tum transcribes the target DNA in the plasmid. However, even in the absence of IPTG the lacUVS promoter may allow some 
expression of T7 RNA polymerase, and, when dealing with toxic genes, this may be sufficient to prevent the establishment of 
plasmids in the expression host. Therefore some pET plasmids (eg the pET-29 series) have been developed with the T7lac 
promoter (233), in which case the plasmid contains a lac operator sequence downstream of the T7 promoter. The natural promoter 
and coding sequence for the lac repressor (lad) is oriented such that the T7lac promoter and the lad promoters diverge, hence the 
lac repressor acts both at the lacUVS promoter in the host chromosome to repress transcription of the T7 RNA polymerase gene, 
and at the T7/ac promoter in the vector to block transcription of the target gene by any T7 RNA polymerase that is made (233). 
Some of the most common expression hosts used to express target proteins from pET plasmids are the two bacterial strains 
BL2l(DE3) and BL21(DE3)pLysS. Both these strains were used in the expression studies (see section 4.2.1). The BL2l(DE3) 
strain lacks the lon protease and the ompT outer membrane protease which helps reduce the degradation of proteins during 
purification (234), and thereby improves the stability of proteins. The pLysS strain of BL2I(DE3) contains a plasmid which 
produces a small amount of T7 lysozyme. This enzyme has the bifunctional properties of cutting a specific bond in the 
peptidoglycan layer of the E.coli cell wall, as well as acting as a natural inhibitor ofT7 RNA polymerase, thereby providing extra 
stability to target genes (235). The low amount of lysozyme produced has very little effect on target gene expression once the T7 
RNA polymerase is induced, since more polymerase is produced than can be inhibited by the lysozyme. Lysozyme is unable to 
pass through the inner cell membrane; relatively high levels of the enzyme can be tolerated by the cells and therefore rapid oflysis 
of cells can be induced by combining the lysozyme with other treatments that would normally not cause cell lysis, eg freeze-thaw, 
chloroform, and mild detergent (eg 0.1% Triton X-100) (pET System Manual). 
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(b) Optimisation of Recombinant Protein Expression Using the pET-29b(+) Vector 
The four clones (2, 6, II and 16) generated by the DNA ligand screening technique were subcloned from pBluescript SK into 
pET-29b(+) (Novagen) using restriction site combinations Sac/ I BamHJ (Clone 2) and Sa/11 Xbal (Clones 6, II and 16). These 
combinations allowed for directional cloning of the inserts. The inserts were also released from Bluescript with EcoRJ and 
subcloned into pET-29b(+) using the same site. Correct orientation of the inserts was ensured by restriction mapping. The "b" 
reading frame was chosen in the pET-29 vector series in order to retain the same reading frame as originally provided by the 
Bluescript plasmid. The expression constructs were established in several different E.coli host strains, viz JMI09, HBIOI and 
DH5a, and expression of the constructs was induced in the host strains BL21 DE3 and pLysS using several colonies originating 
from each original host, and subsequently placed in both expression hosts. A plasmid referred to as the "induction control" which 
has matching elements to the pET-29 vector, and codes for the P-galactosidase protein (pET System Manual) was provided in the 
DE3 lysogen host and was always used as a positive control to test induction by IPTG. Apart from optimising both the initial and 
expression hosts for Clones 2, 6, II and 16, other conditions used to optimise expression included varying the culture volumes 
(0.2 ml to 50 ml), the temperature of induction {16°C, 20°C, 30°C and 37°C), and length of induction (0.5 to 6 hours). The 
percentage SDS gel used to analyse the total cell protein was varied in order to optimise the separation of proteins and the gels 
were stained with both Coomassie and silver (see sections 2.26). Optimisation of expression resulted in the expression of a single 
clone in the pET plasmid. Clone II was expressed successfully as a- 25 kDa protein in the expression host BL21DE3 (for details 
see fig 4.1 ). Expression of Clone 11 was further optimised by performing a time course of induction at various temperatures. Log 
phase cells were induced at l6°C, 20°C, 30°C (fig (ii) (a)) and 37°C (fig (ii) (b)) and aliquots of induced cells were removed at 
hourly intervals for 6 hours. Uninduced and induced cells were analysed by SDS-PAGE. Recombinant protein expression from 
Clone II is maximally induced at 37°C for 3- 4 hours (fig (ii) (b), lanes 7- 8) and at 30°C for a period of 5-6 hours (fig (ii) (a), 
Janes 24 - 25). Induction at l6°C (fig (ii) (a) lanes 3 - 9) can only be detected very faintly after six hours, and at 20°C (lanes I 0 -
16) it is detected at low levels from about 5 hours onwards. At both 30°C and 37°C the induction occurs strongly after three hours 
and continues with increasing time. Protein molecular weight standards are shown in lane I of fig (ii) (a) and (b), and the 
uninduced and induced proteins resulting from the induction control plasmid are shown in lanes 2 and 3 respectively (fig (ii) (b)). 
(c) Soluble Forms of Recombinant Protein Expression 
Several methods were applied in attempts to isolate recombinant protein from Clone II in a soluble form in order to confirm its 
DNA-binding ability. The first method (Stratagene Protocols) involved harvesting the cells (induction with IPTG at mid log 
phase, growth at 37°C for 3-4 hours), resuspension in lysis buffer (section 2.14.3.1) which was supplemented with lysozyme and 
Triton X-100 to lyse the cells, and subsequent separation of the cellular debris from the soluble proteins in the supernatant by 
centrifugation. Soluble protein extracts were analysed by SDS-PAGE and silver stained, as shown in fig (iii). Lane 1 represents 
protein molecular weight markers, lanes 2 and 3 are uninduced and induced cell extracts from the control plasmid (P-gal is shown 
by the asterisk), lanes 4 and 6 are uninduced extracts from Clone 11, whereas lanes 5 and 7 represent soluble protein extracts 
derived from induced cells of Clone 11 (recombinant protein is marked by the arrow). It appears that both the P-gal protein (lane 
3) and the protein from Clone 11 (lanes 5 and 7) are at least partially soluble. These extracts were titrated in gel shift experiments 
with the E/H fragment (see section 2.21) however the induced protein showed no DNA-binding ability (data not shown). This 
could possibly be attributed to either too much detergent present in the extract, lack of Mg2+ and Zn2+ ions during isolation, or· 
incorrect folding of the recombinant protein. These potential problems were addressed by dialysing the bacterial extracts into 
dialysis buffer (see section 2.19) containing 4 mM MgC12 and 2 mM ZnCI2, however this did not alter the DNA binding ability of 
the extracts. Several attempts to improve the isolation of soluble recombinant protein (by varying the temperature, length of 
induction, changing the expression host) were not successful, and the induction and isolation methods of soluble protein appeared 
to be unreliable, since the induced proteins could not reproducibly be detected in the supernatant. 
The purification of soluble recombinant protein was attempted by an alternative method, which exploits the fusion of recombinant 
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Fig (ii) Optimisation of Recombinant Protein Expression from Clone 11 in the pET-29b(+) Expression 
YW2r 
Recombinant expression from Clone 11 in pET-29b(+) in BL21DE3 cells was optimised by an induction time 
course over a range of temperatures (16°C, 20°C and 30°C, (a) and 37°C, (b)). Cells were grown to OD600 = 0.4 
and induced at 0 hours (lane 2 in (a) and (b)). Aliquots of induced protein from Clone 11 for each temperature ((a) 
lanes 3 - 9 (l6°C), lanes 10 - 16 (20°C), lanes 17 - 25 (30°) and (b) lanes 4 - 10 (37°C}) were removed at regular 
time intervals (0.5 - 6 hours) and analysed by 10 % SDS-PAGE with subsequent silver staining. Host cells 
containing the control plasmid coding for the ~-gal protein (see asterisk) were induced for 3 hours at 37°C (panel 
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Fig (iii) Soluble Recombinant Protein Expression from Clone 11 in the pET~29b(+) Expression Vector 
Soluble protein extracts from BL21 DE3 cells containing the Clone 11 expression construct (Janes 4 - 7) or the 
induction control plasmid (lanes 2 - 3) were analysed by 10% SDS-PAGE (silver stained). Duplicate extracts 
from induced cells containing Clone II (Janes 5 and 7) express a recombinant protein at - 25 kDa compared 
to uninduced cell extracts (lanes 4 and 6). Similarly, the ~-gal protein (marked by the asterisk, see lane 3) 
induced from the induction control plasmid, ·can be distinguished above the background of uninduced cell 
extract (lane 2). Standard molecular weight markers are indicated (lane I). 
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Manual and see section 2.14.3.2). The mid-log phase cells were subjected to standard induction conditions with ImM IPTG at 
30°C or 37°C. The cells were pelleted and resuspended in column binding buffer containing protease inhibitors (see section 
2.14.3.2). The suspension was subjected to sonication in bursts (the length and number of sonication steps was varied in order to 
optimise the release of the recombinant proteins), and several washes of the pellet in order to firstly reduce the viscosity, and 
secondly to help solubilise any recombinant protein precipitates. Remaining cell debris was removed by centrifugation. Soluble 
protein extracts containing recombinant protein from Clone II were subjected to Nickel chromatography, however the amount of 
recombinant protein that was solubilised by sonication was probably insufficient to be visualised in the Nickel column elution 
profile as analysed by SDS-PAGE. These results were confirmed by repeating the same procedure with the induced 13-gal protein. 
The successful induction of the 13-gal protein in total cell extracts is shown in the Coomassie stained SDS gel (fig (iii), lane 3). 
Repeated sonication and wash steps released more 13-gal-protein into the supernatant, these fractions were pooled and fractionated 
by Nickel column chromatography using gravity flow (see section 2.14.3.2) followed by SDS-PAGE analysis. The column was 
washed once with binding buffer and once with washing buffer. Subsequently, proteins were eluted in 15 fractions of I ml each 
using elution buffer, after which the column was stripped with a high salt solution. All the fractions collected from the column 
were TCA precipitated before analysis by 10% SDS-PAGE which was silver stained as Coomassie was not sensitive enough to 
visualise the protein bands (data not shown). Proteins eluted from the column during both the wash steps, and the remaining 
proteins eluted in fractions I - 15, however from the profile it was not possible to gage where the 13-gal protein eluted. Similar 
results were obtained for both the 13-gal control protein as well as the recombinant protein from Clone II, indicating that either 
insufficient solubilised protein was released for subsequent detection in the elution profile, or the Nickel column was prone to ion 
leaching. It is possible that Nickel is lost from the resin as a result of the wash steps, leading to the loss of the protein-metal 
complexes, or these complexes could have leached out gradually over several of the eluting fractions. These factors, together with 
the fact that the expressed recombinant proteins were not easily solubilised and released into the supernatant could all contribute 
to the fact that neither the 13-galactosidase protein nor the recombinant Clone II protein could be discerned in the elution profile. 
Therefore the recombinant protein purification was approached using a different technique, viz by first denaturing the insoluble 
recombinant proteins using denaturing agents, in order to release greater amounts of recombinant proteins. 
(d) Inclusion Body Isolation Methods 
Insoluble inclusion bodies (dense aggregates of overexpressed protein which can accumulate in the cytoplasm) may be used as a 
source for further purification of the target protein (Lin and Cheng, 1991) (186). Their dense nature allows them to be precipitated 
away from other E.coli proteins, and sometimes, depending on the nature of the protein, they can be dissociated by strong 
denaturing reagents, such as urea or guanidine HCI. The solubilised protein can then be refolded by slowly removing or diluting 
the denaturant, and the renatured protein can be further purified. 
Several methods pertaining to inclusion body isolations and renaturation of recombinant protein were applied. One method (pET 
System Manual, and section 2.14.3.3) involved resuspension of the induced cells in binding buffer (see section 2.14.3.2), followed 
by sonication of the suspension in brief bursts to aid resuspension of cells and shearing of the DNA. The resuspended cells were 
washed twice in binding buffer with subsequent resuspension in binding buffer supplemented with 6 M guanidine HCI or 6 M 
urea. Resuspension was aided by sonication, which was repeated several times in order to release more trapped proteins from the 
pelleted inclusion bodies. The suspension was incubated on ice to dissolve the proteins, and the supernatant was subsequently 
dialysed into dialysis buffer (see section 2.19) in order to remove the guanidine HCI. 
A second protocol used to isolate inclusion bodies followed the method described by Calzone et al (1991) (120) (see section 
2.14.3.3). This involved standard induction and expression of the recombinant protein, after which the cells were lysed by 
addition of lysozyme and by short bursts of sonication. The suspension was supplemented with NP-40 and sucrose, after which 
the insoluble material was removed by centrifugation. Soluble proteins were selectively precipitated with ammonium sulphate, 
and the resuspended proteins were dialysed against dialysis buffer (see section 2.19). 
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A third method of inclusion body isolation, developed to isolate active eukaryotic proteins, was outlined by Lin and Cheng (1991) 
(see section 2.14.3.3). The induced cells were pelleted and resuspended, the outer membranes were removed to form spheroplasts 
which were lysed by repeated sonication in short bursts. RNA and DNA were digested enzymatically. The crude inclusion bodies 
were pelleted and washed several times, after which they were resuspended by sonication and denatured in 5 M guanidine HCI. 
The suspension was supplemented with a large volume of buffer and the proteins were renatured overnight, and subsequently 
dialysed into the buffer of choice (dialysis buffer). 
Despite several attempts to solubilise the expressed recombinant protein by means of extensive sonication, combined with 
denaturation agents such as urea and guanidine HCI, none of the methods outlined above successfully dissociated the inclusion 
bodies containing the protein expressed from Clone II, as assessed by means of SDS-PAGE analysis. The dialysed protein 
extracts, obtained after extensive sonication of the inclusion bodies (and denaturation of the released proteins) showed no 
enrichment of the expressed recombinant protein when compared to the insoluble fraction (data not shown). The expressed 
recombinant protein remained in the insoluble fractions of the inclusion body, ie recombinant proteins could not be solubilised, 
showing that despite the denaturation I renaturation protocols these methods do not result in the successful isolation of the 
recombinant protein expressed by Clone II. 
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Appendix XV 
Recombinant Protein Expression in Eukaryotic COS Cells 
Prokaryotic gene expression lacks post-translational modifications, which may lead to incorrect folding of the protein or loss of 
biological activity of eukaryotic recombinant proteins (151), whereas eukaryotic systems effect higher stability of the target 
protein because of proper folding, activation, processing and assembly (208). An eukaryotic expression plasmid requires a SV40 
origin of replication for high copy number amplification in the host cell. It also needs an efficient promoter element for 
transcription initiation, mRNA processing signals, a polylinker for easy cloning of inserts, a selectable marker to select for stably 
integrated cells, and often expression vectors have plasmid backbone sequences which enable their propagation in bacterial cells 
(151, 208). All these requirements are met by the expression plasmid pCIS (see Appendix VIII) into which the insert from Clone 
II was cloned using the Xbal I Not/ restriction sites in the multiple cloning site. Transient eukaryotic expression is limiting, 
though, since usually only 5 - 50 % of the cell population is able to acquire and express the DNA (151 ). Expression of the protein 
will last over a period of days to several weeks, until the DNA is lost from the population. COS cells express high levels of the 
SV 40 large tumour (T) antigen which initiates replication of the expression plasmid from the SV 40 origin ( 151 ). Transfected 
DNA can be amplified to exceed I 00 000 copies of the plasmid per cell, which implies that very high recombinant expression 
levels can be achieved. Cells transfected with Clone 11 were allowed to express for 24 - 48 hours after which they were harvested 
and processed into whole cell extracts and nuclear extracts (see section 2.15). The extracts were analysed by SDS-PAGE, as 
shown in fig (iv). Whole cell extract and nuclear extract ofuntransfected cells are shown in lanes 2 and 3 respectively, whereas the 
whole cell extract and nuclear extract of transfected cells is shown in lanes 4 and 5 respectively. Several differences (marked by 
the arrows) are apparent between the total cell extracts and nuclear extJacts for both the transfected and untransfected cell 
populations, however there are no distinguishable differences between untransfected and transfected cells for either type of extract 
generated (compare lane 2 with lane 4, and lane 3 with lane 5). This was verified by analysis of the extracts in EMSAs using the 
labelled E/H probe (data not shown), which revealed no DNA-binding activity in any of the extracts shown in fig (iv). These 
results imply that either the mammalian expression system is very inefficient, possibly due to low transfection success, such that 
the expression of the recombinant protein could not be ascertained or, alternatively, the protein cannot be expressed in this host 
environment. Since the expression of the protein was not detected in the COS cells, the vector system should have been examined 
in more detail to confirm the underlying problems (151 ). For instance, the expected structure of the expression construct should 
have been reconfirmed by DNA sequencing. In addition, a positive control using the same vector with another insert (which is 
known to express reliably in the system) would be needed to determine the transfection efficiency. The expected size of the RNA, 
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Fig (iv) Eukaryotic Protein Expression of Clone 11 in COS Cells 
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Clone II was subcloned from pBluescript into pCIS an the expression construct was transfected into COS cells. 
Untransfected (lanes 2 and 3) and untransfected cells (lanes 4 and 5) were harvested after 24 - 48 hours and 
processed into total cell extracts (CE, lanes 2 and 4) and nuclear extracts (NE, lanes 3 and 5). The differences 
observed between cell extracts and nuclear extracts are marked by arrows, however there appear to be no 
differences between the extracts from untransfected and transfected cell populations (compare lane 2 with 4 and 
Jane 3 with 5). The standard molecular weight markers are indicated in lane 1. 
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